,,,,,
Input,Match type,Approved symbol,Approved name,HGNC ID,Location
MTARC1,Approved symbol,MTARC1,mitochondrial amidoxime reducing component 1,HGNC:26189,1q41
MARCHF2,Approved symbol,MARCHF2,membrane associated ring-CH-type finger 2,HGNC:28038,19p13.2
March4,Previous symbol,MARCHF4,membrane associated ring-CH-type finger 4,HGNC:29269,2q35
March7,Previous symbol,MARCHF7,membrane associated ring-CH-type finger 7,HGNC:17393,2q24.2
SEPT3,Previous symbol,SEPTIN3,septin 3,HGNC:10750,22q13.2
A1BG,Approved symbol,A1BG,alpha-1-B glycoprotein,HGNC:5,19q13.43
A2M,Approved symbol,A2M,alpha-2-macroglobulin,HGNC:7,12p13.31
A2ML1,Approved symbol,A2ML1,alpha-2-macroglobulin like 1,HGNC:23336,12p13.31
A3GALT2,Approved symbol,A3GALT2,"alpha 1,3-galactosyltransferase 2",HGNC:30005,1p35.1
AADACL3,Approved symbol,AADACL3,arylacetamide deacetylase like 3,HGNC:32037,1p36.21
AADAT,Approved symbol,AADAT,aminoadipate aminotransferase,HGNC:17929,4q33
AAK1,Approved symbol,AAK1,AP2 associated kinase 1,HGNC:19679,2p13.3
AARD,Approved symbol,AARD,alanine and arginine rich domain containing protein,HGNC:33842,8q24.11
AATK,Approved symbol,AATK,apoptosis associated tyrosine kinase,HGNC:21,17q25.3
ABCA10,Approved symbol,ABCA10,ATP binding cassette subfamily A member 10,HGNC:30,17q24.3
ABCA12,Approved symbol,ABCA12,ATP binding cassette subfamily A member 12,HGNC:14637,2q35
ABCA13,Approved symbol,ABCA13,ATP binding cassette subfamily A member 13,HGNC:14638,7p12.3
ABCA2,Approved symbol,ABCA2,ATP binding cassette subfamily A member 2,HGNC:32,9q34.3
ABCA4,Approved symbol,ABCA4,ATP binding cassette subfamily A member 4,HGNC:34,1p22.1
ABCA6,Approved symbol,ABCA6,ATP binding cassette subfamily A member 6,HGNC:36,17q24.2-q24.3
ABCB1,Approved symbol,ABCB1,ATP binding cassette subfamily B member 1,HGNC:40,7q21.12
ABCB10,Approved symbol,ABCB10,ATP binding cassette subfamily B member 10,HGNC:41,1q42.13
ABCB5,Approved symbol,ABCB5,ATP binding cassette subfamily B member 5,HGNC:46,7p21.1
ABCB7,Approved symbol,ABCB7,ATP binding cassette subfamily B member 7,HGNC:48,Xq13.3
ABCB8,Approved symbol,ABCB8,ATP binding cassette subfamily B member 8,HGNC:49,7q36.1
ABCB9,Approved symbol,ABCB9,ATP binding cassette subfamily B member 9,HGNC:50,12q24.31
ABCC11,Approved symbol,ABCC11,ATP binding cassette subfamily C member 11,HGNC:14639,16q12.1
ABCC12,Approved symbol,ABCC12,ATP binding cassette subfamily C member 12,HGNC:14640,16q12.1
ABCC2,Approved symbol,ABCC2,ATP binding cassette subfamily C member 2,HGNC:53,10q24.2
ABCC3,Approved symbol,ABCC3,ATP binding cassette subfamily C member 3,HGNC:54,17q21.33
ABCC5,Approved symbol,ABCC5,ATP binding cassette subfamily C member 5,HGNC:56,3q27.1
ABCC6,Approved symbol,ABCC6,ATP binding cassette subfamily C member 6,HGNC:57,16p13.11
ABCC8,Approved symbol,ABCC8,ATP binding cassette subfamily C member 8,HGNC:59,11p15.1
ABCC9,Approved symbol,ABCC9,ATP binding cassette subfamily C member 9,HGNC:60,12p12.1
ABCD3,Approved symbol,ABCD3,ATP binding cassette subfamily D member 3,HGNC:67,1p21.3
ABCF2,Approved symbol,ABCF2,ATP binding cassette subfamily F member 2,HGNC:71,7q36.1
ABCG2,Approved symbol,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),HGNC:74,4q22.1
ABCG4,Approved symbol,ABCG4,ATP binding cassette subfamily G member 4,HGNC:13884,11q23.3
ABHD10,Approved symbol,ABHD10,"abhydrolase domain containing 10, depalmitoylase",HGNC:25656,3q13.2
ABHD13,Approved symbol,ABHD13,abhydrolase domain containing 13,HGNC:20293,13q33.3
ABHD16A,Approved symbol,ABHD16A,"abhydrolase domain containing 16A, phospholipase",HGNC:13921,6p21.33
ABHD8,Approved symbol,ABHD8,abhydrolase domain containing 8,HGNC:23759,19p13.11
ABLIM3,Approved symbol,ABLIM3,actin binding LIM protein family member 3,HGNC:29132,5q32
ABR,Approved symbol,ABR,ABR activator of RhoGEF and GTPase,HGNC:81,17p13.3
ABT1,Approved symbol,ABT1,activator of basal transcription 1,HGNC:17369,6p22.2
AC003090.1,Unmatched,,,,
ZNF8,Approved symbol,ZNF8,zinc finger protein 8,HGNC:13154,19q13.43
AC011525.2,Unmatched,,,,
AC018696.1,Unmatched,,,,
AC026150.6,Unmatched,,,,
AC073343.13,Unmatched,,,,
CROCC2,Approved symbol,CROCC2,"ciliary rootlet coiled-coil, rootletin family member 2",HGNC:51677,2q37.3
MAGEL2,Approved symbol,MAGEL2,MAGE family member L2,HGNC:6814,15q11.2
ACACA,Approved symbol,ACACA,acetyl-CoA carboxylase alpha,HGNC:84,17q12
ACACB,Approved symbol,ACACB,acetyl-CoA carboxylase beta,HGNC:85,12q24.11
ACAD8,Approved symbol,ACAD8,acyl-CoA dehydrogenase family member 8,HGNC:87,11q25
ACADS,Approved symbol,ACADS,acyl-CoA dehydrogenase short chain,HGNC:90,12q24.31
ACAN,Approved symbol,ACAN,aggrecan,HGNC:319,15q26.1
ACAP3,Approved symbol,ACAP3,"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3",HGNC:16754,1p36.33
ACBD3,Approved symbol,ACBD3,acyl-CoA binding domain containing 3,HGNC:15453,1q42.12
ACE,Approved symbol,ACE,angiotensin I converting enzyme,HGNC:2707,17q23.3
ACE2,Approved symbol,ACE2,angiotensin converting enzyme 2,HGNC:13557,Xp22.2
ACKR2,Approved symbol,ACKR2,atypical chemokine receptor 2,HGNC:1565,3p22.1
ACKR3,Approved symbol,ACKR3,atypical chemokine receptor 3,HGNC:23692,2q37.3
ACO2,Approved symbol,ACO2,aconitase 2,HGNC:118,22q13.2
ACOX2,Approved symbol,ACOX2,acyl-CoA oxidase 2,HGNC:120,3p14.3
ACOX3,Approved symbol,ACOX3,"acyl-CoA oxidase 3, pristanoyl",HGNC:121,4p16.1
ACP1,Approved symbol,ACP1,acid phosphatase 1,HGNC:122,2p25.3
ACP1,Alias symbol,NDUFAB1,NADH:ubiquinone oxidoreductase subunit AB1,HGNC:7694,16p12.2
ACP2,Approved symbol,ACP2,"acid phosphatase 2, lysosomal",HGNC:123,11p11.2
ACRC,Previous symbol,GCNA,germ cell nuclear acidic peptidase,HGNC:15805,Xq13.1
ACSF3,Approved symbol,ACSF3,acyl-CoA synthetase family member 3,HGNC:27288,16q24.3
ACSL6,Approved symbol,ACSL6,acyl-CoA synthetase long chain family member 6,HGNC:16496,5q31.1
ACSM2B,Approved symbol,ACSM2B,acyl-CoA synthetase medium chain family member 2B,HGNC:30931,16p12.3
ACSM4,Approved symbol,ACSM4,acyl-CoA synthetase medium chain family member 4,HGNC:32016,12p13.31
ACSM5,Approved symbol,ACSM5,acyl-CoA synthetase medium chain family member 5,HGNC:26060,16p12.3
ACSS3,Approved symbol,ACSS3,acyl-CoA synthetase short chain family member 3,HGNC:24723,12q21.31
ACTB,Approved symbol,ACTB,actin beta,HGNC:132,7p22.1
ACTC1,Approved symbol,ACTC1,actin alpha cardiac muscle 1,HGNC:143,15q14
ACTL7B,Approved symbol,ACTL7B,actin like 7B,HGNC:162,9q31.3
ACTN2,Approved symbol,ACTN2,actinin alpha 2,HGNC:164,1q43
ACTN4,Approved symbol,ACTN4,actinin alpha 4,HGNC:166,19q13.2
ACTR8,Approved symbol,ACTR8,actin related protein 8,HGNC:14672,3p21.1
ACVR1,Approved symbol,ACVR1,activin A receptor type 1,HGNC:171,2q24.1
ADAD1,Approved symbol,ADAD1,adenosine deaminase domain containing 1,HGNC:30713,4q27
ADAD2,Approved symbol,ADAD2,adenosine deaminase domain containing 2,HGNC:30714,16q24.1
ADAM11,Approved symbol,ADAM11,ADAM metallopeptidase domain 11,HGNC:189,17q21.31
ADAM12,Approved symbol,ADAM12,ADAM metallopeptidase domain 12,HGNC:190,10q26.2
ADAM2,Approved symbol,ADAM2,ADAM metallopeptidase domain 2,HGNC:198,8p11.22
ADAM23,Approved symbol,ADAM23,ADAM metallopeptidase domain 23,HGNC:202,2q33.3
ADAM23,Alias symbol,ADAM28,ADAM metallopeptidase domain 28,HGNC:206,8p21.2
ADAM28,Approved symbol,ADAM28,ADAM metallopeptidase domain 28,HGNC:206,8p21.2
ADAM29,Approved symbol,ADAM29,ADAM metallopeptidase domain 29,HGNC:207,4q34.1
ADAM32,Approved symbol,ADAM32,ADAM metallopeptidase domain 32,HGNC:15479,8p11.22
ADAM9,Approved symbol,ADAM9,ADAM metallopeptidase domain 9,HGNC:216,8p11.22
ADAMDEC1,Approved symbol,ADAMDEC1,ADAM like decysin 1,HGNC:16299,8p21.2
ADAMTS1,Approved symbol,ADAMTS1,ADAM metallopeptidase with thrombospondin type 1 motif 1,HGNC:217,21q21.3
ADAMTS10,Approved symbol,ADAMTS10,ADAM metallopeptidase with thrombospondin type 1 motif 10,HGNC:13201,19p13.2
ADAMTS12,Approved symbol,ADAMTS12,ADAM metallopeptidase with thrombospondin type 1 motif 12,HGNC:14605,5p13.3-p13.2
ADAMTS13,Approved symbol,ADAMTS13,ADAM metallopeptidase with thrombospondin type 1 motif 13,HGNC:1366,9q34.2
ADAMTS14,Approved symbol,ADAMTS14,ADAM metallopeptidase with thrombospondin type 1 motif 14,HGNC:14899,10q22.1
ADAMTS15,Approved symbol,ADAMTS15,ADAM metallopeptidase with thrombospondin type 1 motif 15,HGNC:16305,11q24.3
ADAMTS16,Approved symbol,ADAMTS16,ADAM metallopeptidase with thrombospondin type 1 motif 16,HGNC:17108,5p15.32
ADAMTS17,Approved symbol,ADAMTS17,ADAM metallopeptidase with thrombospondin type 1 motif 17,HGNC:17109,15q26.3
ADAMTS18,Approved symbol,ADAMTS18,ADAM metallopeptidase with thrombospondin type 1 motif 18,HGNC:17110,16q23.1
ADAMTS19,Approved symbol,ADAMTS19,ADAM metallopeptidase with thrombospondin type 1 motif 19,HGNC:17111,5q23.3
ADAMTS2,Approved symbol,ADAMTS2,ADAM metallopeptidase with thrombospondin type 1 motif 2,HGNC:218,5q35.3
ADAMTS20,Approved symbol,ADAMTS20,ADAM metallopeptidase with thrombospondin type 1 motif 20,HGNC:17178,12q12
ADAMTS4,Approved symbol,ADAMTS4,ADAM metallopeptidase with thrombospondin type 1 motif 4,HGNC:220,1q23.3
ADAMTS6,Approved symbol,ADAMTS6,ADAM metallopeptidase with thrombospondin type 1 motif 6,HGNC:222,5q12.3
ADAMTS7,Approved symbol,ADAMTS7,ADAM metallopeptidase with thrombospondin type 1 motif 7,HGNC:223,15q25.1
ADAP1,Approved symbol,ADAP1,ArfGAP with dual PH domains 1,HGNC:16486,7p22.3
ADAR,Approved symbol,ADAR,adenosine deaminase RNA specific,HGNC:225,1q21.3
ADARB1,Approved symbol,ADARB1,adenosine deaminase RNA specific B1,HGNC:226,21q22.3
ADARB2,Approved symbol,ADARB2,adenosine deaminase RNA specific B2 (inactive),HGNC:227,10p15.3
ADAT3,Approved symbol,ADAT3,adenosine deaminase tRNA specific 3,HGNC:25151,19p13.3
ADCK4,Previous symbol,COQ8B,coenzyme Q8B,HGNC:19041,19q13.2
ADCY1,Approved symbol,ADCY1,adenylate cyclase 1,HGNC:232,7p12.3
ADCY2,Approved symbol,ADCY2,adenylate cyclase 2,HGNC:233,5p15.31
ADCY3,Approved symbol,ADCY3,adenylate cyclase 3,HGNC:234,2p23.3
ADCY3,Previous symbol,ADCY8,adenylate cyclase 8,HGNC:239,8q24.22
ADCY5,Approved symbol,ADCY5,adenylate cyclase 5,HGNC:236,3q21.1
ADCY6,Approved symbol,ADCY6,adenylate cyclase 6,HGNC:237,12q13.12
ADCY8,Approved symbol,ADCY8,adenylate cyclase 8,HGNC:239,8q24.22
ADCY9,Approved symbol,ADCY9,adenylate cyclase 9,HGNC:240,16p13.3
ADCYAP1,Approved symbol,ADCYAP1,adenylate cyclase activating polypeptide 1,HGNC:241,18p11.32
ADH7,Approved symbol,ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",HGNC:256,4q23
ADNP2,Approved symbol,ADNP2,ADNP homeobox 2,HGNC:23803,18q23
ADRA1A,Approved symbol,ADRA1A,adrenoceptor alpha 1A,HGNC:277,8p21.2
ADRA1A,Alias symbol,ADRA1D,adrenoceptor alpha 1D,HGNC:280,20p13
ADRA1B,Approved symbol,ADRA1B,adrenoceptor alpha 1B,HGNC:278,5q33.3
ADRA1D,Approved symbol,ADRA1D,adrenoceptor alpha 1D,HGNC:280,20p13
ADRA2B,Approved symbol,ADRA2B,adrenoceptor alpha 2B,HGNC:282,2q11.2
ADRBK1,Previous symbol,GRK2,G protein-coupled receptor kinase 2,HGNC:289,11q13.2
ADSS,Previous symbol,ADSS2,adenylosuccinate synthase 2,HGNC:292,1q44
AFAP1L1,Approved symbol,AFAP1L1,actin filament associated protein 1 like 1,HGNC:26714,5q32
AGAP1,Approved symbol,AGAP1,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1",HGNC:16922,2q37.2
AGAP2,Approved symbol,AGAP2,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2",HGNC:16921,12q14.1
AGAP3,Approved symbol,AGAP3,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 3",HGNC:16923,7q36.1
AGO2,Approved symbol,AGO2,argonaute RISC catalytic component 2,HGNC:3263,8q24.3
AGR2,Approved symbol,AGR2,"anterior gradient 2, protein disulphide isomerase family member",HGNC:328,7p21.1
AGTPBP1,Approved symbol,AGTPBP1,ATP/GTP binding carboxypeptidase 1,HGNC:17258,9q21.33
AGTR2,Approved symbol,AGTR2,angiotensin II receptor type 2,HGNC:338,Xq23
AGXT,Approved symbol,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,HGNC:341,2q37.3
AHDC1,Approved symbol,AHDC1,AT-hook DNA binding motif containing 1,HGNC:25230,1p36.11-p35.3
AHNAK,Approved symbol,AHNAK,AHNAK nucleoprotein,HGNC:347,11q12.3
AHNAK2,Approved symbol,AHNAK2,AHNAK nucleoprotein 2,HGNC:20125,14q32.33
AHSA1,Approved symbol,AHSA1,activator of HSP90 ATPase activity 1,HGNC:1189,14q24.3
AHSG,Approved symbol,AHSG,alpha 2-HS glycoprotein,HGNC:349,3q27.3
AIMP1,Approved symbol,AIMP1,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,HGNC:10648,4q24
AIP,Approved symbol,AIP,aryl hydrocarbon receptor interacting protein,HGNC:358,11q13.2
AIP,Alias symbol,AURKAIP1,aurora kinase A interacting protein 1,HGNC:24114,1p36.33
AIPL1,Approved symbol,AIPL1,aryl hydrocarbon receptor interacting protein like 1,HGNC:359,17p13.2
AJAP1,Approved symbol,AJAP1,adherens junctions associated protein 1,HGNC:30801,1p36.32
AK5,Approved symbol,AK5,adenylate kinase 5,HGNC:365,1p31.1
AK8,Approved symbol,AK8,adenylate kinase 8,HGNC:26526,9q34.13
AKAP13,Approved symbol,AKAP13,A-kinase anchoring protein 13,HGNC:371,15q25.3
AKAP14,Approved symbol,AKAP14,A-kinase anchoring protein 14,HGNC:24061,Xq24
AKNA,Approved symbol,AKNA,AT-hook transcription factor,HGNC:24108,9q32
AKNAD1,Approved symbol,AKNAD1,AKNA domain containing 1,HGNC:28398,1p13.3
AKR1D1,Approved symbol,AKR1D1,aldo-keto reductase family 1 member D1,HGNC:388,7q33
AKT1S1,Approved symbol,AKT1S1,AKT1 substrate 1,HGNC:28426,19q13.33
AKT3,Approved symbol,AKT3,AKT serine/threonine kinase 3,HGNC:393,1q43-q44
AL354898.1,Unmatched,,,,
AL359538.2,Unmatched,,,,
ALAS1,Approved symbol,ALAS1,5'-aminolevulinate synthase 1,HGNC:396,3p21.2
ALCAM,Approved symbol,ALCAM,activated leukocyte cell adhesion molecule,HGNC:400,3q13.11
ALDH16A1,Approved symbol,ALDH16A1,aldehyde dehydrogenase 16 family member A1,HGNC:28114,19q13.33
ALDH18A1,Approved symbol,ALDH18A1,aldehyde dehydrogenase 18 family member A1,HGNC:9722,10q24.1
ALDH1A2,Approved symbol,ALDH1A2,aldehyde dehydrogenase 1 family member A2,HGNC:15472,15q21.3
ALDH1B1,Approved symbol,ALDH1B1,aldehyde dehydrogenase 1 family member B1,HGNC:407,9p13.1
ALK,Approved symbol,ALK,ALK receptor tyrosine kinase,HGNC:427,2p23.2-p23.1
ALKBH2,Approved symbol,ALKBH2,"alkB homolog 2, alpha-ketoglutarate dependent dioxygenase",HGNC:32487,12q24.11
ALMS1,Approved symbol,ALMS1,ALMS1 centrosome and basal body associated protein,HGNC:428,2p13.1
ALOX12,Approved symbol,ALOX12,"arachidonate 12-lipoxygenase, 12S type",HGNC:429,17p13.1
ALOX15B,Approved symbol,ALOX15B,arachidonate 15-lipoxygenase type B,HGNC:434,17p13.1
ALPPL2,Previous symbol,ALPG,"alkaline phosphatase, germ cell",HGNC:441,2q37.1
ALS2,Approved symbol,ALS2,alsin Rho guanine nucleotide exchange factor ALS2,HGNC:443,2q33.1
AMER1,Approved symbol,AMER1,APC membrane recruitment protein 1,HGNC:26837,Xq11.2
AMER2,Approved symbol,AMER2,APC membrane recruitment protein 2,HGNC:26360,13q12.13
AMER3,Approved symbol,AMER3,APC membrane recruitment protein 3,HGNC:26771,2q21.1
AMH,Approved symbol,AMH,anti-Mullerian hormone,HGNC:464,19p13.3
AMPD1,Approved symbol,AMPD1,adenosine monophosphate deaminase 1,HGNC:468,1p13.2
AMPD3,Approved symbol,AMPD3,adenosine monophosphate deaminase 3,HGNC:470,11p15.4
AMZ1,Approved symbol,AMZ1,archaelysin family metallopeptidase 1,HGNC:22231,7p22.3
ANAPC5,Approved symbol,ANAPC5,anaphase promoting complex subunit 5,HGNC:15713,12q24.31
ANAPC7,Approved symbol,ANAPC7,anaphase promoting complex subunit 7,HGNC:17380,12q24.11
ANGPT1,Approved symbol,ANGPT1,angiopoietin 1,HGNC:484,8q23.1
ANGPTL3,Approved symbol,ANGPTL3,angiopoietin like 3,HGNC:491,1p31.3
ANGPTL4,Approved symbol,ANGPTL4,angiopoietin like 4,HGNC:16039,19p13.2
ANK1,Approved symbol,ANK1,ankyrin 1,HGNC:492,8p11.21
ANK2,Approved symbol,ANK2,ankyrin 2,HGNC:493,4q25-q26
ANKDD1A,Approved symbol,ANKDD1A,ankyrin repeat and death domain containing 1A,HGNC:28002,15q22.31
ANKFY1,Approved symbol,ANKFY1,ankyrin repeat and FYVE domain containing 1,HGNC:20763,17p13.2
ANKH,Approved symbol,ANKH,ANKH inorganic pyrophosphate transport regulator,HGNC:15492,5p15.2
ANKHD1,Approved symbol,ANKHD1,ankyrin repeat and KH domain containing 1,HGNC:24714,5q31.3
ANKIB1,Approved symbol,ANKIB1,ankyrin repeat and IBR domain containing 1,HGNC:22215,7q21.2
ANKK1,Approved symbol,ANKK1,ankyrin repeat and kinase domain containing 1,HGNC:21027,11q23.2
ANKLE1,Approved symbol,ANKLE1,ankyrin repeat and LEM domain containing 1,HGNC:26812,19p13.11
ANKLE2,Approved symbol,ANKLE2,ankyrin repeat and LEM domain containing 2,HGNC:29101,12q24.33
ANKMY2,Approved symbol,ANKMY2,ankyrin repeat and MYND domain containing 2,HGNC:25370,7p21.1
ANKRA2,Approved symbol,ANKRA2,ankyrin repeat family A member 2,HGNC:13208,5q13.2
ANKRD17,Approved symbol,ANKRD17,ankyrin repeat domain 17,HGNC:23575,4q13.3
ANKRD24,Approved symbol,ANKRD24,ankyrin repeat domain 24,HGNC:29424,19p13.3
ANKRD26,Approved symbol,ANKRD26,ankyrin repeat domain containing 26,HGNC:29186,10p12.1
ANKRD27,Approved symbol,ANKRD27,ankyrin repeat domain 27,HGNC:25310,19q13.11
ANKRD28,Approved symbol,ANKRD28,ankyrin repeat domain 28,HGNC:29024,3p25.1
ANKRD30A,Approved symbol,ANKRD30A,ankyrin repeat domain 30A,HGNC:17234,10p11.21
ANKRD30B,Approved symbol,ANKRD30B,ankyrin repeat domain 30B,HGNC:24165,18p11.21
ANKRD34B,Approved symbol,ANKRD34B,ankyrin repeat domain 34B,HGNC:33736,5q14.1
ANKRD36B,Approved symbol,ANKRD36B,ankyrin repeat domain 36B,HGNC:29333,2q11.2
ANKRD42,Approved symbol,ANKRD42,ankyrin repeat domain 42,HGNC:26752,11q14.1
ANKRD54,Approved symbol,ANKRD54,ankyrin repeat domain 54,HGNC:25185,22q13.1
ANKRD61,Approved symbol,ANKRD61,ankyrin repeat domain 61,HGNC:22467,7p22.1
ANKRD62,Approved symbol,ANKRD62,ankyrin repeat domain 62,HGNC:35241,18p11.21
ANKS1A,Approved symbol,ANKS1A,ankyrin repeat and sterile alpha motif domain containing 1A,HGNC:20961,6p21.31
ANKS1B,Approved symbol,ANKS1B,ankyrin repeat and sterile alpha motif domain containing 1B,HGNC:24600,12q23.1
ANO4,Approved symbol,ANO4,anoctamin 4,HGNC:23837,12q23.1
ANO7,Approved symbol,ANO7,anoctamin 7,HGNC:31677,2q37.3
ANO8,Approved symbol,ANO8,anoctamin 8,HGNC:29329,19p13.11
ANPEP,Approved symbol,ANPEP,"alanyl aminopeptidase, membrane",HGNC:500,15q26.1
ANTXR2,Approved symbol,ANTXR2,ANTXR cell adhesion molecule 2,HGNC:21732,4q21.21
ANXA5,Approved symbol,ANXA5,annexin A5,HGNC:543,4q27
ANXA6,Approved symbol,ANXA6,annexin A6,HGNC:544,5q33.1
AP1S2,Approved symbol,AP1S2,adaptor related protein complex 1 subunit sigma 2,HGNC:560,Xp22.2
AP2B1,Approved symbol,AP2B1,adaptor related protein complex 2 subunit beta 1,HGNC:563,17q12
AP2M1,Approved symbol,AP2M1,adaptor related protein complex 2 subunit mu 1,HGNC:564,3q27.1
AP3B1,Approved symbol,AP3B1,adaptor related protein complex 3 subunit beta 1,HGNC:566,5q14.1
AP3M1,Approved symbol,AP3M1,adaptor related protein complex 3 subunit mu 1,HGNC:569,10q22.2
AP3S1,Approved symbol,AP3S1,adaptor related protein complex 3 subunit sigma 1,HGNC:2013,5q22.3-q23.1
AP3S2,Approved symbol,AP3S2,adaptor related protein complex 3 subunit sigma 2,HGNC:571,15q26.1
AP5Z1,Approved symbol,AP5Z1,adaptor related protein complex 5 subunit zeta 1,HGNC:22197,7p22.1
APBA1,Approved symbol,APBA1,amyloid beta precursor protein binding family A member 1,HGNC:578,9q21.12
APBA2,Approved symbol,APBA2,amyloid beta precursor protein binding family A member 2,HGNC:579,15q13.1
APBA3,Approved symbol,APBA3,amyloid beta precursor protein binding family A member 3,HGNC:580,19p13.3
APBB1IP,Approved symbol,APBB1IP,amyloid beta precursor protein binding family B member 1 interacting protein,HGNC:17379,10p12.1
APBB3,Approved symbol,APBB3,amyloid beta precursor protein binding family B member 3,HGNC:20708,5q31.3
APC,Approved symbol,APC,APC regulator of WNT signaling pathway,HGNC:583,5q22.2
APEX2,Approved symbol,APEX2,apurinic/apyrimidinic endodeoxyribonuclease 2,HGNC:17889,Xp11.21
APLNR,Approved symbol,APLNR,apelin receptor,HGNC:339,11q12.1
APLP1,Approved symbol,APLP1,amyloid beta precursor like protein 1,HGNC:597,19q13.12
APMAP,Approved symbol,APMAP,adipocyte plasma membrane associated protein,HGNC:13238,20p11.21
APOA5,Approved symbol,APOA5,apolipoprotein A5,HGNC:17288,11q23.3
APOB,Approved symbol,APOB,apolipoprotein B,HGNC:603,2p24.1
APOL1,Approved symbol,APOL1,apolipoprotein L1,HGNC:618,22q12.3
APOLD1,Approved symbol,APOLD1,apolipoprotein L domain containing 1,HGNC:25268,12p13.1
AQP11,Approved symbol,AQP11,aquaporin 11,HGNC:19940,11q14.1
AQPEP,Alias symbol,LVRN,laeverin,HGNC:26904,5q23.1
AR,Approved symbol,AR,androgen receptor,HGNC:644,Xq12
AR,Alias symbol,AKR1B1,aldo-keto reductase family 1 member B,HGNC:381,7q33
ARAP1,Approved symbol,ARAP1,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1",HGNC:16925,11q13.4
ARAP2,Approved symbol,ARAP2,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2",HGNC:16924,4p14
ARAP3,Approved symbol,ARAP3,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3",HGNC:24097,5q31.3
AREL1,Approved symbol,AREL1,apoptosis resistant E3 ubiquitin protein ligase 1,HGNC:20363,14q24.3
ARF6,Approved symbol,ARF6,ADP ribosylation factor 6,HGNC:659,14q21.3
ARFGAP1,Approved symbol,ARFGAP1,ADP ribosylation factor GTPase activating protein 1,HGNC:15852,20q13.33
ARFGAP1,Previous symbol,ARFGAP3,ADP ribosylation factor GTPase activating protein 3,HGNC:661,22q13.2
ARFGAP2,Approved symbol,ARFGAP2,ADP ribosylation factor GTPase activating protein 2,HGNC:13504,11p11.2
ARFGEF1,Approved symbol,ARFGEF1,ADP ribosylation factor guanine nucleotide exchange factor 1,HGNC:15772,8q13.2
ARGLU1,Approved symbol,ARGLU1,arginine and glutamate rich 1,HGNC:25482,13q33.3
ARHGAP12,Approved symbol,ARHGAP12,Rho GTPase activating protein 12,HGNC:16348,10p11.22
ARHGAP21,Approved symbol,ARHGAP21,Rho GTPase activating protein 21,HGNC:23725,10p12.1
ARHGAP22,Approved symbol,ARHGAP22,Rho GTPase activating protein 22,HGNC:30320,10q11.22-q11.23
ARHGAP23,Approved symbol,ARHGAP23,Rho GTPase activating protein 23,HGNC:29293,17q12
ARHGAP26,Approved symbol,ARHGAP26,Rho GTPase activating protein 26,HGNC:17073,5q31.3
ARHGAP28,Approved symbol,ARHGAP28,Rho GTPase activating protein 28,HGNC:25509,18p11.31
ARHGAP30,Approved symbol,ARHGAP30,Rho GTPase activating protein 30,HGNC:27414,1q23.3
ARHGAP32,Approved symbol,ARHGAP32,Rho GTPase activating protein 32,HGNC:17399,11q24.3
ARHGAP36,Approved symbol,ARHGAP36,Rho GTPase activating protein 36,HGNC:26388,Xq26.1
ARHGAP39,Approved symbol,ARHGAP39,Rho GTPase activating protein 39,HGNC:29351,8q24.3
ARHGAP40,Approved symbol,ARHGAP40,Rho GTPase activating protein 40,HGNC:16226,20q11.23
ARHGAP44,Approved symbol,ARHGAP44,Rho GTPase activating protein 44,HGNC:29096,17p12
ARHGEF10,Approved symbol,ARHGEF10,Rho guanine nucleotide exchange factor 10,HGNC:14103,8p23.3
ARHGEF10L,Approved symbol,ARHGEF10L,Rho guanine nucleotide exchange factor 10 like,HGNC:25540,1p36.13
ARHGEF11,Approved symbol,ARHGEF11,Rho guanine nucleotide exchange factor 11,HGNC:14580,1q23.1
ARHGEF12,Approved symbol,ARHGEF12,Rho guanine nucleotide exchange factor 12,HGNC:14193,11q23.3
ARHGEF15,Approved symbol,ARHGEF15,Rho guanine nucleotide exchange factor 15,HGNC:15590,17p13.1
ARHGEF17,Approved symbol,ARHGEF17,Rho guanine nucleotide exchange factor 17,HGNC:21726,11q13.4
ARHGEF18,Approved symbol,ARHGEF18,Rho/Rac guanine nucleotide exchange factor 18,HGNC:17090,19p13.2
ARHGEF25,Approved symbol,ARHGEF25,Rho guanine nucleotide exchange factor 25,HGNC:30275,12q13.3
ARHGEF26,Approved symbol,ARHGEF26,Rho guanine nucleotide exchange factor 26,HGNC:24490,3q25.2
ARHGEF3,Approved symbol,ARHGEF3,Rho guanine nucleotide exchange factor 3,HGNC:683,3p14.3
ARHGEF33,Approved symbol,ARHGEF33,Rho guanine nucleotide exchange factor 33,HGNC:37252,2p22.1
ARHGEF4,Approved symbol,ARHGEF4,Rho guanine nucleotide exchange factor 4,HGNC:684,2q21.1
ARHGEF7,Approved symbol,ARHGEF7,Rho guanine nucleotide exchange factor 7,HGNC:15607,13q34
ARID1A,Approved symbol,ARID1A,AT-rich interaction domain 1A,HGNC:11110,1p36.11
ARID1B,Approved symbol,ARID1B,AT-rich interaction domain 1B,HGNC:18040,6q25.3
ARID3B,Approved symbol,ARID3B,AT-rich interaction domain 3B,HGNC:14350,15q24.1
ARID4B,Approved symbol,ARID4B,AT-rich interaction domain 4B,HGNC:15550,1q42.3
ARL13A,Approved symbol,ARL13A,ADP ribosylation factor like GTPase 13A,HGNC:31709,Xq22.1
ARL17A,Approved symbol,ARL17A,ADP ribosylation factor like GTPase 17A,HGNC:24096,17q21.31
ARL3,Approved symbol,ARL3,ADP ribosylation factor like GTPase 3,HGNC:694,10q24.32
ARL6IP4,Approved symbol,ARL6IP4,ADP ribosylation factor like GTPase 6 interacting protein 4,HGNC:18076,12q24.31
ARL6IP6,Approved symbol,ARL6IP6,ADP ribosylation factor like GTPase 6 interacting protein 6,HGNC:24048,2q23.3
ARMC1,Approved symbol,ARMC1,armadillo repeat containing 1,HGNC:17684,8q13.1
ARMC12,Approved symbol,ARMC12,armadillo repeat containing 12,HGNC:21099,6p21.31
ARMC2,Approved symbol,ARMC2,armadillo repeat containing 2,HGNC:23045,6q21
ARMC4,Previous symbol,ODAD2,outer dynein arm docking complex subunit 2,HGNC:25583,10p12.1
ARMCX5,Approved symbol,ARMCX5,armadillo repeat containing X-linked 5,HGNC:25772,Xq22.1
ARPC3,Approved symbol,ARPC3,actin related protein 2/3 complex subunit 3,HGNC:706,12q24.11
ARPP21,Approved symbol,ARPP21,cAMP regulated phosphoprotein 21,HGNC:16968,3p22.3
ARRB2,Approved symbol,ARRB2,arrestin beta 2,HGNC:712,17p13.2
ARSD,Approved symbol,ARSD,arylsulfatase D,HGNC:717,Xp22.33
ARSF,Approved symbol,ARSF,arylsulfatase F,HGNC:721,Xp22.33
ART5,Approved symbol,ART5,ADP-ribosyltransferase 5,HGNC:24049,11p15.4
ASAP1,Approved symbol,ASAP1,"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1",HGNC:2720,8q24.21-q24.22
ASB10,Approved symbol,ASB10,ankyrin repeat and SOCS box containing 10,HGNC:17185,7q36.1
ASB12,Approved symbol,ASB12,ankyrin repeat and SOCS box containing 12,HGNC:19763,Xq11.2
ASB14,Approved symbol,ASB14,ankyrin repeat and SOCS box containing 14,HGNC:19766,3p14.3
ASB17,Approved symbol,ASB17,ankyrin repeat and SOCS box containing 17,HGNC:19769,1p31.1
ASB8,Approved symbol,ASB8,ankyrin repeat and SOCS box containing 8,HGNC:17183,12q13.11
ASCL1,Approved symbol,ASCL1,achaete-scute family bHLH transcription factor 1,HGNC:738,12q23.2
ASPH,Approved symbol,ASPH,aspartate beta-hydroxylase,HGNC:757,8q12.3
ASPHD2,Approved symbol,ASPHD2,aspartate beta-hydroxylase domain containing 2,HGNC:30437,22q12.1
ASPM,Approved symbol,ASPM,assembly factor for spindle microtubules,HGNC:19048,1q31.3
ASRGL1,Approved symbol,ASRGL1,asparaginase and isoaspartyl peptidase 1,HGNC:16448,11q12.3
ASTE1,Approved symbol,ASTE1,asteroid homolog 1,HGNC:25021,3q22.1
ASTN1,Approved symbol,ASTN1,astrotactin 1,HGNC:773,1q25.2
ASTN2,Approved symbol,ASTN2,astrotactin 2,HGNC:17021,9q33.1
ATAD1,Approved symbol,ATAD1,ATPase family AAA domain containing 1,HGNC:25903,10q23.31
ATAD2B,Approved symbol,ATAD2B,ATPase family AAA domain containing 2B,HGNC:29230,2p24.1-p23.3
ATAD3B,Approved symbol,ATAD3B,ATPase family AAA domain containing 3B,HGNC:24007,1p36.33
ATAD5,Approved symbol,ATAD5,ATPase family AAA domain containing 5,HGNC:25752,17q11.2
ATAT1,Approved symbol,ATAT1,alpha tubulin acetyltransferase 1,HGNC:21186,6p21.33
ATE1,Approved symbol,ATE1,arginyltransferase 1,HGNC:782,10q26.13
ATF6,Approved symbol,ATF6,activating transcription factor 6,HGNC:791,1q23.3
ATF6B,Approved symbol,ATF6B,activating transcription factor 6 beta,HGNC:2349,6p21.3
ATF7IP,Approved symbol,ATF7IP,activating transcription factor 7 interacting protein,HGNC:20092,12p13.1
ATG13,Approved symbol,ATG13,autophagy related 13,HGNC:29091,11p11.2
ATG16L2,Approved symbol,ATG16L2,autophagy related 16 like 2,HGNC:25464,11q13.4
ATG4A,Approved symbol,ATG4A,autophagy related 4A cysteine peptidase,HGNC:16489,Xq22.3
ATM,Approved symbol,ATM,ATM serine/threonine kinase,HGNC:795,11q22.3
ATMIN,Approved symbol,ATMIN,ATM interactor,HGNC:29034,16q23.2
ATOH1,Approved symbol,ATOH1,atonal bHLH transcription factor 1,HGNC:797,4q22.2
ATOH8,Approved symbol,ATOH8,atonal bHLH transcription factor 8,HGNC:24126,2p11.2
ATP10A,Approved symbol,ATP10A,ATPase phospholipid transporting 10A (putative),HGNC:13542,15q12
ATP10B,Approved symbol,ATP10B,ATPase phospholipid transporting 10B (putative),HGNC:13543,5q34
ATP11B,Approved symbol,ATP11B,ATPase phospholipid transporting 11B (putative),HGNC:13553,3q26.33
ATP12A,Approved symbol,ATP12A,ATPase H+/K+ transporting non-gastric alpha2 subunit,HGNC:13816,13q12.12
ATP13A1,Approved symbol,ATP13A1,ATPase 13A1,HGNC:24215,19p13.11
ATP13A3,Approved symbol,ATP13A3,ATPase 13A3,HGNC:24113,3q29
ATP1A2,Approved symbol,ATP1A2,ATPase Na+/K+ transporting subunit alpha 2,HGNC:800,1q23.2
ATP1B4,Approved symbol,ATP1B4,ATPase Na+/K+ transporting family member beta 4,HGNC:808,Xq24
ATP2A1,Approved symbol,ATP2A1,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1,HGNC:811,16p11.2
ATP2B1,Approved symbol,ATP2B1,ATPase plasma membrane Ca2+ transporting 1,HGNC:814,12q21.33
ATP2B2,Approved symbol,ATP2B2,ATPase plasma membrane Ca2+ transporting 2,HGNC:815,3p25.3
ATP2B2,Previous symbol,ATP2B4,ATPase plasma membrane Ca2+ transporting 4,HGNC:817,1q32.1
ATP2B3,Approved symbol,ATP2B3,ATPase plasma membrane Ca2+ transporting 3,HGNC:816,Xq28
ATP2C1,Approved symbol,ATP2C1,ATPase secretory pathway Ca2+ transporting 1,HGNC:13211,3q22.1
ATP4A,Approved symbol,ATP4A,ATPase H+/K+ transporting subunit alpha,HGNC:819,19q13.12
ATP5A1,Previous symbol,ATP5F1A,ATP synthase F1 subunit alpha,HGNC:823,18q21.1
ATP5B,Previous symbol,ATP5F1B,ATP synthase F1 subunit beta,HGNC:830,12q13.3
ATP6V0A1,Approved symbol,ATP6V0A1,ATPase H+ transporting V0 subunit a1,HGNC:865,17q21.2
ATP7A,Approved symbol,ATP7A,ATPase copper transporting alpha,HGNC:869,Xq21.1
ATP7B,Approved symbol,ATP7B,ATPase copper transporting beta,HGNC:870,13q14.3
ATP8A2,Approved symbol,ATP8A2,ATPase phospholipid transporting 8A2,HGNC:13533,13q12.13
ATP8B1,Approved symbol,ATP8B1,ATPase phospholipid transporting 8B1,HGNC:3706,18q21.31
ATP8B4,Approved symbol,ATP8B4,ATPase phospholipid transporting 8B4 (putative),HGNC:13536,15q21.2
ATRIP,Approved symbol,ATRIP,ATR interacting protein,HGNC:33499,3p21.31
ATRNL1,Approved symbol,ATRNL1,attractin like 1,HGNC:29063,10q25.3
ATRX,Approved symbol,ATRX,ATRX chromatin remodeler,HGNC:886,Xq21.1
ATXN1L,Approved symbol,ATXN1L,ataxin 1 like,HGNC:33279,16q22.2
ATXN2,Approved symbol,ATXN2,ataxin 2,HGNC:10555,12q24.12
ATXN7,Approved symbol,ATXN7,ataxin 7,HGNC:10560,3p14.1
ATXN7L1,Approved symbol,ATXN7L1,ataxin 7 like 1,HGNC:22210,7q22.3
AURKB,Approved symbol,AURKB,aurora kinase B,HGNC:11390,17p13.1
AVP,Approved symbol,AVP,arginine vasopressin,HGNC:894,20p13
AVP,Alias symbol,NLRP3,NLR family pyrin domain containing 3,HGNC:16400,1q44
AXIN1,Approved symbol,AXIN1,axin 1,HGNC:903,16p13.3
B3GAT2,Approved symbol,B3GAT2,"beta-1,3-glucuronyltransferase 2",HGNC:922,6q13
B4GALNT2,Approved symbol,B4GALNT2,"beta-1,4-N-acetyl-galactosaminyltransferase 2",HGNC:24136,17q21.32
B4GALNT4,Approved symbol,B4GALNT4,"beta-1,4-N-acetyl-galactosaminyltransferase 4",HGNC:26315,11p15.5
BAAT,Approved symbol,BAAT,bile acid-CoA:amino acid N-acyltransferase,HGNC:932,9q31.1
BACH2,Approved symbol,BACH2,BTB domain and CNC homolog 2,HGNC:14078,6q15
BAHD1,Approved symbol,BAHD1,bromo adjacent homology domain containing 1,HGNC:29153,15q15.1
BAI1,Previous symbol,ADGRB1,adhesion G protein-coupled receptor B1,HGNC:943,8q24.3
BAI3,Previous symbol,ADGRB3,adhesion G protein-coupled receptor B3,HGNC:945,6q12-q13
BAIAP2,Approved symbol,BAIAP2,BAR/IMD domain containing adaptor protein 2,HGNC:947,17q25.3
BAIAP2L1,Approved symbol,BAIAP2L1,BAR/IMD domain containing adaptor protein 2 like 1,HGNC:21649,7q21.3-q22.1
BAIAP3,Approved symbol,BAIAP3,BAI1 associated protein 3,HGNC:948,16p13.3
BANP,Approved symbol,BANP,BTG3 associated nuclear protein,HGNC:13450,16q24.2
BASP1,Approved symbol,BASP1,brain abundant membrane attached signal protein 1,HGNC:957,5p15.1
BAZ1B,Approved symbol,BAZ1B,bromodomain adjacent to zinc finger domain 1B,HGNC:961,7q11.23
BAZ2A,Approved symbol,BAZ2A,bromodomain adjacent to zinc finger domain 2A,HGNC:962,12q13.3
BAZ2B,Approved symbol,BAZ2B,bromodomain adjacent to zinc finger domain 2B,HGNC:963,2q24.2
BCAN,Approved symbol,BCAN,brevican,HGNC:23059,1q23.1
BCAR3,Approved symbol,BCAR3,"BCAR3 adaptor protein, NSP family member",HGNC:973,1p22.1
BCAT1,Approved symbol,BCAT1,branched chain amino acid transaminase 1,HGNC:976,12p12.1
BCL11A,Approved symbol,BCL11A,BAF chromatin remodeling complex subunit BCL11A,HGNC:13221,2p16.1
BCL2L1,Approved symbol,BCL2L1,BCL2 like 1,HGNC:992,20q11.21
BCL2L13,Approved symbol,BCL2L13,BCL2 like 13,HGNC:17164,22q11.21
BCL9L,Approved symbol,BCL9L,BCL9 like,HGNC:23688,11q23.3
BCMO1,Previous symbol,BCO1,beta-carotene oxygenase 1,HGNC:13815,16q23.2
BCR,Approved symbol,BCR,BCR activator of RhoGEF and GTPase,HGNC:1014,22q11.23
BDP1,Approved symbol,BDP1,"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB",HGNC:13652,5q13.2
BDP1,Alias symbol,PTPN18,protein tyrosine phosphatase non-receptor type 18,HGNC:9649,2q21.1
BEGAIN,Approved symbol,BEGAIN,brain enriched guanylate kinase associated,HGNC:24163,14q32.2
BEND2,Approved symbol,BEND2,BEN domain containing 2,HGNC:28509,Xp22.13
BEND6,Approved symbol,BEND6,BEN domain containing 6,HGNC:20871,6p12.1
BFSP1,Approved symbol,BFSP1,beaded filament structural protein 1,HGNC:1040,20p12.1
BHLHA15,Approved symbol,BHLHA15,basic helix-loop-helix family member a15,HGNC:22265,7q21.3
BICC1,Approved symbol,BICC1,BicC family RNA binding protein 1,HGNC:19351,10q21.1
BIN2,Approved symbol,BIN2,bridging integrator 2,HGNC:1053,12q13.13
BIRC8,Approved symbol,BIRC8,baculoviral IAP repeat containing 8,HGNC:14878,19q13.42
BLM,Approved symbol,BLM,BLM RecQ like helicase,HGNC:1058,15q26.1
BLOC1S3,Approved symbol,BLOC1S3,biogenesis of lysosomal organelles complex 1 subunit 3,HGNC:20914,19q13.32
BLOC1S4,Approved symbol,BLOC1S4,biogenesis of lysosomal organelles complex 1 subunit 4,HGNC:24206,4p16.1
BLZF1,Approved symbol,BLZF1,basic leucine zipper nuclear factor 1,HGNC:1065,1q24.2
BMP1,Approved symbol,BMP1,bone morphogenetic protein 1,HGNC:1067,8p21.3
BMPR1A,Approved symbol,BMPR1A,bone morphogenetic protein receptor type 1A,HGNC:1076,10q23.2
BMS1,Approved symbol,BMS1,BMS1 ribosome biogenesis factor,HGNC:23505,10q11.21
BMX,Approved symbol,BMX,BMX non-receptor tyrosine kinase,HGNC:1079,Xp22.2
BNC2,Approved symbol,BNC2,basonuclin 2,HGNC:30988,9p22.3-p22.2
BNIP3,Approved symbol,BNIP3,BCL2 interacting protein 3,HGNC:1084,10q26.3
BOC,Approved symbol,BOC,"BOC cell adhesion associated, oncogene regulated",HGNC:17173,3q13.2
BOLA3,Approved symbol,BOLA3,bolA family member 3,HGNC:24415,2p13.1
BOLL,Approved symbol,BOLL,"boule homolog, RNA binding protein",HGNC:14273,2q33.1
BPIFB1,Approved symbol,BPIFB1,BPI fold containing family B member 1,HGNC:16108,20q11.21
BPIFB3,Approved symbol,BPIFB3,BPI fold containing family B member 3,HGNC:16178,20q11.21
BPIFB4,Approved symbol,BPIFB4,BPI fold containing family B member 4,HGNC:16179,20q11.21
BRCA1,Approved symbol,BRCA1,BRCA1 DNA repair associated,HGNC:1100,17q21.31
BRCA2,Approved symbol,BRCA2,BRCA2 DNA repair associated,HGNC:1101,13q13.1
BRD2,Approved symbol,BRD2,bromodomain containing 2,HGNC:1103,6p21.32
BRD7,Approved symbol,BRD7,bromodomain containing 7,HGNC:14310,16q12.1
BRICD5,Approved symbol,BRICD5,BRICHOS domain containing 5,HGNC:28309,16p13.3
BRINP1,Approved symbol,BRINP1,BMP/retinoic acid inducible neural specific 1,HGNC:2687,9q33.1
BRINP2,Approved symbol,BRINP2,BMP/retinoic acid inducible neural specific 2,HGNC:13746,1q25.2
BRIP1,Approved symbol,BRIP1,BRCA1 interacting helicase 1,HGNC:20473,17q23.2
BRPF3,Approved symbol,BRPF3,bromodomain and PHD finger containing 3,HGNC:14256,6p21.31
BRSK2,Approved symbol,BRSK2,BR serine/threonine kinase 2,HGNC:11405,11p15.5
BRWD1,Approved symbol,BRWD1,bromodomain and WD repeat domain containing 1,HGNC:12760,21q22.2
BSDC1,Approved symbol,BSDC1,BSD domain containing 1,HGNC:25501,1p35.1
BSN,Approved symbol,BSN,bassoon presynaptic cytomatrix protein,HGNC:1117,3p21.31
BSPH1,Approved symbol,BSPH1,binder of sperm protein homolog 1,HGNC:33906,19q13.33
BST1,Approved symbol,BST1,bone marrow stromal cell antigen 1,HGNC:1118,4p15.32
BST1,Alias symbol,PGAP1,post-GPI attachment to proteins inositol deacylase 1,HGNC:25712,2q33.1
BTBD17,Approved symbol,BTBD17,BTB domain containing 17,HGNC:33758,17q25.1
BTBD2,Approved symbol,BTBD2,BTB domain containing 2,HGNC:15504,19p13.3
BTK,Approved symbol,BTK,Bruton tyrosine kinase,HGNC:1133,Xq22.1
BTLA,Approved symbol,BTLA,B and T lymphocyte associated,HGNC:21087,3q13.2
BTN3A3,Approved symbol,BTN3A3,butyrophilin subfamily 3 member A3,HGNC:1140,6p22.2
BZRAP1,Previous symbol,TSPOAP1,TSPO associated protein 1,HGNC:16831,17q22
C10orf107,Previous symbol,CABCOCO1,ciliary associated calcium binding coiled-coil 1,HGNC:28678,10q21.2
C10orf120,Approved symbol,C10orf120,chromosome 10 open reading frame 120,HGNC:25707,10q26.13
C10orf71,Approved symbol,C10orf71,chromosome 10 open reading frame 71,HGNC:26973,10q11.23
C10orf76,Previous symbol,ARMH3,armadillo like helical domain containing 3,HGNC:25788,10q24.32
C10orf90,Approved symbol,C10orf90,chromosome 10 open reading frame 90,HGNC:26563,10q26.2
C10orf95,Approved symbol,C10orf95,chromosome 10 open reading frame 95,HGNC:25880,10q24.32
C11orf16,Approved symbol,C11orf16,chromosome 11 open reading frame 16,HGNC:1169,11p15.4
C11orf30,Previous symbol,EMSY,"EMSY transcriptional repressor, BRCA2 interacting",HGNC:18071,11q13.5
RASSF7,Approved symbol,RASSF7,Ras association domain family member 7,HGNC:1166,11p15.5
C11orf63,Previous symbol,JHY,junctional cadherin complex regulator,HGNC:26288,11q24.1
C11orf86,Approved symbol,C11orf86,chromosome 11 open reading frame 86,HGNC:34442,11q13.2
C11orf88,Previous symbol,HOATZ,HOATZ cilia and flagella associated protein,HGNC:25061,11q23.1
C11orf96,Approved symbol,C11orf96,chromosome 11 open reading frame 96,HGNC:38675,11p11.2
C12orf4,Approved symbol,C12orf4,chromosome 12 open reading frame 4,HGNC:1184,12p13.32
C12orf55,Previous symbol,CFAP54,cilia and flagella associated protein 54,HGNC:26456,12q23.1
C14orf159,Previous symbol,DGLUCY,D-glutamate cyclase,HGNC:20498,14q32.11
C14orf183,Previous symbol,LINC01599,long intergenic non-protein coding RNA 1599,HGNC:27285,14q21.3
C14orf37,Previous symbol,ARMH4,armadillo like helical domain containing 4,HGNC:19846,14q23.1
C15orf26,Previous symbol,CFAP161,cilia and flagella associated protein 161,HGNC:26782,15q25.1
C15orf40,Approved symbol,C15orf40,chromosome 15 open reading frame 40,HGNC:28443,15q25.2
C15orf54,Previous symbol,LINC02915,long intergenic non-protein coding RNA 2915,HGNC:33797,15q14
C15orf56,Previous symbol,PAK6-AS1,PAK6 antisense RNA 1,HGNC:33868,15q15.1
C16orf11,Previous symbol,PRR35,proline rich 35,HGNC:14139,16p13.3
C16orf13,Previous symbol,METTL26,methyltransferase like 26,HGNC:14141,16p13.3
C16orf62,Previous symbol,VPS35L,VPS35 endosomal protein sorting factor like,HGNC:24641,16p12.3
C17orf104,Previous symbol,MEIOC,meiosis specific with coiled-coil domain,HGNC:26670,17q21.31
C17orf112,Previous symbol,LINC02876,long intergenic non-protein coding RNA 2876,HGNC:42963,17q22
C17orf47,Previous symbol,SEPTIN4,septin 4,HGNC:9165,17q22
C17orf49,Approved symbol,C17orf49,chromosome 17 open reading frame 49,HGNC:28737,17p13.1
C17orf70,Previous symbol,FAAP100,FA core complex associated protein 100,HGNC:26171,17q25.3
C17orf72,Previous symbol,PRR29,proline rich 29,HGNC:25673,17q23.3
C17orf74,Previous symbol,SPEM2,SPEM family member 2,HGNC:27315,17p13.1
C17orf98,Approved symbol,C17orf98,chromosome 17 open reading frame 98,HGNC:34492,17q12
C18orf63,Approved symbol,C18orf63,chromosome 18 open reading frame 63,HGNC:40037,18q22.3
C18orf8,Previous symbol,RMC1,regulator of MON1-CCZ1,HGNC:24326,18q11.2
C19orf24,Previous symbol,FAM174C,family with sequence similarity 174 member C,HGNC:26073,19p13.3
C19orf26,Previous symbol,CBARP,CACN subunit beta associated regulatory protein,HGNC:28617,19p13.3
C19orf35,Previous symbol,PEAK3,PEAK family member 3,HGNC:24793,19p13.3
C19orf40,Previous symbol,FAAP24,FA core complex associated protein 24,HGNC:28467,19q13.11
C19orf45,Previous symbol,TEX45,testis expressed 45,HGNC:24745,19p13.2
C19orf47,Approved symbol,C19orf47,chromosome 19 open reading frame 47,HGNC:26723,19q13.2
C19orf71,Approved symbol,C19orf71,chromosome 19 open reading frame 71,HGNC:34496,19p13.3
C19orf84,Approved symbol,C19orf84,chromosome 19 open reading frame 84,HGNC:27112,19q13.41
C1D,Approved symbol,C1D,C1D nuclear receptor corepressor,HGNC:29911,2p14
C1orf105,Approved symbol,C1orf105,chromosome 1 open reading frame 105,HGNC:29591,1q24.3
C1orf112,Approved symbol,C1orf112,chromosome 1 open reading frame 112,HGNC:25565,1q24.2
C1orf168,Previous symbol,FYB2,FYN binding protein 2,HGNC:27295,1p32.2
C1orf170,Previous symbol,PERM1,"PPARGC1 and ESRR induced regulator, muscle 1",HGNC:28208,1p36.33
C1orf173,Previous symbol,ERICH3,glutamate rich 3,HGNC:25346,1p31.1
C1orf185,Approved symbol,C1orf185,chromosome 1 open reading frame 185,HGNC:28096,1p32.3
C1orf222,Previous symbol,CFAP74,cilia and flagella associated protein 74,HGNC:29368,1p36.33
C1orf35,Approved symbol,C1orf35,chromosome 1 open reading frame 35,HGNC:19032,1q42.13
C1orf94,Approved symbol,C1orf94,chromosome 1 open reading frame 94,HGNC:28250,1p35.1
C1orf95,Previous symbol,STUM,"stum, mechanosensory transduction mediator homolog",HGNC:30491,1q42.12
C1QBP,Approved symbol,C1QBP,complement C1q binding protein,HGNC:1243,17p13.2
C1QL2,Approved symbol,C1QL2,complement C1q like 2,HGNC:24181,2q14.2
C1QL3,Approved symbol,C1QL3,complement C1q like 3,HGNC:19359,10p13
C1QTNF2,Approved symbol,C1QTNF2,C1q and TNF related 2,HGNC:14325,5q33.3
C1QTNF3,Approved symbol,C1QTNF3,C1q and TNF related 3,HGNC:14326,5p13.2
C1QTNF8,Approved symbol,C1QTNF8,C1q and TNF related 8,HGNC:31374,16p13.3
C20orf112,Previous symbol,NOL4L,nucleolar protein 4 like,HGNC:16106,20q11.21
C20orf194,Previous symbol,DNAAF9,dynein axonemal assembly factor 9,HGNC:17721,20p13
C20orf26,Previous symbol,CFAP61,cilia and flagella associated protein 61,HGNC:15872,20p11.23
C20orf96,Approved symbol,C20orf96,chromosome 20 open reading frame 96,HGNC:16227,20p13
C21orf59,Previous symbol,CFAP298,cilia and flagella associated protein 298,HGNC:1301,21q22.11
C22orf23,Approved symbol,C22orf23,chromosome 22 open reading frame 23,HGNC:18589,22q13.1
C22orf26,Previous symbol,PRR34,PRR34 long non-coding RNA,HGNC:25606,22q13.31
C22orf42,Approved symbol,C22orf42,chromosome 22 open reading frame 42,HGNC:27160,22q12.3
C22orf46,Approved symbol,C22orf46,chromosome 22 putative open reading frame 46,HGNC:26294,22q13.2
C2CD4C,Approved symbol,C2CD4C,C2 calcium dependent domain containing 4C,HGNC:29417,19p13.3
C2orf16,Approved symbol,C2orf16,chromosome 2 open reading frame 16,HGNC:25275,2p23.3
C2orf61,Previous symbol,STPG4,sperm-tail PG-rich repeat containing 4,HGNC:26850,2p21
C2orf71,Previous symbol,PCARE,photoreceptor cilium actin regulator,HGNC:34383,2p23.2
C2orf72,Approved symbol,C2orf72,chromosome 2 open reading frame 72,HGNC:27418,2q37.1
C3,Approved symbol,C3,complement C3,HGNC:1318,19p13.3
C3orf30,Previous symbol,TEX55,testis expressed 55,HGNC:26553,3q13.32
C3orf55,Previous symbol,SLC66A1L,solute carrier family 66 member 1 like,HGNC:25146,3q25.32
C3orf80,Approved symbol,C3orf80,chromosome 3 open reading frame 80,HGNC:40048,3q25.33
C3orf84,Approved symbol,C3orf84,chromosome 3 open reading frame 84,HGNC:44666,3p21.31
C4orf26,Previous symbol,ODAPH,odontogenesis associated phosphoprotein,HGNC:26300,4q21.1
C5AR2,Approved symbol,C5AR2,complement C5a receptor 2,HGNC:4527,19q13.32
C5orf22,Approved symbol,C5orf22,chromosome 5 open reading frame 22,HGNC:25639,5p13.3
C5orf24,Approved symbol,C5orf24,chromosome 5 open reading frame 24,HGNC:26746,5q31.1
C5orf30,Previous symbol,MACIR,macrophage immunometabolism regulator,HGNC:25052,5q21.1
C5orf46,Approved symbol,C5orf46,chromosome 5 open reading frame 46,HGNC:33768,5q32
C5orf54,Previous symbol,ZBED8,zinc finger BED-type containing 8,HGNC:30804,5q33.3
C5orf58,Approved symbol,C5orf58,chromosome 5 open reading frame 58,HGNC:37272,5q35.1
C6orf1,Previous symbol,SMIM29,small integral membrane protein 29,HGNC:1340,6p21.31
C6orf10,Previous symbol,TSBP1,testis expressed basic protein 1,HGNC:13922,6p21.32
C6orf118,Approved symbol,C6orf118,chromosome 6 open reading frame 118,HGNC:21233,6q27
C6orf183,Previous symbol,CCDC162P,"coiled-coil domain containing 162, pseudogene",HGNC:21565,6q21
C6orf222,Previous symbol,BNIP5,BCL2 interacting protein 5,HGNC:33769,6p21.31
C7,Approved symbol,C7,complement C7,HGNC:1346,5p13.1
C7,Alias symbol,CXCL10,C-X-C motif chemokine ligand 10,HGNC:10637,4q21.1
C7orf25,Approved symbol,C7orf25,chromosome 7 open reading frame 25,HGNC:21703,7p14.1
C7orf50,Approved symbol,C7orf50,chromosome 7 open reading frame 50,HGNC:22421,7p22.3
C8orf34,Approved symbol,C8orf34,chromosome 8 open reading frame 34,HGNC:30905,8q13.2
C8orf76,Approved symbol,C8orf76,chromosome 8 open reading frame 76,HGNC:25924,8q24.13
C8orf82,Approved symbol,C8orf82,chromosome 8 open reading frame 82,HGNC:33826,8q24.3
C8orf87,Previous symbol,LINC02906,long intergenic non-protein coding RNA 2906,HGNC:42974,8q22.1
C9orf139,Previous symbol,LINC02908,long intergenic non-protein coding RNA 2908,HGNC:31426,9q34.3
C9orf89,Previous symbol,CARD19,caspase recruitment domain family member 19,HGNC:28148,9q22.31
C9orf9,Previous symbol,SPACA9,sperm acrosome associated 9,HGNC:1367,9q34.13
CA10,Approved symbol,CA10,carbonic anhydrase 10,HGNC:1369,17q21.33-q22
CA13,Approved symbol,CA13,carbonic anhydrase 13,HGNC:14914,8q21.2
CA5A,Approved symbol,CA5A,carbonic anhydrase 5A,HGNC:1377,16q24.2
CABIN1,Approved symbol,CABIN1,calcineurin binding protein 1,HGNC:24187,22q11.23
CABLES1,Approved symbol,CABLES1,Cdk5 and Abl enzyme substrate 1,HGNC:25097,18q11.2
CABP5,Approved symbol,CABP5,calcium binding protein 5,HGNC:13714,19q13.33
CACNA1A,Approved symbol,CACNA1A,calcium voltage-gated channel subunit alpha1 A,HGNC:1388,19p13.13
CACNA1B,Approved symbol,CACNA1B,calcium voltage-gated channel subunit alpha1 B,HGNC:1389,9q34.3
CACNA1C,Approved symbol,CACNA1C,calcium voltage-gated channel subunit alpha1 C,HGNC:1390,12p13.33
CACNA1D,Approved symbol,CACNA1D,calcium voltage-gated channel subunit alpha1 D,HGNC:1391,3p21.1
CACNA1E,Approved symbol,CACNA1E,calcium voltage-gated channel subunit alpha1 E,HGNC:1392,1q25.3
CACNA1F,Approved symbol,CACNA1F,calcium voltage-gated channel subunit alpha1 F,HGNC:1393,Xp11.23
CACNA1G,Approved symbol,CACNA1G,calcium voltage-gated channel subunit alpha1 G,HGNC:1394,17q21.33
CACNA1H,Approved symbol,CACNA1H,calcium voltage-gated channel subunit alpha1 H,HGNC:1395,16p13.3
CACNA1I,Approved symbol,CACNA1I,calcium voltage-gated channel subunit alpha1 I,HGNC:1396,22q13.1
CACNA1S,Approved symbol,CACNA1S,calcium voltage-gated channel subunit alpha1 S,HGNC:1397,1q32.1
CACNA2D1,Approved symbol,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,HGNC:1399,7q21.11
CACNA2D3,Approved symbol,CACNA2D3,calcium voltage-gated channel auxiliary subunit alpha2delta 3,HGNC:15460,3p21.1-p14.3
CACNA2D4,Approved symbol,CACNA2D4,calcium voltage-gated channel auxiliary subunit alpha2delta 4,HGNC:20202,12p13.33
CACNB2,Approved symbol,CACNB2,calcium voltage-gated channel auxiliary subunit beta 2,HGNC:1402,10p12
CACNB3,Approved symbol,CACNB3,calcium voltage-gated channel auxiliary subunit beta 3,HGNC:1403,12q13.12
CACNG2,Approved symbol,CACNG2,calcium voltage-gated channel auxiliary subunit gamma 2,HGNC:1406,22q12.3
CACNG4,Approved symbol,CACNG4,calcium voltage-gated channel auxiliary subunit gamma 4,HGNC:1408,17q24.2
CAD,Approved symbol,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",HGNC:1424,2p23.3
CAD,Alias symbol,DFFB,DNA fragmentation factor subunit beta,HGNC:2773,1p36.32
CAD,Alias symbol,B4GALNT2,"beta-1,4-N-acetyl-galactosaminyltransferase 2",HGNC:24136,17q21.32
CAD,Alias symbol,ACOD1,aconitate decarboxylase 1,HGNC:33904,13q22.3
CADM1,Approved symbol,CADM1,cell adhesion molecule 1,HGNC:5951,11q23.3
CADM3,Approved symbol,CADM3,cell adhesion molecule 3,HGNC:17601,1q23.2
CADM4,Approved symbol,CADM4,cell adhesion molecule 4,HGNC:30825,19q13.31
CADPS,Approved symbol,CADPS,calcium dependent secretion activator,HGNC:1426,3p14.2
CADPS2,Approved symbol,CADPS2,calcium dependent secretion activator 2,HGNC:16018,7q31.32
CALD1,Approved symbol,CALD1,caldesmon 1,HGNC:1441,7q33
CALHM2,Approved symbol,CALHM2,calcium homeostasis modulator family member 2,HGNC:23493,10q24.33
CALR3,Approved symbol,CALR3,calreticulin 3,HGNC:20407,19p13.11
CALU,Approved symbol,CALU,calumenin,HGNC:1458,7q32.1
CAMK1D,Approved symbol,CAMK1D,calcium/calmodulin dependent protein kinase ID,HGNC:19341,10p13
CAMK2B,Approved symbol,CAMK2B,calcium/calmodulin dependent protein kinase II beta,HGNC:1461,7p13
CAMK4,Approved symbol,CAMK4,calcium/calmodulin dependent protein kinase IV,HGNC:1464,5q22.1
CAMKK1,Approved symbol,CAMKK1,calcium/calmodulin dependent protein kinase kinase 1,HGNC:1469,17p13.2
CAMKV,Approved symbol,CAMKV,CaM kinase like vesicle associated,HGNC:28788,3p21.31
CAMSAP1,Approved symbol,CAMSAP1,calmodulin regulated spectrin associated protein 1,HGNC:19946,9q34.3
CAMTA1,Approved symbol,CAMTA1,calmodulin binding transcription activator 1,HGNC:18806,1p36.31-p36.23
CAMTA2,Approved symbol,CAMTA2,calmodulin binding transcription activator 2,HGNC:18807,17p13.2
CAND1,Approved symbol,CAND1,cullin associated and neddylation dissociated 1,HGNC:30688,12q14.3-q15
CAND2,Approved symbol,CAND2,cullin associated and neddylation dissociated 2 (putative),HGNC:30689,3p25.2
CANT1,Approved symbol,CANT1,calcium activated nucleotidase 1,HGNC:19721,17q25.3
CANX,Approved symbol,CANX,calnexin,HGNC:1473,5q35.3
CAPN11,Approved symbol,CAPN11,calpain 11,HGNC:1478,6p21.1
CAPN12,Approved symbol,CAPN12,calpain 12,HGNC:13249,19q13.2
CAPN13,Approved symbol,CAPN13,calpain 13,HGNC:16663,2p23.1
CAPN15,Approved symbol,CAPN15,calpain 15,HGNC:11182,16p13.3
CAPN5,Approved symbol,CAPN5,calpain 5,HGNC:1482,11q13.5
CAPN6,Approved symbol,CAPN6,calpain 6,HGNC:1483,Xq23
CAPNS1,Approved symbol,CAPNS1,calpain small subunit 1,HGNC:1481,19q13.12
CARD14,Approved symbol,CARD14,caspase recruitment domain family member 14,HGNC:16446,17q25.3
CARM1,Approved symbol,CARM1,coactivator associated arginine methyltransferase 1,HGNC:23393,19p13.2
CARS,Previous symbol,CARS1,cysteinyl-tRNA synthetase 1,HGNC:1493,11p15.4
CARS2,Approved symbol,CARS2,"cysteinyl-tRNA synthetase 2, mitochondrial",HGNC:25695,13q34
CASC1,Previous symbol,DNAI7,dynein axonemal intermediate chain 7,HGNC:29599,12p12.1
CASC3,Approved symbol,CASC3,CASC3 exon junction complex subunit,HGNC:17040,17q21.1
CASC5,Previous symbol,KNL1,kinetochore scaffold 1,HGNC:24054,15q15.1
CASD1,Approved symbol,CASD1,CAS1 domain containing 1,HGNC:16014,7q21.3
CASK,Approved symbol,CASK,calcium/calmodulin dependent serine protein kinase,HGNC:1497,Xp11.4
CASKIN1,Approved symbol,CASKIN1,CASK interacting protein 1,HGNC:20879,16p13.3
CASP8,Approved symbol,CASP8,caspase 8,HGNC:1509,2q33.1
CASP8AP2,Approved symbol,CASP8AP2,caspase 8 associated protein 2,HGNC:1510,6q15
CATSPER4,Approved symbol,CATSPER4,cation channel sperm associated 4,HGNC:23220,1p36.11
CATSPERB,Approved symbol,CATSPERB,cation channel sperm associated auxiliary subunit beta,HGNC:20500,14q32.12
CAV1,Approved symbol,CAV1,caveolin 1,HGNC:1527,7q31.2
CBFA2T2,Approved symbol,CBFA2T2,CBFA2/RUNX1 partner transcriptional co-repressor 2,HGNC:1536,20q11.21-q11.22
CBFA2T3,Approved symbol,CBFA2T3,CBFA2/RUNX1 partner transcriptional co-repressor 3,HGNC:1537,16q24.3
CBR3,Approved symbol,CBR3,carbonyl reductase 3,HGNC:1549,21q22.12
CBS,Approved symbol,CBS,cystathionine beta-synthase,HGNC:1550,21q22.3
CBX6,Approved symbol,CBX6,chromobox 6,HGNC:1556,22q13.1
CBX8,Approved symbol,CBX8,chromobox 8,HGNC:15962,17q25.3
CC2D1A,Approved symbol,CC2D1A,coiled-coil and C2 domain containing 1A,HGNC:30237,19p13.12
CC2D2A,Approved symbol,CC2D2A,coiled-coil and C2 domain containing 2A,HGNC:29253,4p15.32
CCBE1,Approved symbol,CCBE1,collagen and calcium binding EGF domains 1,HGNC:29426,18q21.32
CCDC102B,Approved symbol,CCDC102B,coiled-coil domain containing 102B,HGNC:26295,18q22.1
CCDC104,Previous symbol,CFAP36,cilia and flagella associated protein 36,HGNC:30540,2p16.1
CCDC105,Approved symbol,CCDC105,coiled-coil domain containing 105,HGNC:26866,19p13.12
CCDC108,Previous symbol,CFAP65,cilia and flagella associated protein 65,HGNC:25325,2q35
CCDC110,Approved symbol,CCDC110,coiled-coil domain containing 110,HGNC:28504,4q35.1
CCDC120,Approved symbol,CCDC120,coiled-coil domain containing 120,HGNC:28910,Xp11.23
CCDC124,Approved symbol,CCDC124,coiled-coil domain containing 124,HGNC:25171,19p13.11
CCDC125,Approved symbol,CCDC125,coiled-coil domain containing 125,HGNC:28924,5q13.2
CCDC136,Approved symbol,CCDC136,coiled-coil domain containing 136,HGNC:22225,7q32.1
CCDC141,Approved symbol,CCDC141,coiled-coil domain containing 141,HGNC:26821,2q31.2
CCDC147,Previous symbol,CFAP58,cilia and flagella associated protein 58,HGNC:26676,10q25.1
CCDC155,Previous symbol,KASH5,KASH domain containing 5,HGNC:26520,19q13.33
CCDC157,Approved symbol,CCDC157,coiled-coil domain containing 157,HGNC:33854,22q12.2
CCDC159,Approved symbol,CCDC159,coiled-coil domain containing 159,HGNC:26996,19p13.2
CCDC166,Approved symbol,CCDC166,coiled-coil domain containing 166,HGNC:41910,8q24.3
CCDC169-SOHLH2,Approved symbol,CCDC169-SOHLH2,CCDC169-SOHLH2 readthrough,HGNC:38866,13q13.3
CCDC171,Approved symbol,CCDC171,coiled-coil domain containing 171,HGNC:29828,9p22.3
CCDC176,Previous symbol,BBOF1,basal body orientation factor 1,HGNC:19855,14q24.3
CCDC177,Approved symbol,CCDC177,coiled-coil domain containing 177,HGNC:23243,14q24.1
CCDC178,Approved symbol,CCDC178,coiled-coil domain containing 178,HGNC:29588,18q12.1
CCDC18,Approved symbol,CCDC18,coiled-coil domain containing 18,HGNC:30370,1p22.1
CCDC180,Approved symbol,CCDC180,coiled-coil domain containing 180,HGNC:29303,9q22.33
CCDC27,Approved symbol,CCDC27,coiled-coil domain containing 27,HGNC:26546,1p36.32
CCDC3,Approved symbol,CCDC3,coiled-coil domain containing 3,HGNC:23813,10p13
CCDC37,Previous symbol,CFAP100,cilia and flagella associated protein 100,HGNC:26842,3q21.3
CCDC42,Approved symbol,CCDC42,coiled-coil domain containing 42,HGNC:26528,17p13.1
CCDC63,Approved symbol,CCDC63,coiled-coil domain containing 63,HGNC:26669,12q24.11
CCDC64,Previous symbol,BICDL1,BICD family like cargo adaptor 1,HGNC:28095,12q24.23
CCDC80,Approved symbol,CCDC80,coiled-coil domain containing 80,HGNC:30649,3q13.2
CCDC85A,Approved symbol,CCDC85A,coiled-coil domain containing 85A,HGNC:29400,2p16.1
CCDC88A,Approved symbol,CCDC88A,coiled-coil domain containing 88A,HGNC:25523,2p16.1
CCDC88B,Approved symbol,CCDC88B,coiled-coil domain containing 88B,HGNC:26757,11q13.1
CCHCR1,Approved symbol,CCHCR1,coiled-coil alpha-helical rod protein 1,HGNC:13930,6p21.33
CCKAR,Approved symbol,CCKAR,cholecystokinin A receptor,HGNC:1570,4p15.2
CCKBR,Approved symbol,CCKBR,cholecystokinin B receptor,HGNC:1571,11p15.4
CCL19,Approved symbol,CCL19,C-C motif chemokine ligand 19,HGNC:10617,9p13.3
CCM2L,Approved symbol,CCM2L,CCM2 like scaffold protein,HGNC:16153,20q11.21
CCNA1,Approved symbol,CCNA1,cyclin A1,HGNC:1577,13q13.3
CCNB3,Approved symbol,CCNB3,cyclin B3,HGNC:18709,Xp11.22
CCNJ,Approved symbol,CCNJ,cyclin J,HGNC:23434,10q24.1
CCNL1,Approved symbol,CCNL1,cyclin L1,HGNC:20569,3q25.31
CCNL1,Previous symbol,MCM2,minichromosome maintenance complex component 2,HGNC:6944,3q21.3
CCNYL1,Approved symbol,CCNYL1,cyclin Y like 1,HGNC:26868,2q33.3
CCRL2,Approved symbol,CCRL2,C-C motif chemokine receptor like 2,HGNC:1612,3p21.31
CCT3,Approved symbol,CCT3,chaperonin containing TCP1 subunit 3,HGNC:1616,1q22
CCT5,Approved symbol,CCT5,chaperonin containing TCP1 subunit 5,HGNC:1618,5p15.2
CCT8L2,Approved symbol,CCT8L2,chaperonin containing TCP1 subunit 8 like 2,HGNC:15553,22q11.1
CD109,Approved symbol,CD109,CD109 molecule,HGNC:21685,6q13
CD19,Approved symbol,CD19,CD19 molecule,HGNC:1633,16p11.2
CD1C,Approved symbol,CD1C,CD1c molecule,HGNC:1636,1q23.1
CD22,Approved symbol,CD22,CD22 molecule,HGNC:1643,19q13.12
CD33,Approved symbol,CD33,CD33 molecule,HGNC:1659,19q13.41
CD34,Approved symbol,CD34,CD34 molecule,HGNC:1662,1q32.2
CD3E,Approved symbol,CD3E,CD3e molecule,HGNC:1674,11q23.3
CD4,Approved symbol,CD4,CD4 molecule,HGNC:1678,12p13.31
CD48,Approved symbol,CD48,CD48 molecule,HGNC:1683,1q23.3
CD5,Approved symbol,CD5,CD5 molecule,HGNC:1685,11q12.2
CD55,Approved symbol,CD55,CD55 molecule (Cromer blood group),HGNC:2665,1q32.2
CD5L,Approved symbol,CD5L,CD5 molecule like,HGNC:1690,1q23.1
CD6,Approved symbol,CD6,CD6 molecule,HGNC:1691,11q12.2
CD97,Previous symbol,ADGRE5,adhesion G protein-coupled receptor E5,HGNC:1711,19p13.12
CDC14A,Approved symbol,CDC14A,cell division cycle 14A,HGNC:1718,1p21.2
CDC16,Approved symbol,CDC16,cell division cycle 16,HGNC:1720,13q34
CDC27,Approved symbol,CDC27,cell division cycle 27,HGNC:1728,17q21.32
CDC37L1,Approved symbol,CDC37L1,cell division cycle 37 like 1,HGNC:17179,9p24.1
CDC42BPA,Approved symbol,CDC42BPA,CDC42 binding protein kinase alpha,HGNC:1737,1q42.13
CDC42BPB,Approved symbol,CDC42BPB,CDC42 binding protein kinase beta,HGNC:1738,14q32.32
CDC42BPG,Approved symbol,CDC42BPG,CDC42 binding protein kinase gamma,HGNC:29829,11q13.1
CDC42EP4,Approved symbol,CDC42EP4,CDC42 effector protein 4,HGNC:17147,17q25.1
CDCA2,Approved symbol,CDCA2,cell division cycle associated 2,HGNC:14623,8p21.2
CDCA5,Approved symbol,CDCA5,cell division cycle associated 5,HGNC:14626,11q13.1
CDH1,Approved symbol,CDH1,cadherin 1,HGNC:1748,16q22.1
CDH1,Alias symbol,FZR1,fizzy and cell division cycle 20 related 1,HGNC:24824,19p13.3
CDH10,Approved symbol,CDH10,cadherin 10,HGNC:1749,5p14.2-p14.1
CDH11,Approved symbol,CDH11,cadherin 11,HGNC:1750,16q21
CDH12,Approved symbol,CDH12,cadherin 12,HGNC:1751,5p14.3
CDH16,Approved symbol,CDH16,cadherin 16,HGNC:1755,16q22.1
CDH18,Approved symbol,CDH18,cadherin 18,HGNC:1757,5p14.3
CDH2,Approved symbol,CDH2,cadherin 2,HGNC:1759,18q12.1
CDH20,Approved symbol,CDH20,cadherin 20,HGNC:1760,18q21.33
CDH20,Alias symbol,PCDHGB4,"protocadherin gamma subfamily B, 4",HGNC:8711,5q31
CDH22,Approved symbol,CDH22,cadherin 22,HGNC:13251,20q13.12
CDH23,Approved symbol,CDH23,cadherin related 23,HGNC:13733,10q22.1
CDH24,Approved symbol,CDH24,cadherin 24,HGNC:14265,14q11.2
CDH5,Approved symbol,CDH5,cadherin 5,HGNC:1764,16q21
CDH7,Approved symbol,CDH7,cadherin 7,HGNC:1766,18q22.1
CDH7,Alias symbol,CDH19,cadherin 19,HGNC:1758,18q22.1
CDH7,Alias symbol,CDH20,cadherin 20,HGNC:1760,18q21.33
CDH8,Approved symbol,CDH8,cadherin 8,HGNC:1767,16q21
CDH9,Approved symbol,CDH9,cadherin 9,HGNC:1768,5p14.1
CDHR1,Approved symbol,CDHR1,cadherin related family member 1,HGNC:14550,10q23.1
CDHR4,Approved symbol,CDHR4,cadherin related family member 4,HGNC:34527,3p21.31
CDK11B,Approved symbol,CDK11B,cyclin dependent kinase 11B,HGNC:1729,1p36.33
CDK12,Approved symbol,CDK12,cyclin dependent kinase 12,HGNC:24224,17q12
CDK13,Approved symbol,CDK13,cyclin dependent kinase 13,HGNC:1733,7p14.1
CDK15,Approved symbol,CDK15,cyclin dependent kinase 15,HGNC:14434,2q33.1
CDK17,Approved symbol,CDK17,cyclin dependent kinase 17,HGNC:8750,12q23.1
CDK18,Approved symbol,CDK18,cyclin dependent kinase 18,HGNC:8751,1q32.1
CDK5,Approved symbol,CDK5,cyclin dependent kinase 5,HGNC:1774,7q36.1
CDK5R1,Approved symbol,CDK5R1,cyclin dependent kinase 5 regulatory subunit 1,HGNC:1775,17q11.2
CDK5RAP2,Approved symbol,CDK5RAP2,CDK5 regulatory subunit associated protein 2,HGNC:18672,9q33.2
CDKL1,Approved symbol,CDKL1,cyclin dependent kinase like 1,HGNC:1781,14q21.3
CDKL5,Approved symbol,CDKL5,cyclin dependent kinase like 5,HGNC:11411,Xp22.13
CDKN2A,Approved symbol,CDKN2A,cyclin dependent kinase inhibitor 2A,HGNC:1787,9p21.3
CDKN2AIPNL,Approved symbol,CDKN2AIPNL,CDKN2A interacting protein N-terminal like,HGNC:30545,5q31.1
CDRT1,Previous symbol,FBXW10B,F-box and WD repeat domain containing 10B,HGNC:14379,17p12
CDS2,Approved symbol,CDS2,CDP-diacylglycerol synthase 2,HGNC:1801,20p12.3
CDSN,Approved symbol,CDSN,corneodesmosin,HGNC:1802,6p21.33
CDT1,Approved symbol,CDT1,chromatin licensing and DNA replication factor 1,HGNC:24576,16q24.3
CDX2,Approved symbol,CDX2,caudal type homeobox 2,HGNC:1806,13q12.2
CDX4,Approved symbol,CDX4,caudal type homeobox 4,HGNC:1808,Xq13.2
CDYL2,Approved symbol,CDYL2,chromodomain Y like 2,HGNC:23030,16q23.2
CEACAM5,Approved symbol,CEACAM5,CEA cell adhesion molecule 5,HGNC:1817,19q13.2
CEBPA,Approved symbol,CEBPA,CCAAT enhancer binding protein alpha,HGNC:1833,19q13.11
CEBPE,Approved symbol,CEBPE,CCAAT enhancer binding protein epsilon,HGNC:1836,14q11.2
CEBPZ,Approved symbol,CEBPZ,CCAAT enhancer binding protein zeta,HGNC:24218,2p22.2
CECR5,Previous symbol,HDHD5,haloacid dehalogenase like hydrolase domain containing 5,HGNC:1843,22q11.1
CELA2A,Approved symbol,CELA2A,chymotrypsin like elastase 2A,HGNC:24609,1p36.21
CELF2,Approved symbol,CELF2,CUGBP Elav-like family member 2,HGNC:2550,10p14
CELF3,Approved symbol,CELF3,CUGBP Elav-like family member 3,HGNC:11967,1q21.3
CELF4,Approved symbol,CELF4,CUGBP Elav-like family member 4,HGNC:14015,18q12.2
CELSR1,Approved symbol,CELSR1,cadherin EGF LAG seven-pass G-type receptor 1,HGNC:1850,22q13.31
CELSR2,Approved symbol,CELSR2,cadherin EGF LAG seven-pass G-type receptor 2,HGNC:3231,1p13.3
CELSR3,Approved symbol,CELSR3,cadherin EGF LAG seven-pass G-type receptor 3,HGNC:3230,3p21.31
CENPA,Approved symbol,CENPA,centromere protein A,HGNC:1851,2p23.3
CENPE,Approved symbol,CENPE,centromere protein E,HGNC:1856,4q24
CENPF,Approved symbol,CENPF,centromere protein F,HGNC:1857,1q41
CENPJ,Approved symbol,CENPJ,centromere protein J,HGNC:17272,13q12.12-q12.13
CENPO,Approved symbol,CENPO,centromere protein O,HGNC:28152,2p23.3
CEP152,Approved symbol,CEP152,centrosomal protein 152,HGNC:29298,15q21.1
CEP170B,Approved symbol,CEP170B,centrosomal protein 170B,HGNC:20362,14q32.33
CEP250,Approved symbol,CEP250,centrosomal protein 250,HGNC:1859,20q11.22
CEP290,Approved symbol,CEP290,centrosomal protein 290,HGNC:29021,12q21.32
CEP41,Approved symbol,CEP41,centrosomal protein 41,HGNC:12370,7q32.2
CEP85L,Approved symbol,CEP85L,centrosomal protein 85 like,HGNC:21638,6q22.31
CEP89,Approved symbol,CEP89,centrosomal protein 89,HGNC:25907,19q13.11
CERCAM,Approved symbol,CERCAM,cerebral endothelial cell adhesion molecule,HGNC:23723,9q34.11
CES1,Approved symbol,CES1,carboxylesterase 1,HGNC:1863,16q12.2
CETN1,Approved symbol,CETN1,centrin 1,HGNC:1866,18p11.32
CETN3,Approved symbol,CETN3,centrin 3,HGNC:1868,5q14.3
CFB,Approved symbol,CFB,complement factor B,HGNC:1037,6p21.33
CFH,Approved symbol,CFH,complement factor H,HGNC:4883,1q31.3
CFHR2,Approved symbol,CFHR2,complement factor H related 2,HGNC:4890,1q31.3
CFHR4,Approved symbol,CFHR4,complement factor H related 4,HGNC:16979,1q31.3
CFI,Approved symbol,CFI,complement factor I,HGNC:5394,4q25
CFLAR,Approved symbol,CFLAR,CASP8 and FADD like apoptosis regulator,HGNC:1876,2q33.1
CGB8,Approved symbol,CGB8,chorionic gonadotropin subunit beta 8,HGNC:16453,19q13.33
CGB7,Approved symbol,CGB7,chorionic gonadotropin subunit beta 7,HGNC:16451,19q13.33
CGRRF1,Approved symbol,CGRRF1,cell growth regulator with ring finger domain 1,HGNC:15528,14q22.2
CHAD,Approved symbol,CHAD,chondroadherin,HGNC:1909,17q21.33
CHCHD6,Approved symbol,CHCHD6,coiled-coil-helix-coiled-coil-helix domain containing 6,HGNC:28184,3q21.3
CHD1,Approved symbol,CHD1,chromodomain helicase DNA binding protein 1,HGNC:1915,5q15-q21.1
CHD5,Approved symbol,CHD5,chromodomain helicase DNA binding protein 5,HGNC:16816,1p36.31
CHD5,Alias symbol,GET1,guided entry of tail-anchored proteins factor 1,HGNC:12790,21q22.2
CHD5,Alias symbol,CHD6,chromodomain helicase DNA binding protein 6,HGNC:19057,20q12
CHD6,Approved symbol,CHD6,chromodomain helicase DNA binding protein 6,HGNC:19057,20q12
CHD9,Approved symbol,CHD9,chromodomain helicase DNA binding protein 9,HGNC:25701,16q12.2
CHDC2,Previous symbol,CFAP47,cilia and flagella associated protein 47,HGNC:26708,Xp21.1
CHDH,Approved symbol,CHDH,choline dehydrogenase,HGNC:24288,3p21.1
CHEK1,Approved symbol,CHEK1,checkpoint kinase 1,HGNC:1925,11q24.2
CHEK2,Approved symbol,CHEK2,checkpoint kinase 2,HGNC:16627,22q12.1
CHGA,Approved symbol,CHGA,chromogranin A,HGNC:1929,14q32.12
CHID1,Approved symbol,CHID1,chitinase domain containing 1,HGNC:28474,11p15.5
CHL1,Approved symbol,CHL1,cell adhesion molecule L1 like,HGNC:1939,3p26.3
CHL1,Alias symbol,DDX11,DEAD/H-box helicase 11,HGNC:2736,12p11.21
CHM,Approved symbol,CHM,CHM Rab escort protein,HGNC:1940,Xq21.2
CHMP4C,Approved symbol,CHMP4C,charged multivesicular body protein 4C,HGNC:30599,8q21.13
CHPF,Approved symbol,CHPF,chondroitin polymerizing factor,HGNC:24291,2q35
CHPF2,Approved symbol,CHPF2,chondroitin polymerizing factor 2,HGNC:29270,7q36.1
CHRD,Approved symbol,CHRD,chordin,HGNC:1949,3q27.1
CHRM2,Approved symbol,CHRM2,cholinergic receptor muscarinic 2,HGNC:1951,7q33
CHRM3,Approved symbol,CHRM3,cholinergic receptor muscarinic 3,HGNC:1952,1q43
CHRM4,Approved symbol,CHRM4,cholinergic receptor muscarinic 4,HGNC:1953,11p11.2
CHRNA1,Approved symbol,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,HGNC:1955,2q31.1
CHRNA4,Approved symbol,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,HGNC:1958,20q13.33
CHRNA6,Approved symbol,CHRNA6,cholinergic receptor nicotinic alpha 6 subunit,HGNC:15963,8p11.21
CHST13,Approved symbol,CHST13,carbohydrate sulfotransferase 13,HGNC:21755,3q21.3
CHST15,Approved symbol,CHST15,carbohydrate sulfotransferase 15,HGNC:18137,10q26.13
CHST4,Approved symbol,CHST4,carbohydrate sulfotransferase 4,HGNC:1972,16q22.2
CHST7,Approved symbol,CHST7,carbohydrate sulfotransferase 7,HGNC:13817,Xp11.3
CHSY3,Approved symbol,CHSY3,chondroitin sulfate synthase 3,HGNC:24293,5q23.3
CHTF18,Approved symbol,CHTF18,chromosome transmission fidelity factor 18,HGNC:18435,16p13.3
CIC,Approved symbol,CIC,capicua transcriptional repressor,HGNC:14214,19q13.2
CIR1,Approved symbol,CIR1,"corepressor interacting with RBPJ, CIR1",HGNC:24217,2q31.1
CITED1,Approved symbol,CITED1,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1,HGNC:1986,Xq13.1
CIZ1,Approved symbol,CIZ1,CDKN1A interacting zinc finger protein 1,HGNC:16744,9q34.11
CKAP2,Approved symbol,CKAP2,cytoskeleton associated protein 2,HGNC:1990,13q14.3
CKM,Approved symbol,CKM,"creatine kinase, M-type",HGNC:1994,19q13.32
CKMT2,Approved symbol,CKMT2,"creatine kinase, mitochondrial 2",HGNC:1996,5q14.1
CLASP1,Approved symbol,CLASP1,cytoplasmic linker associated protein 1,HGNC:17088,2q14.2-q14.3
CLASP2,Approved symbol,CLASP2,cytoplasmic linker associated protein 2,HGNC:17078,3p22.3
CLASRP,Approved symbol,CLASRP,CLK4 associating serine/arginine rich protein,HGNC:17731,19q13.32
CLCF1,Approved symbol,CLCF1,cardiotrophin like cytokine factor 1,HGNC:17412,11q13.2
CLCN1,Approved symbol,CLCN1,chloride voltage-gated channel 1,HGNC:2019,7q34
CLCNKA,Approved symbol,CLCNKA,chloride voltage-gated channel Ka,HGNC:2026,1p36.13
CLDN11,Approved symbol,CLDN11,claudin 11,HGNC:8514,3q26.2
CLDN17,Approved symbol,CLDN17,claudin 17,HGNC:2038,21q21.3
CLDN5,Approved symbol,CLDN5,claudin 5,HGNC:2047,22q11.21
CLDND1,Approved symbol,CLDND1,claudin domain containing 1,HGNC:1322,3q11.2
CLEC14A,Approved symbol,CLEC14A,C-type lectin domain containing 14A,HGNC:19832,14q21.1
CLEC4G,Approved symbol,CLEC4G,C-type lectin domain family 4 member G,HGNC:24591,19p13.2
CLGN,Approved symbol,CLGN,calmegin,HGNC:2060,4q31.1
CLIC1,Approved symbol,CLIC1,chloride intracellular channel 1,HGNC:2062,6p21.33
CLINT1,Approved symbol,CLINT1,clathrin interactor 1,HGNC:23186,5q33.3
CLIP4,Approved symbol,CLIP4,CAP-Gly domain containing linker protein family member 4,HGNC:26108,2p23.2
CLIP4,Alias symbol,UBASH3A,ubiquitin associated and SH3 domain containing A,HGNC:12462,21q22.3
CLK2,Approved symbol,CLK2,CDC like kinase 2,HGNC:2069,1q22
CLK3,Approved symbol,CLK3,CDC like kinase 3,HGNC:2071,15q24.1
CLMP,Approved symbol,CLMP,CXADR like membrane protein,HGNC:24039,11q24.1
CLN3,Approved symbol,CLN3,"CLN3 lysosomal/endosomal transmembrane protein, battenin",HGNC:2074,16p12.1
CLN8,Approved symbol,CLN8,CLN8 transmembrane ER and ERGIC protein,HGNC:2079,8p23.3
CLP1,Approved symbol,CLP1,cleavage factor polyribonucleotide kinase subunit 1,HGNC:16999,11q12.1
CLPB,Approved symbol,CLPB,caseinolytic mitochondrial matrix peptidase chaperone subunit B,HGNC:30664,11q13.4
CLSPN,Approved symbol,CLSPN,claspin,HGNC:19715,1p34.3
CLSTN2,Approved symbol,CLSTN2,calsyntenin 2,HGNC:17448,3q23
CLTA,Approved symbol,CLTA,clathrin light chain A,HGNC:2090,9p13.3
CLU,Approved symbol,CLU,clusterin,HGNC:2095,8p21.1
CLUH,Approved symbol,CLUH,clustered mitochondria homolog,HGNC:29094,17p13.3
CLVS1,Approved symbol,CLVS1,clavesin 1,HGNC:23139,8q12.2-q12.3
CMA1,Approved symbol,CMA1,chymase 1,HGNC:2097,14q12
CMBL,Approved symbol,CMBL,carboxymethylenebutenolidase homolog,HGNC:25090,5p15.2
CMC4,Approved symbol,CMC4,C-X9-C motif containing 4,HGNC:35428,Xq28
CMKLR1,Approved symbol,CMKLR1,chemerin chemokine-like receptor 1,HGNC:2121,12q23.3
CMTM4,Approved symbol,CMTM4,CKLF like MARVEL transmembrane domain containing 4,HGNC:19175,16q22.1-q22.3
CMTM8,Approved symbol,CMTM8,CKLF like MARVEL transmembrane domain containing 8,HGNC:19179,3p22.3
CMTR1,Approved symbol,CMTR1,cap methyltransferase 1,HGNC:21077,6p21.2
CMYA5,Approved symbol,CMYA5,cardiomyopathy associated 5,HGNC:14305,5q14.1
CNBD1,Approved symbol,CNBD1,cyclic nucleotide binding domain containing 1,HGNC:26663,8q21.3
CNBD2,Approved symbol,CNBD2,cyclic nucleotide binding domain containing 2,HGNC:16145,20q11.23
CNDP1,Approved symbol,CNDP1,carnosine dipeptidase 1,HGNC:20675,18q22.3
CNDP2,Approved symbol,CNDP2,carnosine dipeptidase 2,HGNC:24437,18q22.3
CNGB1,Approved symbol,CNGB1,cyclic nucleotide gated channel subunit beta 1,HGNC:2151,16q21
CNIH3,Approved symbol,CNIH3,cornichon family AMPA receptor auxiliary protein 3,HGNC:26802,1q42.12
CNNM2,Approved symbol,CNNM2,cyclin and CBS domain divalent metal cation transport mediator 2,HGNC:103,10q24.32
CNOT6,Approved symbol,CNOT6,CCR4-NOT transcription complex subunit 6,HGNC:14099,5q35.3
CNOT7,Approved symbol,CNOT7,CCR4-NOT transcription complex subunit 7,HGNC:14101,8p22
CNR1,Approved symbol,CNR1,cannabinoid receptor 1,HGNC:2159,6q15
CNR1,Alias symbol,PCDHA@,"protocadherin alpha cluster, complex locus",HGNC:8662,5q31
CNR1,Alias symbol,PCDHA4,protocadherin alpha 4,HGNC:8670,5q31.3
CNTD2,Previous symbol,CCNP,cyclin P,HGNC:25805,19q13.2
CNTLN,Approved symbol,CNTLN,centlein,HGNC:23432,9p22.2
CNTN1,Approved symbol,CNTN1,contactin 1,HGNC:2171,12q12
CNTN2,Approved symbol,CNTN2,contactin 2,HGNC:2172,1q32.1
CNTN5,Approved symbol,CNTN5,contactin 5,HGNC:2175,11q22.1
CNTN6,Approved symbol,CNTN6,contactin 6,HGNC:2176,3p26.3
CNTNAP2,Approved symbol,CNTNAP2,contactin associated protein 2,HGNC:13830,7q35-q36.1
CNTNAP3,Approved symbol,CNTNAP3,contactin associated protein family member 3,HGNC:13834,9p12
CNTNAP3B,Approved symbol,CNTNAP3B,contactin associated protein family member 3B,HGNC:32035,9p11.2
CNTNAP4,Approved symbol,CNTNAP4,contactin associated protein family member 4,HGNC:18747,16q23.1
CNTNAP5,Approved symbol,CNTNAP5,contactin associated protein family member 5,HGNC:18748,2q14.3
CNTRL,Approved symbol,CNTRL,centriolin,HGNC:1858,9q33.2
COASY,Approved symbol,COASY,Coenzyme A synthase,HGNC:29932,17q21.2
COBLL1,Approved symbol,COBLL1,cordon-bleu WH2 repeat protein like 1,HGNC:23571,2q24.3
COCH,Approved symbol,COCH,cochlin,HGNC:2180,14q12
COG4,Approved symbol,COG4,component of oligomeric golgi complex 4,HGNC:18620,16q22.1
COG6,Approved symbol,COG6,component of oligomeric golgi complex 6,HGNC:18621,13q14.11
COIL,Approved symbol,COIL,coilin,HGNC:2184,17q22
COL11A1,Approved symbol,COL11A1,collagen type XI alpha 1 chain,HGNC:2186,1p21.1
COL11A2,Approved symbol,COL11A2,collagen type XI alpha 2 chain,HGNC:2187,6p21.32
COL12A1,Approved symbol,COL12A1,collagen type XII alpha 1 chain,HGNC:2188,6q13-q14.1
COL13A1,Approved symbol,COL13A1,collagen type XIII alpha 1 chain,HGNC:2190,10q22.1
COL14A1,Approved symbol,COL14A1,collagen type XIV alpha 1 chain,HGNC:2191,8q24.12
COL15A1,Approved symbol,COL15A1,collagen type XV alpha 1 chain,HGNC:2192,9q22.33
COL16A1,Approved symbol,COL16A1,collagen type XVI alpha 1 chain,HGNC:2193,1p35.2
COL18A1,Approved symbol,COL18A1,collagen type XVIII alpha 1 chain,HGNC:2195,21q22.3
COL19A1,Approved symbol,COL19A1,collagen type XIX alpha 1 chain,HGNC:2196,6q13
COL1A2,Approved symbol,COL1A2,collagen type I alpha 2 chain,HGNC:2198,7q21.3
COL22A1,Approved symbol,COL22A1,collagen type XXII alpha 1 chain,HGNC:22989,8q24.23-q24.3
COL27A1,Approved symbol,COL27A1,collagen type XXVII alpha 1 chain,HGNC:22986,9q32
COL28A1,Approved symbol,COL28A1,collagen type XXVIII alpha 1 chain,HGNC:22442,7p21.3
COL2A1,Approved symbol,COL2A1,collagen type II alpha 1 chain,HGNC:2200,12q13.11
COL3A1,Approved symbol,COL3A1,collagen type III alpha 1 chain,HGNC:2201,2q32.2
COL4A2,Approved symbol,COL4A2,collagen type IV alpha 2 chain,HGNC:2203,13q34
COL4A3,Approved symbol,COL4A3,collagen type IV alpha 3 chain,HGNC:2204,2q36.3
COL4A4,Approved symbol,COL4A4,collagen type IV alpha 4 chain,HGNC:2206,2q36.3
COL4A5,Approved symbol,COL4A5,collagen type IV alpha 5 chain,HGNC:2207,Xq22.3
COL4A6,Approved symbol,COL4A6,collagen type IV alpha 6 chain,HGNC:2208,Xq22.3
COL5A1,Approved symbol,COL5A1,collagen type V alpha 1 chain,HGNC:2209,9q34.3
COL6A1,Approved symbol,COL6A1,collagen type VI alpha 1 chain,HGNC:2211,21q22.3
COL6A3,Approved symbol,COL6A3,collagen type VI alpha 3 chain,HGNC:2213,2q37.3
COL6A5,Approved symbol,COL6A5,collagen type VI alpha 5 chain,HGNC:26674,3q22.1
COL6A6,Approved symbol,COL6A6,collagen type VI alpha 6 chain,HGNC:27023,3q22.1
COL7A1,Approved symbol,COL7A1,collagen type VII alpha 1 chain,HGNC:2214,3p21.31
COL8A1,Approved symbol,COL8A1,collagen type VIII alpha 1 chain,HGNC:2215,3q12.1
COL9A1,Approved symbol,COL9A1,collagen type IX alpha 1 chain,HGNC:2217,6q13
COLEC11,Approved symbol,COLEC11,collectin subfamily member 11,HGNC:17213,2p25.3
COLEC12,Approved symbol,COLEC12,collectin subfamily member 12,HGNC:16016,18p11.32
COLGALT1,Approved symbol,COLGALT1,collagen beta(1-O)galactosyltransferase 1,HGNC:26182,19p13.11
COMP,Approved symbol,COMP,cartilage oligomeric matrix protein,HGNC:2227,19p13.11
COPB2,Approved symbol,COPB2,COPI coat complex subunit beta 2,HGNC:2232,3q23
COPRS,Approved symbol,COPRS,coordinator of PRMT5 and differentiation stimulator,HGNC:28848,17q11.2
COQ10A,Approved symbol,COQ10A,coenzyme Q10A,HGNC:26515,12q13.3
COQ4,Approved symbol,COQ4,coenzyme Q4,HGNC:19693,9q34.11
COQ5,Approved symbol,COQ5,"coenzyme Q5, methyltransferase",HGNC:28722,12q24.31
CORO2A,Approved symbol,CORO2A,coronin 2A,HGNC:2255,9q22.33
CORO2B,Approved symbol,CORO2B,coronin 2B,HGNC:2256,15q23
CORT,Approved symbol,CORT,cortistatin,HGNC:2257,1p36.22
COX15,Approved symbol,COX15,cytochrome c oxidase assembly homolog COX15,HGNC:2263,10q24.2
COX7B2,Approved symbol,COX7B2,cytochrome c oxidase subunit 7B2,HGNC:24381,4p12
CPA6,Approved symbol,CPA6,carboxypeptidase A6,HGNC:17245,8q13.2
CPA6,Alias symbol,CYP2A6,cytochrome P450 family 2 subfamily A member 6,HGNC:2610,19q13.2
CPAMD8,Approved symbol,CPAMD8,C3 and PZP like alpha-2-macroglobulin domain containing 8,HGNC:23228,19p13.11
CPD,Approved symbol,CPD,carboxypeptidase D,HGNC:2301,17q11.2
CPD,Alias symbol,HOMER2,homer scaffold protein 2,HGNC:17513,15q25.2
CPEB2,Approved symbol,CPEB2,cytoplasmic polyadenylation element binding protein 2,HGNC:21745,4p15.32
CPNE5,Approved symbol,CPNE5,copine 5,HGNC:2318,6p21.2
CPNE7,Approved symbol,CPNE7,copine 7,HGNC:2320,16q24.3
CPS1,Approved symbol,CPS1,carbamoyl-phosphate synthase 1,HGNC:2323,2q34
CPS1,Alias symbol,CYP21A2,cytochrome P450 family 21 subfamily A member 2,HGNC:2600,6p21.33
CPS1,Alias symbol,PM20D1,peptidase M20 domain containing 1,HGNC:26518,1q32.1
CPSF1,Approved symbol,CPSF1,cleavage and polyadenylation specific factor 1,HGNC:2324,8q24.3
CPSF3L,Previous symbol,INTS11,integrator complex subunit 11,HGNC:26052,1p36.33
CPSF6,Approved symbol,CPSF6,cleavage and polyadenylation specific factor 6,HGNC:13871,12q15
CPT1B,Approved symbol,CPT1B,carnitine palmitoyltransferase 1B,HGNC:2329,22q13.33
CPXM2,Approved symbol,CPXM2,"carboxypeptidase X, M14 family member 2",HGNC:26977,10q26.13
CR1,Approved symbol,CR1,complement C3b/C4b receptor 1 (Knops blood group),HGNC:2334,1q32.2
CRAMP1L,Previous symbol,CRAMP1,cramped chromatin regulator homolog 1,HGNC:14122,16p13.3
CRB1,Approved symbol,CRB1,crumbs cell polarity complex component 1,HGNC:2343,1q31.3
CRB2,Approved symbol,CRB2,crumbs cell polarity complex component 2,HGNC:18688,9q33.3
CREBBP,Approved symbol,CREBBP,CREB binding protein,HGNC:2348,16p13.3
CREG1,Approved symbol,CREG1,cellular repressor of E1A stimulated genes 1,HGNC:2351,1q24.2
CRHBP,Approved symbol,CRHBP,corticotropin releasing hormone binding protein,HGNC:2356,5q13.3
CRHR1,Approved symbol,CRHR1,corticotropin releasing hormone receptor 1,HGNC:2357,17q21.31
CRIM1,Approved symbol,CRIM1,cysteine rich transmembrane BMP regulator 1,HGNC:2359,2p22.2
CRIP2,Approved symbol,CRIP2,cysteine rich protein 2,HGNC:2361,14q32.33
CRISP1,Approved symbol,CRISP1,cysteine rich secretory protein 1,HGNC:304,6p12.3
CRISPLD2,Approved symbol,CRISPLD2,cysteine rich secretory protein LCCL domain containing 2,HGNC:25248,16q24.1
CRMP1,Approved symbol,CRMP1,collapsin response mediator protein 1,HGNC:2365,4p16.2
CROCC,Approved symbol,CROCC,"ciliary rootlet coiled-coil, rootletin",HGNC:21299,1p36.13
CRTAC1,Approved symbol,CRTAC1,cartilage acidic protein 1,HGNC:14882,10q24.2
CRTAP,Approved symbol,CRTAP,cartilage associated protein,HGNC:2379,3p22.3
CRY2,Approved symbol,CRY2,cryptochrome circadian regulator 2,HGNC:2385,11p11.2
CRYBA4,Approved symbol,CRYBA4,crystallin beta A4,HGNC:2396,22q12.1
CRYBG3,Approved symbol,CRYBG3,crystallin beta-gamma domain containing 3,HGNC:34427,3q11.2
CRYZL1,Approved symbol,CRYZL1,crystallin zeta like 1,HGNC:2420,21q22.11
CSF1R,Approved symbol,CSF1R,colony stimulating factor 1 receptor,HGNC:2433,5q32
CSF2RB,Approved symbol,CSF2RB,colony stimulating factor 2 receptor subunit beta,HGNC:2436,22q12.3
CSF3R,Approved symbol,CSF3R,colony stimulating factor 3 receptor,HGNC:2439,1p34.3
CSH1,Approved symbol,CSH1,chorionic somatomammotropin hormone 1,HGNC:2440,17q23.3
CSHL1,Approved symbol,CSHL1,chorionic somatomammotropin hormone like 1,HGNC:2442,17q23.3
CSMD1,Approved symbol,CSMD1,CUB and Sushi multiple domains 1,HGNC:14026,8p23.2
CSMD2,Approved symbol,CSMD2,CUB and Sushi multiple domains 2,HGNC:19290,1p35.1
CSMD3,Approved symbol,CSMD3,CUB and Sushi multiple domains 3,HGNC:19291,8q23.3
CSNK1A1,Approved symbol,CSNK1A1,casein kinase 1 alpha 1,HGNC:2451,5q32
CSNK1A1L,Approved symbol,CSNK1A1L,casein kinase 1 alpha 1 like,HGNC:20289,13q13.3
CSNK1D,Approved symbol,CSNK1D,casein kinase 1 delta,HGNC:2452,17q25.3
CSPG4,Approved symbol,CSPG4,chondroitin sulfate proteoglycan 4,HGNC:2466,15q24.2
CSPG5,Approved symbol,CSPG5,chondroitin sulfate proteoglycan 5,HGNC:2467,3p21.31
CSRNP1,Approved symbol,CSRNP1,cysteine and serine rich nuclear protein 1,HGNC:14300,3p22.2
CSRP3,Approved symbol,CSRP3,cysteine and glycine rich protein 3,HGNC:2472,11p15.1
CSTA,Approved symbol,CSTA,cystatin A,HGNC:2481,3q21.1
CT47B1,Approved symbol,CT47B1,cancer/testis antigen family 47 member B1,HGNC:33293,Xq24
CT55,Approved symbol,CT55,cancer/testis antigen 55,HGNC:26047,Xq26.3
CTAGE5,Previous symbol,MIA2,MIA SH3 domain ER export factor 2,HGNC:18432,14q13.2
ZNF229,Approved symbol,ZNF229,zinc finger protein 229,HGNC:13022,19q13.31
CTC-786C10.1,Unmatched,,,,
CTCFL,Approved symbol,CTCFL,CCCTC-binding factor like,HGNC:16234,20q13.31
CTD-2325P2.3,Unmatched,,,,
PRDM11,Approved symbol,PRDM11,PR/SET domain 11,HGNC:13996,11p11.2
PTP4A3,Approved symbol,PTP4A3,protein tyrosine phosphatase 4A3,HGNC:9636,8q24.3
CTF1,Approved symbol,CTF1,cardiotrophin 1,HGNC:2499,16p11.2
CTH,Approved symbol,CTH,cystathionine gamma-lyase,HGNC:2501,1p31.1
CTH,Alias symbol,VSIG2,V-set and immunoglobulin domain containing 2,HGNC:17149,11q24.2
CTNNA1,Approved symbol,CTNNA1,catenin alpha 1,HGNC:2509,5q31.2
CTNNA2,Approved symbol,CTNNA2,catenin alpha 2,HGNC:2510,2p12
CTNND2,Approved symbol,CTNND2,catenin delta 2,HGNC:2516,5p15.2
CTSC,Approved symbol,CTSC,cathepsin C,HGNC:2528,11q14.2
CTSF,Approved symbol,CTSF,cathepsin F,HGNC:2531,11q13.2
CTTN,Approved symbol,CTTN,cortactin,HGNC:3338,11q13.3
CTTNBP2,Approved symbol,CTTNBP2,cortactin binding protein 2,HGNC:15679,7q31.31
CTU1,Approved symbol,CTU1,cytosolic thiouridylase subunit 1,HGNC:29590,19q13.41
CUBN,Approved symbol,CUBN,cubilin,HGNC:2548,10p13
CUEDC1,Approved symbol,CUEDC1,CUE domain containing 1,HGNC:31350,17q22
CUEDC2,Approved symbol,CUEDC2,CUE domain containing 2,HGNC:28352,10q24.32
CUL3,Approved symbol,CUL3,cullin 3,HGNC:2553,2q36.2
CUL4A,Approved symbol,CUL4A,cullin 4A,HGNC:2554,13q34
CUL9,Approved symbol,CUL9,cullin 9,HGNC:15982,6p21.1
CUX2,Approved symbol,CUX2,cut like homeobox 2,HGNC:19347,12q24.11-q24.12
CWC25,Approved symbol,CWC25,CWC25 spliceosome associated protein homolog,HGNC:25989,17q12
CXADR,Approved symbol,CXADR,CXADR Ig-like cell adhesion molecule,HGNC:2559,21q21.1
CXCL14,Approved symbol,CXCL14,C-X-C motif chemokine ligand 14,HGNC:10640,5q31.1
CXCR5,Approved symbol,CXCR5,C-X-C motif chemokine receptor 5,HGNC:1060,11q23.3
CXorf21,Previous symbol,TASL,TLR adaptor interacting with endolysosomal SLC15A4,HGNC:25667,Xp21.2
CXorf22,Previous symbol,CFAP47,cilia and flagella associated protein 47,HGNC:26708,Xp21.1
CXorf64,Previous symbol,PRR32,proline rich 32,HGNC:34498,Xq25
CYB5R2,Approved symbol,CYB5R2,cytochrome b5 reductase 2,HGNC:24376,11p15.4
CYB5R3,Approved symbol,CYB5R3,cytochrome b5 reductase 3,HGNC:2873,22q13.2
CYFIP1,Approved symbol,CYFIP1,cytoplasmic FMR1 interacting protein 1,HGNC:13759,15q11.2
CYLC1,Approved symbol,CYLC1,cylicin 1,HGNC:2582,Xq21.1
CYLD,Approved symbol,CYLD,CYLD lysine 63 deubiquitinase,HGNC:2584,16q12.1
CYP11A1,Approved symbol,CYP11A1,cytochrome P450 family 11 subfamily A member 1,HGNC:2590,15q24.1
CYP17A1,Approved symbol,CYP17A1,cytochrome P450 family 17 subfamily A member 1,HGNC:2593,10q24.32
CYP21A2,Approved symbol,CYP21A2,cytochrome P450 family 21 subfamily A member 2,HGNC:2600,6p21.33
CYP26A1,Approved symbol,CYP26A1,cytochrome P450 family 26 subfamily A member 1,HGNC:2603,10q23.33
CYP26C1,Approved symbol,CYP26C1,cytochrome P450 family 26 subfamily C member 1,HGNC:20577,10q23.33
CYP2A7,Approved symbol,CYP2A7,cytochrome P450 family 2 subfamily A member 7,HGNC:2611,19q13.2
CYP2F1,Approved symbol,CYP2F1,cytochrome P450 family 2 subfamily F member 1,HGNC:2632,19q13.2
CYP2S1,Approved symbol,CYP2S1,cytochrome P450 family 2 subfamily S member 1,HGNC:15654,19q13.2
CYP2W1,Approved symbol,CYP2W1,cytochrome P450 family 2 subfamily W member 1,HGNC:20243,7p22.3
CYP3A5,Approved symbol,CYP3A5,cytochrome P450 family 3 subfamily A member 5,HGNC:2638,7q22.1
CYP4F11,Approved symbol,CYP4F11,cytochrome P450 family 4 subfamily F member 11,HGNC:13265,19p13.12
DAAM1,Approved symbol,DAAM1,dishevelled associated activator of morphogenesis 1,HGNC:18142,14q23.1
DAAM2,Approved symbol,DAAM2,dishevelled associated activator of morphogenesis 2,HGNC:18143,6p21.2
DAB1,Approved symbol,DAB1,DAB adaptor protein 1,HGNC:2661,1p32.2
DACH2,Approved symbol,DACH2,dachshund family transcription factor 2,HGNC:16814,Xq21.2
DACT1,Approved symbol,DACT1,dishevelled binding antagonist of beta catenin 1,HGNC:17748,14q23.1
DACT2,Approved symbol,DACT2,dishevelled binding antagonist of beta catenin 2,HGNC:21231,6q27
DAG1,Approved symbol,DAG1,dystroglycan 1,HGNC:2666,3p21.31
DAGLA,Approved symbol,DAGLA,diacylglycerol lipase alpha,HGNC:1165,11q12.2
DAGLB,Approved symbol,DAGLB,diacylglycerol lipase beta,HGNC:28923,7p22.1
DAK,Previous symbol,TKFC,triokinase and FMN cyclase,HGNC:24552,11q12.2
DAPK1,Approved symbol,DAPK1,death associated protein kinase 1,HGNC:2674,9q21.33
DAZAP1,Approved symbol,DAZAP1,DAZ associated protein 1,HGNC:2683,19p13.3
DBNL,Approved symbol,DBNL,drebrin like,HGNC:2696,7p13
DBX2,Approved symbol,DBX2,developing brain homeobox 2,HGNC:33186,12q12
DCAF12L1,Approved symbol,DCAF12L1,DDB1 and CUL4 associated factor 12 like 1,HGNC:29395,Xq25
DCAF12L2,Approved symbol,DCAF12L2,DDB1 and CUL4 associated factor 12 like 2,HGNC:32950,Xq25
DCAF6,Approved symbol,DCAF6,DDB1 and CUL4 associated factor 6,HGNC:30002,1q24.2
DCAF8L1,Approved symbol,DCAF8L1,DDB1 and CUL4 associated factor 8 like 1,HGNC:31810,Xp21.3
DCC,Approved symbol,DCC,DCC netrin 1 receptor,HGNC:2701,18q21.2
DCD,Approved symbol,DCD,dermcidin,HGNC:14669,12q13.2
DCDC1,Approved symbol,DCDC1,doublecortin domain containing 1,HGNC:20625,11p14.1
DCHS1,Approved symbol,DCHS1,dachsous cadherin-related 1,HGNC:13681,11p15.4
DCHS2,Approved symbol,DCHS2,dachsous cadherin-related 2,HGNC:23111,4q31.3
DCLK1,Approved symbol,DCLK1,doublecortin like kinase 1,HGNC:2700,13q13.3
DCLK2,Approved symbol,DCLK2,doublecortin like kinase 2,HGNC:19002,4q31.23-q31.3
DCLRE1B,Approved symbol,DCLRE1B,DNA cross-link repair 1B,HGNC:17641,1p13.2
DCLRE1C,Approved symbol,DCLRE1C,DNA cross-link repair 1C,HGNC:17642,10p13
DCPS,Approved symbol,DCPS,"decapping enzyme, scavenger",HGNC:29812,11q24.2
DCTD,Approved symbol,DCTD,dCMP deaminase,HGNC:2710,4q35.1
DCUN1D1,Approved symbol,DCUN1D1,defective in cullin neddylation 1 domain containing 1,HGNC:18184,3q26.33
DCUN1D3,Approved symbol,DCUN1D3,defective in cullin neddylation 1 domain containing 3,HGNC:28734,16p12.3
DDAH1,Approved symbol,DDAH1,dimethylarginine dimethylaminohydrolase 1,HGNC:2715,1p22.3
DDC,Approved symbol,DDC,dopa decarboxylase,HGNC:2719,7p12.2-p12.1
DDHD2,Approved symbol,DDHD2,DDHD domain containing 2,HGNC:29106,8p11.23
DDR2,Approved symbol,DDR2,discoidin domain receptor tyrosine kinase 2,HGNC:2731,1q23.3
DDX18,Approved symbol,DDX18,DEAD-box helicase 18,HGNC:2741,2q14.1
DDX20,Approved symbol,DDX20,DEAD-box helicase 20,HGNC:2743,1p13.2
DDX25,Approved symbol,DDX25,DEAD-box helicase 25,HGNC:18698,11q24.2
DDX26B,Previous symbol,INTS6L,integrator complex subunit 6 like,HGNC:27334,Xq26.3
DDX31,Approved symbol,DDX31,DEAD-box helicase 31,HGNC:16715,9q34.13
DDX58,Approved symbol,DDX58,DExD/H-box helicase 58,HGNC:19102,9p21.1
DDX59,Approved symbol,DDX59,DEAD-box helicase 59,HGNC:25360,1q32.1
DEFB113,Approved symbol,DEFB113,defensin beta 113,HGNC:18094,6p12.3
DEFB118,Approved symbol,DEFB118,defensin beta 118,HGNC:16196,20q11.21
DENND2A,Approved symbol,DENND2A,DENN domain containing 2A,HGNC:22212,7q34
DENND2D,Approved symbol,DENND2D,DENN domain containing 2D,HGNC:26192,1p13.3-p13.2
DENND4A,Approved symbol,DENND4A,DENN domain containing 4A,HGNC:24321,15q22.31
DENND5B,Approved symbol,DENND5B,DENN domain containing 5B,HGNC:28338,12p11.21
DENND6B,Approved symbol,DENND6B,DENN domain containing 6B,HGNC:32690,22q13.33
DEPDC1,Approved symbol,DEPDC1,DEP domain containing 1,HGNC:22949,1p31.3
DEPDC5,Approved symbol,DEPDC5,"DEP domain containing 5, GATOR1 subcomplex subunit",HGNC:18423,22q12.2-q12.3
DFFA,Approved symbol,DFFA,DNA fragmentation factor subunit alpha,HGNC:2772,1p36.22
DFNA5,Previous symbol,GSDME,gasdermin E,HGNC:2810,7p15.3
DGAT1,Approved symbol,DGAT1,diacylglycerol O-acyltransferase 1,HGNC:2843,8q24.3
DGKD,Approved symbol,DGKD,diacylglycerol kinase delta,HGNC:2851,2q37.1
DGKH,Approved symbol,DGKH,diacylglycerol kinase eta,HGNC:2854,13q14.11
DGKI,Approved symbol,DGKI,diacylglycerol kinase iota,HGNC:2855,7q33
DGKZ,Approved symbol,DGKZ,diacylglycerol kinase zeta,HGNC:2857,11p11.2
DHCR7,Approved symbol,DHCR7,7-dehydrocholesterol reductase,HGNC:2860,11q13.4
DHDH,Approved symbol,DHDH,dihydrodiol dehydrogenase,HGNC:17887,19q13.33
DHRS4L2,Approved symbol,DHRS4L2,dehydrogenase/reductase 4 like 2,HGNC:19731,14q11.2
DHRS9,Approved symbol,DHRS9,dehydrogenase/reductase 9,HGNC:16888,2q31.1
DHRSX,Approved symbol,DHRSX,dehydrogenase/reductase X-linked,HGNC:18399,Xp22.33 and Yp11.2
DHX15,Approved symbol,DHX15,DEAH-box helicase 15,HGNC:2738,4p15.2
DHX29,Approved symbol,DHX29,DExH-box helicase 29,HGNC:15815,5q11.2
DHX30,Approved symbol,DHX30,DExH-box helicase 30,HGNC:16716,3p21.31
DHX32,Approved symbol,DHX32,DEAH-box helicase 32 (putative),HGNC:16717,10q26.2
DHX33,Approved symbol,DHX33,DEAH-box helicase 33,HGNC:16718,17p13.2
DHX34,Approved symbol,DHX34,DExH-box helicase 34,HGNC:16719,19q13.32
DHX37,Approved symbol,DHX37,DEAH-box helicase 37,HGNC:17210,12q24.31
DIAPH1,Approved symbol,DIAPH1,diaphanous related formin 1,HGNC:2876,5q31.3
DIAPH2,Approved symbol,DIAPH2,diaphanous related formin 2,HGNC:2877,Xq21.33
DIAPH3,Approved symbol,DIAPH3,diaphanous related formin 3,HGNC:15480,13q21.2
DICER1,Approved symbol,DICER1,"dicer 1, ribonuclease III",HGNC:17098,14q32.13
DIO2,Approved symbol,DIO2,iodothyronine deiodinase 2,HGNC:2884,14q31.1
DIS3L,Approved symbol,DIS3L,DIS3 like exosome 3'-5' exoribonuclease,HGNC:28698,15q22.31
DISC1,Approved symbol,DISC1,DISC1 scaffold protein,HGNC:2888,1q42.2
DKKL1,Approved symbol,DKKL1,dickkopf like acrosomal protein 1,HGNC:16528,19q13.33
DLC1,Approved symbol,DLC1,DLC1 Rho GTPase activating protein,HGNC:2897,8p22
DLC1,Alias symbol,DLEC1,DLEC1 cilia and flagella associated protein,HGNC:2899,3p22.2
DLC1,Alias symbol,DYNLL1,dynein light chain LC8-type 1,HGNC:15476,12q24.31
DLEC1,Approved symbol,DLEC1,DLEC1 cilia and flagella associated protein,HGNC:2899,3p22.2
DLG2,Approved symbol,DLG2,discs large MAGUK scaffold protein 2,HGNC:2901,11q14.1
DLG2,Previous symbol,MPP2,MAGUK p55 scaffold protein 2,HGNC:7220,17q21.31
DLG3,Approved symbol,DLG3,discs large MAGUK scaffold protein 3,HGNC:2902,Xq13.1
DLG3,Previous symbol,MPP3,MAGUK p55 scaffold protein 3,HGNC:7221,17q21.31
DLGAP1,Approved symbol,DLGAP1,DLG associated protein 1,HGNC:2905,18p11.31
DLGAP2,Approved symbol,DLGAP2,DLG associated protein 2,HGNC:2906,8p23.3
DMBT1,Approved symbol,DMBT1,deleted in malignant brain tumors 1,HGNC:2926,10q26.13
DMD,Approved symbol,DMD,dystrophin,HGNC:2928,Xp21.2-p21.1
DMKN,Approved symbol,DMKN,dermokine,HGNC:25063,19q13.12
DMRT2,Approved symbol,DMRT2,doublesex and mab-3 related transcription factor 2,HGNC:2935,9p24.3
DMXL2,Approved symbol,DMXL2,Dmx like 2,HGNC:2938,15q21.2
DNAH1,Approved symbol,DNAH1,dynein axonemal heavy chain 1,HGNC:2940,3p21.1
DNAH10,Approved symbol,DNAH10,dynein axonemal heavy chain 10,HGNC:2941,12q24.31
DNAH11,Approved symbol,DNAH11,dynein axonemal heavy chain 11,HGNC:2942,7p15.3
DNAH17,Approved symbol,DNAH17,dynein axonemal heavy chain 17,HGNC:2946,17q25.3
DNAH2,Approved symbol,DNAH2,dynein axonemal heavy chain 2,HGNC:2948,17p13.1
DNAH5,Approved symbol,DNAH5,dynein axonemal heavy chain 5,HGNC:2950,5p15.2
DNAH6,Approved symbol,DNAH6,dynein axonemal heavy chain 6,HGNC:2951,2p11.2
DNAH7,Approved symbol,DNAH7,dynein axonemal heavy chain 7,HGNC:18661,2q32.3
DNAH8,Approved symbol,DNAH8,dynein axonemal heavy chain 8,HGNC:2952,6p21.2
DNAH9,Approved symbol,DNAH9,dynein axonemal heavy chain 9,HGNC:2953,17p12
DNAI1,Approved symbol,DNAI1,dynein axonemal intermediate chain 1,HGNC:2954,9p13.3
DNAI2,Approved symbol,DNAI2,dynein axonemal intermediate chain 2,HGNC:18744,17q25.1
DNAJB1,Approved symbol,DNAJB1,DnaJ heat shock protein family (Hsp40) member B1,HGNC:5270,19p13.12
DNAJB11,Approved symbol,DNAJB11,DnaJ heat shock protein family (Hsp40) member B11,HGNC:14889,3q27.3
DNAJB3,Approved symbol,DNAJB3,DnaJ heat shock protein family (Hsp40) member B3,HGNC:32397,2q37.1
DNAJC13,Approved symbol,DNAJC13,DnaJ heat shock protein family (Hsp40) member C13,HGNC:30343,3q22.1
DNAJC14,Approved symbol,DNAJC14,DnaJ heat shock protein family (Hsp40) member C14,HGNC:24581,12q13.2
DNAJC2,Approved symbol,DNAJC2,DnaJ heat shock protein family (Hsp40) member C2,HGNC:13192,7q22.1
DNAJC25,Approved symbol,DNAJC25,DnaJ heat shock protein family (Hsp40) member C25,HGNC:34187,9q31.3
DNAJC4,Approved symbol,DNAJC4,DnaJ heat shock protein family (Hsp40) member C4,HGNC:5271,11q13.1
DNAJC6,Approved symbol,DNAJC6,DnaJ heat shock protein family (Hsp40) member C6,HGNC:15469,1p31.3
DNM1,Approved symbol,DNM1,dynamin 1,HGNC:2972,9q34.11
DNM2,Approved symbol,DNM2,dynamin 2,HGNC:2974,19p13.2
DNM3,Approved symbol,DNM3,dynamin 3,HGNC:29125,1q24.3
DNMT3B,Approved symbol,DNMT3B,DNA methyltransferase 3 beta,HGNC:2979,20q11.21
DNPEP,Approved symbol,DNPEP,aspartyl aminopeptidase,HGNC:2981,2q35
DNTT,Approved symbol,DNTT,DNA nucleotidylexotransferase,HGNC:2983,10q24.1
DNTTIP2,Approved symbol,DNTTIP2,deoxynucleotidyltransferase terminal interacting protein 2,HGNC:24013,1p22.1
DOCK1,Approved symbol,DOCK1,dedicator of cytokinesis 1,HGNC:2987,10q26.2
DOCK10,Approved symbol,DOCK10,dedicator of cytokinesis 10,HGNC:23479,2q36.2
DOCK11,Approved symbol,DOCK11,dedicator of cytokinesis 11,HGNC:23483,Xq24
DOCK2,Approved symbol,DOCK2,dedicator of cytokinesis 2,HGNC:2988,5q35.1
DOCK3,Approved symbol,DOCK3,dedicator of cytokinesis 3,HGNC:2989,3p21.2
DOCK4,Approved symbol,DOCK4,dedicator of cytokinesis 4,HGNC:19192,7q31.1
DOCK5,Approved symbol,DOCK5,dedicator of cytokinesis 5,HGNC:23476,8p21.2
DOK3,Approved symbol,DOK3,docking protein 3,HGNC:24583,5q35.3
DOK4,Approved symbol,DOK4,docking protein 4,HGNC:19868,16q21
DOK7,Approved symbol,DOK7,docking protein 7,HGNC:26594,4p16.3
DOPEY1,Previous symbol,DOP1A,DOP1 leucine zipper like protein A,HGNC:21194,6q14.1
DOPEY2,Previous symbol,DOP1B,DOP1 leucine zipper like protein B,HGNC:1291,21q22.12
DOT1L,Approved symbol,DOT1L,DOT1 like histone lysine methyltransferase,HGNC:24948,19p13.3
DPCD,Approved symbol,DPCD,deleted in primary ciliary dyskinesia homolog (mouse),HGNC:24542,10q24.32
DPF3,Approved symbol,DPF3,double PHD fingers 3,HGNC:17427,14q24.2
DPH1,Approved symbol,DPH1,diphthamide biosynthesis 1,HGNC:3003,17p13.3
DPP10,Approved symbol,DPP10,dipeptidyl peptidase like 10,HGNC:20823,2q14.1
DPP4,Approved symbol,DPP4,dipeptidyl peptidase 4,HGNC:3009,2q24.2
DPP9,Approved symbol,DPP9,dipeptidyl peptidase 9,HGNC:18648,19p13.3
DPYD,Approved symbol,DPYD,dihydropyrimidine dehydrogenase,HGNC:3012,1p21.3
DPYS,Approved symbol,DPYS,dihydropyrimidinase,HGNC:3013,8q22.3
DRP2,Approved symbol,DRP2,dystrophin related protein 2,HGNC:3032,Xq22.1
DRP2,Alias symbol,DPYSL2,dihydropyrimidinase like 2,HGNC:3014,8p21.2
DSC2,Approved symbol,DSC2,desmocollin 2,HGNC:3036,18q12.1
DSC2,Alias symbol,DSC3,desmocollin 3,HGNC:3037,18q12.1
DSCAM,Approved symbol,DSCAM,DS cell adhesion molecule,HGNC:3039,21q22.2
DSCAML1,Approved symbol,DSCAML1,DS cell adhesion molecule like 1,HGNC:14656,11q23.3
DSG2,Approved symbol,DSG2,desmoglein 2,HGNC:3049,18q12.1
DSPP,Approved symbol,DSPP,dentin sialophosphoprotein,HGNC:3054,4q22.1
DST,Approved symbol,DST,dystonin,HGNC:1090,6p12.1
DTL,Approved symbol,DTL,denticleless E3 ubiquitin protein ligase homolog,HGNC:30288,1q32.3
DTNA,Approved symbol,DTNA,dystrobrevin alpha,HGNC:3057,18q12.1
DTNBP1,Approved symbol,DTNBP1,dystrobrevin binding protein 1,HGNC:17328,6p22.3
DTX2,Approved symbol,DTX2,deltex E3 ubiquitin ligase 2,HGNC:15973,7q11.23
DTX3L,Approved symbol,DTX3L,deltex E3 ubiquitin ligase 3L,HGNC:30323,3q21.1
DUOX2,Approved symbol,DUOX2,dual oxidase 2,HGNC:13273,15q21.1
DUOXA1,Approved symbol,DUOXA1,dual oxidase maturation factor 1,HGNC:26507,15q21.1
DUS1L,Approved symbol,DUS1L,dihydrouridine synthase 1 like,HGNC:30086,17q25.3
DUS2,Approved symbol,DUS2,dihydrouridine synthase 2,HGNC:26014,16q22.1
DUS3L,Approved symbol,DUS3L,dihydrouridine synthase 3 like,HGNC:26920,19p13.3
DUSP11,Approved symbol,DUSP11,dual specificity phosphatase 11,HGNC:3066,2p13.1
DUSP13,Approved symbol,DUSP13,dual specificity phosphatase 13,HGNC:19681,10q22.2
DUSP19,Approved symbol,DUSP19,dual specificity phosphatase 19,HGNC:18894,2q32.1
DUSP22,Approved symbol,DUSP22,dual specificity phosphatase 22,HGNC:16077,6p25.3
DUSP28,Approved symbol,DUSP28,dual specificity phosphatase 28,HGNC:33237,2q37.3
DUSP8,Approved symbol,DUSP8,dual specificity phosphatase 8,HGNC:3074,11p15.5
DVL1,Approved symbol,DVL1,dishevelled segment polarity protein 1,HGNC:3084,1p36.33
DYM,Approved symbol,DYM,dymeclin,HGNC:21317,18q21.1
DYNC1I1,Approved symbol,DYNC1I1,dynein cytoplasmic 1 intermediate chain 1,HGNC:2963,7q21.3
DYNC2H1,Approved symbol,DYNC2H1,dynein cytoplasmic 2 heavy chain 1,HGNC:2962,11q22.3
DYRK1B,Approved symbol,DYRK1B,dual specificity tyrosine phosphorylation regulated kinase 1B,HGNC:3092,19q13.2
DYRK4,Approved symbol,DYRK4,dual specificity tyrosine phosphorylation regulated kinase 4,HGNC:3095,12p13.32
DYSF,Approved symbol,DYSF,dysferlin,HGNC:3097,2p13.2
DYTN,Approved symbol,DYTN,dystrotelin,HGNC:23279,2q33.3
DZANK1,Approved symbol,DZANK1,double zinc ribbon and ankyrin repeat domains 1,HGNC:15858,20p11.23
DZIP1,Approved symbol,DZIP1,DAZ interacting zinc finger protein 1,HGNC:20908,13q32.1
DZIP3,Approved symbol,DZIP3,DAZ interacting zinc finger protein 3,HGNC:30938,3q13.13
E2F2,Approved symbol,E2F2,E2F transcription factor 2,HGNC:3114,1p36.12
E2F7,Approved symbol,E2F7,E2F transcription factor 7,HGNC:23820,12q21.2
EBF2,Approved symbol,EBF2,EBF transcription factor 2,HGNC:19090,8p21.2
EBF3,Approved symbol,EBF3,EBF transcription factor 3,HGNC:19087,10q26.3
EBLN2,Approved symbol,EBLN2,endogenous Bornavirus like nucleoprotein 2,HGNC:25493,3p13
ECI1,Approved symbol,ECI1,enoyl-CoA delta isomerase 1,HGNC:2703,16p13.3
ECM2,Approved symbol,ECM2,extracellular matrix protein 2,HGNC:3154,9q22.31
ECT2,Approved symbol,ECT2,epithelial cell transforming 2,HGNC:3155,3q26.31
ECT2L,Approved symbol,ECT2L,epithelial cell transforming 2 like,HGNC:21118,6q24.1
EDA,Approved symbol,EDA,ectodysplasin A,HGNC:3157,Xq13.1
EDAR,Approved symbol,EDAR,ectodysplasin A receptor,HGNC:2895,2q13
EDIL3,Approved symbol,EDIL3,EGF like repeats and discoidin domains 3,HGNC:3173,5q14.3
EEA1,Approved symbol,EEA1,early endosome antigen 1,HGNC:3185,12q22
EEF1A1,Approved symbol,EEF1A1,eukaryotic translation elongation factor 1 alpha 1,HGNC:3189,6q13
EEF2K,Approved symbol,EEF2K,eukaryotic elongation factor 2 kinase,HGNC:24615,16p12.2
EEFSEC,Approved symbol,EEFSEC,"eukaryotic elongation factor, selenocysteine-tRNA specific",HGNC:24614,3q21.3
EEPD1,Approved symbol,EEPD1,endonuclease/exonuclease/phosphatase family domain containing 1,HGNC:22223,7p14.2
EFCAB12,Approved symbol,EFCAB12,EF-hand calcium binding domain 12,HGNC:28061,3q21.3
EFCAB2,Approved symbol,EFCAB2,EF-hand calcium binding domain 2,HGNC:28166,1q44
EFCAB3,Approved symbol,EFCAB3,EF-hand calcium binding domain 3,HGNC:26379,17q23.2
EFCAB5,Approved symbol,EFCAB5,EF-hand calcium binding domain 5,HGNC:24801,17q11.2
EFCAB6,Approved symbol,EFCAB6,EF-hand calcium binding domain 6,HGNC:24204,22q13.2-q13.31
EFHC1,Approved symbol,EFHC1,EF-hand domain containing 1,HGNC:16406,6p12.2
EFHD1,Approved symbol,EFHD1,EF-hand domain family member D1,HGNC:29556,2q37.1
EFR3B,Approved symbol,EFR3B,EFR3 homolog B,HGNC:29155,2p23.3
EFTUD1,Previous symbol,EFL1,elongation factor like GTPase 1,HGNC:25789,15q25.2
EGFL7,Approved symbol,EGFL7,EGF like domain multiple 7,HGNC:20594,9q34.3
EGFLAM,Approved symbol,EGFLAM,"EGF like, fibronectin type III and laminin G domains",HGNC:26810,5p13.2-p13.1
EGR4,Approved symbol,EGR4,early growth response 4,HGNC:3241,2p13.2
EHBP1L1,Approved symbol,EHBP1L1,EH domain binding protein 1 like 1,HGNC:30682,11q13.1
EHD1,Approved symbol,EHD1,EH domain containing 1,HGNC:3242,11q13.1
EHHADH,Approved symbol,EHHADH,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase,HGNC:3247,3q27.2
EHMT2,Approved symbol,EHMT2,euchromatic histone lysine methyltransferase 2,HGNC:14129,6p21.33
EIF2AK4,Approved symbol,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,HGNC:19687,15q15.1
EIF4A2,Approved symbol,EIF4A2,eukaryotic translation initiation factor 4A2,HGNC:3284,3q27.3
EIF4E1B,Approved symbol,EIF4E1B,eukaryotic translation initiation factor 4E family member 1B,HGNC:33179,5q35.2
EIF4E2,Approved symbol,EIF4E2,eukaryotic translation initiation factor 4E family member 2,HGNC:3293,2q37.1
EIF4G1,Approved symbol,EIF4G1,eukaryotic translation initiation factor 4 gamma 1,HGNC:3296,3q27.1
EIF4G3,Approved symbol,EIF4G3,eukaryotic translation initiation factor 4 gamma 3,HGNC:3298,1p36.12
EIF5A,Approved symbol,EIF5A,eukaryotic translation initiation factor 5A,HGNC:3300,17p13.1
ELFN1,Approved symbol,ELFN1,extracellular leucine rich repeat and fibronectin type III domain containing 1,HGNC:33154,7p22.3
ELFN2,Approved symbol,ELFN2,extracellular leucine rich repeat and fibronectin type III domain containing 2,HGNC:29396,22q13.1
ELK1,Approved symbol,ELK1,ETS transcription factor ELK1,HGNC:3321,Xp11.23
ELK1,Alias symbol,KCNH4,potassium voltage-gated channel subfamily H member 4,HGNC:6253,17q21.2
ELL,Approved symbol,ELL,elongation factor for RNA polymerase II,HGNC:23114,19p13.11
ELMO3,Approved symbol,ELMO3,engulfment and cell motility 3,HGNC:17289,16q22.1
ELP4,Approved symbol,ELP4,elongator acetyltransferase complex subunit 4,HGNC:1171,11p13
ELTD1,Previous symbol,ADGRL4,adhesion G protein-coupled receptor L4,HGNC:20822,1p31.1
EMILIN1,Approved symbol,EMILIN1,elastin microfibril interfacer 1,HGNC:19880,2p23.3
EML6,Approved symbol,EML6,EMAP like 6,HGNC:35412,2p16.1
EN1,Approved symbol,EN1,engrailed homeobox 1,HGNC:3342,2q14.2
ENDOD1,Approved symbol,ENDOD1,endonuclease domain containing 1,HGNC:29129,11q21
ENDOV,Approved symbol,ENDOV,endonuclease V,HGNC:26640,17q25.3
ENO2,Approved symbol,ENO2,enolase 2,HGNC:3353,12p13.31
ENOX1,Approved symbol,ENOX1,ecto-NOX disulfide-thiol exchanger 1,HGNC:25474,13q14.11
ENOX2,Approved symbol,ENOX2,ecto-NOX disulfide-thiol exchanger 2,HGNC:2259,Xq26.1
ENPEP,Approved symbol,ENPEP,glutamyl aminopeptidase,HGNC:3355,4q25
ENPP2,Approved symbol,ENPP2,ectonucleotide pyrophosphatase/phosphodiesterase 2,HGNC:3357,8q24.12
ENPP4,Approved symbol,ENPP4,ectonucleotide pyrophosphatase/phosphodiesterase 4,HGNC:3359,6p21.1
ENPP7,Approved symbol,ENPP7,ectonucleotide pyrophosphatase/phosphodiesterase 7,HGNC:23764,17q25.3
ENSR00000287235,Unmatched,,,,
ENSR00000371346,Unmatched,,,,
ENSR00000413817,Unmatched,,,,
ENTPD1,Approved symbol,ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1,HGNC:3363,10q24.1
ENTPD1-AS1,Approved symbol,ENTPD1-AS1,ENTPD1 antisense RNA 1,HGNC:45203,10q24.1
ENTPD7,Approved symbol,ENTPD7,ectonucleoside triphosphate diphosphohydrolase 7,HGNC:19745,10q24.2
EP300,Approved symbol,EP300,E1A binding protein p300,HGNC:3373,22q13.2
EP400,Approved symbol,EP400,E1A binding protein p400,HGNC:11958,12q24.33
EPB41L3,Approved symbol,EPB41L3,erythrocyte membrane protein band 4.1 like 3,HGNC:3380,18p11.31
EPB41L4A,Approved symbol,EPB41L4A,erythrocyte membrane protein band 4.1 like 4A,HGNC:13278,5q22.1-q22.2
EPB41L4B,Approved symbol,EPB41L4B,erythrocyte membrane protein band 4.1 like 4B,HGNC:19818,9q31.3
EPB42,Approved symbol,EPB42,erythrocyte membrane protein band 4.2,HGNC:3381,15q15.2
EPC1,Approved symbol,EPC1,enhancer of polycomb homolog 1,HGNC:19876,10p11.22
EPG5,Approved symbol,EPG5,ectopic P-granules 5 autophagy tethering factor,HGNC:29331,18q12.3-q21.1
EPHA10,Approved symbol,EPHA10,EPH receptor A10,HGNC:19987,1p34.3
EPHA3,Approved symbol,EPHA3,EPH receptor A3,HGNC:3387,3p11.1
EPHA7,Approved symbol,EPHA7,EPH receptor A7,HGNC:3390,6q16.1
EPHA8,Approved symbol,EPHA8,EPH receptor A8,HGNC:3391,1p36.12
EPHB2,Approved symbol,EPHB2,EPH receptor B2,HGNC:3393,1p36.12
EPHX3,Approved symbol,EPHX3,epoxide hydrolase 3,HGNC:23760,19p13.12
EPM2A,Approved symbol,EPM2A,"EPM2A glucan phosphatase, laforin",HGNC:3413,6q24.3
EPN2,Approved symbol,EPN2,epsin 2,HGNC:18639,17p11.2
EPPK1,Approved symbol,EPPK1,epiplakin 1,HGNC:15577,8q24.3
EPS15L1,Approved symbol,EPS15L1,epidermal growth factor receptor pathway substrate 15 like 1,HGNC:24634,19p13.11
EPS8,Approved symbol,EPS8,epidermal growth factor receptor pathway substrate 8,HGNC:3420,12p12.3
EPS8L1,Approved symbol,EPS8L1,EPS8 like 1,HGNC:21295,19q13.42
EQTN,Approved symbol,EQTN,equatorin,HGNC:1359,9p21.2
ERAS,Approved symbol,ERAS,ES cell expressed Ras,HGNC:5174,Xp11.23
ERBB2IP,Previous symbol,ERBIN,erbb2 interacting protein,HGNC:15842,5q12.3
ERBB3,Approved symbol,ERBB3,erb-b2 receptor tyrosine kinase 3,HGNC:3431,12q13.2
ERBB4,Approved symbol,ERBB4,erb-b2 receptor tyrosine kinase 4,HGNC:3432,2q34
ERC2,Approved symbol,ERC2,ELKS/RAB6-interacting/CAST family member 2,HGNC:31922,3p14.3
ERCC6L,Approved symbol,ERCC6L,"ERCC excision repair 6 like, spindle assembly checkpoint helicase",HGNC:20794,Xq13.1
ERCC6L2,Approved symbol,ERCC6L2,ERCC excision repair 6 like 2,HGNC:26922,9q22.32
ERGIC2,Approved symbol,ERGIC2,ERGIC and golgi 2,HGNC:30208,12p11.22
ERI3,Approved symbol,ERI3,ERI1 exoribonuclease family member 3,HGNC:17276,1p34.1
ERN2,Approved symbol,ERN2,endoplasmic reticulum to nucleus signaling 2,HGNC:16942,16p12.2
ERO1LB,Previous symbol,ERO1B,endoplasmic reticulum oxidoreductase 1 beta,HGNC:14355,1q42.3
ERP44,Approved symbol,ERP44,endoplasmic reticulum protein 44,HGNC:18311,9q31.1
ESPL1,Approved symbol,ESPL1,"extra spindle pole bodies like 1, separase",HGNC:16856,12q13.13
ESPN,Approved symbol,ESPN,espin,HGNC:13281,1p36.31
ESR1,Approved symbol,ESR1,estrogen receptor 1,HGNC:3467,6q25.1-q25.2
ESRP1,Approved symbol,ESRP1,epithelial splicing regulatory protein 1,HGNC:25966,8q22.1
ESRRG,Approved symbol,ESRRG,estrogen related receptor gamma,HGNC:3474,1q41
ESYT2,Approved symbol,ESYT2,extended synaptotagmin 2,HGNC:22211,7q36.3
ETAA1,Approved symbol,ETAA1,ETAA1 activator of ATR kinase,HGNC:24648,2p14
ETF1,Approved symbol,ETF1,eukaryotic translation termination factor 1,HGNC:3477,5q31.2
ETNK1,Approved symbol,ETNK1,ethanolamine kinase 1,HGNC:24649,12p12.1
ETV1,Approved symbol,ETV1,ETS variant transcription factor 1,HGNC:3490,7p21.2
ETV3L,Approved symbol,ETV3L,ETS variant transcription factor 3 like,HGNC:33834,1q23.1
ETV5,Approved symbol,ETV5,ETS variant transcription factor 5,HGNC:3494,3q27.2
EVC,Approved symbol,EVC,EvC ciliary complex subunit 1,HGNC:3497,4p16.2
EVC2,Approved symbol,EVC2,EvC ciliary complex subunit 2,HGNC:19747,4p16.2
EVI5,Approved symbol,EVI5,ecotropic viral integration site 5,HGNC:3501,1p22.1
EVPL,Approved symbol,EVPL,envoplakin,HGNC:3503,17q25.1
EVX1,Approved symbol,EVX1,even-skipped homeobox 1,HGNC:3506,7p15.2
EXO1,Approved symbol,EXO1,exonuclease 1,HGNC:3511,1q43
EXOC3L1,Approved symbol,EXOC3L1,exocyst complex component 3 like 1,HGNC:27540,16q22.1
EXOSC2,Approved symbol,EXOSC2,exosome component 2,HGNC:17097,9q34.12
EXOSC5,Approved symbol,EXOSC5,exosome component 5,HGNC:24662,19q13.2
EXOSC9,Approved symbol,EXOSC9,exosome component 9,HGNC:9137,4q27
EXPH5,Approved symbol,EXPH5,exophilin 5,HGNC:30578,11q22.3
EXT1,Approved symbol,EXT1,exostosin glycosyltransferase 1,HGNC:3512,8q24.11
EXT2,Approved symbol,EXT2,exostosin glycosyltransferase 2,HGNC:3513,11p11.2
EYA4,Approved symbol,EYA4,EYA transcriptional coactivator and phosphatase 4,HGNC:3522,6q23.2
EYS,Approved symbol,EYS,eyes shut homolog,HGNC:21555,6q12
EZH2,Approved symbol,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,HGNC:3527,7q36.1
F8,Approved symbol,F8,coagulation factor VIII,HGNC:3546,Xq28
F9,Approved symbol,F9,coagulation factor IX,HGNC:3551,Xq27.1
FAM101A,Previous symbol,RFLNA,refilin A,HGNC:27051,12q24.31
FAM105A,Previous symbol,OTULINL,OTU deubiquitinase with linear linkage specificity like,HGNC:25629,5p15.2
FAM107B,Approved symbol,FAM107B,family with sequence similarity 107 member B,HGNC:23726,10p13
FAM110C,Approved symbol,FAM110C,family with sequence similarity 110 member C,HGNC:33340,2p25.3
FAM115A,Previous symbol,TCAF1,TRPM8 channel associated factor 1,HGNC:22201,7q35
FAM120AOS,Approved symbol,FAM120AOS,family with sequence similarity 120A opposite strand,HGNC:23389,9q22.31
FAM120C,Approved symbol,FAM120C,family with sequence similarity 120C,HGNC:16949,Xp11.22
FAM122C,Previous symbol,PABIR3,PABIR family member 3,HGNC:25202,Xq26.3
FAM127C,Previous symbol,RTL8B,retrotransposon Gag like 8B,HGNC:33156,Xq26.3
FAM129C,Previous symbol,NIBAN3,niban apoptosis regulator 3,HGNC:24130,19p13.11
FAM132A,Previous symbol,C1QTNF12,C1q and TNF related 12,HGNC:32308,1p36.33
FAM135B,Approved symbol,FAM135B,family with sequence similarity 135 member B,HGNC:28029,8q24.23
FAM13B,Approved symbol,FAM13B,family with sequence similarity 13 member B,HGNC:1335,5q31.2
FAM13C,Approved symbol,FAM13C,family with sequence similarity 13 member C,HGNC:19371,10q21.1
FAM149A,Approved symbol,FAM149A,family with sequence similarity 149 member A,HGNC:24527,4q35.1
FAM153B,Approved symbol,FAM153B,family with sequence similarity 153 member B,HGNC:27323,5q35.2
FAM155B,Previous symbol,NALF2,NALCN channel auxiliary factor 2,HGNC:30701,Xq13.1
FAM160A2,Previous symbol,FHIP1B,FHF complex subunit HOOK interacting protein 1B,HGNC:25378,11p15.4
FAM163B,Approved symbol,FAM163B,family with sequence similarity 163 member B,HGNC:33277,9q34.2
FAM168B,Approved symbol,FAM168B,family with sequence similarity 168 member B,HGNC:27016,2q21.1
FAM170B,Approved symbol,FAM170B,family with sequence similarity 170 member B,HGNC:19736,10q11.23
FAM171B,Approved symbol,FAM171B,family with sequence similarity 171 member B,HGNC:29412,2q32.1
FAM175B,Previous symbol,ABRAXAS2,"abraxas 2, BRISC complex subunit",HGNC:28975,10q26.13
FAM181A,Approved symbol,FAM181A,family with sequence similarity 181 member A,HGNC:20491,14q32.12
FAM185A,Approved symbol,FAM185A,family with sequence similarity 185 member A,HGNC:22412,7q22.1
FAM189A2,Approved symbol,FAM189A2,family with sequence similarity 189 member A2,HGNC:24820,9q21.12
FAM193B,Approved symbol,FAM193B,family with sequence similarity 193 member B,HGNC:25524,5q35.3
FAM194B,Previous symbol,ERICH6B,glutamate rich 6B,HGNC:26523,13q14.13
FAM195A,Previous symbol,MCRIP2,MAPK regulated corepressor interacting protein 2,HGNC:14142,16p13.3
FAM196A,Previous symbol,INSYN2A,inhibitory synaptic factor 2A,HGNC:33859,10q26.2
FAM19A3,Previous symbol,TAFA3,TAFA chemokine like family member 3,HGNC:21590,1p13.2
FAM208A,Previous symbol,TASOR,transcription activation suppressor,HGNC:30314,3p14.3
FAM208B,Previous symbol,TASOR2,transcription activation suppressor family member 2,HGNC:23484,10p15.1
FAM214B,Approved symbol,FAM214B,family with sequence similarity 214 member B,HGNC:25666,9p13.3
FAM221A,Approved symbol,FAM221A,family with sequence similarity 221 member A,HGNC:27977,7p15.3
FAM227B,Approved symbol,FAM227B,family with sequence similarity 227 member B,HGNC:26543,15q21.2
FAM230A,Approved symbol,FAM230A,family with sequence similarity 230 member A,HGNC:45045,22q11.21
FAM3A,Approved symbol,FAM3A,FAM3 metabolism regulating signaling molecule A,HGNC:13749,Xq28
FAM46A,Previous symbol,TENT5A,terminal nucleotidyltransferase 5A,HGNC:18345,6q14.1
FAM47C,Approved symbol,FAM47C,family with sequence similarity 47 member C,HGNC:25301,Xp21.1
FAM65A,Previous symbol,RIPOR1,RHO family interacting cell polarization regulator 1,HGNC:25836,16q22.1
FAM71A,Previous symbol,GARIN4,golgi associated RAB2 interactor family member 4,HGNC:26541,1q32.3
FAM76B,Approved symbol,FAM76B,family with sequence similarity 76 member B,HGNC:28492,11q21
FAM83B,Approved symbol,FAM83B,family with sequence similarity 83 member B,HGNC:21357,6p12.1
FAM83F,Approved symbol,FAM83F,family with sequence similarity 83 member F,HGNC:25148,22q13.1
FAM83H,Approved symbol,FAM83H,family with sequence similarity 83 member H,HGNC:24797,8q24.3
FAM84B,Previous symbol,LRATD2,LRAT domain containing 2,HGNC:24166,8q24.21
FAM8A1,Approved symbol,FAM8A1,family with sequence similarity 8 member A1,HGNC:16372,6p22.3
FAM92B,Previous symbol,CIBAR2,CBY1 interacting BAR domain containing 2,HGNC:24781,16q24.1
FAM98A,Approved symbol,FAM98A,family with sequence similarity 98 member A,HGNC:24520,2p22.3
FAM98B,Approved symbol,FAM98B,family with sequence similarity 98 member B,HGNC:26773,15q14
FAN1,Approved symbol,FAN1,FANCD2 and FANCI associated nuclease 1,HGNC:29170,15q13.3
FANCA,Approved symbol,FANCA,FA complementation group A,HGNC:3582,16q24.3
FANCC,Approved symbol,FANCC,FA complementation group C,HGNC:3584,9q22.32
FANCD2P2,Approved symbol,FANCD2P2,FANCD2 pseudogene 2,HGNC:44488,3p25.2
FANCE,Approved symbol,FANCE,FA complementation group E,HGNC:3586,6p21.31
FANCI,Approved symbol,FANCI,FA complementation group I,HGNC:25568,15q26.1
FAP,Approved symbol,FAP,fibroblast activation protein alpha,HGNC:3590,2q24.2
FARP1,Approved symbol,FARP1,"FERM, ARH/RhoGEF and pleckstrin domain protein 1",HGNC:3591,13q32.2
FAT1,Approved symbol,FAT1,FAT atypical cadherin 1,HGNC:3595,4q35.2
FAT3,Approved symbol,FAT3,FAT atypical cadherin 3,HGNC:23112,11q14.3
FAT4,Approved symbol,FAT4,FAT atypical cadherin 4,HGNC:23109,4q28.1
FATE1,Approved symbol,FATE1,fetal and adult testis expressed 1,HGNC:24683,Xq28
FAXC,Approved symbol,FAXC,"failed axon connections homolog, metaxin like GST domain containing",HGNC:20742,6q16.2
FBF1,Approved symbol,FBF1,Fas binding factor 1,HGNC:24674,17q25.1
FBL,Approved symbol,FBL,fibrillarin,HGNC:3599,19q13.2
FBLN2,Approved symbol,FBLN2,fibulin 2,HGNC:3601,3p25.1
FBN2,Approved symbol,FBN2,fibrillin 2,HGNC:3604,5q23.3
FBN3,Approved symbol,FBN3,fibrillin 3,HGNC:18794,19p13.2
FBRSL1,Approved symbol,FBRSL1,fibrosin like 1,HGNC:29308,12q24.33
FBXL12,Approved symbol,FBXL12,F-box and leucine rich repeat protein 12,HGNC:13611,19p13.2
FBXL13,Approved symbol,FBXL13,F-box and leucine rich repeat protein 13,HGNC:21658,7q22.1
FBXL16,Approved symbol,FBXL16,F-box and leucine rich repeat protein 16,HGNC:14150,16p13.3
FBXL17,Approved symbol,FBXL17,F-box and leucine rich repeat protein 17,HGNC:13615,5q21.3
FBXL18,Approved symbol,FBXL18,F-box and leucine rich repeat protein 18,HGNC:21874,7p22.1
FBXL21,Previous symbol,FBXL21P,"F-box and leucine rich repeat protein 21, pseudogene",HGNC:13600,5q31.1
FBXL4,Approved symbol,FBXL4,F-box and leucine rich repeat protein 4,HGNC:13601,6q16.1-q16.2
FBXL6,Approved symbol,FBXL6,F-box and leucine rich repeat protein 6,HGNC:13603,8q24.3
FBXO15,Approved symbol,FBXO15,F-box protein 15,HGNC:13617,18q22.3
FBXO33,Approved symbol,FBXO33,F-box protein 33,HGNC:19833,14q21.1
FBXO4,Approved symbol,FBXO4,F-box protein 4,HGNC:13583,5p13.1
FBXO40,Approved symbol,FBXO40,F-box protein 40,HGNC:29816,3q13.33
FBXO41,Approved symbol,FBXO41,F-box protein 41,HGNC:29409,2p13.2
FBXO44,Approved symbol,FBXO44,F-box protein 44,HGNC:24847,1p36.22
FBXO47,Approved symbol,FBXO47,F-box protein 47,HGNC:31969,17q12
FBXO9,Approved symbol,FBXO9,F-box protein 9,HGNC:13588,6p12.1
FBXW11,Approved symbol,FBXW11,F-box and WD repeat domain containing 11,HGNC:13607,5q35.1
FBXW2,Approved symbol,FBXW2,F-box and WD repeat domain containing 2,HGNC:13608,9q33.2
FCER1A,Approved symbol,FCER1A,Fc epsilon receptor Ia,HGNC:3609,1q23.2
FCGBP,Approved symbol,FCGBP,Fc gamma binding protein,HGNC:13572,19q13.2
FCGRT,Approved symbol,FCGRT,Fc gamma receptor and transporter,HGNC:3621,19q13.33
FCN1,Approved symbol,FCN1,ficolin 1,HGNC:3623,9q34.3
FCRL5,Approved symbol,FCRL5,Fc receptor like 5,HGNC:18508,1q23.1
FDXR,Approved symbol,FDXR,ferredoxin reductase,HGNC:3642,17q25.1
FER,Approved symbol,FER,FER tyrosine kinase,HGNC:3655,5q21.3
FER1L5,Approved symbol,FER1L5,fer-1 like family member 5,HGNC:19044,2q11.2
FER1L6,Approved symbol,FER1L6,fer-1 like family member 6,HGNC:28065,8q24.13
FERMT1,Approved symbol,FERMT1,FERM domain containing kindlin 1,HGNC:15889,20p12.3
FERMT3,Approved symbol,FERMT3,FERM domain containing kindlin 3,HGNC:23151,11q13.1
FES,Approved symbol,FES,"FES proto-oncogene, tyrosine kinase",HGNC:3657,15q26.1
FFAR1,Approved symbol,FFAR1,free fatty acid receptor 1,HGNC:4498,19q13.12
FGD2,Approved symbol,FGD2,"FYVE, RhoGEF and PH domain containing 2",HGNC:3664,6p21.2
FGD3,Approved symbol,FGD3,"FYVE, RhoGEF and PH domain containing 3",HGNC:16027,9q22.31
FGD5,Approved symbol,FGD5,"FYVE, RhoGEF and PH domain containing 5",HGNC:19117,3p25.1
FGF12,Approved symbol,FGF12,fibroblast growth factor 12,HGNC:3668,3q28-q29
FGF13,Approved symbol,FGF13,fibroblast growth factor 13,HGNC:3670,Xq26.3-q27.1
FGF14,Approved symbol,FGF14,fibroblast growth factor 14,HGNC:3671,13q33.1
FGF21,Approved symbol,FGF21,fibroblast growth factor 21,HGNC:3678,19q13.33
FGF22,Approved symbol,FGF22,fibroblast growth factor 22,HGNC:3679,19p13.3
FGF23,Approved symbol,FGF23,fibroblast growth factor 23,HGNC:3680,12p13.32
FGF4,Approved symbol,FGF4,fibroblast growth factor 4,HGNC:3682,11q13.3
FGFRL1,Approved symbol,FGFRL1,fibroblast growth factor receptor like 1,HGNC:3693,4p16.3
FGG,Approved symbol,FGG,fibrinogen gamma chain,HGNC:3694,4q32.1
FGL2,Approved symbol,FGL2,fibrinogen like 2,HGNC:3696,7q11.23
FHIT,Approved symbol,FHIT,fragile histidine triad diadenosine triphosphatase,HGNC:3701,3p14.2
FHL1,Approved symbol,FHL1,four and a half LIM domains 1,HGNC:3702,Xq26.3
FHL1,Alias symbol,CFH,complement factor H,HGNC:4883,1q31.3
FHL2,Approved symbol,FHL2,four and a half LIM domains 2,HGNC:3703,2q12.2
FHOD3,Approved symbol,FHOD3,formin homology 2 domain containing 3,HGNC:26178,18q12.2
FIG4,Approved symbol,FIG4,FIG4 phosphoinositide 5-phosphatase,HGNC:16873,6q21
FIGNL1,Approved symbol,FIGNL1,fidgetin like 1,HGNC:13286,7p12.2
FILIP1L,Approved symbol,FILIP1L,filamin A interacting protein 1 like,HGNC:24589,3q12.1
FKBP3,Approved symbol,FKBP3,FKBP prolyl isomerase 3,HGNC:3719,14q21.2
FKBPL,Approved symbol,FKBPL,FKBP prolyl isomerase like,HGNC:13949,6p21.32
FLAD1,Approved symbol,FLAD1,flavin adenine dinucleotide synthetase 1,HGNC:24671,1q21.3
FLG,Approved symbol,FLG,filaggrin,HGNC:3748,1q21.3
FLG,Alias symbol,FGFR1,fibroblast growth factor receptor 1,HGNC:3688,8p11.23
FLG2,Approved symbol,FLG2,filaggrin 2,HGNC:33276,1q21.3
FLNA,Approved symbol,FLNA,filamin A,HGNC:3754,Xq28
FLNB,Approved symbol,FLNB,filamin B,HGNC:3755,3p14.3
FLRT2,Approved symbol,FLRT2,fibronectin leucine rich transmembrane protein 2,HGNC:3761,14q31.3
FLT1,Approved symbol,FLT1,fms related receptor tyrosine kinase 1,HGNC:3763,13q12.3
FLVCR2,Approved symbol,FLVCR2,FLVCR heme transporter 2,HGNC:20105,14q24.3
FLYWCH1,Approved symbol,FLYWCH1,FLYWCH-type zinc finger 1,HGNC:25404,16p13.3
FMN1,Approved symbol,FMN1,formin 1,HGNC:3768,15q13.3
FMN2,Approved symbol,FMN2,formin 2,HGNC:14074,1q43
FMO1,Approved symbol,FMO1,flavin containing dimethylaniline monoxygenase 1,HGNC:3769,1q24.3
FNBP1,Approved symbol,FNBP1,formin binding protein 1,HGNC:17069,9q34.11
FNDC1,Approved symbol,FNDC1,fibronectin type III domain containing 1,HGNC:21184,6q25.3
FNDC3A,Approved symbol,FNDC3A,fibronectin type III domain containing 3A,HGNC:20296,13q14.2
FNIP2,Approved symbol,FNIP2,folliculin interacting protein 2,HGNC:29280,4q32.1
FOLH1,Approved symbol,FOLH1,folate hydrolase 1,HGNC:3788,11p11.12
FOSB,Approved symbol,FOSB,"FosB proto-oncogene, AP-1 transcription factor subunit",HGNC:3797,19q13.32
FOXB1,Approved symbol,FOXB1,forkhead box B1,HGNC:3799,15q22.2
FOXB2,Approved symbol,FOXB2,forkhead box B2,HGNC:23315,9q21.2
FOXC1,Approved symbol,FOXC1,forkhead box C1,HGNC:3800,6p25.3
FOXD2,Approved symbol,FOXD2,forkhead box D2,HGNC:3803,1p33
FOXF1,Approved symbol,FOXF1,forkhead box F1,HGNC:3809,16q24.1
FOXG1,Approved symbol,FOXG1,forkhead box G1,HGNC:3811,14q12
FOXI1,Approved symbol,FOXI1,forkhead box I1,HGNC:3815,5q35.1
FOXI3,Approved symbol,FOXI3,forkhead box I3,HGNC:35123,2p11.2
FOXK2,Approved symbol,FOXK2,forkhead box K2,HGNC:6036,17q25.3
FOXN4,Approved symbol,FOXN4,forkhead box N4,HGNC:21399,12q24.11
FOXO1,Approved symbol,FOXO1,forkhead box O1,HGNC:3819,13q14.11
FOXO4,Approved symbol,FOXO4,forkhead box O4,HGNC:7139,Xq13.1
FOXO6,Approved symbol,FOXO6,forkhead box O6,HGNC:24814,1p34.2
FOXP1,Approved symbol,FOXP1,forkhead box P1,HGNC:3823,3p13
FOXP2,Approved symbol,FOXP2,forkhead box P2,HGNC:13875,7q31.1
FOXP3,Approved symbol,FOXP3,forkhead box P3,HGNC:6106,Xp11.23
FPGS,Approved symbol,FPGS,folylpolyglutamate synthase,HGNC:3824,9q34.11
FRAS1,Approved symbol,FRAS1,Fraser extracellular matrix complex subunit 1,HGNC:19185,4q21.21
FREM2,Approved symbol,FREM2,FRAS1 related extracellular matrix 2,HGNC:25396,13q13.3
FREM3,Approved symbol,FREM3,FRAS1 related extracellular matrix 3,HGNC:25172,4q31.21
FRMD3,Approved symbol,FRMD3,FERM domain containing 3,HGNC:24125,9q21.32
FRMD4A,Approved symbol,FRMD4A,FERM domain containing 4A,HGNC:25491,10p13
FRMPD1,Approved symbol,FRMPD1,FERM and PDZ domain containing 1,HGNC:29159,9p13.2
FRMPD4,Approved symbol,FRMPD4,FERM and PDZ domain containing 4,HGNC:29007,Xp22.2
FRS2,Approved symbol,FRS2,fibroblast growth factor receptor substrate 2,HGNC:16971,12q15
FRYL,Approved symbol,FRYL,FRY like transcription coactivator,HGNC:29127,4p11
FSCN2,Approved symbol,FSCN2,"fascin actin-bundling protein 2, retinal",HGNC:3960,17q25.3
FSD1L,Approved symbol,FSD1L,fibronectin type III and SPRY domain containing 1 like,HGNC:13753,9q31.2
FSHR,Approved symbol,FSHR,follicle stimulating hormone receptor,HGNC:3969,2p16.3
FSIP2,Approved symbol,FSIP2,fibrous sheath interacting protein 2,HGNC:21675,2q32.1
FSTL3,Approved symbol,FSTL3,follistatin like 3,HGNC:3973,19p13.3
FSTL5,Approved symbol,FSTL5,follistatin like 5,HGNC:21386,4q32.2
FTCD,Approved symbol,FTCD,formimidoyltransferase cyclodeaminase,HGNC:3974,21q22.3
FTSJ2,Previous symbol,MRM2,mitochondrial rRNA methyltransferase 2,HGNC:16352,7p22.3
FTSJ3,Approved symbol,FTSJ3,FtsJ RNA 2'-O-methyltransferase 3,HGNC:17136,17q23.3
FUBP1,Approved symbol,FUBP1,far upstream element binding protein 1,HGNC:4004,1p31.1
FUBP3,Approved symbol,FUBP3,far upstream element binding protein 3,HGNC:4005,9q34.11-q34.12
FUCA2,Approved symbol,FUCA2,alpha-L-fucosidase 2,HGNC:4008,6q24.2
FUNDC2,Approved symbol,FUNDC2,FUN14 domain containing 2,HGNC:24925,Xq28
FURIN,Approved symbol,FURIN,"furin, paired basic amino acid cleaving enzyme",HGNC:8568,15q26.1
FUT4,Approved symbol,FUT4,fucosyltransferase 4,HGNC:4015,11q21
FUZ,Approved symbol,FUZ,fuzzy planar cell polarity protein,HGNC:26219,19q13.33
FXN,Approved symbol,FXN,frataxin,HGNC:3951,9q21.11
FXR2,Approved symbol,FXR2,FMR1 autosomal homolog 2,HGNC:4024,17p13.1
FZD10,Approved symbol,FZD10,frizzled class receptor 10,HGNC:4039,12q24.33
FZD9,Approved symbol,FZD9,frizzled class receptor 9,HGNC:4047,7q11.23
FZR1,Approved symbol,FZR1,fizzy and cell division cycle 20 related 1,HGNC:24824,19p13.3
G6PD,Approved symbol,G6PD,glucose-6-phosphate dehydrogenase,HGNC:4057,Xq28
GAB3,Approved symbol,GAB3,GRB2 associated binding protein 3,HGNC:17515,Xq28
GAB4,Approved symbol,GAB4,GRB2 associated binding protein family member 4,HGNC:18325,22q11.1
GABBR2,Approved symbol,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,HGNC:4507,9q22.33
GABPB1,Approved symbol,GABPB1,GA binding protein transcription factor subunit beta 1,HGNC:4074,15q21.2
GABPB1,Previous symbol,GABPAP,GABPA pseudogene,HGNC:4072,7q11.21
GABPB2,Approved symbol,GABPB2,GA binding protein transcription factor subunit beta 2,HGNC:28441,1q21.3
GABPB2,Previous symbol,GABPB1,GA binding protein transcription factor subunit beta 1,HGNC:4074,15q21.2
GABRA2,Approved symbol,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,HGNC:4076,4p12
GABRA3,Approved symbol,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,HGNC:4077,Xq28
GABRA4,Approved symbol,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,HGNC:4078,4p12
GABRA5,Approved symbol,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,HGNC:4079,15q12
GABRA6,Approved symbol,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,HGNC:4080,5q34
GABRB3,Approved symbol,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,HGNC:4083,15q12
GABRG2,Approved symbol,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,HGNC:4087,5q34
GABRG3,Approved symbol,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,HGNC:4088,15q12
GABRQ,Approved symbol,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,HGNC:14454,Xq28
GAK,Approved symbol,GAK,cyclin G associated kinase,HGNC:4113,4p16.3
GAL3ST1,Approved symbol,GAL3ST1,galactose-3-O-sulfotransferase 1,HGNC:24240,22q12.2
GALC,Approved symbol,GALC,galactosylceramidase,HGNC:4115,14q31.3
GALM,Approved symbol,GALM,galactose mutarotase,HGNC:24063,2p22.1
GALNS,Approved symbol,GALNS,galactosamine (N-acetyl)-6-sulfatase,HGNC:4122,16q24.3
GALNT12,Approved symbol,GALNT12,polypeptide N-acetylgalactosaminyltransferase 12,HGNC:19877,9q22.33
GALNT13,Approved symbol,GALNT13,polypeptide N-acetylgalactosaminyltransferase 13,HGNC:23242,2q23.3-q24.1
GALNT14,Approved symbol,GALNT14,polypeptide N-acetylgalactosaminyltransferase 14,HGNC:22946,2p23.1
GALNT15,Approved symbol,GALNT15,polypeptide N-acetylgalactosaminyltransferase 15,HGNC:21531,3p25.1
GALNT15,Previous symbol,GALNTL5,polypeptide N-acetylgalactosaminyltransferase like 5,HGNC:21725,7q36.1
GALNT15,Alias symbol,GALNT18,polypeptide N-acetylgalactosaminyltransferase 18,HGNC:30488,11p15.4
GALNT16,Approved symbol,GALNT16,polypeptide N-acetylgalactosaminyltransferase 16,HGNC:23233,14q24.1
GALNT5,Approved symbol,GALNT5,polypeptide N-acetylgalactosaminyltransferase 5,HGNC:4127,2q24.1
GALNT7,Approved symbol,GALNT7,polypeptide N-acetylgalactosaminyltransferase 7,HGNC:4129,4q34.1
GALNT7,Alias symbol,GALNT15,polypeptide N-acetylgalactosaminyltransferase 15,HGNC:21531,3p25.1
GALNT8,Approved symbol,GALNT8,polypeptide N-acetylgalactosaminyltransferase 8,HGNC:4130,12p13.32
GALNT9,Approved symbol,GALNT9,polypeptide N-acetylgalactosaminyltransferase 9,HGNC:4131,12q24.33
GAMT,Approved symbol,GAMT,guanidinoacetate N-methyltransferase,HGNC:4136,19p13.3
GANAB,Approved symbol,GANAB,glucosidase II alpha subunit,HGNC:4138,11q12.3
GAREM,Previous symbol,GAREM1,GRB2 associated regulator of MAPK1 subtype 1,HGNC:26136,18q12.1
GARS,Previous symbol,GARS1,glycyl-tRNA synthetase 1,HGNC:4162,7p14.3
GAS1,Approved symbol,GAS1,growth arrest specific 1,HGNC:4165,9q21.33
GAS2L3,Approved symbol,GAS2L3,growth arrest specific 2 like 3,HGNC:27475,12q23.1
GAS6,Approved symbol,GAS6,growth arrest specific 6,HGNC:4168,13q34
GATA1,Approved symbol,GATA1,GATA binding protein 1,HGNC:4170,Xp11.23
GATA4,Approved symbol,GATA4,GATA binding protein 4,HGNC:4173,8p23.1
GATA5,Approved symbol,GATA5,GATA binding protein 5,HGNC:15802,20q13.33
GATAD2A,Approved symbol,GATAD2A,GATA zinc finger domain containing 2A,HGNC:29989,19p13.11
GATSL3,Previous symbol,CASTOR1,cytosolic arginine sensor for mTORC1 subunit 1,HGNC:34423,22q12.2
GBA2,Approved symbol,GBA2,glucosylceramidase beta 2,HGNC:18986,9p13.3
GBF1,Approved symbol,GBF1,golgi brefeldin A resistant guanine nucleotide exchange factor 1,HGNC:4181,10q24.32
GBGT1,Approved symbol,GBGT1,"globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)",HGNC:20460,9q34.2
GBP2,Approved symbol,GBP2,guanylate binding protein 2,HGNC:4183,1p22.2
GBP5,Approved symbol,GBP5,guanylate binding protein 5,HGNC:19895,1p22.2
GCAT,Approved symbol,GCAT,glycine C-acetyltransferase,HGNC:4188,22q13.1
GCDH,Approved symbol,GCDH,glutaryl-CoA dehydrogenase,HGNC:4189,19p13.13
GCK,Approved symbol,GCK,glucokinase,HGNC:4195,7p13
GCK,Alias symbol,MAP4K2,mitogen-activated protein kinase kinase kinase kinase 2,HGNC:6864,11q13.1
GCKR,Approved symbol,GCKR,glucokinase regulator,HGNC:4196,2p23.3
GCKR,Alias symbol,MAP4K5,mitogen-activated protein kinase kinase kinase kinase 5,HGNC:6867,14q22.1
GCLC,Approved symbol,GCLC,glutamate-cysteine ligase catalytic subunit,HGNC:4311,6p12.1
GCLM,Approved symbol,GCLM,glutamate-cysteine ligase modifier subunit,HGNC:4312,1p22.1
GCM1,Approved symbol,GCM1,glial cells missing transcription factor 1,HGNC:4197,6p12.1
GCM2,Approved symbol,GCM2,glial cells missing transcription factor 2,HGNC:4198,6p24.2
GCN1L1,Previous symbol,GCN1,GCN1 activator of EIF2AK4,HGNC:4199,12q24.23
GCNT1,Approved symbol,GCNT1,glucosaminyl (N-acetyl) transferase 1,HGNC:4203,9q21.13
GCNT2,Approved symbol,GCNT2,glucosaminyl (N-acetyl) transferase 2 (I blood group),HGNC:4204,6p24.3-p24.2
GCNT4,Approved symbol,GCNT4,glucosaminyl (N-acetyl) transferase 4,HGNC:17973,5q13.3
GDA,Approved symbol,GDA,guanine deaminase,HGNC:4212,9q21.13
GDA,Alias symbol,SLC25A16,solute carrier family 25 member 16,HGNC:10986,10q21.3
GDA,Alias symbol,PAEP,progestagen associated endometrial protein,HGNC:8573,9q34.3
GDAP1L1,Approved symbol,GDAP1L1,ganglioside induced differentiation associated protein 1 like 1,HGNC:4213,20q13.12
GDF1,Approved symbol,GDF1,growth differentiation factor 1,HGNC:4214,19p13.11
GDF5,Approved symbol,GDF5,growth differentiation factor 5,HGNC:4220,20q11.22
GDNF-AS1,Approved symbol,GDNF-AS1,GDNF antisense RNA 1,HGNC:43592,5p13.2
GDPD1,Approved symbol,GDPD1,glycerophosphodiester phosphodiesterase domain containing 1,HGNC:20883,17q22
GEMIN4,Approved symbol,GEMIN4,gem nuclear organelle associated protein 4,HGNC:15717,17p13.3
GEN1,Approved symbol,GEN1,GEN1 Holliday junction 5' flap endonuclease,HGNC:26881,2p24.2
GFM1,Approved symbol,GFM1,G elongation factor mitochondrial 1,HGNC:13780,3q25.32
GFM2,Approved symbol,GFM2,GTP dependent ribosome recycling factor mitochondrial 2,HGNC:29682,5q13.3
GFOD2,Approved symbol,GFOD2,glucose-fructose oxidoreductase domain containing 2,HGNC:28159,16q22.1
GFRA2,Approved symbol,GFRA2,GDNF family receptor alpha 2,HGNC:4244,8p21.3
GFRA3,Approved symbol,GFRA3,GDNF family receptor alpha 3,HGNC:4245,5q31.2
GFRAL,Approved symbol,GFRAL,GDNF family receptor alpha like,HGNC:32789,6p12.1
GGA3,Approved symbol,GGA3,"golgi associated, gamma adaptin ear containing, ARF binding protein 3",HGNC:17079,17q25.1
GGACT,Approved symbol,GGACT,gamma-glutamylamine cyclotransferase,HGNC:25100,13q32.3
GGT1,Approved symbol,GGT1,gamma-glutamyltransferase 1,HGNC:4250,22q11.23
GGT5,Approved symbol,GGT5,gamma-glutamyltransferase 5,HGNC:4260,22q11.23
GGT6,Approved symbol,GGT6,gamma-glutamyltransferase 6,HGNC:26891,17p13.2
GGT7,Approved symbol,GGT7,gamma-glutamyltransferase 7,HGNC:4259,20q11.22
GH2,Approved symbol,GH2,growth hormone 2,HGNC:4262,17q23.3
GIMAP1,Approved symbol,GIMAP1,"GTPase, IMAP family member 1",HGNC:23237,7q36.1
GIMAP8,Approved symbol,GIMAP8,"GTPase, IMAP family member 8",HGNC:21792,7q36.1
GINS1,Approved symbol,GINS1,GINS complex subunit 1,HGNC:28980,20p11.21
GIPC2,Approved symbol,GIPC2,GIPC PDZ domain containing family member 2,HGNC:18177,1p31.1
GIPC3,Approved symbol,GIPC3,GIPC PDZ domain containing family member 3,HGNC:18183,19p13.3
GIT1,Approved symbol,GIT1,GIT ArfGAP 1,HGNC:4272,17q11.2
GJA8,Approved symbol,GJA8,gap junction protein alpha 8,HGNC:4281,1q21.2
GJA9,Approved symbol,GJA9,gap junction protein alpha 9,HGNC:19155,1p34.3
GJA9,Previous symbol,GJD2,gap junction protein delta 2,HGNC:19154,15q14
GJB1,Approved symbol,GJB1,gap junction protein beta 1,HGNC:4283,Xq13.1
GJB5,Approved symbol,GJB5,gap junction protein beta 5,HGNC:4287,1p34.3
GLB1L3,Approved symbol,GLB1L3,galactosidase beta 1 like 3,HGNC:25147,11q25
GLCCI1,Approved symbol,GLCCI1,glucocorticoid induced 1,HGNC:18713,7p21.3
GLCE,Approved symbol,GLCE,glucuronic acid epimerase,HGNC:17855,15q23
GLDC,Approved symbol,GLDC,glycine decarboxylase,HGNC:4313,9p24.1
GLG1,Approved symbol,GLG1,golgi glycoprotein 1,HGNC:4316,16q23.1
GLI2,Approved symbol,GLI2,GLI family zinc finger 2,HGNC:4318,2q14.2
GLI3,Approved symbol,GLI3,GLI family zinc finger 3,HGNC:4319,7p14.1
GLIPR1L1,Approved symbol,GLIPR1L1,GLIPR1 like 1,HGNC:28392,12q21.2
GLIPR1L2,Approved symbol,GLIPR1L2,GLIPR1 like 2,HGNC:28592,12q21.2
GLIS1,Approved symbol,GLIS1,GLIS family zinc finger 1,HGNC:29525,1p32.3
GLS,Approved symbol,GLS,glutaminase,HGNC:4331,2q32.2
GLS,Alias symbol,GLS2,glutaminase 2,HGNC:29570,12q13.3
GLT1D1,Approved symbol,GLT1D1,glycosyltransferase 1 domain containing 1,HGNC:26483,12q24.33
GLTSCR1,Previous symbol,BICRA,BRD4 interacting chromatin remodeling complex associated protein,HGNC:4332,19q13.33
GLYATL2,Approved symbol,GLYATL2,glycine-N-acyltransferase like 2,HGNC:24178,11q12.1
GMCL1,Approved symbol,GMCL1,"germ cell-less 1, spermatogenesis associated",HGNC:23843,2p13.3
GMIP,Approved symbol,GMIP,GEM interacting protein,HGNC:24852,19p13.11
GML,Approved symbol,GML,glycosylphosphatidylinositol anchored molecule like,HGNC:4375,8q24.3
GMPR2,Approved symbol,GMPR2,guanosine monophosphate reductase 2,HGNC:4377,14q12
GMPS,Approved symbol,GMPS,guanine monophosphate synthase,HGNC:4378,3q25.31
GNA12,Approved symbol,GNA12,G protein subunit alpha 12,HGNC:4380,7p22.3-p22.2
GNA14,Approved symbol,GNA14,G protein subunit alpha 14,HGNC:4382,9q21.2
GNA15,Approved symbol,GNA15,G protein subunit alpha 15,HGNC:4383,19p13.3
GNAI1,Approved symbol,GNAI1,G protein subunit alpha i1,HGNC:4384,7q21.11
GNAI2,Approved symbol,GNAI2,G protein subunit alpha i2,HGNC:4385,3p21.31
GNAL,Approved symbol,GNAL,G protein subunit alpha L,HGNC:4388,18p11.21
GNAS,Approved symbol,GNAS,GNAS complex locus,HGNC:4392,20q13.32
GNAS-AS1,Approved symbol,GNAS-AS1,GNAS antisense RNA 1,HGNC:24872,20q13.32
GNB1L,Approved symbol,GNB1L,G protein subunit beta 1 like,HGNC:4397,22q11.21
GNE,Approved symbol,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,HGNC:23657,9p13.3
GNL3,Approved symbol,GNL3,G protein nucleolar 3,HGNC:29931,3p21.1
GNL3L,Approved symbol,GNL3L,G protein nucleolar 3 like,HGNC:25553,Xp11.22
GNLY,Approved symbol,GNLY,granulysin,HGNC:4414,2p11.2
GNPAT,Approved symbol,GNPAT,glyceronephosphate O-acyltransferase,HGNC:4416,1q42.2
GNPDA1,Approved symbol,GNPDA1,glucosamine-6-phosphate deaminase 1,HGNC:4417,5q31.3
GNS,Approved symbol,GNS,glucosamine (N-acetyl)-6-sulfatase,HGNC:4422,12q14.3
GOLGA2,Approved symbol,GOLGA2,golgin A2,HGNC:4425,9q34.11
GOLGA3,Approved symbol,GOLGA3,golgin A3,HGNC:4426,12q24.33
GOLGA4,Approved symbol,GOLGA4,golgin A4,HGNC:4427,3p22.2
GOLGA6L2,Approved symbol,GOLGA6L2,golgin A6 family like 2,HGNC:26695,15q11.2
GOPC,Approved symbol,GOPC,golgi associated PDZ and coiled-coil motif containing,HGNC:17643,6q22.1
GORASP2,Approved symbol,GORASP2,golgi reassembly stacking protein 2,HGNC:17500,2q31.1
GOSR1,Approved symbol,GOSR1,golgi SNAP receptor complex member 1,HGNC:4430,17q11.2
GOSR2,Approved symbol,GOSR2,golgi SNAP receptor complex member 2,HGNC:4431,17q21.32
GP2,Approved symbol,GP2,glycoprotein 2,HGNC:4441,16p12.3
GP5,Approved symbol,GP5,glycoprotein V platelet,HGNC:4443,3q29
GPAM,Approved symbol,GPAM,"glycerol-3-phosphate acyltransferase, mitochondrial",HGNC:24865,10q25.2
GPAT2,Approved symbol,GPAT2,"glycerol-3-phosphate acyltransferase 2, mitochondrial",HGNC:27168,2q11.2
GPBP1L1,Approved symbol,GPBP1L1,GC-rich promoter binding protein 1 like 1,HGNC:28843,1p34.1
GPC6,Approved symbol,GPC6,glypican 6,HGNC:4454,13q31.3-q32.1
GPCPD1,Approved symbol,GPCPD1,glycerophosphocholine phosphodiesterase 1,HGNC:26957,20p12.3
GPHN,Approved symbol,GPHN,gephyrin,HGNC:15465,14q23.3
GPKOW,Approved symbol,GPKOW,G-patch domain and KOW motifs,HGNC:30677,Xp11.23
GPM6A,Approved symbol,GPM6A,glycoprotein M6A,HGNC:4460,4q34.2
GPNMB,Approved symbol,GPNMB,glycoprotein nmb,HGNC:4462,7p15.3
GPR111,Previous symbol,ADGRF2,adhesion G protein-coupled receptor F2,HGNC:18991,6p12.3
GPR112,Previous symbol,ADGRG4,adhesion G protein-coupled receptor G4,HGNC:18992,Xq26.3
GPR115,Previous symbol,ADGRF4,adhesion G protein-coupled receptor F4,HGNC:19011,6p12.3
GPR12,Approved symbol,GPR12,G protein-coupled receptor 12,HGNC:4466,13q12.13
GPR123,Previous symbol,ADGRA1,adhesion G protein-coupled receptor A1,HGNC:13838,10q26.3
GPR124,Previous symbol,ADGRA2,adhesion G protein-coupled receptor A2,HGNC:17849,8p11.23
GPR132,Approved symbol,GPR132,G protein-coupled receptor 132,HGNC:17482,14q32.33
GPR143,Approved symbol,GPR143,G protein-coupled receptor 143,HGNC:20145,Xp22.2
GPR149,Approved symbol,GPR149,G protein-coupled receptor 149,HGNC:23627,3q25.2
GPR150,Approved symbol,GPR150,G protein-coupled receptor 150,HGNC:23628,5q15
GPR156,Approved symbol,GPR156,G protein-coupled receptor 156,HGNC:20844,3q13.33
GPR158,Approved symbol,GPR158,G protein-coupled receptor 158,HGNC:23689,10p12.1
GPR179,Approved symbol,GPR179,G protein-coupled receptor 179,HGNC:31371,17q12
GPR182,Approved symbol,GPR182,G protein-coupled receptor 182,HGNC:13708,12q13.3
GPR21,Approved symbol,GPR21,G protein-coupled receptor 21,HGNC:4476,9q33.2
GPR25,Approved symbol,GPR25,G protein-coupled receptor 25,HGNC:4480,1q32.1
GPR35,Approved symbol,GPR35,G protein-coupled receptor 35,HGNC:4492,2q37.3
GPR37,Approved symbol,GPR37,G protein-coupled receptor 37,HGNC:4494,7q31.33
GPR56,Previous symbol,ADGRG1,adhesion G protein-coupled receptor G1,HGNC:4512,16q21
GPR61,Approved symbol,GPR61,G protein-coupled receptor 61,HGNC:13300,1p13.3
GPR68,Approved symbol,GPR68,G protein-coupled receptor 68,HGNC:4519,14q32.11
GPR78,Approved symbol,GPR78,G protein-coupled receptor 78,HGNC:4528,4p16.1
GPRASP2,Approved symbol,GPRASP2,G protein-coupled receptor associated sorting protein 2,HGNC:25169,Xq22.1
GPRC5C,Approved symbol,GPRC5C,G protein-coupled receptor class C group 5 member C,HGNC:13309,17q25.1
GPRC6A,Approved symbol,GPRC6A,G protein-coupled receptor class C group 6 member A,HGNC:18510,6q22.1
GPX2,Approved symbol,GPX2,glutathione peroxidase 2,HGNC:4554,14q23.3
GPX3,Approved symbol,GPX3,glutathione peroxidase 3,HGNC:4555,5q33.1
GPX6,Approved symbol,GPX6,glutathione peroxidase 6,HGNC:4558,6p22.1
GPX6,Alias symbol,GPX7,glutathione peroxidase 7,HGNC:4559,1p32.3
GRAMD1A,Approved symbol,GRAMD1A,GRAM domain containing 1A,HGNC:29305,19q13.11
GRAMD1B,Approved symbol,GRAMD1B,GRAM domain containing 1B,HGNC:29214,11q24.1
GRAMD1C,Approved symbol,GRAMD1C,GRAM domain containing 1C,HGNC:25252,3q13.31
GRAMD4,Approved symbol,GRAMD4,GRAM domain containing 4,HGNC:29113,22q13.31
GRASP,Previous symbol,TAMALIN,trafficking regulator and scaffold protein tamalin,HGNC:18707,12q13.13
GRHPR,Approved symbol,GRHPR,glyoxylate and hydroxypyruvate reductase,HGNC:4570,9p13.2
GRIA1,Approved symbol,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,HGNC:4571,5q33.2
GRIA2,Approved symbol,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,HGNC:4572,4q32.1
GRIA4,Approved symbol,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,HGNC:4574,11q22.3
GRID1,Approved symbol,GRID1,glutamate ionotropic receptor delta type subunit 1,HGNC:4575,10q23.1-q23.2
GRIK1,Approved symbol,GRIK1,glutamate ionotropic receptor kainate type subunit 1,HGNC:4579,21q21.3
GRIK2,Approved symbol,GRIK2,glutamate ionotropic receptor kainate type subunit 2,HGNC:4580,6q16.3
GRIK2,Previous symbol,GRIK5,glutamate ionotropic receptor kainate type subunit 5,HGNC:4583,19q13.2
GRIK4,Approved symbol,GRIK4,glutamate ionotropic receptor kainate type subunit 4,HGNC:4582,11q23.3
GRIK5,Approved symbol,GRIK5,glutamate ionotropic receptor kainate type subunit 5,HGNC:4583,19q13.2
GRIN2A,Approved symbol,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,HGNC:4585,16p13.2
GRIN2B,Approved symbol,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,HGNC:4586,12p13.1
GRIN2C,Approved symbol,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,HGNC:4587,17q25.1
GRIN2D,Approved symbol,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,HGNC:4588,19q13.33
GRIN3A,Approved symbol,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,HGNC:16767,9q31.1
GRIP1,Approved symbol,GRIP1,glutamate receptor interacting protein 1,HGNC:18708,12q14.3
GRIP1,Alias symbol,NCOA2,nuclear receptor coactivator 2,HGNC:7669,8q13.3
GRIP1,Alias symbol,LGALS12,galectin 12,HGNC:15788,11q12.3
GRM1,Approved symbol,GRM1,glutamate metabotropic receptor 1,HGNC:4593,6q24.3
GRM3,Approved symbol,GRM3,glutamate metabotropic receptor 3,HGNC:4595,7q21.11-q21.12
GRM5,Approved symbol,GRM5,glutamate metabotropic receptor 5,HGNC:4597,11q14.2-q14.3
GRM6,Approved symbol,GRM6,glutamate metabotropic receptor 6,HGNC:4598,5q35.3
GRM7,Approved symbol,GRM7,glutamate metabotropic receptor 7,HGNC:4599,3p26.1
GRM8,Approved symbol,GRM8,glutamate metabotropic receptor 8,HGNC:4600,7q31.33
GRP,Approved symbol,GRP,gastrin releasing peptide,HGNC:4605,18q21.32
GRP,Alias symbol,UCMA,upper zone of growth plate and cartilage matrix associated,HGNC:25205,10p13
GRP,Alias symbol,LGALSL,galectin like,HGNC:25012,2p14
GRPEL1,Approved symbol,GRPEL1,"GrpE like 1, mitochondrial",HGNC:19696,4p16.1
GRPR,Approved symbol,GRPR,gastrin releasing peptide receptor,HGNC:4609,Xp22.2
GRSF1,Approved symbol,GRSF1,G-rich RNA sequence binding factor 1,HGNC:4610,4q13.3
GRTP1,Approved symbol,GRTP1,growth hormone regulated TBC protein 1,HGNC:20310,13q34
GRXCR1,Approved symbol,GRXCR1,glutaredoxin and cysteine rich domain containing 1,HGNC:31673,4p13
GSC2,Approved symbol,GSC2,goosecoid homeobox 2,HGNC:4613,22q11.21
GSDMC,Approved symbol,GSDMC,gasdermin C,HGNC:7151,8q24.21
GSG1L,Approved symbol,GSG1L,GSG1 like,HGNC:28283,16p12.1
GSN,Approved symbol,GSN,gelsolin,HGNC:4620,9q33.2
GSPT2,Approved symbol,GSPT2,G1 to S phase transition 2,HGNC:4622,Xp11.22
GSR,Approved symbol,GSR,glutathione-disulfide reductase,HGNC:4623,8p12
GSTA2,Approved symbol,GSTA2,glutathione S-transferase alpha 2,HGNC:4627,6p12.2
GSTM3,Approved symbol,GSTM3,glutathione S-transferase mu 3,HGNC:4635,1p13.3
GSTO1,Approved symbol,GSTO1,glutathione S-transferase omega 1,HGNC:13312,10q25.1
GSX1,Approved symbol,GSX1,GS homeobox 1,HGNC:20374,13q12.2
GTF2A1,Approved symbol,GTF2A1,general transcription factor IIA subunit 1,HGNC:4646,14q31.1
GTF2H1,Approved symbol,GTF2H1,general transcription factor IIH subunit 1,HGNC:4655,11p15.1
GTF3C1,Approved symbol,GTF3C1,general transcription factor IIIC subunit 1,HGNC:4664,16p12.1
GTF3C2,Approved symbol,GTF3C2,general transcription factor IIIC subunit 2,HGNC:4665,2p23.3
GTPBP1,Approved symbol,GTPBP1,GTP binding protein 1,HGNC:4669,22q13.1
GUCY1A2,Approved symbol,GUCY1A2,guanylate cyclase 1 soluble subunit alpha 2,HGNC:4684,11q22.3
GUCY2C,Approved symbol,GUCY2C,guanylate cyclase 2C,HGNC:4688,12p12.3
GUF1,Approved symbol,GUF1,GTP binding elongation factor GUF1,HGNC:25799,4p12
GUSB,Approved symbol,GUSB,glucuronidase beta,HGNC:4696,7q11.21
GXYLT1,Approved symbol,GXYLT1,glucoside xylosyltransferase 1,HGNC:27482,12q12
GYG2,Approved symbol,GYG2,glycogenin 2,HGNC:4700,Xp22.33
GYPC,Approved symbol,GYPC,glycophorin C (Gerbich blood group),HGNC:4704,2q14.3
GYS1,Approved symbol,GYS1,glycogen synthase 1,HGNC:4706,19q13.33
GZF1,Approved symbol,GZF1,GDNF inducible zinc finger protein 1,HGNC:15808,20p11.21
GZMB,Approved symbol,GZMB,granzyme B,HGNC:4709,14q12
H1FNT,Previous symbol,H1-7,H1.7 linker histone,HGNC:24893,12q13.11
H2AFY,Previous symbol,MACROH2A1,macroH2A.1 histone,HGNC:4740,5q31.1
H6PD,Approved symbol,H6PD,hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,HGNC:4795,1p36.22
HABP2,Approved symbol,HABP2,hyaluronan binding protein 2,HGNC:4798,10q25.3
HACE1,Approved symbol,HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,HGNC:21033,6q16.3
HACL1,Approved symbol,HACL1,2-hydroxyacyl-CoA lyase 1,HGNC:17856,3p25.1
HAMP,Approved symbol,HAMP,hepcidin antimicrobial peptide,HGNC:15598,19q13.12
HAO1,Approved symbol,HAO1,hydroxyacid oxidase 1,HGNC:4809,20p12.3
HAS1,Approved symbol,HAS1,hyaluronan synthase 1,HGNC:4818,19q13.41
HAS1,Alias symbol,DDX18,DEAD-box helicase 18,HGNC:2741,2q14.1
HAS1,Alias symbol,HNF1A-AS1,HNF1A antisense RNA 1,HGNC:26785,12q24.31
HAS2,Approved symbol,HAS2,hyaluronan synthase 2,HGNC:4819,8q24.13
HAS3,Approved symbol,HAS3,hyaluronan synthase 3,HGNC:4820,16q22.1
HAUS5,Approved symbol,HAUS5,HAUS augmin like complex subunit 5,HGNC:29130,19q13.12
HAUS7,Approved symbol,HAUS7,HAUS augmin like complex subunit 7,HGNC:32979,Xq28
HBP1,Approved symbol,HBP1,HMG-box transcription factor 1,HGNC:23200,7q22.3
HCFC1R1,Approved symbol,HCFC1R1,host cell factor C1 regulator 1,HGNC:21198,16p13.3
HCN1,Approved symbol,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,HGNC:4845,5p12
HCN2,Approved symbol,HCN2,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2,HGNC:4846,19p13.3
HCN3,Approved symbol,HCN3,hyperpolarization activated cyclic nucleotide gated potassium channel 3,HGNC:19183,1q22
HDAC11,Approved symbol,HDAC11,histone deacetylase 11,HGNC:19086,3p25.1
HDAC4,Approved symbol,HDAC4,histone deacetylase 4,HGNC:14063,2q37.3
HDAC7,Approved symbol,HDAC7,histone deacetylase 7,HGNC:14067,12q13.11
HDAC8,Approved symbol,HDAC8,histone deacetylase 8,HGNC:13315,Xq13.1
HDLBP,Approved symbol,HDLBP,high density lipoprotein binding protein,HGNC:4857,2q37.3
HEATR1,Approved symbol,HEATR1,HEAT repeat containing 1,HGNC:25517,1q43
HEATR5B,Approved symbol,HEATR5B,HEAT repeat containing 5B,HGNC:29273,2p22.2
HECTD2,Approved symbol,HECTD2,HECT domain E3 ubiquitin protein ligase 2,HGNC:26736,10q23.32
HECTD3,Approved symbol,HECTD3,HECT domain E3 ubiquitin protein ligase 3,HGNC:26117,1p34.1
HECTD4,Approved symbol,HECTD4,HECT domain E3 ubiquitin protein ligase 4,HGNC:26611,12q24.13
HECW1,Approved symbol,HECW1,"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1",HGNC:22195,7p14.1-p13
HECW2,Approved symbol,HECW2,"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2",HGNC:29853,2q32.3
HELQ,Approved symbol,HELQ,"helicase, POLQ like",HGNC:18536,4q21.23
HELT,Approved symbol,HELT,helt bHLH transcription factor,HGNC:33783,4q35.1
HELZ2,Approved symbol,HELZ2,helicase with zinc finger 2,HGNC:30021,20q13.33
HEPH,Approved symbol,HEPH,hephaestin,HGNC:4866,Xq12
HEPHL1,Approved symbol,HEPHL1,hephaestin like 1,HGNC:30477,11q21
HERC1,Approved symbol,HERC1,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1,HGNC:4867,15q22.31
HERC5,Approved symbol,HERC5,HECT and RLD domain containing E3 ubiquitin protein ligase 5,HGNC:24368,4q22.1
HES2,Approved symbol,HES2,hes family bHLH transcription factor 2,HGNC:16005,1p36.31
HES4,Approved symbol,HES4,hes family bHLH transcription factor 4,HGNC:24149,1p36.33
HEXIM2,Approved symbol,HEXIM2,HEXIM P-TEFb complex subunit 2,HGNC:28591,17q21.31
HEY1,Approved symbol,HEY1,hes related family bHLH transcription factor with YRPW motif 1,HGNC:4880,8q21.13
HEY2,Approved symbol,HEY2,hes related family bHLH transcription factor with YRPW motif 2,HGNC:4881,6q22.31
HGFAC,Approved symbol,HGFAC,HGF activator,HGNC:4894,4p16.3
HGS,Approved symbol,HGS,hepatocyte growth factor-regulated tyrosine kinase substrate,HGNC:4897,17q25.3
HHIP,Approved symbol,HHIP,hedgehog interacting protein,HGNC:14866,4q31.21
HHIPL1,Approved symbol,HHIPL1,HHIP like 1,HGNC:19710,14q32.2
HHIPL2,Approved symbol,HHIPL2,HHIP like 2,HGNC:25842,1q41
HHLA1,Approved symbol,HHLA1,HERV-H LTR-associating 1,HGNC:4904,8q24.22
HIC1,Approved symbol,HIC1,HIC ZBTB transcriptional repressor 1,HGNC:4909,17p13.3
HINT1,Approved symbol,HINT1,histidine triad nucleotide binding protein 1,HGNC:4912,5q23.3
HIP1,Approved symbol,HIP1,huntingtin interacting protein 1,HGNC:4913,7q11.23
HIP1R,Approved symbol,HIP1R,huntingtin interacting protein 1 related,HGNC:18415,12q24.31
HIPK2,Approved symbol,HIPK2,homeodomain interacting protein kinase 2,HGNC:14402,7q34
HIRIP3,Approved symbol,HIRIP3,HIRA interacting protein 3,HGNC:4917,16p11.2
HIST1H1D,Previous symbol,H1-3,"H1.3 linker histone, cluster member",HGNC:4717,6p22.2
HIST1H1E,Previous symbol,H1-4,"H1.4 linker histone, cluster member",HGNC:4718,6p22.2
HIST1H2BG,Previous symbol,H2BC8,H2B clustered histone 8,HGNC:4746,6p22.2
HIST1H3I,Previous symbol,H3C11,H3 clustered histone 11,HGNC:4771,6p22.1
HIST1H4C,Previous symbol,H4C3,H4 clustered histone 3,HGNC:4787,6p22.2
HIST2H2BF,Previous symbol,H2BC18,H2B clustered histone 18,HGNC:24700,1q21.2
HIVEP1,Approved symbol,HIVEP1,HIVEP zinc finger 1,HGNC:4920,6p24.1
HJURP,Approved symbol,HJURP,Holliday junction recognition protein,HGNC:25444,2q37.1
HK3,Approved symbol,HK3,hexokinase 3,HGNC:4925,5q35.2
HK3,Alias symbol,HOOK3,hook microtubule tethering protein 3,HGNC:23576,8p11.21
HLA-DMB,Approved symbol,HLA-DMB,"major histocompatibility complex, class II, DM beta",HGNC:4935,6p21.32
HLCS,Approved symbol,HLCS,holocarboxylase synthetase,HGNC:4976,21q22.13
HLX,Approved symbol,HLX,H2.0 like homeobox,HGNC:4978,1q41
HMCN1,Approved symbol,HMCN1,hemicentin 1,HGNC:19194,1q25.3-q31.1
HMCN2,Approved symbol,HMCN2,hemicentin 2,HGNC:21293,9q34.11
HMGB3,Approved symbol,HMGB3,high mobility group box 3,HGNC:5004,Xq28
HMX2,Approved symbol,HMX2,H6 family homeobox 2,HGNC:5018,10q26.13
HMX3,Approved symbol,HMX3,H6 family homeobox 3,HGNC:5019,10q26.13
HNF4A,Approved symbol,HNF4A,hepatocyte nuclear factor 4 alpha,HGNC:5024,20q13.12
HNRNPCL1,Approved symbol,HNRNPCL1,heterogeneous nuclear ribonucleoprotein C like 1,HGNC:29295,1p36.21
HNRNPL,Approved symbol,HNRNPL,heterogeneous nuclear ribonucleoprotein L,HGNC:5045,19q13.2
HOOK2,Approved symbol,HOOK2,hook microtubule tethering protein 2,HGNC:19885,19p13.13
HOOK3,Approved symbol,HOOK3,hook microtubule tethering protein 3,HGNC:23576,8p11.21
HOXA3,Approved symbol,HOXA3,homeobox A3,HGNC:5104,7p15.2
HOXB5,Approved symbol,HOXB5,homeobox B5,HGNC:5116,17q21.32
HOXB7,Approved symbol,HOXB7,homeobox B7,HGNC:5118,17q21.32
HOXD3,Approved symbol,HOXD3,homeobox D3,HGNC:5137,2q31.1
HPCAL4,Approved symbol,HPCAL4,hippocalcin like 4,HGNC:18212,1p34.2
HPN,Approved symbol,HPN,hepsin,HGNC:5155,19q13.11
HPS3,Approved symbol,HPS3,HPS3 biogenesis of lysosomal organelles complex 2 subunit 1,HGNC:15597,3q24
HPS5,Approved symbol,HPS5,HPS5 biogenesis of lysosomal organelles complex 2 subunit 2,HGNC:17022,11p15.1
HPS6,Approved symbol,HPS6,HPS6 biogenesis of lysosomal organelles complex 2 subunit 3,HGNC:18817,10q24.32
HRNR,Approved symbol,HRNR,hornerin,HGNC:20846,1q21.3
HS6ST2,Approved symbol,HS6ST2,heparan sulfate 6-O-sulfotransferase 2,HGNC:19133,Xq26.2
HS6ST3,Approved symbol,HS6ST3,heparan sulfate 6-O-sulfotransferase 3,HGNC:19134,13q32.1
HSCB,Approved symbol,HSCB,HscB mitochondrial iron-sulfur cluster cochaperone,HGNC:28913,22q12.1
HSD11B1,Approved symbol,HSD11B1,hydroxysteroid 11-beta dehydrogenase 1,HGNC:5208,1q32.2
HSD17B10,Approved symbol,HSD17B10,hydroxysteroid 17-beta dehydrogenase 10,HGNC:4800,Xp11.22
HSD17B12,Approved symbol,HSD17B12,hydroxysteroid 17-beta dehydrogenase 12,HGNC:18646,11p11.2
HSD17B14,Approved symbol,HSD17B14,hydroxysteroid 17-beta dehydrogenase 14,HGNC:23238,19q13.33
HSD3B1,Approved symbol,HSD3B1,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1",HGNC:5217,1p12
HSP90AA1,Approved symbol,HSP90AA1,heat shock protein 90 alpha family class A member 1,HGNC:5253,14q32.31
HSPA1L,Approved symbol,HSPA1L,heat shock protein family A (Hsp70) member 1 like,HGNC:5234,6p21.33
HSPA2,Approved symbol,HSPA2,heat shock protein family A (Hsp70) member 2,HGNC:5235,14q23.3
HSPB6,Approved symbol,HSPB6,heat shock protein family B (small) member 6,HGNC:26511,19q13.12
HSPB7,Approved symbol,HSPB7,heat shock protein family B (small) member 7,HGNC:5249,1p36.13
HSPD1,Approved symbol,HSPD1,heat shock protein family D (Hsp60) member 1,HGNC:5261,2q33.1
HSPG2,Approved symbol,HSPG2,heparan sulfate proteoglycan 2,HGNC:5273,1p36.12
HTR1E,Approved symbol,HTR1E,5-hydroxytryptamine receptor 1E,HGNC:5291,6q14.3
HTR2A,Approved symbol,HTR2A,5-hydroxytryptamine receptor 2A,HGNC:5293,13q14.2
HTR2B,Approved symbol,HTR2B,5-hydroxytryptamine receptor 2B,HGNC:5294,2q37.1
HTR2C,Approved symbol,HTR2C,5-hydroxytryptamine receptor 2C,HGNC:5295,Xq23
HTR3E,Approved symbol,HTR3E,5-hydroxytryptamine receptor 3E,HGNC:24005,3q27.1
HTR5A,Approved symbol,HTR5A,5-hydroxytryptamine receptor 5A,HGNC:5300,7q36.2
HTRA4,Approved symbol,HTRA4,HtrA serine peptidase 4,HGNC:26909,8p11.22
HTT,Approved symbol,HTT,huntingtin,HGNC:4851,4p16.3
HTT,Previous symbol,SLC6A4,solute carrier family 6 member 4,HGNC:11050,17q11.2
HUNK,Approved symbol,HUNK,hormonally up-regulated Neu-associated kinase,HGNC:13326,21q22.11
HUWE1,Approved symbol,HUWE1,"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1",HGNC:30892,Xp11.22
HYAL2,Approved symbol,HYAL2,hyaluronidase 2,HGNC:5321,3p21.31
HYAL4,Approved symbol,HYAL4,hyaluronidase 4,HGNC:5323,7q31.32
HYDIN,Approved symbol,HYDIN,HYDIN axonemal central pair apparatus protein,HGNC:19368,16q22.2
HYI,Approved symbol,HYI,hydroxypyruvate isomerase (putative),HGNC:26948,1p34.2
IARS,Previous symbol,IARS1,isoleucyl-tRNA synthetase 1,HGNC:5330,9q22.31
IARS2,Approved symbol,IARS2,"isoleucyl-tRNA synthetase 2, mitochondrial",HGNC:29685,1q41
ICAM3,Approved symbol,ICAM3,intercellular adhesion molecule 3,HGNC:5346,19p13.2
ICOS,Approved symbol,ICOS,inducible T cell costimulator,HGNC:5351,2q33.2
ICOSLG,Approved symbol,ICOSLG,inducible T cell costimulator ligand,HGNC:17087,21q22.3
ICT1,Previous symbol,MRPL58,mitochondrial ribosomal protein L58,HGNC:5359,17q25.1
ID3,Approved symbol,ID3,"inhibitor of DNA binding 3, HLH protein",HGNC:5362,1p36.12
IDH3B,Approved symbol,IDH3B,isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta,HGNC:5385,20p13
IDI2,Approved symbol,IDI2,isopentenyl-diphosphate delta isomerase 2,HGNC:23487,10p15.3
IDO2,Approved symbol,IDO2,"indoleamine 2,3-dioxygenase 2",HGNC:27269,8p11.21
IDS,Approved symbol,IDS,iduronate 2-sulfatase,HGNC:5389,Xq28
IDUA,Approved symbol,IDUA,alpha-L-iduronidase,HGNC:5391,4p16.3
IFFO2,Approved symbol,IFFO2,intermediate filament family orphan 2,HGNC:27006,1p36.13
IFI16,Approved symbol,IFI16,interferon gamma inducible protein 16,HGNC:5395,1q23.1
IFIH1,Approved symbol,IFIH1,interferon induced with helicase C domain 1,HGNC:18873,2q24.2
IFIT1,Approved symbol,IFIT1,interferon induced protein with tetratricopeptide repeats 1,HGNC:5407,10q23.31
IFIT5,Approved symbol,IFIT5,interferon induced protein with tetratricopeptide repeats 5,HGNC:13328,10q23.31
IFNA16,Approved symbol,IFNA16,interferon alpha 16,HGNC:5421,9p21.3
IFNG,Approved symbol,IFNG,interferon gamma,HGNC:5438,12q15
IFNK,Approved symbol,IFNK,interferon kappa,HGNC:21714,9p21.2
IFRD1,Approved symbol,IFRD1,interferon related developmental regulator 1,HGNC:5456,7q31.1
IFT172,Approved symbol,IFT172,intraflagellar transport 172,HGNC:30391,2p23.3
IFT27,Approved symbol,IFT27,intraflagellar transport 27,HGNC:18626,22q12.3
IGDCC3,Approved symbol,IGDCC3,immunoglobulin superfamily DCC subclass member 3,HGNC:9700,15q22.31
IGDCC4,Approved symbol,IGDCC4,immunoglobulin superfamily DCC subclass member 4,HGNC:13770,15q22.31
IGF2,Approved symbol,IGF2,insulin like growth factor 2,HGNC:5466,11p15.5
IGF2R,Approved symbol,IGF2R,insulin like growth factor 2 receptor,HGNC:5467,6q25.3
IGFBP7,Approved symbol,IGFBP7,insulin like growth factor binding protein 7,HGNC:5476,4q12
IGFBPL1,Approved symbol,IGFBPL1,insulin like growth factor binding protein like 1,HGNC:20081,9p13.1
IGFN1,Approved symbol,IGFN1,immunoglobulin like and fibronectin type III domain containing 1,HGNC:24607,1q32.1
IGSF1,Approved symbol,IGSF1,immunoglobulin superfamily member 1,HGNC:5948,Xq25
IGSF10,Approved symbol,IGSF10,immunoglobulin superfamily member 10,HGNC:26384,3q25.1
IGSF11,Approved symbol,IGSF11,immunoglobulin superfamily member 11,HGNC:16669,3q13.32
IGSF22,Approved symbol,IGSF22,immunoglobulin superfamily member 22,HGNC:26750,11p15.1
IGSF8,Approved symbol,IGSF8,immunoglobulin superfamily member 8,HGNC:17813,1q23.2
IGSF9B,Approved symbol,IGSF9B,immunoglobulin superfamily member 9B,HGNC:32326,11q25
IKBKB,Approved symbol,IKBKB,inhibitor of nuclear factor kappa B kinase subunit beta,HGNC:5960,8p11.21
IKZF1,Approved symbol,IKZF1,IKAROS family zinc finger 1,HGNC:13176,7p12.2
IL10RA,Approved symbol,IL10RA,interleukin 10 receptor subunit alpha,HGNC:5964,11q23.3
IL12RB1,Approved symbol,IL12RB1,interleukin 12 receptor subunit beta 1,HGNC:5971,19p13.11
IL12RB2,Approved symbol,IL12RB2,interleukin 12 receptor subunit beta 2,HGNC:5972,1p31.3
IL17D,Approved symbol,IL17D,interleukin 17D,HGNC:5984,13q12.11
IL17F,Approved symbol,IL17F,interleukin 17F,HGNC:16404,6p12.2
IL19,Approved symbol,IL19,interleukin 19,HGNC:5990,1q32.1
IL1RAP,Approved symbol,IL1RAP,interleukin 1 receptor accessory protein,HGNC:5995,3q28
IL1RAPL1,Approved symbol,IL1RAPL1,interleukin 1 receptor accessory protein like 1,HGNC:5996,Xp21.3-p21.2
IL1RAPL2,Approved symbol,IL1RAPL2,interleukin 1 receptor accessory protein like 2,HGNC:5997,Xq22.3
IL23A,Approved symbol,IL23A,interleukin 23 subunit alpha,HGNC:15488,12q13.3
IL31RA,Approved symbol,IL31RA,interleukin 31 receptor A,HGNC:18969,5q11.2
IL4R,Approved symbol,IL4R,interleukin 4 receptor,HGNC:6015,16p12.1
IL5RA,Approved symbol,IL5RA,interleukin 5 receptor subunit alpha,HGNC:6017,3p26.2
IL6,Approved symbol,IL6,interleukin 6,HGNC:6018,7p15.3
IL6ST,Approved symbol,IL6ST,interleukin 6 cytokine family signal transducer,HGNC:6021,5q11.2
IL7R,Approved symbol,IL7R,interleukin 7 receptor,HGNC:6024,5p13.2
ILDR2,Approved symbol,ILDR2,immunoglobulin like domain containing receptor 2,HGNC:18131,1q24.1
ILVBL,Approved symbol,ILVBL,ilvB acetolactate synthase like,HGNC:6041,19p13.12
IMMP2L,Approved symbol,IMMP2L,inner mitochondrial membrane peptidase subunit 2,HGNC:14598,7q31.1
INA,Approved symbol,INA,internexin neuronal intermediate filament protein alpha,HGNC:6057,10q24.33
INF2,Approved symbol,INF2,inverted formin 2,HGNC:23791,14q32.33
INHBA,Approved symbol,INHBA,inhibin subunit beta A,HGNC:6066,7p14.1
INMT,Approved symbol,INMT,indolethylamine N-methyltransferase,HGNC:6069,7p14.3
INO80,Approved symbol,INO80,INO80 complex ATPase subunit,HGNC:26956,15q15.1
INO80D,Approved symbol,INO80D,INO80 complex subunit D,HGNC:25997,2q33.3
INPP4B,Approved symbol,INPP4B,inositol polyphosphate-4-phosphatase type II B,HGNC:6075,4q31.21
INPP5A,Approved symbol,INPP5A,inositol polyphosphate-5-phosphatase A,HGNC:6076,10q26.3
INPP5E,Approved symbol,INPP5E,inositol polyphosphate-5-phosphatase E,HGNC:21474,9q34.3
INPP5E,Previous symbol,PMPCA,"peptidase, mitochondrial processing subunit alpha",HGNC:18667,9q34.3
INSC,Approved symbol,INSC,INSC spindle orientation adaptor protein,HGNC:33116,11p15.2
INSL6,Approved symbol,INSL6,insulin like 6,HGNC:6089,9p24.1
INSM1,Approved symbol,INSM1,INSM transcriptional repressor 1,HGNC:6090,20p11.23
INSM2,Approved symbol,INSM2,INSM transcriptional repressor 2,HGNC:17539,14q13.2
INSRR,Approved symbol,INSRR,insulin receptor related receptor,HGNC:6093,1q23.1
INTS1,Approved symbol,INTS1,integrator complex subunit 1,HGNC:24555,7p22.3
INTS12,Approved symbol,INTS12,integrator complex subunit 12,HGNC:25067,4q24
IP6K1,Approved symbol,IP6K1,inositol hexakisphosphate kinase 1,HGNC:18360,3p21.31
IPO13,Approved symbol,IPO13,importin 13,HGNC:16853,1p34.1
IPO4,Approved symbol,IPO4,importin 4,HGNC:19426,14q12
IPO5,Approved symbol,IPO5,importin 5,HGNC:6402,13q32.2
IPO8,Approved symbol,IPO8,importin 8,HGNC:9853,12p11.21
IPP,Approved symbol,IPP,intracisternal A particle-promoted polypeptide,HGNC:6108,1p34.1
IQCA1,Approved symbol,IQCA1,IQ motif containing with AAA domain 1,HGNC:26195,2q37.2-q37.3
IQCD,Approved symbol,IQCD,IQ motif containing D,HGNC:25168,12q24.13
IQCE,Approved symbol,IQCE,IQ motif containing E,HGNC:29171,7p22.3
IQCH,Approved symbol,IQCH,IQ motif containing H,HGNC:25721,15q23
IQCH,Alias symbol,SPATA17,spermatogenesis associated 17,HGNC:25184,1q41
IQGAP1,Approved symbol,IQGAP1,IQ motif containing GTPase activating protein 1,HGNC:6110,15q26.1
IQGAP2,Approved symbol,IQGAP2,IQ motif containing GTPase activating protein 2,HGNC:6111,5q13.3
IQSEC1,Approved symbol,IQSEC1,IQ motif and Sec7 domain ArfGEF 1,HGNC:29112,3p25.2
IQSEC2,Approved symbol,IQSEC2,IQ motif and Sec7 domain ArfGEF 2,HGNC:29059,Xp11.22
IQSEC3,Approved symbol,IQSEC3,IQ motif and Sec7 domain ArfGEF 3,HGNC:29193,12p13.33
IRAK1,Approved symbol,IRAK1,interleukin 1 receptor associated kinase 1,HGNC:6112,Xq28
IRAK4,Approved symbol,IRAK4,interleukin 1 receptor associated kinase 4,HGNC:17967,12q12
IRF2BP2,Approved symbol,IRF2BP2,interferon regulatory factor 2 binding protein 2,HGNC:21729,1q42.3
IRF6,Approved symbol,IRF6,interferon regulatory factor 6,HGNC:6121,1q32.2
IRF9,Approved symbol,IRF9,interferon regulatory factor 9,HGNC:6131,14q12
IRS1,Approved symbol,IRS1,insulin receptor substrate 1,HGNC:6125,2q36.3
IRS2,Approved symbol,IRS2,insulin receptor substrate 2,HGNC:6126,13q34
IRS4,Approved symbol,IRS4,insulin receptor substrate 4,HGNC:6128,Xq22.3
IRX1,Approved symbol,IRX1,iroquois homeobox 1,HGNC:14358,5p15.33
IRX3,Approved symbol,IRX3,iroquois homeobox 3,HGNC:14360,16q12.2
IRX6,Approved symbol,IRX6,iroquois homeobox 6,HGNC:14675,16q12.2
ISCA1,Approved symbol,ISCA1,iron-sulfur cluster assembly 1,HGNC:28660,9q21.33
ISL2,Approved symbol,ISL2,ISL LIM homeobox 2,HGNC:18524,15q24.3
ISLR,Approved symbol,ISLR,immunoglobulin superfamily containing leucine rich repeat,HGNC:6133,15q24.1
ISLR2,Approved symbol,ISLR2,immunoglobulin superfamily containing leucine rich repeat 2,HGNC:29286,15q24.1
ITCH,Approved symbol,ITCH,itchy E3 ubiquitin protein ligase,HGNC:13890,20q11.22
ITFG2,Approved symbol,ITFG2,integrin alpha FG-GAP repeat containing 2,HGNC:30879,12p13.33
ITFG3,Previous symbol,FAM234A,family with sequence similarity 234 member A,HGNC:14163,16p13.3
ITGA2B,Approved symbol,ITGA2B,integrin subunit alpha 2b,HGNC:6138,17q21.31
ITGA3,Approved symbol,ITGA3,integrin subunit alpha 3,HGNC:6139,17q21.33
ITGA7,Approved symbol,ITGA7,integrin subunit alpha 7,HGNC:6143,12q13.2
ITGA8,Approved symbol,ITGA8,integrin subunit alpha 8,HGNC:6144,10p13
ITGAD,Approved symbol,ITGAD,integrin subunit alpha D,HGNC:6146,16p11.2
ITGAE,Approved symbol,ITGAE,integrin subunit alpha E,HGNC:6147,17p13.2
ITGAM,Approved symbol,ITGAM,integrin subunit alpha M,HGNC:6149,16p11.2
ITGAV,Approved symbol,ITGAV,integrin subunit alpha V,HGNC:6150,2q32.1
ITGAX,Approved symbol,ITGAX,integrin subunit alpha X,HGNC:6152,16p11.2
ITGB4,Approved symbol,ITGB4,integrin subunit beta 4,HGNC:6158,17q25.1
ITGB7,Approved symbol,ITGB7,integrin subunit beta 7,HGNC:6162,12q13.13
ITGBL1,Approved symbol,ITGBL1,integrin subunit beta like 1,HGNC:6164,13q33.1
ITIH2,Approved symbol,ITIH2,inter-alpha-trypsin inhibitor heavy chain 2,HGNC:6167,10p14
ITIH3,Approved symbol,ITIH3,inter-alpha-trypsin inhibitor heavy chain 3,HGNC:6168,3p21.1
ITIH5,Approved symbol,ITIH5,inter-alpha-trypsin inhibitor heavy chain 5,HGNC:21449,10p14
ITIH6,Approved symbol,ITIH6,inter-alpha-trypsin inhibitor heavy chain family member 6,HGNC:28907,Xp11.22
ITM2A,Approved symbol,ITM2A,integral membrane protein 2A,HGNC:6173,Xq21.1
ITPKB,Approved symbol,ITPKB,inositol-trisphosphate 3-kinase B,HGNC:6179,1q42.12
ITPR1,Approved symbol,ITPR1,"inositol 1,4,5-trisphosphate receptor type 1",HGNC:6180,3p26.1
ITPR3,Approved symbol,ITPR3,"inositol 1,4,5-trisphosphate receptor type 3",HGNC:6182,6p21.31
ITPRIPL2,Approved symbol,ITPRIPL2,ITPRIP like 2,HGNC:27257,16p12.3
ITSN2,Approved symbol,ITSN2,intersectin 2,HGNC:6184,2p23.3
IVL,Approved symbol,IVL,involucrin,HGNC:6187,1q21.3
IYD,Approved symbol,IYD,iodotyrosine deiodinase,HGNC:21071,6q25.1
IZUMO1,Approved symbol,IZUMO1,izumo sperm-egg fusion 1,HGNC:28539,19q13.33
IZUMO3,Approved symbol,IZUMO3,IZUMO family member 3,HGNC:31421,9p21.3
JADE3,Approved symbol,JADE3,jade family PHD finger 3,HGNC:22982,Xp11.3
JAK3,Approved symbol,JAK3,Janus kinase 3,HGNC:6193,19p13.11
JAKMIP1,Approved symbol,JAKMIP1,janus kinase and microtubule interacting protein 1,HGNC:26460,4p16.1
JAKMIP2,Approved symbol,JAKMIP2,janus kinase and microtubule interacting protein 2,HGNC:29067,5q32
JARID2,Approved symbol,JARID2,jumonji and AT-rich interaction domain containing 2,HGNC:6196,6p22.3
JMJD1C,Approved symbol,JMJD1C,jumonji domain containing 1C,HGNC:12313,10q21.3
JPH2,Approved symbol,JPH2,junctophilin 2,HGNC:14202,20q13.12
JPH3,Approved symbol,JPH3,junctophilin 3,HGNC:14203,16q24.2
JTB,Approved symbol,JTB,jumping translocation breakpoint,HGNC:6201,1q21.3
JUND,Approved symbol,JUND,"JunD proto-oncogene, AP-1 transcription factor subunit",HGNC:6206,19p13.11
KALRN,Approved symbol,KALRN,kalirin RhoGEF kinase,HGNC:4814,3q21.1-q21.2
KANK3,Approved symbol,KANK3,KN motif and ankyrin repeat domains 3,HGNC:24796,19p13.2
KANK4,Approved symbol,KANK4,KN motif and ankyrin repeat domains 4,HGNC:27263,1p31.3
KARS,Previous symbol,KARS1,lysyl-tRNA synthetase 1,HGNC:6215,16q23.1
KAT2A,Approved symbol,KAT2A,lysine acetyltransferase 2A,HGNC:4201,17q21.2
KAT6A,Approved symbol,KAT6A,lysine acetyltransferase 6A,HGNC:13013,8p11.21
KATNAL2,Approved symbol,KATNAL2,katanin catalytic subunit A1 like 2,HGNC:25387,18q21.1
KAZN,Approved symbol,KAZN,"kazrin, periplakin interacting protein",HGNC:29173,1p36.21
KBTBD11,Approved symbol,KBTBD11,kelch repeat and BTB domain containing 11,HGNC:29104,8p23.3
KBTBD11-OT1,Approved symbol,KBTBD11-OT1,KBTBD11 overlapping transcript 1,HGNC:49147,8p23.3
KBTBD4,Approved symbol,KBTBD4,kelch repeat and BTB domain containing 4,HGNC:23761,11p11.2
KCNA5,Approved symbol,KCNA5,potassium voltage-gated channel subfamily A member 5,HGNC:6224,12p13.32
KCNA6,Approved symbol,KCNA6,potassium voltage-gated channel subfamily A member 6,HGNC:6225,12p13.32
KCNC1,Approved symbol,KCNC1,potassium voltage-gated channel subfamily C member 1,HGNC:6233,11p15.1
KCNC4,Approved symbol,KCNC4,potassium voltage-gated channel subfamily C member 4,HGNC:6236,1p13.3
KCND1,Approved symbol,KCND1,potassium voltage-gated channel subfamily D member 1,HGNC:6237,Xp11.23
KCND2,Approved symbol,KCND2,potassium voltage-gated channel subfamily D member 2,HGNC:6238,7q31.31
KCND3,Approved symbol,KCND3,potassium voltage-gated channel subfamily D member 3,HGNC:6239,1p13.2
KCNG1,Approved symbol,KCNG1,potassium voltage-gated channel modifier subfamily G member 1,HGNC:6248,20q13.13
KCNG2,Approved symbol,KCNG2,potassium voltage-gated channel modifier subfamily G member 2,HGNC:6249,18q23
KCNH1,Approved symbol,KCNH1,potassium voltage-gated channel subfamily H member 1,HGNC:6250,1q32.2
KCNH2,Approved symbol,KCNH2,potassium voltage-gated channel subfamily H member 2,HGNC:6251,7q36.1
KCNH3,Approved symbol,KCNH3,potassium voltage-gated channel subfamily H member 3,HGNC:6252,12q13.12
KCNH5,Approved symbol,KCNH5,potassium voltage-gated channel subfamily H member 5,HGNC:6254,14q23.2
KCNH6,Approved symbol,KCNH6,potassium voltage-gated channel subfamily H member 6,HGNC:18862,17q23.3
KCNH7,Approved symbol,KCNH7,potassium voltage-gated channel subfamily H member 7,HGNC:18863,2q24.2
KCNH8,Approved symbol,KCNH8,potassium voltage-gated channel subfamily H member 8,HGNC:18864,3p24.3
KCNJ12,Approved symbol,KCNJ12,potassium inwardly rectifying channel subfamily J member 12,HGNC:6258,17p11.2
KCNJ2,Approved symbol,KCNJ2,potassium inwardly rectifying channel subfamily J member 2,HGNC:6263,17q24.3
KCNJ5,Approved symbol,KCNJ5,potassium inwardly rectifying channel subfamily J member 5,HGNC:6266,11q24.3
KCNJ6,Approved symbol,KCNJ6,potassium inwardly rectifying channel subfamily J member 6,HGNC:6267,21q22.13
KCNK13,Approved symbol,KCNK13,potassium two pore domain channel subfamily K member 13,HGNC:6275,14q32.11
KCNK3,Approved symbol,KCNK3,potassium two pore domain channel subfamily K member 3,HGNC:6278,2p23.3
KCNK4,Approved symbol,KCNK4,potassium two pore domain channel subfamily K member 4,HGNC:6279,11q13.1
KCNK9,Approved symbol,KCNK9,potassium two pore domain channel subfamily K member 9,HGNC:6283,8q24.3
KCNMA1,Approved symbol,KCNMA1,potassium calcium-activated channel subfamily M alpha 1,HGNC:6284,10q22.3
KCNMB1,Approved symbol,KCNMB1,potassium calcium-activated channel subfamily M regulatory beta subunit 1,HGNC:6285,5q35.1
KCNMB2,Approved symbol,KCNMB2,potassium calcium-activated channel subfamily M regulatory beta subunit 2,HGNC:6286,3q26.32
KCNMB2,Previous symbol,KCNMB3,potassium calcium-activated channel subfamily M regulatory beta subunit 3,HGNC:6287,3q26.32
KCNMB3,Approved symbol,KCNMB3,potassium calcium-activated channel subfamily M regulatory beta subunit 3,HGNC:6287,3q26.32
KCNN1,Approved symbol,KCNN1,potassium calcium-activated channel subfamily N member 1,HGNC:6290,19p13.11
KCNN2,Approved symbol,KCNN2,potassium calcium-activated channel subfamily N member 2,HGNC:6291,5q22.3
KCNQ2,Approved symbol,KCNQ2,potassium voltage-gated channel subfamily Q member 2,HGNC:6296,20q13.33
KCNQ3,Approved symbol,KCNQ3,potassium voltage-gated channel subfamily Q member 3,HGNC:6297,8q24.22
KCNQ5,Approved symbol,KCNQ5,potassium voltage-gated channel subfamily Q member 5,HGNC:6299,6q13
KCNS2,Approved symbol,KCNS2,potassium voltage-gated channel modifier subfamily S member 2,HGNC:6301,8q22.2
KCNU1,Approved symbol,KCNU1,potassium calcium-activated channel subfamily U member 1,HGNC:18867,8p11.23
KCNV2,Approved symbol,KCNV2,potassium voltage-gated channel modifier subfamily V member 2,HGNC:19698,9p24.2
KCTD13,Approved symbol,KCTD13,potassium channel tetramerization domain containing 13,HGNC:22234,16p11.2
KCTD15,Approved symbol,KCTD15,potassium channel tetramerization domain containing 15,HGNC:23297,19q13.11
KCTD19,Approved symbol,KCTD19,potassium channel tetramerization domain containing 19,HGNC:24753,16q22.1
KDELC1,Previous symbol,POGLUT2,protein O-glucosyltransferase 2,HGNC:19350,13q33.1
KDELC2,Previous symbol,POGLUT3,protein O-glucosyltransferase 3,HGNC:28496,11q22.3
KDM4C,Approved symbol,KDM4C,lysine demethylase 4C,HGNC:17071,9p24.1
KDM7A,Approved symbol,KDM7A,lysine demethylase 7A,HGNC:22224,7q34
KDR,Approved symbol,KDR,kinase insert domain receptor,HGNC:6307,4q12
KEAP1,Approved symbol,KEAP1,kelch like ECH associated protein 1,HGNC:23177,19p13.2
KEL,Approved symbol,KEL,Kell metallo-endopeptidase (Kell blood group),HGNC:6308,7q34
KHDRBS3,Approved symbol,KHDRBS3,"KH RNA binding domain containing, signal transduction associated 3",HGNC:18117,8q24.23
KIAA0020,Previous symbol,PUM3,pumilio RNA binding family member 3,HGNC:29676,9p24.2
KIAA0226,Previous symbol,RUBCN,rubicon autophagy regulator,HGNC:28991,3q29
KIAA0232,Approved symbol,KIAA0232,KIAA0232,HGNC:28992,4p16.1
KIAA0319L,Approved symbol,KIAA0319L,KIAA0319 like,HGNC:30071,1p34.3
KIAA0355,Previous symbol,GARRE1,granule associated Rac and RHOG effector 1,HGNC:29016,19q13.11
KIAA0391,Previous symbol,PRORP,protein only RNase P catalytic subunit,HGNC:19958,14q13.2
KIAA0556,Previous symbol,KATNIP,katanin interacting protein,HGNC:29068,16p12.1
KIAA0825,Approved symbol,KIAA0825,KIAA0825,HGNC:28532,5q15
KIAA0895,Approved symbol,KIAA0895,KIAA0895,HGNC:22206,7p14.2
KIAA0895L,Approved symbol,KIAA0895L,KIAA0895 like,HGNC:34408,16q22.1
KIAA0922,Previous symbol,TMEM131L,transmembrane 131 like,HGNC:29146,4q31.3
KIAA0947,Previous symbol,ICE1,interactor of little elongation complex ELL subunit 1,HGNC:29154,5p15.32
KIAA1024,Previous symbol,MINAR1,membrane integral NOTCH2 associated receptor 1,HGNC:29172,15q25.1
KIAA1033,Previous symbol,WASHC4,WASH complex subunit 4,HGNC:29174,12q23.3
KIAA1107,Approved symbol,KIAA1107,KIAA1107,HGNC:29192,1p22.1
KIAA1109,Approved symbol,KIAA1109,KIAA1109,HGNC:26953,4q27
KIAA1161,Previous symbol,MYORG,myogenesis regulating glycosidase (putative),HGNC:19918,9p13.3
KIAA1199,Previous symbol,CEMIP,cell migration inducing hyaluronidase 1,HGNC:29213,15q25.1
KIAA1210,Approved symbol,KIAA1210,KIAA1210,HGNC:29218,Xq24
KIAA1239,Previous symbol,NWD2,NACHT and WD repeat domain containing 2,HGNC:29229,4p14
KIAA1244,Previous symbol,ARFGEF3,ARFGEF family member 3,HGNC:21213,6q23.3-q24.1
KIAA1324L,Previous symbol,ELAPOR2,endosome-lysosome associated apoptosis and autophagy regulator family member 2,HGNC:21945,7q21.12
KIAA1328,Approved symbol,KIAA1328,KIAA1328,HGNC:29248,18q12.2
KIAA1407,Previous symbol,CCDC191,coiled-coil domain containing 191,HGNC:29272,3q13.31
KIAA1429,Previous symbol,VIRMA,vir like m6A methyltransferase associated,HGNC:24500,8q22.1
KIAA1456,Previous symbol,TRMT9B,tRNA methyltransferase 9B (putative),HGNC:26725,8p22
KIAA1468,Previous symbol,RELCH,"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing",HGNC:29289,18q21.33
KIAA1522,Approved symbol,KIAA1522,KIAA1522,HGNC:29301,1p35.1
KIAA1549,Approved symbol,KIAA1549,KIAA1549,HGNC:22219,7q34
KIAA1549L,Approved symbol,KIAA1549L,KIAA1549 like,HGNC:24836,11p13
KIAA1598,Previous symbol,SHTN1,shootin 1,HGNC:29319,10q25.3
KIAA1644,Previous symbol,SHISAL1,shisa like 1,HGNC:29335,22q13.31
KIAA1683,Previous symbol,IQCN,IQ motif containing N,HGNC:29350,19p13.11
KIAA1841,Previous symbol,SANBR,SANT and BTB domain regulator of CSR,HGNC:29387,2p15
KIAA1919,Previous symbol,MFSD4B,major facilitator superfamily domain containing 4B,HGNC:21053,6q21
KIAA2018,Previous symbol,USF3,upstream transcription factor family member 3,HGNC:30494,3q13.2
KIAA2026,Approved symbol,KIAA2026,KIAA2026,HGNC:23378,9p24.1
KIDINS220,Approved symbol,KIDINS220,kinase D interacting substrate 220,HGNC:29508,2p25.1
KIF13B,Approved symbol,KIF13B,kinesin family member 13B,HGNC:14405,8p12
KIF15,Approved symbol,KIF15,kinesin family member 15,HGNC:17273,3p21.31
KIF1A,Approved symbol,KIF1A,kinesin family member 1A,HGNC:888,2q37.3
KIF1B,Approved symbol,KIF1B,kinesin family member 1B,HGNC:16636,1p36.22
KIF20B,Approved symbol,KIF20B,kinesin family member 20B,HGNC:7212,10q23.31
KIF21A,Approved symbol,KIF21A,kinesin family member 21A,HGNC:19349,12q12
KIF25,Approved symbol,KIF25,kinesin family member 25,HGNC:6390,6q27
KIF26A,Approved symbol,KIF26A,kinesin family member 26A,HGNC:20226,14q32.33
KIF26B,Approved symbol,KIF26B,kinesin family member 26B,HGNC:25484,1q44
KIF2A,Approved symbol,KIF2A,kinesin family member 2A,HGNC:6318,5q12.1
KIF2B,Approved symbol,KIF2B,kinesin family member 2B,HGNC:29443,17q22
KIF4B,Approved symbol,KIF4B,kinesin family member 4B,HGNC:6322,5q33.2
KIF5A,Approved symbol,KIF5A,kinesin family member 5A,HGNC:6323,12q13.3
KIF7,Approved symbol,KIF7,kinesin family member 7,HGNC:30497,15q26.1
KIF9-AS1,Approved symbol,KIF9-AS1,KIF9 antisense RNA 1,HGNC:26822,3p21.31
KIFC3,Approved symbol,KIFC3,kinesin family member C3,HGNC:6326,16q21
KIR2DL3,Approved symbol,KIR2DL3,"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3",HGNC:6331,19q13.42
KIR2DS4,Approved symbol,KIR2DS4,"killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4",HGNC:6336,19q13.42
KIR3DL1,Approved symbol,KIR3DL1,"killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1",HGNC:6338,19q13.42
KIRREL,Previous symbol,KIRREL1,kirre like nephrin family adhesion molecule 1,HGNC:15734,1q23.1
KIT,Approved symbol,KIT,"KIT proto-oncogene, receptor tyrosine kinase",HGNC:6342,4q12
KL,Approved symbol,KL,klotho,HGNC:6344,13q13.1
KLC1,Approved symbol,KLC1,kinesin light chain 1,HGNC:6387,14q32.33
KLC2,Approved symbol,KLC2,kinesin light chain 2,HGNC:20716,11q13.2
KLC3,Approved symbol,KLC3,kinesin light chain 3,HGNC:20717,19q13.32
KLC4,Approved symbol,KLC4,kinesin light chain 4,HGNC:21624,6p21.1
KLF10,Approved symbol,KLF10,Kruppel like factor 10,HGNC:11810,8q22.3
KLF11,Approved symbol,KLF11,Kruppel like factor 11,HGNC:11811,2p25.1
KLF14,Approved symbol,KLF14,Kruppel like factor 14,HGNC:23025,7q32.2
KLF14,Alias symbol,SP6,Sp6 transcription factor,HGNC:14530,17q21.32
KLF15,Approved symbol,KLF15,Kruppel like factor 15,HGNC:14536,3q21.3
KLF2,Approved symbol,KLF2,Kruppel like factor 2,HGNC:6347,19p13.11
KLF5,Approved symbol,KLF5,Kruppel like factor 5,HGNC:6349,13q22.1
KLHDC7B,Approved symbol,KLHDC7B,kelch domain containing 7B,HGNC:25145,22q13.33
KLHL1,Approved symbol,KLHL1,kelch like family member 1,HGNC:6352,13q21.33
KLHL13,Approved symbol,KLHL13,kelch like family member 13,HGNC:22931,Xq24
KLHL15,Approved symbol,KLHL15,kelch like family member 15,HGNC:29347,Xp22.11
KLHL17,Approved symbol,KLHL17,kelch like family member 17,HGNC:24023,1p36.33
KLHL18,Approved symbol,KLHL18,kelch like family member 18,HGNC:29120,3p21.31
KLHL21,Approved symbol,KLHL21,kelch like family member 21,HGNC:29041,1p36.31
KLHL29,Approved symbol,KLHL29,kelch like family member 29,HGNC:29404,2p24.1
KLHL3,Approved symbol,KLHL3,kelch like family member 3,HGNC:6354,5q31.2
KLHL33,Approved symbol,KLHL33,kelch like family member 33,HGNC:31952,14q11.2
KLHL38,Approved symbol,KLHL38,kelch like family member 38,HGNC:34435,8q24.13
KLHL4,Approved symbol,KLHL4,kelch like family member 4,HGNC:6355,Xq21.31
KLHL42,Approved symbol,KLHL42,kelch like family member 42,HGNC:29252,12p11.22
KLK5,Approved symbol,KLK5,kallikrein related peptidase 5,HGNC:6366,19q13.41
KLLN,Approved symbol,KLLN,"killin, p53 regulated DNA replication inhibitor",HGNC:37212,10q23
KLRC1,Approved symbol,KLRC1,killer cell lectin like receptor C1,HGNC:6374,12p13
KLRG2,Approved symbol,KLRG2,killer cell lectin like receptor G2,HGNC:24778,7q34
KMT2A,Approved symbol,KMT2A,lysine methyltransferase 2A,HGNC:7132,11q23.3
KMT2B,Approved symbol,KMT2B,lysine methyltransferase 2B,HGNC:15840,19q13.12
KMT2C,Approved symbol,KMT2C,lysine methyltransferase 2C,HGNC:13726,7q36.1
KMT2D,Approved symbol,KMT2D,lysine methyltransferase 2D,HGNC:7133,12q13.12
KMT2E,Approved symbol,KMT2E,lysine methyltransferase 2E (inactive),HGNC:18541,7q22.3
KNTC1,Approved symbol,KNTC1,kinetochore associated 1,HGNC:17255,12q24.31
KPNA1,Approved symbol,KPNA1,karyopherin subunit alpha 1,HGNC:6394,3q21.1
KPNA5,Approved symbol,KPNA5,karyopherin subunit alpha 5,HGNC:6398,6q22.1
KRAS,Approved symbol,KRAS,"KRAS proto-oncogene, GTPase",HGNC:6407,12p12.1
KRBA1,Approved symbol,KRBA1,KRAB-A domain containing 1,HGNC:22228,7q36.1
KRBA2,Approved symbol,KRBA2,KRAB-A domain containing 2,HGNC:26989,17p13.1
KREMEN1,Approved symbol,KREMEN1,kringle containing transmembrane protein 1,HGNC:17550,22q12.1
KREMEN2,Approved symbol,KREMEN2,kringle containing transmembrane protein 2,HGNC:18797,16p13.3
KRI1,Approved symbol,KRI1,KRI1 homolog,HGNC:25769,19p13.2
KRT12,Approved symbol,KRT12,keratin 12,HGNC:6414,17q21.2
KRT13,Approved symbol,KRT13,keratin 13,HGNC:6415,17q21.2
KRT26,Approved symbol,KRT26,keratin 26,HGNC:30840,17q21.2
KRT32,Approved symbol,KRT32,keratin 32,HGNC:6449,17q21.2
KRT33B,Approved symbol,KRT33B,keratin 33B,HGNC:6451,17q21.2
KRT34,Approved symbol,KRT34,keratin 34,HGNC:6452,17q21.2
KRT39,Approved symbol,KRT39,keratin 39,HGNC:32971,17q21.2
KRT4,Approved symbol,KRT4,keratin 4,HGNC:6441,12q13.13
KRT6B,Approved symbol,KRT6B,keratin 6B,HGNC:6444,12q13.13
KRT78,Approved symbol,KRT78,keratin 78,HGNC:28926,12q13.13
KRT83,Approved symbol,KRT83,keratin 83,HGNC:6460,12q13.13
KRT84,Approved symbol,KRT84,keratin 84,HGNC:6461,12q13.13
KRT85,Approved symbol,KRT85,keratin 85,HGNC:6462,12q13.13
KRTAP19-1,Approved symbol,KRTAP19-1,keratin associated protein 19-1,HGNC:18936,21q22.11
KRTAP2-4,Approved symbol,KRTAP2-4,keratin associated protein 2-4,HGNC:18891,17q21.2
KRTAP24-1,Approved symbol,KRTAP24-1,keratin associated protein 24-1,HGNC:33902,21q22.11
KRTAP6-2,Approved symbol,KRTAP6-2,keratin associated protein 6-2,HGNC:18932,21q22.11
KSR2,Approved symbol,KSR2,kinase suppressor of ras 2,HGNC:18610,12q24.22-q24.23
KSR2,Alias symbol,CNKSR2,connector enhancer of kinase suppressor of Ras 2,HGNC:19701,Xp22.12
L1CAM,Approved symbol,L1CAM,L1 cell adhesion molecule,HGNC:6470,Xq28
L3MBTL4,Approved symbol,L3MBTL4,L3MBTL histone methyl-lysine binding protein 4,HGNC:26677,18p11.31
LMF1,Approved symbol,LMF1,lipase maturation factor 1,HGNC:14154,16p13.3
LACTB,Approved symbol,LACTB,lactamase beta,HGNC:16468,15q22.2
LACTB2,Approved symbol,LACTB2,lactamase beta 2,HGNC:18512,8q13.3
LACTBL1,Approved symbol,LACTBL1,lactamase beta like 1,HGNC:35445,1p36.12
LAG3,Approved symbol,LAG3,lymphocyte activating 3,HGNC:6476,12p13.31
LAIR2,Approved symbol,LAIR2,leukocyte associated immunoglobulin like receptor 2,HGNC:6478,19q13.42
LAMA1,Approved symbol,LAMA1,laminin subunit alpha 1,HGNC:6481,18p11.31
LAMA2,Approved symbol,LAMA2,laminin subunit alpha 2,HGNC:6482,6q22.33
LAMA3,Approved symbol,LAMA3,laminin subunit alpha 3,HGNC:6483,18q11.2
LAMA3,Alias symbol,LAMA4,laminin subunit alpha 4,HGNC:6484,6q21
LAMA5,Approved symbol,LAMA5,laminin subunit alpha 5,HGNC:6485,20q13.33
LAMB1,Approved symbol,LAMB1,laminin subunit beta 1,HGNC:6486,7q31.1
LAMB2,Approved symbol,LAMB2,laminin subunit beta 2,HGNC:6487,3p21.31
LAMB2,Previous symbol,LAMC1,laminin subunit gamma 1,HGNC:6492,1q25.3
LAMB4,Approved symbol,LAMB4,laminin subunit beta 4,HGNC:6491,7q31.1
LAPTM4B,Approved symbol,LAPTM4B,lysosomal protein transmembrane 4 beta,HGNC:13646,8q22.1
LARGE,Previous symbol,LARGE1,LARGE xylosyl- and glucuronyltransferase 1,HGNC:6511,22q12.3
LARP1,Approved symbol,LARP1,"La ribonucleoprotein 1, translational regulator",HGNC:29531,5q33.2
LARP1B,Approved symbol,LARP1B,La ribonucleoprotein 1B,HGNC:24704,4q28.2
LAS1L,Approved symbol,LAS1L,LAS1 like ribosome biogenesis factor,HGNC:25726,Xq12
LATS1,Approved symbol,LATS1,large tumor suppressor kinase 1,HGNC:6514,6q25.1
LAX1,Approved symbol,LAX1,lymphocyte transmembrane adaptor 1,HGNC:26005,1q32.1
LCE1D,Approved symbol,LCE1D,late cornified envelope 1D,HGNC:29465,1q21.3
LCE1E,Approved symbol,LCE1E,late cornified envelope 1E,HGNC:29466,1q21.3
LCE4A,Approved symbol,LCE4A,late cornified envelope 4A,HGNC:16613,1q21.3
LCE6A,Approved symbol,LCE6A,late cornified envelope 6A,HGNC:31824,1q21.3
LCMT1,Approved symbol,LCMT1,leucine carboxyl methyltransferase 1,HGNC:17557,16p12.1
LCN8,Approved symbol,LCN8,lipocalin 8,HGNC:27038,9q34.3
LCORL,Approved symbol,LCORL,ligand dependent nuclear receptor corepressor like,HGNC:30776,4p15.31
LCT,Approved symbol,LCT,lactase,HGNC:6530,2q21.3
LDHAL6B,Approved symbol,LDHAL6B,lactate dehydrogenase A like 6B,HGNC:21481,15q22.2
LDHB,Approved symbol,LDHB,lactate dehydrogenase B,HGNC:6541,12p12.1
LDLR,Approved symbol,LDLR,low density lipoprotein receptor,HGNC:6547,19p13.2
LDLRAD4,Approved symbol,LDLRAD4,low density lipoprotein receptor class A domain containing 4,HGNC:1224,18p11.21
LECT2,Approved symbol,LECT2,leukocyte cell derived chemotaxin 2,HGNC:6550,5q31.1
LENG8,Approved symbol,LENG8,leukocyte receptor cluster member 8,HGNC:15500,19q13.42
LEPR,Approved symbol,LEPR,leptin receptor,HGNC:6554,1p31.3
LEPREL1,Previous symbol,P3H2,prolyl 3-hydroxylase 2,HGNC:19317,3q28
LEPROT,Approved symbol,LEPROT,leptin receptor overlapping transcript,HGNC:29477,1p31.3
LETM2,Approved symbol,LETM2,leucine zipper and EF-hand containing transmembrane protein 2,HGNC:14648,8p11.23
LEUTX,Approved symbol,LEUTX,leucine twenty homeobox,HGNC:31953,19q13.2
LGALS4,Approved symbol,LGALS4,galectin 4,HGNC:6565,19q13.2
LGR4,Approved symbol,LGR4,leucine rich repeat containing G protein-coupled receptor 4,HGNC:13299,11p14.1
LHFPL3,Approved symbol,LHFPL3,LHFPL tetraspan subfamily member 3,HGNC:6589,7q22.2-q22.3
LHX3,Approved symbol,LHX3,LIM homeobox 3,HGNC:6595,9q34.3
LHX5,Approved symbol,LHX5,LIM homeobox 5,HGNC:14216,12q24.13
LHX6,Approved symbol,LHX6,LIM homeobox 6,HGNC:21735,9q33.2
LHX9,Approved symbol,LHX9,LIM homeobox 9,HGNC:14222,1q31.3
LILRA1,Approved symbol,LILRA1,leukocyte immunoglobulin like receptor A1,HGNC:6602,19q13.42
LILRA2,Approved symbol,LILRA2,leukocyte immunoglobulin like receptor A2,HGNC:6603,19q13.4
LIMA1,Approved symbol,LIMA1,LIM domain and actin binding 1,HGNC:24636,12q13.12
LIMCH1,Approved symbol,LIMCH1,LIM and calponin homology domains 1,HGNC:29191,4p13
LIMD2,Approved symbol,LIMD2,LIM domain containing 2,HGNC:28142,17q23.3
LIMK2,Approved symbol,LIMK2,LIM domain kinase 2,HGNC:6614,22q12.2
LIMS2,Approved symbol,LIMS2,LIM zinc finger domain containing 2,HGNC:16084,2q14.3
LINC00283,Entry withdrawn,LINC00283,,HGNC:38809,
LINGO1,Approved symbol,LINGO1,leucine rich repeat and Ig domain containing 1,HGNC:21205,15q24.3
LINGO4,Approved symbol,LINGO4,leucine rich repeat and Ig domain containing 4,HGNC:31814,1q21.3
LIPE,Approved symbol,LIPE,"lipase E, hormone sensitive type",HGNC:6621,19q13.2
LIPN,Approved symbol,LIPN,lipase family member N,HGNC:23452,10q23.31
LIPT1,Approved symbol,LIPT1,lipoyltransferase 1,HGNC:29569,2q11.2
LIX1,Approved symbol,LIX1,limb and CNS expressed 1,HGNC:18581,5q15
LLGL2,Approved symbol,LLGL2,LLGL scribble cell polarity complex component 2,HGNC:6629,17q25.1
LMAN2L,Approved symbol,LMAN2L,"lectin, mannose binding 2 like",HGNC:19263,2q11.2
LMCD1,Approved symbol,LMCD1,LIM and cysteine rich domains 1,HGNC:6633,3p25.3
LMLN,Approved symbol,LMLN,leishmanolysin like peptidase,HGNC:15991,3q29
LMNA,Approved symbol,LMNA,lamin A/C,HGNC:6636,1q22
LMO1,Approved symbol,LMO1,LIM domain only 1,HGNC:6641,11p15.4
LMTK2,Approved symbol,LMTK2,lemur tyrosine kinase 2,HGNC:17880,7q21.3
LMX1A,Approved symbol,LMX1A,LIM homeobox transcription factor 1 alpha,HGNC:6653,1q23.3
LNP1,Approved symbol,LNP1,leukemia NUP98 fusion partner 1,HGNC:28014,3q12.2
LNP1,Alias symbol,LNPK,"lunapark, ER junction formation factor",HGNC:21610,2q31.1
LNPEP,Approved symbol,LNPEP,leucyl and cystinyl aminopeptidase,HGNC:6656,5q15
LOH12CR1,Previous symbol,BORCS5,BLOC-1 related complex subunit 5,HGNC:17950,12p13.2
LONP2,Approved symbol,LONP2,"lon peptidase 2, peroxisomal",HGNC:20598,16q12.1
LONRF2,Approved symbol,LONRF2,LON peptidase N-terminal domain and ring finger 2,HGNC:24788,2q11.2
LOXHD1,Approved symbol,LOXHD1,lipoxygenase homology PLAT domains 1,HGNC:26521,18q21.1
LOXL2,Approved symbol,LOXL2,lysyl oxidase like 2,HGNC:6666,8p21.3
LPA,Approved symbol,LPA,lipoprotein(a),HGNC:6667,6q25.3-q26
LPAR4,Approved symbol,LPAR4,lysophosphatidic acid receptor 4,HGNC:4478,Xq21.1
LPHN2,Previous symbol,ADGRL2,adhesion G protein-coupled receptor L2,HGNC:18582,1p31.1
LPHN3,Previous symbol,ADGRL3,adhesion G protein-coupled receptor L3,HGNC:20974,4q13.1
LPIN1,Approved symbol,LPIN1,lipin 1,HGNC:13345,2p25.1
LPPR3,Alias symbol,PLPPR3,phospholipid phosphatase related 3,HGNC:23497,19p13.3
LRAT,Approved symbol,LRAT,lecithin retinol acyltransferase,HGNC:6685,4q32.1
LRBA,Approved symbol,LRBA,LPS responsive beige-like anchor protein,HGNC:1742,4q31.3
LRCH1,Approved symbol,LRCH1,leucine rich repeats and calponin homology domain containing 1,HGNC:20309,13q14.13-q14.2
LRCOL1,Approved symbol,LRCOL1,leucine rich colipase like 1,HGNC:44160,12q24.33
LRFN1,Approved symbol,LRFN1,leucine rich repeat and fibronectin type III domain containing 1,HGNC:29290,19q13.2
LRFN2,Approved symbol,LRFN2,leucine rich repeat and fibronectin type III domain containing 2,HGNC:21226,6p21.2-p21.1
LRFN5,Approved symbol,LRFN5,leucine rich repeat and fibronectin type III domain containing 5,HGNC:20360,14q21.1
LRIG3,Approved symbol,LRIG3,leucine rich repeats and immunoglobulin like domains 3,HGNC:30991,12q14.1
LRIT1,Approved symbol,LRIT1,"leucine rich repeat, Ig-like and transmembrane domains 1",HGNC:23404,10q23.1
LRMP,Previous symbol,IRAG2,"inositol 1,4,5-triphosphate receptor associated 2",HGNC:6690,12p12.1
LRP11,Approved symbol,LRP11,LDL receptor related protein 11,HGNC:16936,6q25.1
LRP1B,Approved symbol,LRP1B,LDL receptor related protein 1B,HGNC:6693,2q22.1-q22.2
LRP2,Approved symbol,LRP2,LDL receptor related protein 2,HGNC:6694,2q31.1
LRP2BP,Approved symbol,LRP2BP,LRP2 binding protein,HGNC:25434,4q35.1
LRP2BP,Alias symbol,ANKRD37,ankyrin repeat domain 37,HGNC:29593,4q35.1
LRP3,Approved symbol,LRP3,LDL receptor related protein 3,HGNC:6695,19q13.11
LRP5,Approved symbol,LRP5,LDL receptor related protein 5,HGNC:6697,11q13.2
LRP5L,Approved symbol,LRP5L,LDL receptor related protein 5 like,HGNC:25323,22q11.23
LRPPRC,Approved symbol,LRPPRC,leucine rich pentatricopeptide repeat containing,HGNC:15714,2p21
LRRC18,Approved symbol,LRRC18,leucine rich repeat containing 18,HGNC:23199,10q11.23
LRRC25,Approved symbol,LRRC25,leucine rich repeat containing 25,HGNC:29806,19p13.11
LRRC28,Approved symbol,LRRC28,leucine rich repeat containing 28,HGNC:28355,15q26.3
LRRC30,Approved symbol,LRRC30,leucine rich repeat containing 30,HGNC:30219,18p11.23
LRRC36,Approved symbol,LRRC36,leucine rich repeat containing 36,HGNC:25615,16q22.1
LRRC39,Approved symbol,LRRC39,leucine rich repeat containing 39,HGNC:28228,1p21.2
LRRC40,Approved symbol,LRRC40,leucine rich repeat containing 40,HGNC:26004,1p31.1
LRRC41,Approved symbol,LRRC41,leucine rich repeat containing 41,HGNC:16917,1p34.1-p33
LRRC48,Previous symbol,DRC3,dynein regulatory complex subunit 3,HGNC:25384,17p11.2
LRRC49,Approved symbol,LRRC49,leucine rich repeat containing 49,HGNC:25965,15q23
LRRC56,Approved symbol,LRRC56,leucine rich repeat containing 56,HGNC:25430,11p15.5
LRRC58,Approved symbol,LRRC58,leucine rich repeat containing 58,HGNC:26968,3q13.33
LRRC63,Approved symbol,LRRC63,leucine rich repeat containing 63,HGNC:34296,13q14.13
LRRC7,Approved symbol,LRRC7,leucine rich repeat containing 7,HGNC:18531,1p31.1
LRRC8D,Approved symbol,LRRC8D,leucine rich repeat containing 8 VRAC subunit D,HGNC:16992,1p22.2
LRRFIP2,Approved symbol,LRRFIP2,LRR binding FLII interacting protein 2,HGNC:6703,3p22.2
LRRIQ3,Approved symbol,LRRIQ3,leucine rich repeats and IQ motif containing 3,HGNC:28318,1p31.1
LRRK1,Approved symbol,LRRK1,leucine rich repeat kinase 1,HGNC:18608,15q26.3
LRRK2,Approved symbol,LRRK2,leucine rich repeat kinase 2,HGNC:18618,12q12
LRRN1,Approved symbol,LRRN1,leucine rich repeat neuronal 1,HGNC:20980,3p26.2
LRRN1,Previous symbol,LRCH4,leucine rich repeats and calponin homology domain containing 4,HGNC:6691,7q22.1
LRRN3,Approved symbol,LRRN3,leucine rich repeat neuronal 3,HGNC:17200,7q31.1
LRRN4,Approved symbol,LRRN4,leucine rich repeat neuronal 4,HGNC:16208,20p12.3
LRRTM1,Approved symbol,LRRTM1,leucine rich repeat transmembrane neuronal 1,HGNC:19408,2p12
LRRTM4,Approved symbol,LRRTM4,leucine rich repeat transmembrane neuronal 4,HGNC:19411,2p12
LRWD1,Approved symbol,LRWD1,leucine rich repeats and WD repeat domain containing 1,HGNC:21769,7q22.1
LSMEM1,Approved symbol,LSMEM1,leucine rich single-pass membrane protein 1,HGNC:22036,7q31.1
LSP1,Approved symbol,LSP1,lymphocyte specific protein 1,HGNC:6707,11p15.5
LSS,Approved symbol,LSS,lanosterol synthase,HGNC:6708,21q22.3
LST1,Approved symbol,LST1,leukocyte specific transcript 1,HGNC:14189,6p21.33
LTA4H,Approved symbol,LTA4H,leukotriene A4 hydrolase,HGNC:6710,12q23.1
LTBP2,Approved symbol,LTBP2,latent transforming growth factor beta binding protein 2,HGNC:6715,14q24.3
LTBP2,Previous symbol,LTBP3,latent transforming growth factor beta binding protein 3,HGNC:6716,11q13.1
LTC4S,Approved symbol,LTC4S,leukotriene C4 synthase,HGNC:6719,5q35.3
LTK,Approved symbol,LTK,leukocyte receptor tyrosine kinase,HGNC:6721,15q15.1
LUM,Approved symbol,LUM,lumican,HGNC:6724,12q21.33
LURAP1,Approved symbol,LURAP1,leucine rich adaptor protein 1,HGNC:32327,1p34.1
LUZP2,Approved symbol,LUZP2,leucine zipper protein 2,HGNC:23206,11p14.3
LY6D,Approved symbol,LY6D,lymphocyte antigen 6 family member D,HGNC:13348,8q24.3
LY9,Approved symbol,LY9,lymphocyte antigen 9,HGNC:6730,1q23.3
LYPLA2,Approved symbol,LYPLA2,lysophospholipase 2,HGNC:6738,1p36.11
LYSMD1,Approved symbol,LYSMD1,LysM domain containing 1,HGNC:32070,1q21.3
LYSMD4,Approved symbol,LYSMD4,LysM domain containing 4,HGNC:26571,15q26.3
LYST,Approved symbol,LYST,lysosomal trafficking regulator,HGNC:1968,1q42.3
LZTR1,Approved symbol,LZTR1,leucine zipper like transcription regulator 1,HGNC:6742,22q11.21
LZTS1,Approved symbol,LZTS1,leucine zipper tumor suppressor 1,HGNC:13861,8p21.3
LZTS2,Approved symbol,LZTS2,leucine zipper tumor suppressor 2,HGNC:29381,10q24.31
MAB21L1,Approved symbol,MAB21L1,mab-21 like 1,HGNC:6757,13q13.3
MACF1,Approved symbol,MACF1,microtubule actin crosslinking factor 1,HGNC:13664,1p34.3
MACROD2,Approved symbol,MACROD2,mono-ADP ribosylhydrolase 2,HGNC:16126,20p12.1
MAD1L1,Approved symbol,MAD1L1,mitotic arrest deficient 1 like 1,HGNC:6762,7p22.3
MADD,Approved symbol,MADD,MAP kinase activating death domain,HGNC:6766,11p11.2
MADD,Alias symbol,ETFA,electron transfer flavoprotein subunit alpha,HGNC:3481,15q24.2-q24.3
MAF,Approved symbol,MAF,MAF bZIP transcription factor,HGNC:6776,16q23.2
MAGEA4,Approved symbol,MAGEA4,MAGE family member A4,HGNC:6802,Xq28
MAGEB18,Approved symbol,MAGEB18,MAGE family member B18,HGNC:28515,Xp21.3
MAGEB2,Approved symbol,MAGEB2,MAGE family member B2,HGNC:6809,Xp21.2
MAGEC1,Approved symbol,MAGEC1,MAGE family member C1,HGNC:6812,Xq27.2
MAGEC2,Approved symbol,MAGEC2,MAGE family member C2,HGNC:13574,Xq27.2
MAGEC3,Approved symbol,MAGEC3,MAGE family member C3,HGNC:23798,Xq27.2
MAGED1,Approved symbol,MAGED1,MAGE family member D1,HGNC:6813,Xp11.22
MAGED2,Approved symbol,MAGED2,MAGE family member D2,HGNC:16353,Xp11.21
MAGEE1,Approved symbol,MAGEE1,MAGE family member E1,HGNC:24934,Xq13.3
MAGEE1,Previous symbol,MAGEC2,MAGE family member C2,HGNC:13574,Xq27.2
MAGI1,Approved symbol,MAGI1,"membrane associated guanylate kinase, WW and PDZ domain containing 1",HGNC:946,3p14.1
MAGI1,Previous symbol,CNKSR3,CNKSR family member 3,HGNC:23034,6q25.2
MAGI2,Approved symbol,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",HGNC:18957,7q21.11
MAGIX,Approved symbol,MAGIX,"MAGI family member, X-linked",HGNC:30006,Xp11.23
MAGOHB,Approved symbol,MAGOHB,"mago homolog B, exon junction complex subunit",HGNC:25504,12p13.2
MALRD1,Approved symbol,MALRD1,MAM and LDL receptor class A domain containing 1,HGNC:24331,10p12.31
MAMDC4,Approved symbol,MAMDC4,MAM domain containing 4,HGNC:24083,9q34.3
MAML1,Approved symbol,MAML1,mastermind like transcriptional coactivator 1,HGNC:13632,5q35.3
MAML3,Approved symbol,MAML3,mastermind like transcriptional coactivator 3,HGNC:16272,4q31.1
MAN1A1,Approved symbol,MAN1A1,mannosidase alpha class 1A member 1,HGNC:6821,6q22.31
MAN2B2,Approved symbol,MAN2B2,mannosidase alpha class 2B member 2,HGNC:29623,4p16.1
MAP2,Approved symbol,MAP2,microtubule associated protein 2,HGNC:6839,2q34
MAP2,Alias symbol,METAP2,methionyl aminopeptidase 2,HGNC:16672,12q22
MAP2K1,Approved symbol,MAP2K1,mitogen-activated protein kinase kinase 1,HGNC:6840,15q22.31
MAP2K4,Approved symbol,MAP2K4,mitogen-activated protein kinase kinase 4,HGNC:6844,17p12
MAP2K6,Approved symbol,MAP2K6,mitogen-activated protein kinase kinase 6,HGNC:6846,17q24.3
MAP3K15,Approved symbol,MAP3K15,mitogen-activated protein kinase kinase kinase 15,HGNC:31689,Xp22.12
MAP3K3,Approved symbol,MAP3K3,mitogen-activated protein kinase kinase kinase 3,HGNC:6855,17q23.3
MAP3K9,Approved symbol,MAP3K9,mitogen-activated protein kinase kinase kinase 9,HGNC:6861,14q24.2
MAP4,Approved symbol,MAP4,microtubule associated protein 4,HGNC:6862,3p21.31
MAP4K1,Approved symbol,MAP4K1,mitogen-activated protein kinase kinase kinase kinase 1,HGNC:6863,19q13.2
MAP6,Approved symbol,MAP6,microtubule associated protein 6,HGNC:6868,11q13.5
MAP6D1,Approved symbol,MAP6D1,MAP6 domain containing 1,HGNC:25753,3q27.1
MAP7,Approved symbol,MAP7,microtubule associated protein 7,HGNC:6869,6q23.3
MAP7D1,Approved symbol,MAP7D1,MAP7 domain containing 1,HGNC:25514,1p34.3
MAP7D2,Approved symbol,MAP7D2,MAP7 domain containing 2,HGNC:25899,Xp22.12
MAP9,Approved symbol,MAP9,microtubule associated protein 9,HGNC:26118,4q32.1
MAPK10,Approved symbol,MAPK10,mitogen-activated protein kinase 10,HGNC:6872,4q21.3
MAPK11,Approved symbol,MAPK11,mitogen-activated protein kinase 11,HGNC:6873,22q13.33
MAPK12,Approved symbol,MAPK12,mitogen-activated protein kinase 12,HGNC:6874,22q13.33
MAPK4,Approved symbol,MAPK4,mitogen-activated protein kinase 4,HGNC:6878,18q21.1-q21.2
MAPK7,Approved symbol,MAPK7,mitogen-activated protein kinase 7,HGNC:6880,17p11.2
MAPK8IP2,Approved symbol,MAPK8IP2,mitogen-activated protein kinase 8 interacting protein 2,HGNC:6883,22q13.33
MAPK8IP3,Approved symbol,MAPK8IP3,mitogen-activated protein kinase 8 interacting protein 3,HGNC:6884,16p13.3
MAPKBP1,Approved symbol,MAPKBP1,mitogen-activated protein kinase binding protein 1,HGNC:29536,15q15.1
MAS1L,Approved symbol,MAS1L,"MAS1 proto-oncogene like, G protein-coupled receptor",HGNC:13961,6p22.1
MASP1,Approved symbol,MASP1,MBL associated serine protease 1,HGNC:6901,3q27.3
MASP2,Approved symbol,MASP2,MBL associated serine protease 2,HGNC:6902,1p36.22
MAST2,Approved symbol,MAST2,microtubule associated serine/threonine kinase 2,HGNC:19035,1p34.1
MAST3,Approved symbol,MAST3,microtubule associated serine/threonine kinase 3,HGNC:19036,19p13.11
MAST4,Approved symbol,MAST4,microtubule associated serine/threonine kinase family member 4,HGNC:19037,5q12.3
MAT1A,Approved symbol,MAT1A,methionine adenosyltransferase 1A,HGNC:6903,10q22.3
MATN1,Approved symbol,MATN1,matrilin 1,HGNC:6907,1p35.2
MAVS,Approved symbol,MAVS,mitochondrial antiviral signaling protein,HGNC:29233,20p13
MB21D2,Approved symbol,MB21D2,Mab-21 domain containing 2,HGNC:30438,3q29
MBD4,Approved symbol,MBD4,"methyl-CpG binding domain 4, DNA glycosylase",HGNC:6919,3q21.3
MBTPS2,Approved symbol,MBTPS2,"membrane bound transcription factor peptidase, site 2",HGNC:15455,Xp22.12
MC3R,Approved symbol,MC3R,melanocortin 3 receptor,HGNC:6931,20q13.2
MC5R,Approved symbol,MC5R,melanocortin 5 receptor,HGNC:6933,18p11.21
MCC,Approved symbol,MCC,MCC regulator of WNT signaling pathway,HGNC:6935,5q22.2
MCF2,Approved symbol,MCF2,MCF.2 cell line derived transforming sequence,HGNC:6940,Xq27.1
MCF2L,Approved symbol,MCF2L,MCF.2 cell line derived transforming sequence like,HGNC:14576,13q34
MCF2L2,Approved symbol,MCF2L2,MCF.2 cell line derived transforming sequence-like 2,HGNC:30319,3q27.1
MCHR1,Approved symbol,MCHR1,melanin concentrating hormone receptor 1,HGNC:4479,22q13.2
MCM10,Approved symbol,MCM10,minichromosome maintenance 10 replication initiation factor,HGNC:18043,10p13
MCM2,Approved symbol,MCM2,minichromosome maintenance complex component 2,HGNC:6944,3q21.3
MCM2,Previous symbol,MCM7,minichromosome maintenance complex component 7,HGNC:6950,7q22.1
MCM3AP,Approved symbol,MCM3AP,minichromosome maintenance complex component 3 associated protein,HGNC:6946,21q22.3
MCM4,Approved symbol,MCM4,minichromosome maintenance complex component 4,HGNC:6947,8q11.21
MCM6,Approved symbol,MCM6,minichromosome maintenance complex component 6,HGNC:6949,2q21.3
MCM7,Approved symbol,MCM7,minichromosome maintenance complex component 7,HGNC:6950,7q22.1
MCOLN3,Approved symbol,MCOLN3,mucolipin TRP cation channel 3,HGNC:13358,1p22.3
MCTP2,Approved symbol,MCTP2,multiple C2 and transmembrane domain containing 2,HGNC:25636,15q26.2
MDC1,Approved symbol,MDC1,mediator of DNA damage checkpoint 1,HGNC:21163,6p21.33
MDFIC,Approved symbol,MDFIC,MyoD family inhibitor domain containing,HGNC:28870,7q31.1-q31.2
MDGA1,Approved symbol,MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,HGNC:19267,6p21.2
MDGA2,Approved symbol,MDGA2,MAM domain containing glycosylphosphatidylinositol anchor 2,HGNC:19835,14q21.3
MDH1B,Approved symbol,MDH1B,malate dehydrogenase 1B,HGNC:17836,2q33.3
MDH2,Approved symbol,MDH2,malate dehydrogenase 2,HGNC:6971,7q11.23
MDM1,Approved symbol,MDM1,Mdm1 nuclear protein,HGNC:29917,12q15
MDM4,Approved symbol,MDM4,MDM4 regulator of p53,HGNC:6974,1q32.1
MDN1,Approved symbol,MDN1,midasin AAA ATPase 1,HGNC:18302,6q15
MED12L,Approved symbol,MED12L,mediator complex subunit 12L,HGNC:16050,3q25.1
MED13,Approved symbol,MED13,mediator complex subunit 13,HGNC:22474,17q23.2
MED14,Approved symbol,MED14,mediator complex subunit 14,HGNC:2370,Xp11.4
MED15,Approved symbol,MED15,mediator complex subunit 15,HGNC:14248,22q11.21
MEF2C,Approved symbol,MEF2C,myocyte enhancer factor 2C,HGNC:6996,5q14.3
MEFV,Approved symbol,MEFV,"MEFV innate immuity regulator, pyrin",HGNC:6998,16p13.3
MEGF6,Approved symbol,MEGF6,multiple EGF like domains 6,HGNC:3232,1p36.32
MEGF8,Approved symbol,MEGF8,multiple EGF like domains 8,HGNC:3233,19q13.2
MEI1,Approved symbol,MEI1,meiotic double-stranded break formation protein 1,HGNC:28613,22q13.2
MEI4,Approved symbol,MEI4,meiotic double-stranded break formation protein 4,HGNC:43638,6q14.1
MEIS1,Approved symbol,MEIS1,Meis homeobox 1,HGNC:7000,2p14
MEIS3,Approved symbol,MEIS3,Meis homeobox 3,HGNC:29537,19q13.32
MEIS3,Previous symbol,MEIS3P1,Meis homeobox 3 pseudogene 1,HGNC:7002,17p12
MELK,Approved symbol,MELK,maternal embryonic leucine zipper kinase,HGNC:16870,9p13.2
MEMO1,Approved symbol,MEMO1,mediator of cell motility 1,HGNC:14014,2p22.3
METTL14,Approved symbol,METTL14,"methyltransferase 14, N6-adenosine-methyltransferase subunit",HGNC:29330,4q26
METTL15,Approved symbol,METTL15,methyltransferase like 15,HGNC:26606,11p14.1
METTL16,Approved symbol,METTL16,"methyltransferase 16, N6-methyladenosine",HGNC:28484,17p13.3
METTL17,Approved symbol,METTL17,methyltransferase like 17,HGNC:19280,14q11.2
MFF,Approved symbol,MFF,mitochondrial fission factor,HGNC:24858,2q36.3
MFI2,Previous symbol,MELTF,melanotransferrin,HGNC:7037,3q29
MFN1,Approved symbol,MFN1,mitofusin 1,HGNC:18262,3q26.33
MFSD11,Approved symbol,MFSD11,major facilitator superfamily domain containing 11,HGNC:25458,17q25.1
MFSD6,Approved symbol,MFSD6,major facilitator superfamily domain containing 6,HGNC:24711,2q32.2
MFSD6L,Approved symbol,MFSD6L,major facilitator superfamily domain containing 6 like,HGNC:26656,17p13.1
MFSD9,Approved symbol,MFSD9,major facilitator superfamily domain containing 9,HGNC:28158,2q12.1
MGAT1,Approved symbol,MGAT1,"alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",HGNC:7044,5q35.3
MGAT1,Alias symbol,MOGAT1,monoacylglycerol O-acyltransferase 1,HGNC:18210,2q36.1
MGAT4B,Approved symbol,MGAT4B,"alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B",HGNC:7048,5q35.3
MGMT,Approved symbol,MGMT,O-6-methylguanine-DNA methyltransferase,HGNC:7059,10q26.3
MGRN1,Approved symbol,MGRN1,mahogunin ring finger 1,HGNC:20254,16p13.3
MICAL1,Approved symbol,MICAL1,"microtubule associated monooxygenase, calponin and LIM domain containing 1",HGNC:20619,6q21
MICAL3,Approved symbol,MICAL3,"microtubule associated monooxygenase, calponin and LIM domain containing 3",HGNC:24694,22q11.21
MICALL2,Approved symbol,MICALL2,MICAL like 2,HGNC:29672,7p22.3
MICU1,Approved symbol,MICU1,mitochondrial calcium uptake 1,HGNC:1530,10q22.1
MICU2,Approved symbol,MICU2,mitochondrial calcium uptake 2,HGNC:31830,13q12.11
MID1,Approved symbol,MID1,midline 1,HGNC:7095,Xp22
MIER1,Approved symbol,MIER1,MIER1 transcriptional regulator,HGNC:29657,1p31.3
MIIP,Approved symbol,MIIP,migration and invasion inhibitory protein,HGNC:25715,1p36.22
MIOX,Approved symbol,MIOX,myo-inositol oxygenase,HGNC:14522,22q13.33
MIPEP,Approved symbol,MIPEP,mitochondrial intermediate peptidase,HGNC:7104,13q12.12
MIPOL1,Approved symbol,MIPOL1,mirror-image polydactyly 1,HGNC:21460,14q13.3-q21.1
MITF,Approved symbol,MITF,melanocyte inducing transcription factor,HGNC:7105,3p13
MKL1,Previous symbol,MRTFA,myocardin related transcription factor A,HGNC:14334,22q13.1-q13.2
MKRN3,Approved symbol,MKRN3,makorin ring finger protein 3,HGNC:7114,15q11.2
MKX,Approved symbol,MKX,mohawk homeobox,HGNC:23729,10p12.1
MLK4,Alias symbol,MAP3K21,mitogen-activated protein kinase kinase kinase 21,HGNC:29798,1q42.2
MLLT1,Approved symbol,MLLT1,MLLT1 super elongation complex subunit,HGNC:7134,19p13.3
MLX,Approved symbol,MLX,MAX dimerization protein MLX,HGNC:11645,17q21.2
MLXIPL,Approved symbol,MLXIPL,MLX interacting protein like,HGNC:12744,7q11.23
MMAB,Approved symbol,MMAB,metabolism of cobalamin associated B,HGNC:19331,12q24.11
MMACHC,Approved symbol,MMACHC,metabolism of cobalamin associated C,HGNC:24525,1p34.1
MMP1,Approved symbol,MMP1,matrix metallopeptidase 1,HGNC:7155,11q22.2
MMP10,Approved symbol,MMP10,matrix metallopeptidase 10,HGNC:7156,11q22.2
MMP13,Approved symbol,MMP13,matrix metallopeptidase 13,HGNC:7159,11q22.2
MMP15,Approved symbol,MMP15,matrix metallopeptidase 15,HGNC:7161,16q21
MMP16,Approved symbol,MMP16,matrix metallopeptidase 16,HGNC:7162,8q21.3
MMP17,Approved symbol,MMP17,matrix metallopeptidase 17,HGNC:7163,12q24.33
MMP25,Approved symbol,MMP25,matrix metallopeptidase 25,HGNC:14246,16p13.3
MMP3,Approved symbol,MMP3,matrix metallopeptidase 3,HGNC:7173,11q22.2
MMS22L,Approved symbol,MMS22L,"MMS22 like, DNA repair protein",HGNC:21475,6q16.1
MOCOS,Approved symbol,MOCOS,molybdenum cofactor sulfurase,HGNC:18234,18q12.2
MOCS1,Approved symbol,MOCS1,molybdenum cofactor synthesis 1,HGNC:7190,6p21.2
MON2,Approved symbol,MON2,"MON2 homolog, regulator of endosome-to-Golgi trafficking",HGNC:29177,12q14.1
MORC1,Approved symbol,MORC1,MORC family CW-type zinc finger 1,HGNC:7198,3q13.13
MORN1,Approved symbol,MORN1,MORN repeat containing 1,HGNC:25852,1p36.32
MORN5,Approved symbol,MORN5,MORN repeat containing 5,HGNC:17841,9q33.2
MOS,Approved symbol,MOS,"MOS proto-oncogene, serine/threonine kinase",HGNC:7199,8q12.1
MOS,Alias symbol,MOCOS,molybdenum cofactor sulfurase,HGNC:18234,18q12.2
MOSPD2,Approved symbol,MOSPD2,motile sperm domain containing 2,HGNC:28381,Xp22.2
MOV10L1,Approved symbol,MOV10L1,Mov10 like RISC complex RNA helicase 1,HGNC:7201,22q13.33
MOXD1,Approved symbol,MOXD1,monooxygenase DBH like 1,HGNC:21063,6q23.2
MPDZ,Approved symbol,MPDZ,multiple PDZ domain crumbs cell polarity complex component,HGNC:7208,9p23
MPDZ,Alias symbol,LNX1,ligand of numb-protein X 1,HGNC:6657,4q12
MPHOSPH9,Approved symbol,MPHOSPH9,M-phase phosphoprotein 9,HGNC:7215,12q24.31
MPND,Approved symbol,MPND,MPN domain containing,HGNC:25934,19p13.3
MPO,Approved symbol,MPO,myeloperoxidase,HGNC:7218,17q22
MPP3,Approved symbol,MPP3,MAGUK p55 scaffold protein 3,HGNC:7221,17q21.31
MPP4,Approved symbol,MPP4,MAGUK p55 scaffold protein 4,HGNC:13680,2q33.1
MPP4,Alias symbol,ILF3,interleukin enhancer binding factor 3,HGNC:6038,19p13.2
MPPED2,Approved symbol,MPPED2,metallophosphoesterase domain containing 2,HGNC:1180,11p14.1
MPV17,Approved symbol,MPV17,mitochondrial inner membrane protein MPV17,HGNC:7224,2p23.3
MRC2,Approved symbol,MRC2,mannose receptor C type 2,HGNC:16875,17q23.2
MRGPRG,Approved symbol,MRGPRG,MAS related GPR family member G,HGNC:24829,11p15.4
MRGPRX2,Approved symbol,MRGPRX2,MAS related GPR family member X2,HGNC:17983,11p15.1
MRGPRX3,Approved symbol,MRGPRX3,MAS related GPR family member X3,HGNC:17980,11p15.1
MROH2A,Approved symbol,MROH2A,maestro heat like repeat family member 2A,HGNC:27936,2q37.1
MROH5,Approved symbol,MROH5,maestro heat like repeat family member 5 (gene/pseudogene),HGNC:42976,8q24.3
MROH6,Approved symbol,MROH6,maestro heat like repeat family member 6,HGNC:27814,8q24.3
MROH7-TTC4,Approved symbol,MROH7-TTC4,MROH7-TTC4 readthrough (NMD candidate),HGNC:49180,1p32.3
MROH9,Approved symbol,MROH9,maestro heat like repeat family member 9,HGNC:26287,1q24.3
MRPL11,Approved symbol,MRPL11,mitochondrial ribosomal protein L11,HGNC:14042,11q13.2
MRPL46,Approved symbol,MRPL46,mitochondrial ribosomal protein L46,HGNC:1192,15q25.3
MRPL49,Approved symbol,MRPL49,mitochondrial ribosomal protein L49,HGNC:1176,11q13.1
MRPS23,Approved symbol,MRPS23,mitochondrial ribosomal protein S23,HGNC:14509,17q22
MRRF,Approved symbol,MRRF,mitochondrial ribosome recycling factor,HGNC:7234,9q33.2
MS4A14,Approved symbol,MS4A14,membrane spanning 4-domains A14,HGNC:30706,11q12.2
MS4A7,Approved symbol,MS4A7,membrane spanning 4-domains A7,HGNC:13378,11q12.2
MS4A7,Alias symbol,MS4A4A,membrane spanning 4-domains A4A,HGNC:13371,11q12.2
MSH4,Approved symbol,MSH4,mutS homolog 4,HGNC:7327,1p31.1
MSI1,Approved symbol,MSI1,musashi RNA binding protein 1,HGNC:7330,12q24.31
MSL1,Approved symbol,MSL1,MSL complex subunit 1,HGNC:27905,17q21.1
MSL1,Alias symbol,SNRPB2,small nuclear ribonucleoprotein polypeptide B2,HGNC:11155,20p12.1
MSN,Approved symbol,MSN,moesin,HGNC:7373,Xq12
MSRB3,Approved symbol,MSRB3,methionine sulfoxide reductase B3,HGNC:27375,12q14.3
MTA3,Approved symbol,MTA3,metastasis associated 1 family member 3,HGNC:23784,2p21
MTBP,Approved symbol,MTBP,MDM2 binding protein,HGNC:7417,8q24.12
MTCH2,Approved symbol,MTCH2,mitochondrial carrier 2,HGNC:17587,11p11.2
MTF1,Approved symbol,MTF1,metal regulatory transcription factor 1,HGNC:7428,1p34.3
MTF1,Alias symbol,MELTF,melanotransferrin,HGNC:7037,3q29
MTF1,Alias symbol,MYT1,myelin transcription factor 1,HGNC:7622,20q13.33
MTF2,Approved symbol,MTF2,metal response element binding transcription factor 2,HGNC:29535,1p22.1
MTFR1,Approved symbol,MTFR1,mitochondrial fission regulator 1,HGNC:29510,8q13.1
MTHFSD,Approved symbol,MTHFSD,methenyltetrahydrofolate synthetase domain containing,HGNC:25778,16q24.1
MTM1,Approved symbol,MTM1,myotubularin 1,HGNC:7448,Xq28
MTMR1,Approved symbol,MTMR1,myotubularin related protein 1,HGNC:7449,Xq28
MTMR12,Approved symbol,MTMR12,myotubularin related protein 12,HGNC:18191,5p13.3
MTMR4,Approved symbol,MTMR4,myotubularin related protein 4,HGNC:7452,17q22
MTMR9,Approved symbol,MTMR9,myotubularin related protein 9,HGNC:14596,8p23.1
MTPAP,Approved symbol,MTPAP,mitochondrial poly(A) polymerase,HGNC:25532,10p11.23
MTR,Approved symbol,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,HGNC:7468,1q43
MTRF1L,Approved symbol,MTRF1L,mitochondrial translation release factor 1 like,HGNC:21051,6q25.2
MTRR,Approved symbol,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,HGNC:7473,5p15.31
MTUS2,Approved symbol,MTUS2,microtubule associated scaffold protein 2,HGNC:20595,13q12.3
MTX3,Approved symbol,MTX3,metaxin 3,HGNC:24812,5q14.1
MUC12,Approved symbol,MUC12,"mucin 12, cell surface associated",HGNC:7510,7q22.1
MUC16,Approved symbol,MUC16,"mucin 16, cell surface associated",HGNC:15582,19p13.2
MUC17,Approved symbol,MUC17,"mucin 17, cell surface associated",HGNC:16800,7q22.1
MUC19,Approved symbol,MUC19,"mucin 19, oligomeric",HGNC:14362,12q12
MUC20,Approved symbol,MUC20,"mucin 20, cell surface associated",HGNC:23282,3q29
MUC21,Approved symbol,MUC21,"mucin 21, cell surface associated",HGNC:21661,6p21.33
MUC22,Approved symbol,MUC22,mucin 22,HGNC:39755,6p21.33
MUC5AC,Approved symbol,MUC5AC,"mucin 5AC, oligomeric mucus/gel-forming",HGNC:7515,11p15.5
MUC5B,Approved symbol,MUC5B,"mucin 5B, oligomeric mucus/gel-forming",HGNC:7516,11p15.5
MUC6,Approved symbol,MUC6,"mucin 6, oligomeric mucus/gel-forming",HGNC:7517,11p15.5
MUM1L1,Previous symbol,PWWP3B,PWWP domain containing 3B,HGNC:26583,Xq22.3
MUTYH,Approved symbol,MUTYH,mutY DNA glycosylase,HGNC:7527,1p34.1
MVD,Approved symbol,MVD,mevalonate diphosphate decarboxylase,HGNC:7529,16q24.2
MX1,Approved symbol,MX1,MX dynamin like GTPase 1,HGNC:7532,21q22.3
MXD4,Approved symbol,MXD4,MAX dimerization protein 4,HGNC:13906,4p16.3
MXRA5,Approved symbol,MXRA5,matrix remodeling associated 5,HGNC:7539,Xp22.33
MYBBP1A,Approved symbol,MYBBP1A,MYB binding protein 1a,HGNC:7546,17p13.2
MYBPC2,Approved symbol,MYBPC2,myosin binding protein C2,HGNC:7550,19q13.33
MYBPC3,Approved symbol,MYBPC3,myosin binding protein C3,HGNC:7551,11p11.2
MYCBP2,Approved symbol,MYCBP2,MYC binding protein 2,HGNC:23386,13q22.3
MYF5,Approved symbol,MYF5,myogenic factor 5,HGNC:7565,12q21.31
MYF6,Approved symbol,MYF6,myogenic factor 6,HGNC:7566,12q21.31
MYH1,Approved symbol,MYH1,myosin heavy chain 1,HGNC:7567,17p13.1
MYH10,Approved symbol,MYH10,myosin heavy chain 10,HGNC:7568,17p13.1
MYH13,Approved symbol,MYH13,myosin heavy chain 13,HGNC:7571,17p13.1
MYH14,Approved symbol,MYH14,myosin heavy chain 14,HGNC:23212,19q13.33
MYH14,Alias symbol,MYH7B,myosin heavy chain 7B,HGNC:15906,20q11.22
MYH2,Approved symbol,MYH2,myosin heavy chain 2,HGNC:7572,17p13.1
MYH3,Approved symbol,MYH3,myosin heavy chain 3,HGNC:7573,17p13.1
MYH4,Approved symbol,MYH4,myosin heavy chain 4,HGNC:7574,17p13.1
MYH6,Approved symbol,MYH6,myosin heavy chain 6,HGNC:7576,14q11.2
MYH7B,Approved symbol,MYH7B,myosin heavy chain 7B,HGNC:15906,20q11.22
MYH8,Approved symbol,MYH8,myosin heavy chain 8,HGNC:7578,17p13.1
MYL2,Approved symbol,MYL2,myosin light chain 2,HGNC:7583,12q24.11
MYLK2,Approved symbol,MYLK2,myosin light chain kinase 2,HGNC:16243,20q11.21
MYO10,Approved symbol,MYO10,myosin X,HGNC:7593,5p15.1
MYO16,Approved symbol,MYO16,myosin XVI,HGNC:29822,13q33.3
MYO18A,Approved symbol,MYO18A,myosin XVIIIA,HGNC:31104,17q11.2
MYO18B,Approved symbol,MYO18B,myosin XVIIIB,HGNC:18150,22q12.1
MYO19,Approved symbol,MYO19,myosin XIX,HGNC:26234,17q12
MYO1F,Approved symbol,MYO1F,myosin IF,HGNC:7600,19p13.2
MYO1G,Approved symbol,MYO1G,myosin IG,HGNC:13880,7p13
MYO3A,Approved symbol,MYO3A,myosin IIIA,HGNC:7601,10p12.1
MYO3B,Approved symbol,MYO3B,myosin IIIB,HGNC:15576,2q31.1
MYO5A,Approved symbol,MYO5A,myosin VA,HGNC:7602,15q21.2
MYO6,Approved symbol,MYO6,myosin VI,HGNC:7605,6q14.1
MYO9B,Approved symbol,MYO9B,myosin IXB,HGNC:7609,19p13.11
MYOC,Approved symbol,MYOC,myocilin,HGNC:7610,1q24.3
MYOCD,Approved symbol,MYOCD,myocardin,HGNC:16067,17p12
MYOD1,Approved symbol,MYOD1,myogenic differentiation 1,HGNC:7611,11p15.1
MYOF,Approved symbol,MYOF,myoferlin,HGNC:3656,10q23.33
MYOM1,Approved symbol,MYOM1,myomesin 1,HGNC:7613,18p11.31
MYOM2,Approved symbol,MYOM2,myomesin 2,HGNC:7614,8p23.3
MYRFL,Approved symbol,MYRFL,myelin regulatory factor like,HGNC:26316,12q15
MYSM1,Approved symbol,MYSM1,"Myb like, SWIRM and MPN domains 1",HGNC:29401,1p32.1
MYT1L,Approved symbol,MYT1L,myelin transcription factor 1 like,HGNC:7623,2p25.3
MYZAP,Approved symbol,MYZAP,myocardial zonula adherens protein,HGNC:43444,15q21.3
MZB1,Approved symbol,MZB1,marginal zone B and B1 cell specific protein,HGNC:30125,5q31.2
MZT2B,Approved symbol,MZT2B,mitotic spindle organizing protein 2B,HGNC:25886,2q21.1
N6AMT2,Previous symbol,EEF1AKMT1,EEF1A lysine methyltransferase 1,HGNC:27351,13q12.11
NAA10,Approved symbol,NAA10,"N-alpha-acetyltransferase 10, NatA catalytic subunit",HGNC:18704,Xq28
NAA15,Approved symbol,NAA15,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",HGNC:30782,4q31.1
NAA25,Approved symbol,NAA25,"N-alpha-acetyltransferase 25, NatB auxiliary subunit",HGNC:25783,12q24.13
NAA60,Approved symbol,NAA60,"N-alpha-acetyltransferase 60, NatF catalytic subunit",HGNC:25875,16p13.3
NAALADL2,Approved symbol,NAALADL2,N-acetylated alpha-linked acidic dipeptidase like 2,HGNC:23219,3q26.31
NACAD,Approved symbol,NACAD,NAC alpha domain containing,HGNC:22196,7p13
NALCN,Approved symbol,NALCN,"sodium leak channel, non-selective",HGNC:19082,13q32.3-q33.1
NAMPT,Approved symbol,NAMPT,nicotinamide phosphoribosyltransferase,HGNC:30092,7q22.3
NANOS1,Approved symbol,NANOS1,nanos C2HC-type zinc finger 1,HGNC:23044,10q26.11
NAP1L2,Approved symbol,NAP1L2,nucleosome assembly protein 1 like 2,HGNC:7638,Xq13.2
NAP1L3,Approved symbol,NAP1L3,nucleosome assembly protein 1 like 3,HGNC:7639,Xq21.32
NAPEPLD,Approved symbol,NAPEPLD,N-acyl phosphatidylethanolamine phospholipase D,HGNC:21683,7q22.1
NARFL,Previous symbol,CIAO3,cytosolic iron-sulfur assembly component 3,HGNC:14179,16p13.3
NAT1,Approved symbol,NAT1,N-acetyltransferase 1,HGNC:7645,8p22
NAT1,Previous symbol,SLC6A2,solute carrier family 6 member 2,HGNC:11048,16q12.2
NAT1,Alias symbol,EIF4G2,eukaryotic translation initiation factor 4 gamma 2,HGNC:3297,11p15.4
NAV1,Approved symbol,NAV1,neuron navigator 1,HGNC:15989,1q32.1
NAV2,Approved symbol,NAV2,neuron navigator 2,HGNC:15997,11p15.1
NAV3,Approved symbol,NAV3,neuron navigator 3,HGNC:15998,12q21.2
NBEA,Approved symbol,NBEA,neurobeachin,HGNC:7648,13q13.3
NBN,Approved symbol,NBN,nibrin,HGNC:7652,8q21.3
NBN,Alias symbol,ARTN,artemin,HGNC:727,1p34.1
NBPF3,Approved symbol,NBPF3,NBPF member 3,HGNC:25076,1p36.12
NBR1,Approved symbol,NBR1,NBR1 autophagy cargo receptor,HGNC:6746,17q21.31
NCALD,Approved symbol,NCALD,neurocalcin delta,HGNC:7655,8q22.3
NCAM2,Approved symbol,NCAM2,neural cell adhesion molecule 2,HGNC:7657,21q21.1
NCAPD3,Approved symbol,NCAPD3,non-SMC condensin II complex subunit D3,HGNC:28952,11q25
NCAPG2,Approved symbol,NCAPG2,non-SMC condensin II complex subunit G2,HGNC:21904,7q36.3
NCAPH2,Approved symbol,NCAPH2,non-SMC condensin II complex subunit H2,HGNC:25071,22q13.33
NCF1,Approved symbol,NCF1,neutrophil cytosolic factor 1,HGNC:7660,7q11.23
NCKAP5,Approved symbol,NCKAP5,NCK associated protein 5,HGNC:29847,2q21.2
NCKAP5L,Approved symbol,NCKAP5L,NCK associated protein 5 like,HGNC:29321,12q13.12
NCOA2,Approved symbol,NCOA2,nuclear receptor coactivator 2,HGNC:7669,8q13.3
NCOA3,Approved symbol,NCOA3,nuclear receptor coactivator 3,HGNC:7670,20q13.12
NCOA6,Approved symbol,NCOA6,nuclear receptor coactivator 6,HGNC:15936,20q11.22
NCR1,Approved symbol,NCR1,natural cytotoxicity triggering receptor 1,HGNC:6731,19q13.42
NCR2,Approved symbol,NCR2,natural cytotoxicity triggering receptor 2,HGNC:6732,6p21.1
NDFIP2,Approved symbol,NDFIP2,Nedd4 family interacting protein 2,HGNC:18537,13q31.1
NDN,Approved symbol,NDN,"necdin, MAGE family member",HGNC:7675,15q11.2
NDRG4,Approved symbol,NDRG4,NDRG family member 4,HGNC:14466,16q21
NDST3,Approved symbol,NDST3,N-deacetylase and N-sulfotransferase 3,HGNC:7682,4q26
NDUFAF3,Approved symbol,NDUFAF3,NADH:ubiquinone oxidoreductase complex assembly factor 3,HGNC:29918,3p21.31
NDUFAF6,Approved symbol,NDUFAF6,NADH:ubiquinone oxidoreductase complex assembly factor 6,HGNC:28625,8q22.1
NDUFAF7,Approved symbol,NDUFAF7,NADH:ubiquinone oxidoreductase complex assembly factor 7,HGNC:28816,2p22.2
NDUFS7,Approved symbol,NDUFS7,NADH:ubiquinone oxidoreductase core subunit S7,HGNC:7714,19p13.3
NDUFS8,Approved symbol,NDUFS8,NADH:ubiquinone oxidoreductase core subunit S8,HGNC:7715,11q13.2
NDUFV1,Approved symbol,NDUFV1,NADH:ubiquinone oxidoreductase core subunit V1,HGNC:7716,11q13.2
NEB,Approved symbol,NEB,nebulin,HGNC:7720,2q23.3
NECAB1,Approved symbol,NECAB1,N-terminal EF-hand calcium binding protein 1,HGNC:20983,8q21.3
NEFH,Approved symbol,NEFH,neurofilament heavy chain,HGNC:7737,22q12.2
NEGR1,Approved symbol,NEGR1,neuronal growth regulator 1,HGNC:17302,1p31.1
NEK10,Approved symbol,NEK10,NIMA related kinase 10,HGNC:18592,3p24.1
NEK11,Approved symbol,NEK11,NIMA related kinase 11,HGNC:18593,3q22.1
NEK6,Approved symbol,NEK6,NIMA related kinase 6,HGNC:7749,9q33.3
NEK8,Approved symbol,NEK8,NIMA related kinase 8,HGNC:13387,17q11.2
NEK8,Alias symbol,NEK9,NIMA related kinase 9,HGNC:18591,14q24.3
NELL1,Approved symbol,NELL1,neural EGFL like 1,HGNC:7750,11p15.1
NEO1,Approved symbol,NEO1,neogenin 1,HGNC:7754,15q24.1
NETO1,Approved symbol,NETO1,neuropilin and tolloid like 1,HGNC:13823,18q22.3
NEU4,Approved symbol,NEU4,neuraminidase 4,HGNC:21328,2q37.3
NEURL1,Approved symbol,NEURL1,neuralized E3 ubiquitin protein ligase 1,HGNC:7761,10q24.33
NEURL3,Approved symbol,NEURL3,neuralized E3 ubiquitin protein ligase 3,HGNC:25162,2q11.2
NEURL4,Approved symbol,NEURL4,neuralized E3 ubiquitin protein ligase 4,HGNC:34410,17p13.1
NEUROD2,Approved symbol,NEUROD2,neuronal differentiation 2,HGNC:7763,17q12
NEUROD6,Approved symbol,NEUROD6,neuronal differentiation 6,HGNC:13804,7p14.3
NEUROG3,Approved symbol,NEUROG3,neurogenin 3,HGNC:13806,10q22.1
NF1,Approved symbol,NF1,neurofibromin 1,HGNC:7765,17q11.2
NFASC,Approved symbol,NFASC,neurofascin,HGNC:29866,1q32.1
NFAT5,Approved symbol,NFAT5,nuclear factor of activated T cells 5,HGNC:7774,16q22.1
NFE2L3,Approved symbol,NFE2L3,NFE2 like bZIP transcription factor 3,HGNC:7783,7p15.2
NFIA,Approved symbol,NFIA,nuclear factor I A,HGNC:7784,1p31.3
NFKBID,Approved symbol,NFKBID,NFKB inhibitor delta,HGNC:15671,19q13.12
NFRKB,Approved symbol,NFRKB,nuclear factor related to kappaB binding protein,HGNC:7802,11q24.3
NFS1,Approved symbol,NFS1,NFS1 cysteine desulfurase,HGNC:15910,20q11.22
NHLRC4,Approved symbol,NHLRC4,NHL repeat containing 4,HGNC:26700,16p13.3
NHSL1,Approved symbol,NHSL1,NHS like 1,HGNC:21021,6q24.1
NHSL2,Approved symbol,NHSL2,NHS like 2,HGNC:33737,Xq13.1
NID1,Approved symbol,NID1,nidogen 1,HGNC:7821,1q42.3
NID2,Approved symbol,NID2,nidogen 2,HGNC:13389,14q22.1
NIFK,Approved symbol,NIFK,nucleolar protein interacting with the FHA domain of MKI67,HGNC:17838,2q14.3
NIN,Approved symbol,NIN,ninein,HGNC:14906,14q22.1
NINL,Approved symbol,NINL,ninein like,HGNC:29163,20p11.21
NIPSNAP1,Approved symbol,NIPSNAP1,nipsnap homolog 1,HGNC:7827,22q12.2
NISCH,Approved symbol,NISCH,nischarin,HGNC:18006,3p21.1
NKAIN3,Approved symbol,NKAIN3,sodium/potassium transporting ATPase interacting 3,HGNC:26829,8q12.3
NKAP,Approved symbol,NKAP,NFKB activating protein,HGNC:29873,Xq24
NKD1,Approved symbol,NKD1,NKD inhibitor of WNT signaling pathway 1,HGNC:17045,16q12.1
NKPD1,Approved symbol,NKPD1,NTPase KAP family P-loop domain containing 1,HGNC:24739,19q13.32
NKTR,Approved symbol,NKTR,natural killer cell triggering receptor,HGNC:7833,3p22.1
NKX1-2,Approved symbol,NKX1-2,NK1 homeobox 2,HGNC:31652,10q26.13
NKX2-5,Approved symbol,NKX2-5,NK2 homeobox 5,HGNC:2488,5q34
NKX2-8,Approved symbol,NKX2-8,NK2 homeobox 8,HGNC:16364,14q13.3
NLE1,Approved symbol,NLE1,notchless homolog 1,HGNC:19889,17q12
NLGN1,Approved symbol,NLGN1,neuroligin 1,HGNC:14291,3q26.31
NLGN2,Approved symbol,NLGN2,neuroligin 2,HGNC:14290,17p13.1
NLGN3,Approved symbol,NLGN3,neuroligin 3,HGNC:14289,Xq13.1
NLGN4X,Approved symbol,NLGN4X,neuroligin 4 X-linked,HGNC:14287,Xp22.32-p22.31
NLRC4,Approved symbol,NLRC4,NLR family CARD domain containing 4,HGNC:16412,2p22.3
NLRP1,Approved symbol,NLRP1,NLR family pyrin domain containing 1,HGNC:14374,17p13
NLRP14,Approved symbol,NLRP14,NLR family pyrin domain containing 14,HGNC:22939,11p15.4
NLRP2,Approved symbol,NLRP2,NLR family pyrin domain containing 2,HGNC:22948,19q13.42
NLRP3,Approved symbol,NLRP3,NLR family pyrin domain containing 3,HGNC:16400,1q44
NLRP5,Approved symbol,NLRP5,NLR family pyrin domain containing 5,HGNC:21269,19q13.43
NLRP6,Approved symbol,NLRP6,NLR family pyrin domain containing 6,HGNC:22944,11p15.5
NLRP7,Approved symbol,NLRP7,NLR family pyrin domain containing 7,HGNC:22947,19q13.42
NLRP8,Approved symbol,NLRP8,NLR family pyrin domain containing 8,HGNC:22940,19q13.43
NMBR,Approved symbol,NMBR,neuromedin B receptor,HGNC:7843,6q24.1
NME4,Approved symbol,NME4,NME/NM23 nucleoside diphosphate kinase 4,HGNC:7852,16p13.3
NME8,Approved symbol,NME8,NME/NM23 family member 8,HGNC:16473,7p14.1
NMNAT2,Approved symbol,NMNAT2,nicotinamide nucleotide adenylyltransferase 2,HGNC:16789,1q25.3
NMRK2,Approved symbol,NMRK2,nicotinamide riboside kinase 2,HGNC:17871,19p13.3
NMT1,Approved symbol,NMT1,N-myristoyltransferase 1,HGNC:7857,17q21.31
NOB1,Approved symbol,NOB1,NIN1 (RPN12) binding protein 1 homolog,HGNC:29540,16q22.1
NOD1,Approved symbol,NOD1,nucleotide binding oligomerization domain containing 1,HGNC:16390,7p14.3
NOL11,Approved symbol,NOL11,nucleolar protein 11,HGNC:24557,17q24.2
NOL6,Approved symbol,NOL6,nucleolar protein 6,HGNC:19910,9p13.3
NOL8,Approved symbol,NOL8,nucleolar protein 8,HGNC:23387,9q22.31
NONO,Approved symbol,NONO,non-POU domain containing octamer binding,HGNC:7871,Xq13.1
NOP2,Approved symbol,NOP2,NOP2 nucleolar protein,HGNC:7867,12p13.31
NOP56,Approved symbol,NOP56,NOP56 ribonucleoprotein,HGNC:15911,20p13
NOS1,Approved symbol,NOS1,nitric oxide synthase 1,HGNC:7872,12q24.22
NOS1,Alias symbol,NANOS1,nanos C2HC-type zinc finger 1,HGNC:23044,10q26.11
NOS3,Approved symbol,NOS3,nitric oxide synthase 3,HGNC:7876,7q36.1
NOS3,Alias symbol,NANOS3,nanos C2HC-type zinc finger 3,HGNC:22048,19p13.12
NOTCH1,Approved symbol,NOTCH1,notch receptor 1,HGNC:7881,9q34.3
NOTCH2,Approved symbol,NOTCH2,notch receptor 2,HGNC:7882,1p12
NOTCH3,Approved symbol,NOTCH3,notch receptor 3,HGNC:7883,19p13.12
NOTUM,Approved symbol,NOTUM,"notum, palmitoleoyl-protein carboxylesterase",HGNC:27106,17q25.3
NOVA1,Approved symbol,NOVA1,NOVA alternative splicing regulator 1,HGNC:7886,14q12
NOX1,Approved symbol,NOX1,NADPH oxidase 1,HGNC:7889,Xq22.1
NOX4,Approved symbol,NOX4,NADPH oxidase 4,HGNC:7891,11q14.3
NOX5,Approved symbol,NOX5,NADPH oxidase 5,HGNC:14874,15q23
NPAP1,Approved symbol,NPAP1,nuclear pore associated protein 1,HGNC:1190,15q11.2
NPAS1,Approved symbol,NPAS1,neuronal PAS domain protein 1,HGNC:7894,19q13.32
NPAS2,Approved symbol,NPAS2,neuronal PAS domain protein 2,HGNC:7895,2q11.2
NPAS3,Approved symbol,NPAS3,neuronal PAS domain protein 3,HGNC:19311,14q13.1
NPAS4,Approved symbol,NPAS4,neuronal PAS domain protein 4,HGNC:18983,11q13.2
NPB,Approved symbol,NPB,neuropeptide B,HGNC:30099,17q25.3
NPC1,Approved symbol,NPC1,NPC intracellular cholesterol transporter 1,HGNC:7897,18q11.2
NPEPPS,Approved symbol,NPEPPS,aminopeptidase puromycin sensitive,HGNC:7900,17q21.32
NPFFR1,Approved symbol,NPFFR1,neuropeptide FF receptor 1,HGNC:17425,10q22.1
NPHP1,Approved symbol,NPHP1,nephrocystin 1,HGNC:7905,2q13
NPHP4,Approved symbol,NPHP4,nephrocystin 4,HGNC:19104,1p36.31
NPHS1,Approved symbol,NPHS1,"NPHS1 adhesion molecule, nephrin",HGNC:7908,19q13.12
NPR1,Approved symbol,NPR1,natriuretic peptide receptor 1,HGNC:7943,1q21.3
NPRL3,Approved symbol,NPRL3,"NPR3 like, GATOR1 complex subunit",HGNC:14124,16p13.3
NPTXR,Approved symbol,NPTXR,neuronal pentraxin receptor,HGNC:7954,22q13.1
NPW,Approved symbol,NPW,neuropeptide W,HGNC:30509,16p13.3
NPY4R,Approved symbol,NPY4R,neuropeptide Y receptor Y4,HGNC:9329,10q11.22
NPY5R,Approved symbol,NPY5R,neuropeptide Y receptor Y5,HGNC:7958,4q32.2
NR0B1,Approved symbol,NR0B1,nuclear receptor subfamily 0 group B member 1,HGNC:7960,Xp21.2
NR1I2,Approved symbol,NR1I2,nuclear receptor subfamily 1 group I member 2,HGNC:7968,3q13.33
NR2F1,Approved symbol,NR2F1,nuclear receptor subfamily 2 group F member 1,HGNC:7975,5q15
NR2F2,Approved symbol,NR2F2,nuclear receptor subfamily 2 group F member 2,HGNC:7976,15q26.2
NR4A3,Approved symbol,NR4A3,nuclear receptor subfamily 4 group A member 3,HGNC:7982,9q22
NR6A1,Approved symbol,NR6A1,nuclear receptor subfamily 6 group A member 1,HGNC:7985,9q33.3
NRAP,Approved symbol,NRAP,nebulin related anchoring protein,HGNC:7988,10q25.3
NRAP,Alias symbol,NOL6,nucleolar protein 6,HGNC:19910,9p13.3
NRBP2,Approved symbol,NRBP2,nuclear receptor binding protein 2,HGNC:19339,8q24.3
NRCAM,Approved symbol,NRCAM,neuronal cell adhesion molecule,HGNC:7994,7q31.1
NRD1,Previous symbol,NRDC,nardilysin convertase,HGNC:7995,1p32.3
NRG1,Approved symbol,NRG1,neuregulin 1,HGNC:7997,8p12
NRG3,Approved symbol,NRG3,neuregulin 3,HGNC:7999,10q23.1
NRK,Approved symbol,NRK,Nik related kinase,HGNC:25391,Xq22.3
NRP2,Approved symbol,NRP2,neuropilin 2,HGNC:8005,2q33.3
NRP2,Alias symbol,NELL2,neural EGFL like 2,HGNC:7751,12q12
NRROS,Approved symbol,NRROS,negative regulator of reactive oxygen species,HGNC:24613,3q29
NRXN1,Approved symbol,NRXN1,neurexin 1,HGNC:8008,2p16.3
NRXN3,Approved symbol,NRXN3,neurexin 3,HGNC:8010,14q24.3-q31.1
NSMF,Approved symbol,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,HGNC:29843,9q34.3
NTM,Approved symbol,NTM,neurotrimin,HGNC:17941,11q25
NTN1,Approved symbol,NTN1,netrin 1,HGNC:8029,17p13.1
NTN3,Approved symbol,NTN3,netrin 3,HGNC:8030,16p13.3
NTNG2,Approved symbol,NTNG2,netrin G2,HGNC:14288,9q34.13
NTRK2,Approved symbol,NTRK2,neurotrophic receptor tyrosine kinase 2,HGNC:8032,9q21.33
NTRK3,Approved symbol,NTRK3,neurotrophic receptor tyrosine kinase 3,HGNC:8033,15q25.3
NUAK1,Approved symbol,NUAK1,NUAK family kinase 1,HGNC:14311,12q23.3
NUCB2,Approved symbol,NUCB2,nucleobindin 2,HGNC:8044,11p15.1
NUDCD1,Approved symbol,NUDCD1,NudC domain containing 1,HGNC:24306,8q23.1
NUDCD3,Approved symbol,NUDCD3,NudC domain containing 3,HGNC:22208,7p13
NUDT16L1,Approved symbol,NUDT16L1,nudix hydrolase 16 like 1,HGNC:28154,16p13.3
NUDT21,Approved symbol,NUDT21,nudix hydrolase 21,HGNC:13870,16q13
NUDT5,Approved symbol,NUDT5,nudix hydrolase 5,HGNC:8052,10p14
NUGGC,Approved symbol,NUGGC,"nuclear GTPase, germinal center associated",HGNC:33550,8p21.1
NUMA1,Approved symbol,NUMA1,nuclear mitotic apparatus protein 1,HGNC:8059,11q13.4
NUP153,Approved symbol,NUP153,nucleoporin 153,HGNC:8062,6p22.3
NUP160,Approved symbol,NUP160,nucleoporin 160,HGNC:18017,11p11.2
NUP210,Approved symbol,NUP210,nucleoporin 210,HGNC:30052,3p25.1
NUP98,Approved symbol,NUP98,nucleoporin 98 and 96 precursor,HGNC:8068,11p15.4
NUPL1,Previous symbol,NUP58,nucleoporin 58,HGNC:20261,13q12.13
NUS1,Approved symbol,NUS1,NUS1 dehydrodolichyl diphosphate synthase subunit,HGNC:21042,6q22.1
NWD1,Approved symbol,NWD1,NACHT and WD repeat domain containing 1,HGNC:27619,19p13.11
NXF2B,Approved symbol,NXF2B,nuclear RNA export factor 2B,HGNC:23984,Xq22.1
NXF3,Approved symbol,NXF3,nuclear RNA export factor 3,HGNC:8073,Xq22.1
NXPE2,Approved symbol,NXPE2,neurexophilin and PC-esterase domain family member 2,HGNC:26331,11q23.2
NXPE4,Approved symbol,NXPE4,neurexophilin and PC-esterase domain family member 4,HGNC:23117,11q23.2
NXPH4,Approved symbol,NXPH4,neurexophilin 4,HGNC:8078,12q13.3
NYNRIN,Approved symbol,NYNRIN,NYN domain and retroviral integrase containing,HGNC:20165,14q12
NYX,Approved symbol,NYX,nyctalopin,HGNC:8082,Xp11.4
OBSCN,Approved symbol,OBSCN,"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF",HGNC:15719,1q42.13
OBSL1,Approved symbol,OBSL1,obscurin like cytoskeletal adaptor 1,HGNC:29092,2q35
OC90,Approved symbol,OC90,otoconin 90,HGNC:8100,8q24.22
OCA2,Approved symbol,OCA2,OCA2 melanosomal transmembrane protein,HGNC:8101,15q12-q13.1
OGDHL,Approved symbol,OGDHL,oxoglutarate dehydrogenase L,HGNC:25590,10q11.23
OGT,Approved symbol,OGT,O-linked N-acetylglucosamine (GlcNAc) transferase,HGNC:8127,Xq13.1
OIP5,Approved symbol,OIP5,Opa interacting protein 5,HGNC:20300,15q15.1
OIT3,Approved symbol,OIT3,oncoprotein induced transcript 3,HGNC:29953,10q22.1
OLFM1,Approved symbol,OLFM1,olfactomedin 1,HGNC:17187,9q34.3
OLFML2B,Approved symbol,OLFML2B,olfactomedin like 2B,HGNC:24558,1q23.3
OLIG1,Approved symbol,OLIG1,oligodendrocyte transcription factor 1,HGNC:16983,21q22.11
OLR1,Approved symbol,OLR1,oxidized low density lipoprotein receptor 1,HGNC:8133,12p13.2
OPA3,Approved symbol,OPA3,outer mitochondrial membrane lipid metabolism regulator OPA3,HGNC:8142,19q13.32
OPCML,Approved symbol,OPCML,opioid binding protein/cell adhesion molecule like,HGNC:8143,11q25
OPLAH,Approved symbol,OPLAH,"5-oxoprolinase, ATP-hydrolysing",HGNC:8149,8q24.3
OPN4,Approved symbol,OPN4,opsin 4,HGNC:14449,10q23.2
OR10A6,Approved symbol,OR10A6,olfactory receptor family 10 subfamily A member 6 (gene/pseudogene),HGNC:15132,11p15.4
OR10G8,Approved symbol,OR10G8,olfactory receptor family 10 subfamily G member 8,HGNC:14845,11q24.2
OR10H5,Approved symbol,OR10H5,olfactory receptor family 10 subfamily H member 5,HGNC:15389,19p13.12
OR10J1,Approved symbol,OR10J1,olfactory receptor family 10 subfamily J member 1,HGNC:8175,1q23.2
OR10K1,Approved symbol,OR10K1,olfactory receptor family 10 subfamily K member 1,HGNC:14693,1q23.1
OR10K2,Approved symbol,OR10K2,olfactory receptor family 10 subfamily K member 2,HGNC:14826,1q23.1
OR10R2,Approved symbol,OR10R2,olfactory receptor family 10 subfamily R member 2,HGNC:14820,1q23.1
OR10X1,Approved symbol,OR10X1,olfactory receptor family 10 subfamily X member 1,HGNC:14995,1q23.1
OR10Z1,Approved symbol,OR10Z1,olfactory receptor family 10 subfamily Z member 1,HGNC:14996,1q23.1
OR11A1,Approved symbol,OR11A1,olfactory receptor family 11 subfamily A member 1,HGNC:8176,6p22.2-p21.31
OR11G2,Approved symbol,OR11G2,olfactory receptor family 11 subfamily G member 2,HGNC:15346,14q11.2
OR11H6,Approved symbol,OR11H6,olfactory receptor family 11 subfamily H member 6,HGNC:15349,14q11.2
OR14A16,Approved symbol,OR14A16,olfactory receptor family 14 subfamily A member 16,HGNC:15022,1q44
OR1C1,Approved symbol,OR1C1,olfactory receptor family 1 subfamily C member 1,HGNC:8182,1q44
OR1K1,Approved symbol,OR1K1,olfactory receptor family 1 subfamily K member 1,HGNC:8212,9q33
OR1N1,Approved symbol,OR1N1,olfactory receptor family 1 subfamily N member 1,HGNC:8221,9q33.2
OR1N2,Approved symbol,OR1N2,olfactory receptor family 1 subfamily N member 2,HGNC:15111,9q33.2
OR2A2,Approved symbol,OR2A2,olfactory receptor family 2 subfamily A member 2,HGNC:8230,7q35
OR2A4,Approved symbol,OR2A4,olfactory receptor family 2 subfamily A member 4,HGNC:14729,6q23.2
OR2A7,Approved symbol,OR2A7,olfactory receptor family 2 subfamily A member 7,HGNC:8234,7q35
OR2AP1,Approved symbol,OR2AP1,olfactory receptor family 2 subfamily AP member 1,HGNC:15335,12q13.2
OR2B11,Approved symbol,OR2B11,olfactory receptor family 2 subfamily B member 11,HGNC:31249,1q44
OR2B2,Approved symbol,OR2B2,olfactory receptor family 2 subfamily B member 2,HGNC:13966,6p22.1
OR2B3,Approved symbol,OR2B3,olfactory receptor family 2 subfamily B member 3,HGNC:8238,6p22.1
OR2G2,Approved symbol,OR2G2,olfactory receptor family 2 subfamily G member 2,HGNC:15007,1q44
OR2K2,Approved symbol,OR2K2,olfactory receptor family 2 subfamily K member 2,HGNC:8264,9q31.3
OR2L13,Approved symbol,OR2L13,olfactory receptor family 2 subfamily L member 13,HGNC:19578,1q44
OR2L2,Approved symbol,OR2L2,olfactory receptor family 2 subfamily L member 2,HGNC:8266,1q44
OR2M4,Approved symbol,OR2M4,olfactory receptor family 2 subfamily M member 4,HGNC:8270,1q44
OR2T11,Approved symbol,OR2T11,olfactory receptor family 2 subfamily T member 11,HGNC:19574,1q44
OR2T2,Approved symbol,OR2T2,olfactory receptor family 2 subfamily T member 2,HGNC:14725,1q44
OR2T4,Approved symbol,OR2T4,olfactory receptor family 2 subfamily T member 4,HGNC:15016,1q44
OR2T6,Approved symbol,OR2T6,olfactory receptor family 2 subfamily T member 6,HGNC:15018,1q44
OR2W1,Approved symbol,OR2W1,olfactory receptor family 2 subfamily W member 1,HGNC:8281,6p22.1
OR4A16,Approved symbol,OR4A16,olfactory receptor family 4 subfamily A member 16,HGNC:15153,11q11
OR4C4P,Approved symbol,OR4C4P,olfactory receptor family 4 subfamily C member 4 pseudogene,HGNC:14700,11p11.2
OR4D5,Approved symbol,OR4D5,olfactory receptor family 4 subfamily D member 5,HGNC:14852,11q24.1
OR4D6,Approved symbol,OR4D6,olfactory receptor family 4 subfamily D member 6,HGNC:15175,11q12.1
OR4K5,Approved symbol,OR4K5,olfactory receptor family 4 subfamily K member 5,HGNC:14745,14q11.2
OR4N2,Approved symbol,OR4N2,olfactory receptor family 4 subfamily N member 2,HGNC:14742,14q11.2
OR4N4,Approved symbol,OR4N4,olfactory receptor family 4 subfamily N member 4,HGNC:15375,15q11.2
OR4Q3,Approved symbol,OR4Q3,olfactory receptor family 4 subfamily Q member 3,HGNC:15426,14q11.2
OR4X2,Approved symbol,OR4X2,olfactory receptor family 4 subfamily X member 2,HGNC:15184,11p11.2
OR51A2,Approved symbol,OR51A2,olfactory receptor family 51 subfamily A member 2,HGNC:14764,11p15.4
OR51A4,Approved symbol,OR51A4,olfactory receptor family 51 subfamily A member 4,HGNC:14795,11p15.4
OR51D1,Approved symbol,OR51D1,olfactory receptor family 51 subfamily D member 1,HGNC:15193,11p15.4
OR51E2,Approved symbol,OR51E2,olfactory receptor family 51 subfamily E member 2,HGNC:15195,11p15.4
OR51F2,Approved symbol,OR51F2,olfactory receptor family 51 subfamily F member 2,HGNC:15197,11p15.4
OR51G1,Approved symbol,OR51G1,olfactory receptor family 51 subfamily G member 1,HGNC:14738,11p15.4
OR51M1,Approved symbol,OR51M1,olfactory receptor family 51 subfamily M member 1,HGNC:14847,11p15.4
OR52D1,Approved symbol,OR52D1,olfactory receptor family 52 subfamily D member 1,HGNC:15212,11p15.4
OR52E4,Approved symbol,OR52E4,olfactory receptor family 52 subfamily E member 4,HGNC:15213,11p15.4
OR52I2,Approved symbol,OR52I2,olfactory receptor family 52 subfamily I member 2,HGNC:15221,11p15.4
OR52K1,Approved symbol,OR52K1,olfactory receptor family 52 subfamily K member 1,HGNC:15222,11p15.4
OR52K2,Approved symbol,OR52K2,olfactory receptor family 52 subfamily K member 2,HGNC:15223,11p15.4
OR52M1,Approved symbol,OR52M1,olfactory receptor family 52 subfamily M member 1,HGNC:15225,11p15.4
OR52R1,Approved symbol,OR52R1,olfactory receptor family 52 subfamily R member 1,HGNC:15235,11p15.4
OR5AC2,Approved symbol,OR5AC2,olfactory receptor family 5 subfamily AC member 2,HGNC:15431,3q11.2
OR5AS1,Approved symbol,OR5AS1,olfactory receptor family 5 subfamily AS member 1,HGNC:15261,11q12.1
OR5C1,Approved symbol,OR5C1,olfactory receptor family 5 subfamily C member 1,HGNC:8331,9q33.2
OR5D16,Approved symbol,OR5D16,olfactory receptor family 5 subfamily D member 16,HGNC:15283,11q12.1
OR5K2,Approved symbol,OR5K2,olfactory receptor family 5 subfamily K member 2,HGNC:14774,3q11.2
OR5K4,Approved symbol,OR5K4,olfactory receptor family 5 subfamily K member 4,HGNC:31291,3q11.2
OR5L2,Approved symbol,OR5L2,olfactory receptor family 5 subfamily L member 2,HGNC:8351,11q12.1
OR5M3,Approved symbol,OR5M3,olfactory receptor family 5 subfamily M member 3,HGNC:14806,11q12.1
OR5P2,Approved symbol,OR5P2,olfactory receptor family 5 subfamily P member 2,HGNC:14783,11p15.4
OR5R1,Previous symbol,OR8U3,olfactory receptor family 8 subfamily U member 3,HGNC:14841,11q12.1
OR5T1,Approved symbol,OR5T1,olfactory receptor family 5 subfamily T member 1,HGNC:14821,11q12.1
OR5V1,Approved symbol,OR5V1,olfactory receptor family 5 subfamily V member 1,HGNC:13972,6p22.1
OR5W2,Approved symbol,OR5W2,olfactory receptor family 5 subfamily W member 2,HGNC:15299,11q12.1
OR6C1,Approved symbol,OR6C1,olfactory receptor family 6 subfamily C member 1,HGNC:8355,12q13.2
OR6C76,Approved symbol,OR6C76,olfactory receptor family 6 subfamily C member 76,HGNC:31305,12q13.2
OR6F1,Approved symbol,OR6F1,olfactory receptor family 6 subfamily F member 1,HGNC:15027,1q44
OR6K3,Approved symbol,OR6K3,olfactory receptor family 6 subfamily K member 3,HGNC:15030,1q23.1
OR6P1,Approved symbol,OR6P1,olfactory receptor family 6 subfamily P member 1,HGNC:15036,1q23.1
OR7A17,Approved symbol,OR7A17,olfactory receptor family 7 subfamily A member 17,HGNC:8363,19p13.12
OR7E24,Approved symbol,OR7E24,olfactory receptor family 7 subfamily E member 24,HGNC:8396,19p13.2
OR8B12,Approved symbol,OR8B12,olfactory receptor family 8 subfamily B member 12,HGNC:15307,11q24.2
OR8B2,Approved symbol,OR8B2,olfactory receptor family 8 subfamily B member 2,HGNC:8471,11q24.2
OR8D1,Approved symbol,OR8D1,olfactory receptor family 8 subfamily D member 1,HGNC:8481,11q24.2
OR8D2,Approved symbol,OR8D2,olfactory receptor family 8 subfamily D member 2,HGNC:8482,11q24.2
OR8D4,Approved symbol,OR8D4,olfactory receptor family 8 subfamily D member 4,HGNC:14840,11q24.1
OR8G1,Approved symbol,OR8G1,olfactory receptor family 8 subfamily G member 1,HGNC:8484,11q24.2
OR8H3,Approved symbol,OR8H3,olfactory receptor family 8 subfamily H member 3,HGNC:15309,11q12.1
OR8K1,Approved symbol,OR8K1,olfactory receptor family 8 subfamily K member 1,HGNC:14831,11q12.1
OR9A2,Approved symbol,OR9A2,olfactory receptor family 9 subfamily A member 2,HGNC:15093,7q34
OR9A4,Approved symbol,OR9A4,olfactory receptor family 9 subfamily A member 4,HGNC:15095,7q34
OR9G4,Approved symbol,OR9G4,olfactory receptor family 9 subfamily G member 4,HGNC:15322,11q12.1
OR9K2,Approved symbol,OR9K2,olfactory receptor family 9 subfamily K member 2,HGNC:15339,12q13.2
OR9Q1,Approved symbol,OR9Q1,olfactory receptor family 9 subfamily Q member 1,HGNC:14724,11q12.1
ORAI1,Approved symbol,ORAI1,ORAI calcium release-activated calcium modulator 1,HGNC:25896,12q24.31
ORAI3,Approved symbol,ORAI3,ORAI calcium release-activated calcium modulator 3,HGNC:28185,16p11.2
ORC5,Approved symbol,ORC5,origin recognition complex subunit 5,HGNC:8491,7q22.1-q22.2
ORM1,Approved symbol,ORM1,orosomucoid 1,HGNC:8498,9q32
OS9,Approved symbol,OS9,OS9 endoplasmic reticulum lectin,HGNC:16994,12q13.3-q14.1
OSBP,Approved symbol,OSBP,oxysterol binding protein,HGNC:8503,11q12.1
OSBP2,Approved symbol,OSBP2,oxysterol binding protein 2,HGNC:8504,22q12.2
OSGIN1,Approved symbol,OSGIN1,oxidative stress induced growth inhibitor 1,HGNC:30093,16q23.3
OTOF,Approved symbol,OTOF,otoferlin,HGNC:8515,2p23.3
OTOG,Approved symbol,OTOG,otogelin,HGNC:8516,11p15.1
OTOGL,Approved symbol,OTOGL,otogelin like,HGNC:26901,12q21.31
OTP,Approved symbol,OTP,orthopedia homeobox,HGNC:8518,5q14.1
OTUD4,Approved symbol,OTUD4,OTU deubiquitinase 4,HGNC:24949,4q31.21
OVCH1,Approved symbol,OVCH1,ovochymase 1,HGNC:23080,12p11.22
OVOL1,Approved symbol,OVOL1,ovo like transcriptional repressor 1,HGNC:8525,11q13.1
OVOL1-AS1,Approved symbol,OVOL1-AS1,OVOL1 antisense RNA 1,HGNC:49319,11q13.1
OVOL3,Approved symbol,OVOL3,ovo like zinc finger 3,HGNC:14186,19q13.12
OXCT2,Approved symbol,OXCT2,3-oxoacid CoA-transferase 2,HGNC:18606,1p34.2
OXGR1,Approved symbol,OXGR1,oxoglutarate receptor 1,HGNC:4531,13q32.1
OXR1,Approved symbol,OXR1,oxidation resistance 1,HGNC:15822,8q23.1
OXR1,Alias symbol,HCRTR1,hypocretin receptor 1,HGNC:4848,1p35.2
OXSR1,Approved symbol,OXSR1,oxidative stress responsive kinase 1,HGNC:8508,3p22.2
P2RX2,Approved symbol,P2RX2,purinergic receptor P2X 2,HGNC:15459,12q24.33
P2RX5,Approved symbol,P2RX5,purinergic receptor P2X 5,HGNC:8536,17p13.2
P2RY10,Approved symbol,P2RY10,P2Y receptor family member 10,HGNC:19906,Xq21.1
P2RY13,Approved symbol,P2RY13,purinergic receptor P2Y13,HGNC:4537,3q25.1
P2RY6,Approved symbol,P2RY6,pyrimidinergic receptor P2Y6,HGNC:8543,11q13.4
PABPC1L,Approved symbol,PABPC1L,poly(A) binding protein cytoplasmic 1 like,HGNC:15797,20q13.12
PABPC3,Approved symbol,PABPC3,poly(A) binding protein cytoplasmic 3,HGNC:8556,13q12.13
PACRG,Approved symbol,PACRG,parkin coregulated,HGNC:19152,6q26
PACS1,Approved symbol,PACS1,phosphofurin acidic cluster sorting protein 1,HGNC:30032,11q13.1-q13.2
PACSIN2,Approved symbol,PACSIN2,protein kinase C and casein kinase substrate in neurons 2,HGNC:8571,22q13.2
PAFAH1B2,Approved symbol,PAFAH1B2,platelet activating factor acetylhydrolase 1b catalytic subunit 2,HGNC:8575,11q23.3
PAFAH2,Approved symbol,PAFAH2,platelet activating factor acetylhydrolase 2,HGNC:8579,1p36.11
PAGE5,Approved symbol,PAGE5,PAGE family member 5,HGNC:29992,Xp11.21
PAK1IP1,Approved symbol,PAK1IP1,PAK1 interacting protein 1,HGNC:20882,6p24.2
PAK2,Approved symbol,PAK2,p21 (RAC1) activated kinase 2,HGNC:8591,3q29
PALD1,Approved symbol,PALD1,phosphatase domain containing paladin 1,HGNC:23530,10q22.1
PALM,Approved symbol,PALM,paralemmin,HGNC:8594,19p13.3
PAN2,Approved symbol,PAN2,poly(A) specific ribonuclease subunit PAN2,HGNC:20074,12q13.3
PAN2,Alias symbol,NLRP4,NLR family pyrin domain containing 4,HGNC:22943,19q13.43
PAN2,Alias symbol,RDH14,retinol dehydrogenase 14,HGNC:19979,2p24.2
PANK4,Approved symbol,PANK4,pantothenate kinase 4 (inactive),HGNC:19366,1p36.32
PAPD5,Previous symbol,TENT4B,terminal nucleotidyltransferase 4B,HGNC:30758,16q12.1
PAPL,Alias symbol,ACP7,"acid phosphatase 7, tartrate resistant (putative)",HGNC:33781,19q13.2
PAPOLA,Approved symbol,PAPOLA,poly(A) polymerase alpha,HGNC:14981,14q32.2
PAPPA2,Approved symbol,PAPPA2,pappalysin 2,HGNC:14615,1q25.2
PAPSS2,Approved symbol,PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,HGNC:8604,10q23.2-q23.31
PAQR6,Approved symbol,PAQR6,progestin and adipoQ receptor family member 6,HGNC:30132,1q22
PAQR9,Approved symbol,PAQR9,progestin and adipoQ receptor family member 9,HGNC:30131,3q23
PARD3,Approved symbol,PARD3,par-3 family cell polarity regulator,HGNC:16051,10p11.22-p11.21
PARD6A,Approved symbol,PARD6A,par-6 family cell polarity regulator alpha,HGNC:15943,16q22.1
PARP1,Approved symbol,PARP1,poly(ADP-ribose) polymerase 1,HGNC:270,1q42.12
PARP14,Approved symbol,PARP14,poly(ADP-ribose) polymerase family member 14,HGNC:29232,3q21.1
PARP15,Approved symbol,PARP15,poly(ADP-ribose) polymerase family member 15,HGNC:26876,3q21.1
PARP16,Approved symbol,PARP16,poly(ADP-ribose) polymerase family member 16,HGNC:26040,15q22.31
PARP9,Approved symbol,PARP9,poly(ADP-ribose) polymerase family member 9,HGNC:24118,3q21.1
PARS2,Approved symbol,PARS2,"prolyl-tRNA synthetase 2, mitochondrial",HGNC:30563,1p32.3
PASD1,Approved symbol,PASD1,PAS domain containing repressor 1,HGNC:20686,Xq28
PAX2,Approved symbol,PAX2,paired box 2,HGNC:8616,10q24.31
PAX5,Approved symbol,PAX5,paired box 5,HGNC:8619,9p13.2
PAX8,Approved symbol,PAX8,paired box 8,HGNC:8622,2q14.1
PAXBP1,Approved symbol,PAXBP1,PAX3 and PAX7 binding protein 1,HGNC:13579,21q22.11
PBRM1,Approved symbol,PBRM1,polybromo 1,HGNC:30064,3p21.1
PBXIP1,Approved symbol,PBXIP1,PBX homeobox interacting protein 1,HGNC:21199,1q21.3
PC,Approved symbol,PC,pyruvate carboxylase,HGNC:8636,11q13.2
PC,Alias symbol,PODXL,podocalyxin like,HGNC:9171,7q32.3
PCBP3,Approved symbol,PCBP3,poly(rC) binding protein 3,HGNC:8651,21q22.3
PCCB,Approved symbol,PCCB,propionyl-CoA carboxylase subunit beta,HGNC:8654,3q22.3
PCDH10,Approved symbol,PCDH10,protocadherin 10,HGNC:13404,4q28.3
PCDH11Y,Approved symbol,PCDH11Y,protocadherin 11 Y-linked,HGNC:15813,Yp11.2
PCDH15,Approved symbol,PCDH15,protocadherin related 15,HGNC:14674,10q21.1
PCDH17,Approved symbol,PCDH17,protocadherin 17,HGNC:14267,13q21.1
PCDH18,Approved symbol,PCDH18,protocadherin 18,HGNC:14268,4q28.3
PCDH19,Approved symbol,PCDH19,protocadherin 19,HGNC:14270,Xq22.1
PCDH7,Approved symbol,PCDH7,protocadherin 7,HGNC:8659,4p15.1
PCDH8,Approved symbol,PCDH8,protocadherin 8,HGNC:8660,13q14.3
PCDH9,Approved symbol,PCDH9,protocadherin 9,HGNC:8661,13q21.32
PCDHA1,Approved symbol,PCDHA1,protocadherin alpha 1,HGNC:8663,5q31.3
PCDHA10,Approved symbol,PCDHA10,protocadherin alpha 10,HGNC:8664,5q31.3
PCDHA11,Approved symbol,PCDHA11,protocadherin alpha 11,HGNC:8665,5q31.3
PCDHA12,Approved symbol,PCDHA12,protocadherin alpha 12,HGNC:8666,5q31.3
PCDHA2,Approved symbol,PCDHA2,protocadherin alpha 2,HGNC:8668,5q31.3
PCDHA3,Approved symbol,PCDHA3,protocadherin alpha 3,HGNC:8669,5q31.3
PCDHA4,Approved symbol,PCDHA4,protocadherin alpha 4,HGNC:8670,5q31.3
PCDHA5,Approved symbol,PCDHA5,protocadherin alpha 5,HGNC:8671,5q31.3
PCDHA6,Approved symbol,PCDHA6,protocadherin alpha 6,HGNC:8672,5q31.3
PCDHA7,Approved symbol,PCDHA7,protocadherin alpha 7,HGNC:8673,5q31.3
PCDHA9,Approved symbol,PCDHA9,protocadherin alpha 9,HGNC:8675,5q31.3
PCDHAC2,Approved symbol,PCDHAC2,"protocadherin alpha subfamily C, 2",HGNC:8677,5q31.3
PCDHB1,Approved symbol,PCDHB1,protocadherin beta 1,HGNC:8680,5q31.3
PCDHB12,Approved symbol,PCDHB12,protocadherin beta 12,HGNC:8683,5q31.3
PCDHB13,Approved symbol,PCDHB13,protocadherin beta 13,HGNC:8684,5q31.3
PCDHB16,Approved symbol,PCDHB16,protocadherin beta 16,HGNC:14546,5q31.3
PCDHB2,Approved symbol,PCDHB2,protocadherin beta 2,HGNC:8687,5q31.3
PCDHB3,Approved symbol,PCDHB3,protocadherin beta 3,HGNC:8688,5q31.3
PCDHB4,Approved symbol,PCDHB4,protocadherin beta 4,HGNC:8689,5q31.3
PCDHB8,Approved symbol,PCDHB8,protocadherin beta 8,HGNC:8693,5q31.3
PCDHB9,Approved symbol,PCDHB9,protocadherin beta 9,HGNC:8694,5q31.3
PCDHGA1,Approved symbol,PCDHGA1,"protocadherin gamma subfamily A, 1",HGNC:8696,5q31
PCDHGA11,Approved symbol,PCDHGA11,"protocadherin gamma subfamily A, 11",HGNC:8698,5q31.3
PCDHGA12,Approved symbol,PCDHGA12,"protocadherin gamma subfamily A, 12",HGNC:8699,5q31.3
PCDHGA3,Approved symbol,PCDHGA3,"protocadherin gamma subfamily A, 3",HGNC:8701,5q31.3
PCDHGA5,Approved symbol,PCDHGA5,"protocadherin gamma subfamily A, 5",HGNC:8703,5q31
PCDHGA7,Approved symbol,PCDHGA7,"protocadherin gamma subfamily A, 7",HGNC:8705,5q31
PCDHGA9,Approved symbol,PCDHGA9,"protocadherin gamma subfamily A, 9",HGNC:8707,5q31
PCDHGB1,Approved symbol,PCDHGB1,"protocadherin gamma subfamily B, 1",HGNC:8708,5q31
PCDHGB2,Approved symbol,PCDHGB2,"protocadherin gamma subfamily B, 2",HGNC:8709,5q31
PCDHGB4,Approved symbol,PCDHGB4,"protocadherin gamma subfamily B, 4",HGNC:8711,5q31
PCDHGB6,Approved symbol,PCDHGB6,"protocadherin gamma subfamily B, 6",HGNC:8713,5q31
PCDHGB7,Approved symbol,PCDHGB7,"protocadherin gamma subfamily B, 7",HGNC:8714,5q31.3
PCDP1,Alias symbol,CFAP221,cilia and flagella associated protein 221,HGNC:33720,2q14.2
PCF11,Approved symbol,PCF11,PCF11 cleavage and polyadenylation factor subunit,HGNC:30097,11q14.1
PCIF1,Approved symbol,PCIF1,phosphorylated CTD interacting factor 1,HGNC:16200,20q13.12
PCK1,Approved symbol,PCK1,phosphoenolpyruvate carboxykinase 1,HGNC:8724,20q13.31
PCLO,Approved symbol,PCLO,piccolo presynaptic cytomatrix protein,HGNC:13406,7q21.11
PCNT,Approved symbol,PCNT,pericentrin,HGNC:16068,21q22.3
PCNXL2,Previous symbol,PCNX2,pecanex 2,HGNC:8736,1q42.2
PCNXL3,Previous symbol,PCNX3,pecanex 3,HGNC:18760,11q13.1
PCNXL4,Previous symbol,PCNX4,pecanex 4,HGNC:20349,14q23.1
PCOLCE,Approved symbol,PCOLCE,procollagen C-endopeptidase enhancer,HGNC:8738,7q22.1
PCOLCE2,Approved symbol,PCOLCE2,procollagen C-endopeptidase enhancer 2,HGNC:8739,3q23
PCSK1N,Approved symbol,PCSK1N,proprotein convertase subtilisin/kexin type 1 inhibitor,HGNC:17301,Xp11.23
PCSK5,Approved symbol,PCSK5,proprotein convertase subtilisin/kexin type 5,HGNC:8747,9q21.13
PCSK9,Approved symbol,PCSK9,proprotein convertase subtilisin/kexin type 9,HGNC:20001,1p32.3
PCTP,Approved symbol,PCTP,phosphatidylcholine transfer protein,HGNC:8752,17q22
PCYOX1L,Approved symbol,PCYOX1L,prenylcysteine oxidase 1 like,HGNC:28477,5q32
PDCD2,Approved symbol,PDCD2,programmed cell death 2,HGNC:8762,6q27
PDCD4,Approved symbol,PDCD4,programmed cell death 4,HGNC:8763,10q25.2
PDE12,Approved symbol,PDE12,phosphodiesterase 12,HGNC:25386,3p14.3
PDE1C,Approved symbol,PDE1C,phosphodiesterase 1C,HGNC:8776,7p14.3
PDE3A,Approved symbol,PDE3A,phosphodiesterase 3A,HGNC:8778,12p12.2
PDE3B,Approved symbol,PDE3B,phosphodiesterase 3B,HGNC:8779,11p15.2
PDE4A,Approved symbol,PDE4A,phosphodiesterase 4A,HGNC:8780,19p13.2
PDE4B,Approved symbol,PDE4B,phosphodiesterase 4B,HGNC:8781,1p31.3
PDE4D,Approved symbol,PDE4D,phosphodiesterase 4D,HGNC:8783,5q11.2-q12.1
PDE4DIP,Approved symbol,PDE4DIP,phosphodiesterase 4D interacting protein,HGNC:15580,1q21.2
PDE5A,Approved symbol,PDE5A,phosphodiesterase 5A,HGNC:8784,4q26
PDE6A,Approved symbol,PDE6A,phosphodiesterase 6A,HGNC:8785,5q32
PDE7B,Approved symbol,PDE7B,phosphodiesterase 7B,HGNC:8792,6q23.3
PDE8A,Approved symbol,PDE8A,phosphodiesterase 8A,HGNC:8793,15q25.3
PDF,Approved symbol,PDF,"peptide deformylase, mitochondrial",HGNC:30012,16q22.1
PDF,Alias symbol,GDF15,growth differentiation factor 15,HGNC:30142,19p13.11
PDGFD,Approved symbol,PDGFD,platelet derived growth factor D,HGNC:30620,11q22.3
PDGFRB,Approved symbol,PDGFRB,platelet derived growth factor receptor beta,HGNC:8804,5q32
PDHA1,Approved symbol,PDHA1,pyruvate dehydrogenase E1 subunit alpha 1,HGNC:8806,Xp22.12
PDIA3,Approved symbol,PDIA3,protein disulfide isomerase family A member 3,HGNC:4606,15q15.3
PDIA5,Approved symbol,PDIA5,protein disulfide isomerase family A member 5,HGNC:24811,3q21.1
PDIA6,Approved symbol,PDIA6,protein disulfide isomerase family A member 6,HGNC:30168,2p25.1
PDK4,Approved symbol,PDK4,pyruvate dehydrogenase kinase 4,HGNC:8812,7q21.3
PDLIM3,Approved symbol,PDLIM3,PDZ and LIM domain 3,HGNC:20767,4q35.1
PDLIM5,Approved symbol,PDLIM5,PDZ and LIM domain 5,HGNC:17468,4q22.3
PDPN,Approved symbol,PDPN,podoplanin,HGNC:29602,1p36.21
PDRG1,Approved symbol,PDRG1,p53 and DNA damage regulated 1,HGNC:16119,20q11.21
PDS5A,Approved symbol,PDS5A,PDS5 cohesin associated factor A,HGNC:29088,4p14
PDS5B,Approved symbol,PDS5B,PDS5 cohesin associated factor B,HGNC:20418,13q13.1
PDX1,Approved symbol,PDX1,pancreatic and duodenal homeobox 1,HGNC:6107,13q12.2
PDX1,Alias symbol,PDHX,pyruvate dehydrogenase complex component X,HGNC:21350,11p13
PDXK,Approved symbol,PDXK,pyridoxal kinase,HGNC:8819,21q22.3
PDZD2,Approved symbol,PDZD2,PDZ domain containing 2,HGNC:18486,5p13.3
PDZD4,Approved symbol,PDZD4,PDZ domain containing 4,HGNC:21167,Xq28
PDZD7,Approved symbol,PDZD7,PDZ domain containing 7,HGNC:26257,10q24.31
PDZRN3,Approved symbol,PDZRN3,PDZ domain containing ring finger 3,HGNC:17704,3p13
PEAK1,Approved symbol,PEAK1,pseudopodium enriched atypical kinase 1,HGNC:29431,15q24.3
PEBP4,Approved symbol,PEBP4,phosphatidylethanolamine binding protein 4,HGNC:28319,8p21.3
PEG3,Approved symbol,PEG3,paternally expressed 3,HGNC:8826,19q13.43
PELO,Approved symbol,PELO,pelota mRNA surveillance and ribosome rescue factor,HGNC:8829,5q11.2
PER2,Approved symbol,PER2,period circadian regulator 2,HGNC:8846,2q37.3
PET100,Approved symbol,PET100,PET100 cytochrome c oxidase chaperone,HGNC:40038,19p13.2
PEX10,Approved symbol,PEX10,peroxisomal biogenesis factor 10,HGNC:8851,1p36.32
PEX11B,Approved symbol,PEX11B,peroxisomal biogenesis factor 11 beta,HGNC:8853,1q21.1
PEX26,Approved symbol,PEX26,peroxisomal biogenesis factor 26,HGNC:22965,22q11.21
PEX6,Approved symbol,PEX6,peroxisomal biogenesis factor 6,HGNC:8859,6p21.1
PFAS,Approved symbol,PFAS,phosphoribosylformylglycinamidine synthase,HGNC:8863,17p13.1
PFKFB1,Approved symbol,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1",HGNC:8872,Xp11.21
PFKFB3,Approved symbol,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",HGNC:8874,10p15.1
PFKL,Approved symbol,PFKL,"phosphofructokinase, liver type",HGNC:8876,21q22.3
PFKP,Approved symbol,PFKP,"phosphofructokinase, platelet",HGNC:8878,10p15.2
PGAM2,Approved symbol,PGAM2,phosphoglycerate mutase 2,HGNC:8889,7p13
PGAP1,Approved symbol,PGAP1,post-GPI attachment to proteins inositol deacylase 1,HGNC:25712,2q33.1
PGAP2,Approved symbol,PGAP2,post-GPI attachment to proteins 2,HGNC:17893,11p15.4
PGBD4,Approved symbol,PGBD4,piggyBac transposable element derived 4,HGNC:19401,15q14
PGBD5,Approved symbol,PGBD5,piggyBac transposable element derived 5,HGNC:19405,1q42.13
PGC,Approved symbol,PGC,progastricsin,HGNC:8890,6p21.1
PGK1,Approved symbol,PGK1,phosphoglycerate kinase 1,HGNC:8896,Xq21.1
PGLYRP2,Approved symbol,PGLYRP2,peptidoglycan recognition protein 2,HGNC:30013,19p13.12
PGLYRP3,Approved symbol,PGLYRP3,peptidoglycan recognition protein 3,HGNC:30014,1q21.3
PGM2,Approved symbol,PGM2,phosphoglucomutase 2,HGNC:8906,4p14
PGM2L1,Approved symbol,PGM2L1,phosphoglucomutase 2 like 1,HGNC:20898,11q13.4
PGR,Approved symbol,PGR,progesterone receptor,HGNC:8910,11q22.1
PHACTR1,Approved symbol,PHACTR1,phosphatase and actin regulator 1,HGNC:20990,6p24.1
PHACTR4,Approved symbol,PHACTR4,phosphatase and actin regulator 4,HGNC:25793,1p35.3
PHC2,Approved symbol,PHC2,polyhomeotic homolog 2,HGNC:3183,1p35.1
PHEX,Approved symbol,PHEX,phosphate regulating endopeptidase homolog X-linked,HGNC:8918,Xp22.11
PHF12,Approved symbol,PHF12,PHD finger protein 12,HGNC:20816,17q11.2
PHF20L1,Approved symbol,PHF20L1,PHD finger protein 20 like 1,HGNC:24280,8q24.22
PHF21B,Approved symbol,PHF21B,PHD finger protein 21B,HGNC:25161,22q13.31
PHF23,Approved symbol,PHF23,PHD finger protein 23,HGNC:28428,17p13.1
PHGR1,Approved symbol,PHGR1,"proline, histidine and glycine rich 1",HGNC:37226,15q15.1
PHKA1,Approved symbol,PHKA1,phosphorylase kinase regulatory subunit alpha 1,HGNC:8925,Xq13.1
PHKB,Approved symbol,PHKB,phosphorylase kinase regulatory subunit beta,HGNC:8927,16q12.1
PHOX2A,Approved symbol,PHOX2A,paired like homeobox 2A,HGNC:691,11q13.4
PHOX2B,Approved symbol,PHOX2B,paired like homeobox 2B,HGNC:9143,4p13
PHTF1,Approved symbol,PHTF1,putative homeodomain transcription factor 1,HGNC:8939,1p13.2
PI4K2A,Approved symbol,PI4K2A,phosphatidylinositol 4-kinase type 2 alpha,HGNC:30031,10q24.2
PI4K2B,Approved symbol,PI4K2B,phosphatidylinositol 4-kinase type 2 beta,HGNC:18215,4p15.2
PIANP,Approved symbol,PIANP,PILR alpha associated neural protein,HGNC:25338,12p13.31
PIAS1,Approved symbol,PIAS1,protein inhibitor of activated STAT 1,HGNC:2752,15q23
PICK1,Approved symbol,PICK1,protein interacting with PRKCA 1,HGNC:9394,22q13.1
PIEZO1,Approved symbol,PIEZO1,piezo type mechanosensitive ion channel component 1,HGNC:28993,16q24.3
PIEZO2,Approved symbol,PIEZO2,piezo type mechanosensitive ion channel component 2,HGNC:26270,18p11.22-p11.21
PIGG,Approved symbol,PIGG,phosphatidylinositol glycan anchor biosynthesis class G,HGNC:25985,4p16.3
PIGN,Approved symbol,PIGN,phosphatidylinositol glycan anchor biosynthesis class N,HGNC:8967,18q21.33
PIGT,Approved symbol,PIGT,phosphatidylinositol glycan anchor biosynthesis class T,HGNC:14938,20q13.12
PIK3C2A,Approved symbol,PIK3C2A,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,HGNC:8971,11p15.1
PIK3C2B,Approved symbol,PIK3C2B,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,HGNC:8972,1q32.1
PIK3C3,Approved symbol,PIK3C3,phosphatidylinositol 3-kinase catalytic subunit type 3,HGNC:8974,18q12.3
PIK3CA,Approved symbol,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",HGNC:8975,3q26.32
PIK3R1,Approved symbol,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,HGNC:8979,5q13.1
PIK3R2,Approved symbol,PIK3R2,phosphoinositide-3-kinase regulatory subunit 2,HGNC:8980,19p13.11
PINX1,Approved symbol,PINX1,PIN2 (TERF1) interacting telomerase inhibitor 1,HGNC:30046,8p23.1
PIP4K2B,Approved symbol,PIP4K2B,phosphatidylinositol-5-phosphate 4-kinase type 2 beta,HGNC:8998,17q12
PIP5K1B,Approved symbol,PIP5K1B,phosphatidylinositol-4-phosphate 5-kinase type 1 beta,HGNC:8995,9q21.11
PIP5K1C,Approved symbol,PIP5K1C,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma,HGNC:8996,19p13.3
PITHD1,Approved symbol,PITHD1,PITH domain containing 1,HGNC:25022,1p36.11
PITPNM2,Approved symbol,PITPNM2,phosphatidylinositol transfer protein membrane associated 2,HGNC:21044,12q24.31
PITRM1,Approved symbol,PITRM1,pitrilysin metallopeptidase 1,HGNC:17663,10p15.2
PITX2,Approved symbol,PITX2,paired like homeodomain 2,HGNC:9005,4q25
PIWIL3,Approved symbol,PIWIL3,piwi like RNA-mediated gene silencing 3,HGNC:18443,22q11.23
PKD1,Approved symbol,PKD1,"polycystin 1, transient receptor potential channel interacting",HGNC:9008,16p13.3
PKD1L3,Approved symbol,PKD1L3,"polycystin 1 like 3, transient receptor potential channel interacting",HGNC:21716,16q22.2
PKD2,Approved symbol,PKD2,"polycystin 2, transient receptor potential cation channel",HGNC:9009,4q22.1
PKD2,Alias symbol,PRKD2,protein kinase D2,HGNC:17293,19q13.32
PKD2L2,Approved symbol,PKD2L2,"polycystin 2 like 2, transient receptor potential cation channel",HGNC:9012,5q31.2
PKDREJ,Approved symbol,PKDREJ,polycystin family receptor for egg jelly,HGNC:9015,22q13.31
PKHD1,Approved symbol,PKHD1,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,HGNC:9016,6p12.3-p12.2
PKHD1L1,Approved symbol,PKHD1L1,PKHD1 like 1,HGNC:20313,8q23.1-q23.2
PKIB,Approved symbol,PKIB,cAMP-dependent protein kinase inhibitor beta,HGNC:9018,6q22.31
PKMYT1,Approved symbol,PKMYT1,"protein kinase, membrane associated tyrosine/threonine 1",HGNC:29650,16p13.3
PKN1,Approved symbol,PKN1,protein kinase N1,HGNC:9405,19p13.12
PKN3,Approved symbol,PKN3,protein kinase N3,HGNC:17999,9q34.11
PKP1,Approved symbol,PKP1,plakophilin 1,HGNC:9023,1q32.1
PKP3,Approved symbol,PKP3,plakophilin 3,HGNC:9025,11p15.5
PLA2G15,Approved symbol,PLA2G15,phospholipase A2 group XV,HGNC:17163,16q22.1
PLA2G2E,Approved symbol,PLA2G2E,phospholipase A2 group IIE,HGNC:13414,1p36.13
PLA2G3,Approved symbol,PLA2G3,phospholipase A2 group III,HGNC:17934,22q12.2
PLA2G4F,Approved symbol,PLA2G4F,phospholipase A2 group IVF,HGNC:27396,15q15.1
PLA2G5,Approved symbol,PLA2G5,phospholipase A2 group V,HGNC:9038,1p36.13
PLA2G7,Approved symbol,PLA2G7,phospholipase A2 group VII,HGNC:9040,6p12.3
PLA2R1,Approved symbol,PLA2R1,phospholipase A2 receptor 1,HGNC:9042,2q23-q24
PLAA,Approved symbol,PLAA,phospholipase A2 activating protein,HGNC:9043,9p21.2
PLCB2,Approved symbol,PLCB2,phospholipase C beta 2,HGNC:9055,15q15.1
PLCB3,Approved symbol,PLCB3,phospholipase C beta 3,HGNC:9056,11q13.1
PLCB4,Approved symbol,PLCB4,phospholipase C beta 4,HGNC:9059,20p12.3-p12.2
PLCG1,Approved symbol,PLCG1,phospholipase C gamma 1,HGNC:9065,20q12
PLCH1,Approved symbol,PLCH1,phospholipase C eta 1,HGNC:29185,3q25.31
PLCH2,Approved symbol,PLCH2,phospholipase C eta 2,HGNC:29037,1p36.32
PLCL1,Approved symbol,PLCL1,phospholipase C like 1 (inactive),HGNC:9063,2q33.1
PLCZ1,Approved symbol,PLCZ1,phospholipase C zeta 1,HGNC:19218,12p12.3
PLD2,Approved symbol,PLD2,phospholipase D2,HGNC:9068,17p13.2
PLD3,Approved symbol,PLD3,phospholipase D family member 3,HGNC:17158,19q13.2
PLD5,Approved symbol,PLD5,phospholipase D family member 5,HGNC:26879,1q43
PLEC,Approved symbol,PLEC,plectin,HGNC:9069,8q24.3
PLEKHA4,Approved symbol,PLEKHA4,pleckstrin homology domain containing A4,HGNC:14339,19q13.33
PLEKHA6,Approved symbol,PLEKHA6,pleckstrin homology domain containing A6,HGNC:17053,1q32.1
PLEKHA7,Approved symbol,PLEKHA7,pleckstrin homology domain containing A7,HGNC:27049,11p15
PLEKHA8,Approved symbol,PLEKHA8,pleckstrin homology domain containing A8,HGNC:30037,7p14.3
PLEKHB1,Approved symbol,PLEKHB1,pleckstrin homology domain containing B1,HGNC:19079,11q13.4
PLEKHF2,Approved symbol,PLEKHF2,pleckstrin homology and FYVE domain containing 2,HGNC:20757,8q22.1
PLEKHG1,Approved symbol,PLEKHG1,pleckstrin homology and RhoGEF domain containing G1,HGNC:20884,6q25.1
PLEKHG2,Approved symbol,PLEKHG2,pleckstrin homology and RhoGEF domain containing G2,HGNC:29515,19q13.2
PLEKHG3,Approved symbol,PLEKHG3,pleckstrin homology and RhoGEF domain containing G3,HGNC:20364,14q23.3
PLEKHG4B,Approved symbol,PLEKHG4B,pleckstrin homology and RhoGEF domain containing G4B,HGNC:29399,5p15.33
PLEKHG5,Approved symbol,PLEKHG5,pleckstrin homology and RhoGEF domain containing G5,HGNC:29105,1p36.31
PLEKHH2,Approved symbol,PLEKHH2,"pleckstrin homology, MyTH4 and FERM domain containing H2",HGNC:30506,2p21
PLEKHM2,Approved symbol,PLEKHM2,pleckstrin homology and RUN domain containing M2,HGNC:29131,1p36.21
PLEKHN1,Approved symbol,PLEKHN1,pleckstrin homology domain containing N1,HGNC:25284,1p36.33
PLEKHO2,Approved symbol,PLEKHO2,pleckstrin homology domain containing O2,HGNC:30026,15q22.31
PLG,Approved symbol,PLG,plasminogen,HGNC:9071,6q26
PLIN3,Approved symbol,PLIN3,perilipin 3,HGNC:16893,19p13.3
PLK1,Approved symbol,PLK1,polo like kinase 1,HGNC:9077,16p12.2
KIZ-AS1,Approved symbol,KIZ-AS1,KIZ antisense RNA 1,HGNC:51231,20p11.23
PLK4,Approved symbol,PLK4,polo like kinase 4,HGNC:11397,4q28.1
PLOD2,Approved symbol,PLOD2,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",HGNC:9082,3q24
PLOD3,Approved symbol,PLOD3,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",HGNC:9083,7q22.1
PLSCR4,Approved symbol,PLSCR4,phospholipid scramblase 4,HGNC:16497,3q24
PLSCR5,Approved symbol,PLSCR5,phospholipid scramblase family member 5,HGNC:19952,3q24
PLTP,Approved symbol,PLTP,phospholipid transfer protein,HGNC:9093,20q13.12
PLVAP,Approved symbol,PLVAP,plasmalemma vesicle associated protein,HGNC:13635,19p13.11
PLXDC2,Approved symbol,PLXDC2,plexin domain containing 2,HGNC:21013,10p12.31
PLXNA2,Approved symbol,PLXNA2,plexin A2,HGNC:9100,1q32.2
PLXNA3,Approved symbol,PLXNA3,plexin A3,HGNC:9101,Xq28
PLXNA4,Approved symbol,PLXNA4,plexin A4,HGNC:9102,7q32.3
PLXNB2,Approved symbol,PLXNB2,plexin B2,HGNC:9104,22q13.33
PLXNB3,Approved symbol,PLXNB3,plexin B3,HGNC:9105,Xq28
PLXNC1,Approved symbol,PLXNC1,plexin C1,HGNC:9106,12q22
PLXND1,Approved symbol,PLXND1,plexin D1,HGNC:9107,3q22.1
PMEPA1,Approved symbol,PMEPA1,"prostate transmembrane protein, androgen induced 1",HGNC:14107,20q13.31
PML,Approved symbol,PML,PML nuclear body scaffold,HGNC:9113,15q24.1
PMM1,Approved symbol,PMM1,phosphomannomutase 1,HGNC:9114,22q13.2
PMM2,Approved symbol,PMM2,phosphomannomutase 2,HGNC:9115,16p13.2
PMPCA,Approved symbol,PMPCA,"peptidase, mitochondrial processing subunit alpha",HGNC:18667,9q34.3
PMVK,Approved symbol,PMVK,phosphomevalonate kinase,HGNC:9141,1q21.3
PNLDC1,Approved symbol,PNLDC1,PARN like ribonuclease domain containing exonuclease 1,HGNC:21185,6q25.3
PNLIP,Approved symbol,PNLIP,pancreatic lipase,HGNC:9155,10q25.3
PNLIPRP3,Approved symbol,PNLIPRP3,pancreatic lipase related protein 3,HGNC:23492,10q25.3
PNMA2,Approved symbol,PNMA2,PNMA family member 2,HGNC:9159,8p21.2
PNMAL2,Previous symbol,PNMA8B,PNMA family member 8B,HGNC:29206,19q13.32
PNPLA6,Approved symbol,PNPLA6,patatin like phospholipase domain containing 6,HGNC:16268,19p13.2
PNPLA7,Approved symbol,PNPLA7,patatin like phospholipase domain containing 7,HGNC:24768,9q34.3
PNRC1,Approved symbol,PNRC1,proline rich nuclear receptor coactivator 1,HGNC:17278,6q15
POF1B,Approved symbol,POF1B,POF1B actin binding protein,HGNC:13711,Xq21.1
POGZ,Approved symbol,POGZ,pogo transposable element derived with ZNF domain,HGNC:18801,1q21.3
POLA1,Approved symbol,POLA1,"DNA polymerase alpha 1, catalytic subunit",HGNC:9173,Xp22.11-p21.3
POLD1,Approved symbol,POLD1,"DNA polymerase delta 1, catalytic subunit",HGNC:9175,19q13.3
POLD3,Approved symbol,POLD3,"DNA polymerase delta 3, accessory subunit",HGNC:20932,11q13.4
POLG,Approved symbol,POLG,"DNA polymerase gamma, catalytic subunit",HGNC:9179,15q26.1
POLH,Approved symbol,POLH,DNA polymerase eta,HGNC:9181,6p21.1
POLH,Alias symbol,POLQ,DNA polymerase theta,HGNC:9186,3q13.33
POLI,Approved symbol,POLI,DNA polymerase iota,HGNC:9182,18q21.2
POLK,Approved symbol,POLK,DNA polymerase kappa,HGNC:9183,5q13.3
POLK,Alias symbol,TENT4A,terminal nucleotidyltransferase 4A,HGNC:16705,5p15.31
POLM,Approved symbol,POLM,DNA polymerase mu,HGNC:9185,7p13
POLN,Approved symbol,POLN,DNA polymerase nu,HGNC:18870,4p16.3
POLQ,Approved symbol,POLQ,DNA polymerase theta,HGNC:9186,3q13.33
POLQ,Alias symbol,POLK,DNA polymerase kappa,HGNC:9183,5q13.3
POLR1A,Approved symbol,POLR1A,RNA polymerase I subunit A,HGNC:17264,2p11.2
POLR1E,Approved symbol,POLR1E,RNA polymerase I subunit E,HGNC:17631,9p13.2
POLR3C,Approved symbol,POLR3C,RNA polymerase III subunit C,HGNC:30076,1q21.1
POM121,Approved symbol,POM121,POM121 transmembrane nucleoporin,HGNC:19702,7q11.23
POM121,Alias symbol,POMZP3,POM121 and ZP3 fusion,HGNC:9203,7q11.23
POM121L12,Approved symbol,POM121L12,POM121 transmembrane nucleoporin like 12,HGNC:25369,7p12.1
POMC,Approved symbol,POMC,proopiomelanocortin,HGNC:9201,2p23.3
POMGNT2,Approved symbol,POMGNT2,"protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)",HGNC:25902,3p22.1
POMT1,Approved symbol,POMT1,protein O-mannosyltransferase 1,HGNC:9202,9q34.13
PON1,Approved symbol,PON1,paraoxonase 1,HGNC:9204,7q21.3
POPDC2,Approved symbol,POPDC2,popeye domain containing 2,HGNC:17648,3q13.33
POR,Approved symbol,POR,cytochrome p450 oxidoreductase,HGNC:9208,7q11.23
POR,Alias symbol,PORCN,porcupine O-acyltransferase,HGNC:17652,Xp11.23
POSTN,Approved symbol,POSTN,periostin,HGNC:16953,13q13.3
POTED,Approved symbol,POTED,POTE ankyrin domain family member D,HGNC:23822,21q11.2
POTEF,Approved symbol,POTEF,POTE ankyrin domain family member F,HGNC:33905,2q21.1
POU1F1,Approved symbol,POU1F1,POU class 1 homeobox 1,HGNC:9210,3p11.2
POU3F4,Approved symbol,POU3F4,POU class 3 homeobox 4,HGNC:9217,Xq21.1
POU4F1,Approved symbol,POU4F1,POU class 4 homeobox 1,HGNC:9218,13q31.1
POU5F1,Approved symbol,POU5F1,POU class 5 homeobox 1,HGNC:9221,6p21.33
PPAPDC2,Previous symbol,PLPP6,phospholipid phosphatase 6,HGNC:23682,9p24.1
PPAPDC3,Previous symbol,PLPP7,phospholipid phosphatase 7 (inactive),HGNC:28174,9q34.13
PPARGC1B,Approved symbol,PPARGC1B,PPARG coactivator 1 beta,HGNC:30022,5q32
PPAT,Approved symbol,PPAT,phosphoribosyl pyrophosphate amidotransferase,HGNC:9238,4q12
PPAT,Alias symbol,COASY,Coenzyme A synthase,HGNC:29932,17q21.2
PPCS,Approved symbol,PPCS,phosphopantothenoylcysteine synthetase,HGNC:25686,1p34.2
PPEF1,Approved symbol,PPEF1,protein phosphatase with EF-hand domain 1,HGNC:9243,Xp22.13
PPEF2,Approved symbol,PPEF2,protein phosphatase with EF-hand domain 2,HGNC:9244,4q21.1
PPFIA2,Approved symbol,PPFIA2,PTPRF interacting protein alpha 2,HGNC:9246,12q21.31
PPIA,Approved symbol,PPIA,peptidylprolyl isomerase A,HGNC:9253,7p13
PPIF,Approved symbol,PPIF,peptidylprolyl isomerase F,HGNC:9259,10q22.3
PPIH,Approved symbol,PPIH,peptidylprolyl isomerase H,HGNC:14651,1p34.2
PPIL2,Approved symbol,PPIL2,peptidylprolyl isomerase like 2,HGNC:9261,22q11.21
PPL,Approved symbol,PPL,periplakin,HGNC:9273,16p13.3
PPM1A,Approved symbol,PPM1A,"protein phosphatase, Mg2+/Mn2+ dependent 1A",HGNC:9275,14q23.1
PPM1E,Approved symbol,PPM1E,"protein phosphatase, Mg2+/Mn2+ dependent 1E",HGNC:19322,17q24.2
PPM1K,Approved symbol,PPM1K,"protein phosphatase, Mg2+/Mn2+ dependent 1K",HGNC:25415,4q22.1
PPM1N,Approved symbol,PPM1N,"protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)",HGNC:26845,19q13.32
PPP1CC,Approved symbol,PPP1CC,protein phosphatase 1 catalytic subunit gamma,HGNC:9283,12q24.11
PPP1R12C,Approved symbol,PPP1R12C,protein phosphatase 1 regulatory subunit 12C,HGNC:14947,19q13.42
PPP1R13L,Approved symbol,PPP1R13L,protein phosphatase 1 regulatory subunit 13 like,HGNC:18838,19q13.32
PPP1R26,Approved symbol,PPP1R26,protein phosphatase 1 regulatory subunit 26,HGNC:29089,9q34.3
PPP1R37,Approved symbol,PPP1R37,protein phosphatase 1 regulatory subunit 37,HGNC:27607,19q13.32
PPP1R3A,Approved symbol,PPP1R3A,protein phosphatase 1 regulatory subunit 3A,HGNC:9291,7q31.1
PPP1R3G,Approved symbol,PPP1R3G,protein phosphatase 1 regulatory subunit 3G,HGNC:14945,6p25.1
PPP1R9A,Approved symbol,PPP1R9A,protein phosphatase 1 regulatory subunit 9A,HGNC:14946,7q21.3
PPP1R9B,Approved symbol,PPP1R9B,protein phosphatase 1 regulatory subunit 9B,HGNC:9298,17q21.33
PPP2R1B,Approved symbol,PPP2R1B,protein phosphatase 2 scaffold subunit Abeta,HGNC:9303,11q23.1
PPP2R2B,Approved symbol,PPP2R2B,protein phosphatase 2 regulatory subunit Bbeta,HGNC:9305,5q32
PPP2R2C,Approved symbol,PPP2R2C,protein phosphatase 2 regulatory subunit Bgamma,HGNC:9306,4p16.1
PPP2R3A,Approved symbol,PPP2R3A,protein phosphatase 2 regulatory subunit B''alpha,HGNC:9307,3q22.2-q22.3
PPP2R3B,Approved symbol,PPP2R3B,protein phosphatase 2 regulatory subunit B''beta,HGNC:13417,Xp22.3 and Yp11.3
PPP2R5C,Approved symbol,PPP2R5C,protein phosphatase 2 regulatory subunit B'gamma,HGNC:9311,14q32.31
PPP4R4,Approved symbol,PPP4R4,protein phosphatase 4 regulatory subunit 4,HGNC:23788,14q32.2
PPP6C,Approved symbol,PPP6C,protein phosphatase 6 catalytic subunit,HGNC:9323,9q33.3
PPP6R3,Approved symbol,PPP6R3,protein phosphatase 6 regulatory subunit 3,HGNC:1173,11q13
PPRC1,Approved symbol,PPRC1,PPARG related coactivator 1,HGNC:30025,10q24.32
PPWD1,Approved symbol,PPWD1,peptidylprolyl isomerase domain and WD repeat containing 1,HGNC:28954,5q12.3
PQLC1,Previous symbol,SLC66A2,solute carrier family 66 member 2,HGNC:26188,18q23
PRAC2,Approved symbol,PRAC2,PRAC2 small nuclear protein,HGNC:30143,17q21.32
PRAMEF4,Approved symbol,PRAMEF4,PRAME family member 4,HGNC:31971,1p36.21
PRDM13,Approved symbol,PRDM13,PR/SET domain 13,HGNC:13998,6q16.2
PRDM15,Approved symbol,PRDM15,PR/SET domain 15,HGNC:13999,21q22.3
PRDM2,Approved symbol,PRDM2,PR/SET domain 2,HGNC:9347,1p36.21
PRDM4,Approved symbol,PRDM4,PR/SET domain 4,HGNC:9348,12q23.3
PRDM5,Approved symbol,PRDM5,PR/SET domain 5,HGNC:9349,4q27
PRDM9,Approved symbol,PRDM9,PR/SET domain 9,HGNC:13994,5p14.2
PREB,Approved symbol,PREB,prolactin regulatory element binding,HGNC:9356,2p23.3
PREX2,Approved symbol,PREX2,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2",HGNC:22950,8q13.2
PRICKLE2,Approved symbol,PRICKLE2,prickle planar cell polarity protein 2,HGNC:20340,3p14.1
PRICKLE3,Approved symbol,PRICKLE3,prickle planar cell polarity protein 3,HGNC:6645,Xp11.23
PRKAA2,Approved symbol,PRKAA2,protein kinase AMP-activated catalytic subunit alpha 2,HGNC:9377,1p32.2
PRKAB2,Approved symbol,PRKAB2,protein kinase AMP-activated non-catalytic subunit beta 2,HGNC:9379,1q21.1
PRKAG2,Approved symbol,PRKAG2,protein kinase AMP-activated non-catalytic subunit gamma 2,HGNC:9386,7q36.1
PRKCA,Approved symbol,PRKCA,protein kinase C alpha,HGNC:9393,17q24.2
PRKCB,Approved symbol,PRKCB,protein kinase C beta,HGNC:9395,16p12.2-p12.1
PRKCD,Approved symbol,PRKCD,protein kinase C delta,HGNC:9399,3p21.1
PRKDC,Approved symbol,PRKDC,"protein kinase, DNA-activated, catalytic subunit",HGNC:9413,8q11.21
PRKG2,Approved symbol,PRKG2,protein kinase cGMP-dependent 2,HGNC:9416,4q21.21
PRKRA,Approved symbol,PRKRA,protein activator of interferon induced protein kinase EIF2AK2,HGNC:9438,2q31.2
PRKRIR,Previous symbol,THAP12,THAP domain containing 12,HGNC:9440,11q13.5
PRL,Approved symbol,PRL,prolactin,HGNC:9445,6p22.3
PRMT6,Approved symbol,PRMT6,protein arginine methyltransferase 6,HGNC:18241,1p13.3
PRMT8,Approved symbol,PRMT8,protein arginine methyltransferase 8,HGNC:5188,12p13.32
PROC,Approved symbol,PROC,"protein C, inactivator of coagulation factors Va and VIIIa",HGNC:9451,2q14.3
PRODH,Approved symbol,PRODH,proline dehydrogenase 1,HGNC:9453,22q11.21
PROM2,Approved symbol,PROM2,prominin 2,HGNC:20685,2q11.1
PROSER1,Approved symbol,PROSER1,proline and serine rich 1,HGNC:20291,13q13.3
PRPF31,Approved symbol,PRPF31,pre-mRNA processing factor 31,HGNC:15446,19q13.42
PRPF38A,Approved symbol,PRPF38A,pre-mRNA processing factor 38A,HGNC:25930,1p32.3
PRPF4,Approved symbol,PRPF4,pre-mRNA processing factor 4,HGNC:17349,9q32
PRPF4B,Approved symbol,PRPF4B,pre-mRNA processing factor 4B,HGNC:17346,6p25.2
PRPF6,Approved symbol,PRPF6,pre-mRNA processing factor 6,HGNC:15860,20q13.33
PRPF8,Approved symbol,PRPF8,pre-mRNA processing factor 8,HGNC:17340,17p13.3
PRPS2,Approved symbol,PRPS2,phosphoribosyl pyrophosphate synthetase 2,HGNC:9465,Xp22.2
PRR12,Approved symbol,PRR12,proline rich 12,HGNC:29217,19q13.33
PRR14L,Approved symbol,PRR14L,proline rich 14 like,HGNC:28738,22q12.2
PRR15,Approved symbol,PRR15,proline rich 15,HGNC:22310,7p14.3
PRR23A,Approved symbol,PRR23A,proline rich 23A,HGNC:37172,3q23
PRR23C,Approved symbol,PRR23C,proline rich 23C,HGNC:37173,3q23
PRR25,Approved symbol,PRR25,proline rich 25,HGNC:37230,16p13.3
PRR5,Approved symbol,PRR5,proline rich 5,HGNC:31682,22q13.31
PRR5-ARHGAP8,Approved symbol,PRR5-ARHGAP8,PRR5-ARHGAP8 readthrough,HGNC:34512,22q13.31
PRRC1,Approved symbol,PRRC1,proline rich coiled-coil 1,HGNC:28164,5q23.2
PRRC2B,Approved symbol,PRRC2B,proline rich coiled-coil 2B,HGNC:28121,9q34.13
PRRC2C,Approved symbol,PRRC2C,proline rich coiled-coil 2C,HGNC:24903,1q24.3
PRRT3,Approved symbol,PRRT3,proline rich transmembrane protein 3,HGNC:26591,3p25.3
PRRT4,Approved symbol,PRRT4,proline rich transmembrane protein 4,HGNC:37280,7q32.1
PRSS12,Approved symbol,PRSS12,serine protease 12,HGNC:9477,4q26
PRSS16,Approved symbol,PRSS16,serine protease 16,HGNC:9480,6p22.1
PRSS41,Approved symbol,PRSS41,serine protease 41,HGNC:30715,16p13.3
PRSS56,Approved symbol,PRSS56,serine protease 56,HGNC:39433,2q37.1
PRSS8,Approved symbol,PRSS8,serine protease 8,HGNC:9491,16p11.2
PRUNE2,Approved symbol,PRUNE2,prune homolog 2 with BCH domain,HGNC:25209,9q21.2
PSD,Approved symbol,PSD,pleckstrin and Sec7 domain containing,HGNC:9507,10q24.32
PSG4,Approved symbol,PSG4,pregnancy specific beta-1-glycoprotein 4,HGNC:9521,19q13.31
PSKH1,Approved symbol,PSKH1,protein serine kinase H1,HGNC:9529,16q22.1
PSMB11,Approved symbol,PSMB11,proteasome subunit beta 11,HGNC:31963,14q11.2
PSMD1,Approved symbol,PSMD1,"proteasome 26S subunit, non-ATPase 1",HGNC:9554,2q37.1
PSMD14,Approved symbol,PSMD14,"proteasome 26S subunit, non-ATPase 14",HGNC:16889,2q24.2
PSMD2,Approved symbol,PSMD2,"proteasome 26S subunit ubiquitin receptor, non-ATPase 2",HGNC:9559,3q27.1
PSMD5,Approved symbol,PSMD5,"proteasome 26S subunit, non-ATPase 5",HGNC:9563,9q33.2
PTBP1,Approved symbol,PTBP1,polypyrimidine tract binding protein 1,HGNC:9583,19p13.3
PTCH1,Approved symbol,PTCH1,patched 1,HGNC:9585,9q22.32
PTCHD1,Approved symbol,PTCHD1,patched domain containing 1,HGNC:26392,Xp22.11
PTCHD2,Previous symbol,DISP3,dispatched RND transporter family member 3,HGNC:29251,1p36.22
PTCHD3,Approved symbol,PTCHD3,patched domain containing 3 (gene/pseudogene),HGNC:24776,10p12.1
PTCHD4,Approved symbol,PTCHD4,patched domain containing 4,HGNC:21345,6p12.3
PTF1A,Approved symbol,PTF1A,pancreas associated transcription factor 1a,HGNC:23734,10p12.2
PTGER3,Approved symbol,PTGER3,prostaglandin E receptor 3,HGNC:9595,1p31.1
PTGIR,Approved symbol,PTGIR,prostaglandin I2 receptor,HGNC:9602,19q13.32
PTGS1,Approved symbol,PTGS1,prostaglandin-endoperoxide synthase 1,HGNC:9604,9q33.2
PTP4A2,Approved symbol,PTP4A2,protein tyrosine phosphatase 4A2,HGNC:9635,1p35.2
PTPLB,Previous symbol,HACD2,3-hydroxyacyl-CoA dehydratase 2,HGNC:9640,3q21.1
PTPN13,Approved symbol,PTPN13,protein tyrosine phosphatase non-receptor type 13,HGNC:9646,4q21.3
PTPN3,Approved symbol,PTPN3,protein tyrosine phosphatase non-receptor type 3,HGNC:9655,9q31
PTPN7,Approved symbol,PTPN7,protein tyrosine phosphatase non-receptor type 7,HGNC:9659,1q32.1
PTPRD,Approved symbol,PTPRD,protein tyrosine phosphatase receptor type D,HGNC:9668,9p24.1-p23
PTPRH,Approved symbol,PTPRH,protein tyrosine phosphatase receptor type H,HGNC:9672,19q13.42
PTPRN2,Approved symbol,PTPRN2,protein tyrosine phosphatase receptor type N2,HGNC:9677,7q36.3
PTPRO,Approved symbol,PTPRO,protein tyrosine phosphatase receptor type O,HGNC:9678,12p12.3
PTPRO,Alias symbol,PTPRU,protein tyrosine phosphatase receptor type U,HGNC:9683,1p35.3
PTPRS,Approved symbol,PTPRS,protein tyrosine phosphatase receptor type S,HGNC:9681,19p13.3
PTPRT,Approved symbol,PTPRT,protein tyrosine phosphatase receptor type T,HGNC:9682,20q12-q13.11
PTTG1IP,Approved symbol,PTTG1IP,PTTG1 interacting protein,HGNC:13524,21q22.3
PUF60,Approved symbol,PUF60,poly(U) binding splicing factor 60,HGNC:17042,8q24.3
PUM1,Approved symbol,PUM1,pumilio RNA binding family member 1,HGNC:14957,1p35.2
PUS7,Approved symbol,PUS7,pseudouridine synthase 7,HGNC:26033,7q22.3
PUS7L,Approved symbol,PUS7L,pseudouridine synthase 7 like,HGNC:25276,12q12
PVRL1,Previous symbol,NECTIN1,nectin cell adhesion molecule 1,HGNC:9706,11q23.3
PVRL3,Previous symbol,NECTIN3,nectin cell adhesion molecule 3,HGNC:17664,3q13.13
PWWP2B,Approved symbol,PWWP2B,PWWP domain containing 2B,HGNC:25150,10q26.3
PXDN,Approved symbol,PXDN,peroxidasin,HGNC:14966,2p25.3
PXDNL,Approved symbol,PXDNL,peroxidasin like,HGNC:26359,8q11.22-q11.23
PYGB,Approved symbol,PYGB,glycogen phosphorylase B,HGNC:9723,20p11.21
PZP,Approved symbol,PZP,PZP alpha-2-macroglobulin like,HGNC:9750,12p13.31
QARS1,Approved symbol,QARS1,glutaminyl-tRNA synthetase 1,HGNC:9751,3p21.31
QKI,Approved symbol,QKI,"QKI, KH domain containing RNA binding",HGNC:21100,6q26
QPCT,Approved symbol,QPCT,glutaminyl-peptide cyclotransferase,HGNC:9753,2p22.2
QSOX2,Approved symbol,QSOX2,quiescin sulfhydryl oxidase 2,HGNC:30249,9q34.3
QTRT1,Approved symbol,QTRT1,queuine tRNA-ribosyltransferase catalytic subunit 1,HGNC:23797,19p13.3
R3HCC1L,Approved symbol,R3HCC1L,R3H domain and coiled-coil containing 1 like,HGNC:23512,10q24.2
R3HDM1,Approved symbol,R3HDM1,R3H domain containing 1,HGNC:9757,2q21.3
RAB11A,Approved symbol,RAB11A,"RAB11A, member RAS oncogene family",HGNC:9760,15q22.31
RAB11FIP1,Approved symbol,RAB11FIP1,RAB11 family interacting protein 1,HGNC:30265,8p11.23
RAB1B,Approved symbol,RAB1B,"RAB1B, member RAS oncogene family",HGNC:18370,11q13.2
RAB28,Approved symbol,RAB28,"RAB28, member RAS oncogene family",HGNC:9768,4p15.33
RAB36,Approved symbol,RAB36,"RAB36, member RAS oncogene family",HGNC:9775,22q11.23
RAB38,Approved symbol,RAB38,"RAB38, member RAS oncogene family",HGNC:9776,11q14.2
RAB3GAP2,Approved symbol,RAB3GAP2,RAB3 GTPase activating non-catalytic protein subunit 2,HGNC:17168,1q41
RAB3IL1,Approved symbol,RAB3IL1,RAB3A interacting protein like 1,HGNC:9780,11q12.2-q12.3
RAB40A,Approved symbol,RAB40A,"RAB40A, member RAS oncogene family",HGNC:18283,Xq22.2
RAB40B,Approved symbol,RAB40B,"RAB40B, member RAS oncogene family",HGNC:18284,17q25.3
RAB40C,Approved symbol,RAB40C,"RAB40C, member RAS oncogene family",HGNC:18285,16p13.3
RAB5C,Approved symbol,RAB5C,"RAB5C, member RAS oncogene family",HGNC:9785,17q21.2
RABGAP1L,Approved symbol,RABGAP1L,RAB GTPase activating protein 1 like,HGNC:24663,1q25.1
RABIF,Approved symbol,RABIF,RAB interacting factor,HGNC:9797,1q32.1
RAC2,Approved symbol,RAC2,Rac family small GTPase 2,HGNC:9802,22q13.1
RACGAP1,Approved symbol,RACGAP1,Rac GTPase activating protein 1,HGNC:9804,12q13.12
RAD1,Approved symbol,RAD1,RAD1 checkpoint DNA exonuclease,HGNC:9806,5p13.2
RAD1,Alias symbol,RNASE6,ribonuclease A family member k6,HGNC:10048,14q11.2
RAD1,Alias symbol,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit",HGNC:3436,16p13.12
RAD17,Approved symbol,RAD17,RAD17 checkpoint clamp loader component,HGNC:9807,5q13.2
RAD21,Approved symbol,RAD21,RAD21 cohesin complex component,HGNC:9811,8q24.11
RAD50,Approved symbol,RAD50,RAD50 double strand break repair protein,HGNC:9816,5q31.1
RAD51B,Approved symbol,RAD51B,RAD51 paralog B,HGNC:9822,14q24.1
RAD54B,Approved symbol,RAD54B,RAD54 homolog B,HGNC:17228,8q22.1
RADIL,Approved symbol,RADIL,Rap associating with DIL domain,HGNC:22226,7p22.1
RAET1E,Approved symbol,RAET1E,retinoic acid early transcript 1E,HGNC:16793,6q25.1
RAI1,Approved symbol,RAI1,retinoic acid induced 1,HGNC:9834,17p11.2
RAI1,Alias symbol,RNASE12,ribonuclease A family member 12 (inactive),HGNC:24211,14q11.2
RALGAPA2,Approved symbol,RALGAPA2,Ral GTPase activating protein catalytic subunit alpha 2,HGNC:16207,20p11.23
RALGDS,Approved symbol,RALGDS,ral guanine nucleotide dissociation stimulator,HGNC:9842,9q34.13-q34.2
RANBP1,Approved symbol,RANBP1,RAN binding protein 1,HGNC:9847,22q11.21
RANBP9,Approved symbol,RANBP9,RAN binding protein 9,HGNC:13727,6p23
RAP1GAP,Approved symbol,RAP1GAP,RAP1 GTPase activating protein,HGNC:9858,1p36.12
RAPGEF2,Approved symbol,RAPGEF2,Rap guanine nucleotide exchange factor 2,HGNC:16854,4q32.1
RAPGEF3,Approved symbol,RAPGEF3,Rap guanine nucleotide exchange factor 3,HGNC:16629,12q13.11
RAPGEF4,Approved symbol,RAPGEF4,Rap guanine nucleotide exchange factor 4,HGNC:16626,2q31.1
RAPGEF5,Approved symbol,RAPGEF5,Rap guanine nucleotide exchange factor 5,HGNC:16862,7p15.3
RAPGEF6,Approved symbol,RAPGEF6,Rap guanine nucleotide exchange factor 6,HGNC:20655,5q31.1
RAPH1,Approved symbol,RAPH1,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,HGNC:14436,2q33.2
RARS,Previous symbol,RARS1,arginyl-tRNA synthetase 1,HGNC:9870,5q34
RASA3,Approved symbol,RASA3,RAS p21 protein activator 3,HGNC:20331,13q34
RASA4,Approved symbol,RASA4,RAS p21 protein activator 4,HGNC:23181,7q22.1
RASAL3,Approved symbol,RASAL3,RAS protein activator like 3,HGNC:26129,19p13.12
RASGEF1A,Approved symbol,RASGEF1A,RasGEF domain family member 1A,HGNC:24246,10q11.21
RASGEF1C,Approved symbol,RASGEF1C,RasGEF domain family member 1C,HGNC:27400,5q35.3
RASGRF1,Approved symbol,RASGRF1,Ras protein specific guanine nucleotide releasing factor 1,HGNC:9875,15q25.1
RASGRP3,Approved symbol,RASGRP3,RAS guanyl releasing protein 3,HGNC:14545,2p22.3
RASL11A,Approved symbol,RASL11A,RAS like family 11 member A,HGNC:23802,13q12.2
RASL12,Approved symbol,RASL12,RAS like family 12,HGNC:30289,15q22.31
RASSF10,Approved symbol,RASSF10,Ras association domain family member 10,HGNC:33984,11p15.2
RASSF2,Approved symbol,RASSF2,Ras association domain family member 2,HGNC:9883,20p13
RASSF3,Approved symbol,RASSF3,Ras association domain family member 3,HGNC:14271,12q14.2
RASSF8,Approved symbol,RASSF8,Ras association domain family member 8,HGNC:13232,12p12.1
RB1,Approved symbol,RB1,RB transcriptional corepressor 1,HGNC:9884,13q14.2
RBBP4,Approved symbol,RBBP4,"RB binding protein 4, chromatin remodeling factor",HGNC:9887,1p35.1
RBBP8NL,Approved symbol,RBBP8NL,RBBP8 N-terminal like,HGNC:16144,20q13.33
RBFOX1,Approved symbol,RBFOX1,RNA binding fox-1 homolog 1,HGNC:18222,16p13.3
RBFOX3,Approved symbol,RBFOX3,RNA binding fox-1 homolog 3,HGNC:27097,17q25.3
RBL1,Approved symbol,RBL1,RB transcriptional corepressor like 1,HGNC:9893,20q11.23
RBL2,Approved symbol,RBL2,RB transcriptional corepressor like 2,HGNC:9894,16q12.2
RBM10,Approved symbol,RBM10,RNA binding motif protein 10,HGNC:9896,Xp11.3
RBM19,Approved symbol,RBM19,RNA binding motif protein 19,HGNC:29098,12q24.13-q24.21
RBM23,Approved symbol,RBM23,RNA binding motif protein 23,HGNC:20155,14q11.2
RBM24,Approved symbol,RBM24,RNA binding motif protein 24,HGNC:21539,6p22.3
RBM27,Approved symbol,RBM27,RNA binding motif protein 27,HGNC:29243,5q32
RBM43,Approved symbol,RBM43,RNA binding motif protein 43,HGNC:24790,2q23.3
RBM5,Approved symbol,RBM5,RNA binding motif protein 5,HGNC:9902,3p21.31
RBMS3,Approved symbol,RBMS3,RNA binding motif single stranded interacting protein 3,HGNC:13427,3p24.1
RBMXL2,Approved symbol,RBMXL2,RBMX like 2,HGNC:17886,11p15.4
RBMXL3,Approved symbol,RBMXL3,RBMX like 3,HGNC:26859,Xq23
RBP1,Approved symbol,RBP1,retinol binding protein 1,HGNC:9919,3q23
RBP1,Alias symbol,ARID4A,AT-rich interaction domain 4A,HGNC:9885,14q23.1
RBP3,Approved symbol,RBP3,retinol binding protein 3,HGNC:9921,10q11.22
RBP3,Alias symbol,E2F1,E2F transcription factor 1,HGNC:3113,20q11.22
RBP4,Approved symbol,RBP4,retinol binding protein 4,HGNC:9922,10q23.33
RBPMS,Approved symbol,RBPMS,"RNA binding protein, mRNA processing factor",HGNC:19097,8p12
RCAN1,Approved symbol,RCAN1,regulator of calcineurin 1,HGNC:3040,21q22.12
RDH8,Approved symbol,RDH8,retinol dehydrogenase 8,HGNC:14423,19p13.2
RDX,Approved symbol,RDX,radixin,HGNC:9944,11q22.3
RECK,Approved symbol,RECK,reversion inducing cysteine rich protein with kazal motifs,HGNC:11345,9p13.3
RECQL5,Approved symbol,RECQL5,RecQ like helicase 5,HGNC:9950,17q25
REEP5,Approved symbol,REEP5,receptor accessory protein 5,HGNC:30077,5q22.2
REG3A,Approved symbol,REG3A,regenerating family member 3 alpha,HGNC:8601,2p12
REN,Approved symbol,REN,renin,HGNC:9958,1q32.1
REN,Alias symbol,KCTD11,potassium channel tetramerization domain containing 11,HGNC:21302,17p13.1
RERE,Approved symbol,RERE,arginine-glutamic acid dipeptide repeats,HGNC:9965,1p36.23
RET,Approved symbol,RET,ret proto-oncogene,HGNC:9967,10q11.21
REV1,Approved symbol,REV1,REV1 DNA directed polymerase,HGNC:14060,2q11.2
REV3L,Approved symbol,REV3L,"REV3 like, DNA directed polymerase zeta catalytic subunit",HGNC:9968,6q21
REXO4,Approved symbol,REXO4,"REX4 homolog, 3'-5' exonuclease",HGNC:12820,9q34.2
RFC1,Approved symbol,RFC1,replication factor C subunit 1,HGNC:9969,4p14
RFC1,Alias symbol,SLC19A1,solute carrier family 19 member 1,HGNC:10937,21q22.3
RFC4,Approved symbol,RFC4,replication factor C subunit 4,HGNC:9972,3q27.3
RFPL2,Approved symbol,RFPL2,ret finger protein like 2,HGNC:9979,22q12.3
RFPL4AL1,Approved symbol,RFPL4AL1,ret finger protein like 4A like 1,HGNC:45147,19q13.42
RFX1,Approved symbol,RFX1,regulatory factor X1,HGNC:9982,19p13.12
RFXAP,Approved symbol,RFXAP,regulatory factor X associated protein,HGNC:9988,13q13.3
RGAG1,Previous symbol,RTL9,retrotransposon Gag like 9,HGNC:29245,Xq23
RGAG4,Previous symbol,RTL5,retrotransposon Gag like 5,HGNC:29430,Xq13.1
RGCC,Approved symbol,RGCC,regulator of cell cycle,HGNC:20369,13q14.11
RGL2,Approved symbol,RGL2,ral guanine nucleotide dissociation stimulator like 2,HGNC:9769,6p21.32
RGL4,Approved symbol,RGL4,ral guanine nucleotide dissociation stimulator like 4,HGNC:31911,22q11.23
RGMA,Approved symbol,RGMA,repulsive guidance molecule BMP co-receptor a,HGNC:30308,15q26.1
RGS11,Approved symbol,RGS11,regulator of G protein signaling 11,HGNC:9993,16p13.3
RGS3,Approved symbol,RGS3,regulator of G protein signaling 3,HGNC:9999,9q32
RGS4,Approved symbol,RGS4,regulator of G protein signaling 4,HGNC:10000,1q23.3
RGS7,Approved symbol,RGS7,regulator of G protein signaling 7,HGNC:10003,1q43
RHAG,Approved symbol,RHAG,Rh associated glycoprotein,HGNC:10006,6p12.3
RHBDD2,Approved symbol,RHBDD2,rhomboid domain containing 2,HGNC:23082,7q11.23
RHBDL2,Approved symbol,RHBDL2,rhomboid like 2,HGNC:16083,1p34.3
RHBG,Approved symbol,RHBG,Rh family B glycoprotein,HGNC:14572,1q22
RHNO1,Approved symbol,RHNO1,RAD9-HUS1-RAD1 interacting nuclear orphan 1,HGNC:28206,12p13.33
RHO,Approved symbol,RHO,rhodopsin,HGNC:10012,3q22.1
RHO,Alias symbol,RHOD,ras homolog family member D,HGNC:670,11q13.2
RHOU,Approved symbol,RHOU,ras homolog family member U,HGNC:17794,1q42.13
RIC3,Approved symbol,RIC3,RIC3 acetylcholine receptor chaperone,HGNC:30338,11p15.4
RIC8B,Approved symbol,RIC8B,RIC8 guanine nucleotide exchange factor B,HGNC:25555,12q23.3
RICTOR,Approved symbol,RICTOR,RPTOR independent companion of MTOR complex 2,HGNC:28611,5p13.1
RILPL1,Approved symbol,RILPL1,Rab interacting lysosomal protein like 1,HGNC:26814,12q24.31
RIMBP2,Approved symbol,RIMBP2,RIMS binding protein 2,HGNC:30339,12q24.33
RIMKLB,Approved symbol,RIMKLB,ribosomal modification protein rimK like family member B,HGNC:29228,12p13.31
RIMS1,Approved symbol,RIMS1,regulating synaptic membrane exocytosis 1,HGNC:17282,6q13
RIMS2,Approved symbol,RIMS2,regulating synaptic membrane exocytosis 2,HGNC:17283,8q22.3
RIN3,Approved symbol,RIN3,Ras and Rab interactor 3,HGNC:18751,14q32.12
RINL,Approved symbol,RINL,Ras and Rab interactor like,HGNC:24795,19q13.2
RIPK2,Approved symbol,RIPK2,receptor interacting serine/threonine kinase 2,HGNC:10020,8q21.3
RIPPLY2,Approved symbol,RIPPLY2,ripply transcriptional repressor 2,HGNC:21390,6q14.2
RIPPLY3,Approved symbol,RIPPLY3,ripply transcriptional repressor 3,HGNC:3047,21q22.13
RLF,Approved symbol,RLF,RLF zinc finger,HGNC:10025,1p34.2
RLF,Alias symbol,INSL3,insulin like 3,HGNC:6086,19p13.11
RMI1,Approved symbol,RMI1,RecQ mediated genome instability 1,HGNC:25764,9q21.32
RNASE11,Approved symbol,RNASE11,ribonuclease A family member 11 (inactive),HGNC:19269,14q11.2
RNF103,Approved symbol,RNF103,ring finger protein 103,HGNC:12859,2p11.2
RNF112,Approved symbol,RNF112,ring finger protein 112,HGNC:12968,17p11.2
RNF113A,Approved symbol,RNF113A,ring finger protein 113A,HGNC:12974,Xq24
RNF122,Approved symbol,RNF122,ring finger protein 122,HGNC:21147,8p12
RNF126,Approved symbol,RNF126,ring finger protein 126,HGNC:21151,19p13.3
RNF165,Approved symbol,RNF165,ring finger protein 165,HGNC:31696,18q21.1
RNF175,Approved symbol,RNF175,ring finger protein 175,HGNC:27735,4q31.3
RNF19B,Approved symbol,RNF19B,ring finger protein 19B,HGNC:26886,1p35.1
RNF207,Approved symbol,RNF207,ring finger protein 207,HGNC:32947,1p36.31
RNF208,Approved symbol,RNF208,ring finger protein 208,HGNC:25420,9q34.3
RNF219,Previous symbol,OBI1,ORC ubiquitin ligase 1,HGNC:20308,13q31.1
RNF223,Approved symbol,RNF223,ring finger protein 223,HGNC:40020,1p36.33
RNF25,Approved symbol,RNF25,ring finger protein 25,HGNC:14662,2q35
RNF31,Approved symbol,RNF31,ring finger protein 31,HGNC:16031,14q12
RNF38,Approved symbol,RNF38,ring finger protein 38,HGNC:18052,9p13.2
RNF43,Approved symbol,RNF43,ring finger protein 43,HGNC:18505,17q22
RNF44,Approved symbol,RNF44,ring finger protein 44,HGNC:19180,5q35.2
RNFT2,Approved symbol,RNFT2,"ring finger protein, transmembrane 2",HGNC:25905,12q24.22
RNGTT,Approved symbol,RNGTT,RNA guanylyltransferase and 5'-phosphatase,HGNC:10073,6q15
RNPEP,Approved symbol,RNPEP,arginyl aminopeptidase,HGNC:10078,1q32.1
RNVU1-18,Approved symbol,RNVU1-18,"RNA, variant U1 small nuclear 18",HGNC:37496,1q21.2
ROBO1,Approved symbol,ROBO1,roundabout guidance receptor 1,HGNC:10249,3p12.3
ROM1,Approved symbol,ROM1,retinal outer segment membrane protein 1,HGNC:10254,11q12.3
ROR1,Approved symbol,ROR1,receptor tyrosine kinase like orphan receptor 1,HGNC:10256,1p31.3
ROR1,Alias symbol,RORA,RAR related orphan receptor A,HGNC:10258,15q22.2
ROR2,Approved symbol,ROR2,receptor tyrosine kinase like orphan receptor 2,HGNC:10257,9q22.31
ROR2,Alias symbol,RORA,RAR related orphan receptor A,HGNC:10258,15q22.2
RORB,Approved symbol,RORB,RAR related orphan receptor B,HGNC:10259,9q21.13
ROS1,Approved symbol,ROS1,"ROS proto-oncogene 1, receptor tyrosine kinase",HGNC:10261,6q22.1
RP1,Approved symbol,RP1,RP1 axonemal microtubule associated,HGNC:10263,8q11.23-q12.1
RP1,Alias symbol,STK19,serine/threonine kinase 19,HGNC:11398,6p21.33
RP1,Alias symbol,MAPRE2,microtubule associated protein RP/EB family member 2,HGNC:6891,18q12.1-q12.2
BAHCC1,Approved symbol,BAHCC1,BAH domain and coiled-coil containing 1,HGNC:29279,17q25.3
CPEB1,Approved symbol,CPEB1,cytoplasmic polyadenylation element binding protein 1,HGNC:21744,15q25.2
ZNF516-DT,Approved symbol,ZNF516-DT,ZNF516 divergent transcript,HGNC:51248,18q23
RP11-290F20.3,Unmatched,,,,
WWOX,Approved symbol,WWOX,WW domain containing oxidoreductase,HGNC:12799,16q23.1-q23.2
SCIMP,Approved symbol,SCIMP,SLP adaptor and CSK interacting membrane protein,HGNC:33504,17p13.2
RP11-402P6.9,Unmatched,,,,
UBE2W,Approved symbol,UBE2W,ubiquitin conjugating enzyme E2 W,HGNC:25616,8q21.11
RP11-503N18.3,Unmatched,,,,
RNF217,Approved symbol,RNF217,ring finger protein 217,HGNC:21487,6q22.31
LY6L,Approved symbol,LY6L,lymphocyte antigen 6 family member L,HGNC:52284,8q24.3
TRIM47,Approved symbol,TRIM47,tripartite motif containing 47,HGNC:19020,17q25.1
RP11-56A10.1,Unmatched,,,,
RP11-587D21.4,Unmatched,,,,
RP11-651P23.4,Unmatched,,,,
RP11-680F20.6,Unmatched,,,,
C4orf54,Approved symbol,C4orf54,chromosome 4 open reading frame 54,HGNC:27741,4q23
PPP1R12A,Approved symbol,PPP1R12A,protein phosphatase 1 regulatory subunit 12A,HGNC:7618,12q21.2-q21.31
RP11-883A18.3,Unmatched,,,,
RP11-923I11.5,Unmatched,,,,
RP11-923I11.7,Unmatched,,,,
RP13-60M5.2,Unmatched,,,,
SWT1,Approved symbol,SWT1,SWT1 RNA endoribonuclease homolog,HGNC:16785,1q25.3
RPAP1,Approved symbol,RPAP1,RNA polymerase II associated protein 1,HGNC:24567,15q15.1
RPAP2,Approved symbol,RPAP2,RNA polymerase II associated protein 2,HGNC:25791,1p22.1
RPL10L,Approved symbol,RPL10L,ribosomal protein L10 like,HGNC:17976,14q21.2
RPL13A,Approved symbol,RPL13A,ribosomal protein L13a,HGNC:10304,19q13.33
RPL15,Approved symbol,RPL15,ribosomal protein L15,HGNC:10306,3p24.2
RPL36A-HNRNPH2,Approved symbol,RPL36A-HNRNPH2,RPL36A-HNRNPH2 readthrough,HGNC:48349,Xq22.1
RPL8,Approved symbol,RPL8,ribosomal protein L8,HGNC:10368,8q24.3
RPN2,Approved symbol,RPN2,ribophorin II,HGNC:10382,20q11.23
RPN2,Alias symbol,PSMD1,"proteasome 26S subunit, non-ATPase 1",HGNC:9554,2q37.1
RPRD2,Approved symbol,RPRD2,regulation of nuclear pre-mRNA domain containing 2,HGNC:29039,1q21.2
RPS20,Approved symbol,RPS20,ribosomal protein S20,HGNC:10405,8q12.1
RPS29,Approved symbol,RPS29,ribosomal protein S29,HGNC:10419,14q21.3
RPS3A,Approved symbol,RPS3A,ribosomal protein S3A,HGNC:10421,4q31.3
RPS5,Approved symbol,RPS5,ribosomal protein S5,HGNC:10426,19q13.43
RPS6KA1,Approved symbol,RPS6KA1,ribosomal protein S6 kinase A1,HGNC:10430,1p36.11
RPS6KA5,Approved symbol,RPS6KA5,ribosomal protein S6 kinase A5,HGNC:10434,14q32.11
RPS6KA6,Approved symbol,RPS6KA6,ribosomal protein S6 kinase A6,HGNC:10435,Xq21.1
RPS6KL1,Approved symbol,RPS6KL1,ribosomal protein S6 kinase like 1,HGNC:20222,14q24.2
RPS9,Approved symbol,RPS9,ribosomal protein S9,HGNC:10442,19q13.42
RPTOR,Approved symbol,RPTOR,regulatory associated protein of MTOR complex 1,HGNC:30287,17q25.3
RRAGA,Approved symbol,RRAGA,Ras related GTP binding A,HGNC:16963,9p22.1
RRBP1,Approved symbol,RRBP1,ribosome binding protein 1,HGNC:10448,20p12.1
RREB1,Approved symbol,RREB1,ras responsive element binding protein 1,HGNC:10449,6p24.3
RRP12,Approved symbol,RRP12,ribosomal RNA processing 12 homolog,HGNC:29100,10q24.1
RRP36,Approved symbol,RRP36,ribosomal RNA processing 36,HGNC:21374,6p21.1
RRP9,Approved symbol,RRP9,"ribosomal RNA processing 9, U3 small nucleolar RNA binding protein",HGNC:16829,3p21.2
RRS1,Approved symbol,RRS1,ribosome biogenesis regulator 1 homolog,HGNC:17083,8q13.1
RSBN1,Approved symbol,RSBN1,round spermatid basic protein 1,HGNC:25642,1p13.2
RSC1A1,Approved symbol,RSC1A1,regulator of solute carriers 1,HGNC:10458,1p36.21
RSPH4A,Approved symbol,RSPH4A,radial spoke head component 4A,HGNC:21558,6q22.1
RSPO1,Approved symbol,RSPO1,R-spondin 1,HGNC:21679,1p34.3
RTEL1,Approved symbol,RTEL1,regulator of telomere elongation helicase 1,HGNC:15888,20q13.33
RTL1,Approved symbol,RTL1,retrotransposon Gag like 1,HGNC:14665,14q32.2
RTN1,Approved symbol,RTN1,reticulon 1,HGNC:10467,14q23.1
RTN4IP1,Approved symbol,RTN4IP1,reticulon 4 interacting protein 1,HGNC:18647,6q21
RTN4RL1,Approved symbol,RTN4RL1,reticulon 4 receptor like 1,HGNC:21329,17p13.3
RUFY3,Approved symbol,RUFY3,RUN and FYVE domain containing 3,HGNC:30285,4q13.3
RUFY4,Approved symbol,RUFY4,RUN and FYVE domain containing 4,HGNC:24804,2q35
RUNDC3B,Approved symbol,RUNDC3B,RUN domain containing 3B,HGNC:30286,7q21.12
RUNX1,Approved symbol,RUNX1,RUNX family transcription factor 1,HGNC:10471,21q22.12
RUNX2,Approved symbol,RUNX2,RUNX family transcription factor 2,HGNC:10472,6p21.1
RUVBL1,Approved symbol,RUVBL1,RuvB like AAA ATPase 1,HGNC:10474,3q21.3
RWDD2B,Approved symbol,RWDD2B,RWD domain containing 2B,HGNC:1302,21q21.3
RXFP4,Approved symbol,RXFP4,relaxin family peptide/INSL5 receptor 4,HGNC:14666,1q22
RYR1,Approved symbol,RYR1,ryanodine receptor 1,HGNC:10483,19q13.2
RYR2,Approved symbol,RYR2,ryanodine receptor 2,HGNC:10484,1q43
RYR3,Approved symbol,RYR3,ryanodine receptor 3,HGNC:10485,15q13.3-q14
S100P,Approved symbol,S100P,S100 calcium binding protein P,HGNC:10504,4p16.1
SAG,Approved symbol,SAG,S-antigen visual arrestin,HGNC:10521,2q37.1
SAG,Alias symbol,RNF7,ring finger protein 7,HGNC:10070,3q23
SAGE1,Approved symbol,SAGE1,sarcoma antigen 1,HGNC:30369,Xq26.3
SALL1,Approved symbol,SALL1,spalt like transcription factor 1,HGNC:10524,16q12.1
SALL2,Approved symbol,SALL2,spalt like transcription factor 2,HGNC:10526,14q11.2
SALL3,Approved symbol,SALL3,spalt like transcription factor 3,HGNC:10527,18q23
SALL4,Approved symbol,SALL4,spalt like transcription factor 4,HGNC:15924,20q13.2
SAMD1,Approved symbol,SAMD1,sterile alpha motif domain containing 1,HGNC:17958,19p13.12
SAMD10,Approved symbol,SAMD10,sterile alpha motif domain containing 10,HGNC:16129,20q13.33
SAMD11,Approved symbol,SAMD11,sterile alpha motif domain containing 11,HGNC:28706,1p36.33
SAMD12,Approved symbol,SAMD12,sterile alpha motif domain containing 12,HGNC:31750,8q24.11-q24.12
SAMD13,Approved symbol,SAMD13,sterile alpha motif domain containing 13,HGNC:24582,1p31.1
SAMD14,Approved symbol,SAMD14,sterile alpha motif domain containing 14,HGNC:27312,17q21.33
SAMD3,Approved symbol,SAMD3,sterile alpha motif domain containing 3,HGNC:21574,6q23.1
SAMD4B,Approved symbol,SAMD4B,sterile alpha motif domain containing 4B,HGNC:25492,19q13.2
SAMD5,Approved symbol,SAMD5,sterile alpha motif domain containing 5,HGNC:21180,6q24.3
SAMD8,Approved symbol,SAMD8,sterile alpha motif domain containing 8,HGNC:26320,10q22.2
SAMD9L,Approved symbol,SAMD9L,sterile alpha motif domain containing 9 like,HGNC:1349,7q21.2
SAMSN1,Approved symbol,SAMSN1,"SAM domain, SH3 domain and nuclear localization signals 1",HGNC:10528,21q11.2
SARM1,Approved symbol,SARM1,sterile alpha and TIR motif containing 1,HGNC:17074,17q11.2
SASH3,Approved symbol,SASH3,SAM and SH3 domain containing 3,HGNC:15975,Xq26.1
SATB1,Approved symbol,SATB1,SATB homeobox 1,HGNC:10541,3p24.3
SBF1,Approved symbol,SBF1,SET binding factor 1,HGNC:10542,22q13.33
SBF2,Approved symbol,SBF2,SET binding factor 2,HGNC:2135,11p15.4
SBK1,Approved symbol,SBK1,SH3 domain binding kinase 1,HGNC:17699,16p12.1
SBNO2,Approved symbol,SBNO2,strawberry notch homolog 2,HGNC:29158,19p13.3
SCAF4,Approved symbol,SCAF4,SR-related CTD associated factor 4,HGNC:19304,21q22.11
SCAF8,Approved symbol,SCAF8,SR-related CTD associated factor 8,HGNC:20959,6q25.2
SCAND3,Previous symbol,ZBED9,zinc finger BED-type containing 9,HGNC:13851,6p22.1
SCAPER,Approved symbol,SCAPER,S-phase cyclin A associated protein in the ER,HGNC:13081,15q24.3
SCARA3,Approved symbol,SCARA3,scavenger receptor class A member 3,HGNC:19000,8p21.1
SCARF2,Approved symbol,SCARF2,scavenger receptor class F member 2,HGNC:19869,22q11.21
SCD5,Approved symbol,SCD5,stearoyl-CoA desaturase 5,HGNC:21088,4q21.22
SCEL,Approved symbol,SCEL,sciellin,HGNC:10573,13q22.3
SCG3,Approved symbol,SCG3,secretogranin III,HGNC:13707,15q21.2
SCG3,Alias symbol,SGCG,sarcoglycan gamma,HGNC:10809,13q12.12
SCML4,Approved symbol,SCML4,Scm polycomb group protein like 4,HGNC:21397,6q21
SCN11A,Approved symbol,SCN11A,sodium voltage-gated channel alpha subunit 11,HGNC:10583,3p22.2
SCN3A,Approved symbol,SCN3A,sodium voltage-gated channel alpha subunit 3,HGNC:10590,2q24.3
SCN4A,Approved symbol,SCN4A,sodium voltage-gated channel alpha subunit 4,HGNC:10591,17q23.3
SCN7A,Approved symbol,SCN7A,sodium voltage-gated channel alpha subunit 7,HGNC:10594,2q24.3
SCN9A,Approved symbol,SCN9A,sodium voltage-gated channel alpha subunit 9,HGNC:10597,2q24.3
SCNN1D,Approved symbol,SCNN1D,sodium channel epithelial 1 subunit delta,HGNC:10601,1p36.33
SCNN1G,Approved symbol,SCNN1G,sodium channel epithelial 1 subunit gamma,HGNC:10602,16p12.2
SCO2,Approved symbol,SCO2,synthesis of cytochrome C oxidase 2,HGNC:10604,22q13.33
SCP2,Approved symbol,SCP2,sterol carrier protein 2,HGNC:10606,1p32.3
SCP2,Alias symbol,SYCP2,synaptonemal complex protein 2,HGNC:11490,20q13.33
SCP2,Alias symbol,CTDSP2,CTD small phosphatase 2,HGNC:17077,12q14.1
SCRIB,Approved symbol,SCRIB,scribble planar cell polarity protein,HGNC:30377,8q24.3
SCRN2,Approved symbol,SCRN2,secernin 2,HGNC:30381,17q21.32
SCUBE1,Approved symbol,SCUBE1,"signal peptide, CUB domain and EGF like domain containing 1",HGNC:13441,22q13.2
SCUBE2,Approved symbol,SCUBE2,"signal peptide, CUB domain and EGF like domain containing 2",HGNC:30425,11p15.4
SCUBE3,Approved symbol,SCUBE3,"signal peptide, CUB domain and EGF like domain containing 3",HGNC:13655,6p21.3
SCYL3,Approved symbol,SCYL3,SCY1 like pseudokinase 3,HGNC:19285,1q24.2
SCYL3,Alias symbol,CCL15,C-C motif chemokine ligand 15,HGNC:10613,17q12
SDF4,Approved symbol,SDF4,stromal cell derived factor 4,HGNC:24188,1p36.33
SDHA,Approved symbol,SDHA,succinate dehydrogenase complex flavoprotein subunit A,HGNC:10680,5p15.33
SDHD,Approved symbol,SDHD,succinate dehydrogenase complex subunit D,HGNC:10683,11q23.1
SDK1,Approved symbol,SDK1,sidekick cell adhesion molecule 1,HGNC:19307,7p22.2
SDK2,Approved symbol,SDK2,sidekick cell adhesion molecule 2,HGNC:19308,17q25.1
SDPR,Previous symbol,CAVIN2,caveolae associated protein 2,HGNC:10690,2q32.3
SDR39U1,Approved symbol,SDR39U1,short chain dehydrogenase/reductase family 39U member 1,HGNC:20275,14q12
SEC13,Approved symbol,SEC13,"SEC13 homolog, nuclear pore and COPII coat complex component",HGNC:10697,3p25.3
SEC14L1,Approved symbol,SEC14L1,SEC14 like lipid binding 1,HGNC:10698,17q25.2-q25.3
SEC16A,Approved symbol,SEC16A,"SEC16 homolog A, endoplasmic reticulum export factor",HGNC:29006,9q34.3
SEC22B,Approved symbol,SEC22B,"SEC22 homolog B, vesicle trafficking protein",HGNC:10700,1p12
SEC24A,Approved symbol,SEC24A,"SEC24 homolog A, COPII coat complex component",HGNC:10703,5q31.1
SEC61A2,Approved symbol,SEC61A2,SEC61 translocon subunit alpha 2,HGNC:17702,10p14
SECISBP2,Approved symbol,SECISBP2,SECIS binding protein 2,HGNC:30972,9q22.2
SECISBP2L,Approved symbol,SECISBP2L,SECIS binding protein 2 like,HGNC:28997,15q21.1
SEL1L3,Approved symbol,SEL1L3,SEL1L family member 3,HGNC:29108,4p15.2
SELO,Alias symbol,SELENOO,selenoprotein O,HGNC:30395,22q13.33
SEMA3A,Approved symbol,SEMA3A,semaphorin 3A,HGNC:10723,7q21.11
SEMA3C,Approved symbol,SEMA3C,semaphorin 3C,HGNC:10725,7q21.11
SEMA3D,Approved symbol,SEMA3D,semaphorin 3D,HGNC:10726,7q21.11
SEMA3F,Approved symbol,SEMA3F,semaphorin 3F,HGNC:10728,3p21.31
SEMA4C,Approved symbol,SEMA4C,semaphorin 4C,HGNC:10731,2q11.2
SEMA4G,Approved symbol,SEMA4G,semaphorin 4G,HGNC:10735,10q24.31
SEMA5B,Approved symbol,SEMA5B,semaphorin 5B,HGNC:10737,3q21.1
SEMA6A,Approved symbol,SEMA6A,semaphorin 6A,HGNC:10738,5q23.1
SEMA6B,Approved symbol,SEMA6B,semaphorin 6B,HGNC:10739,19p13.3
SEPHS1,Approved symbol,SEPHS1,selenophosphate synthetase 1,HGNC:19685,10p13
SERHL2,Approved symbol,SERHL2,serine hydrolase like 2,HGNC:29446,22q13.2
SERINC2,Approved symbol,SERINC2,serine incorporator 2,HGNC:23231,1p35.2
SERINC5,Approved symbol,SERINC5,serine incorporator 5,HGNC:18825,5q14.1
SERPINA9,Approved symbol,SERPINA9,serpin family A member 9,HGNC:15995,14q32.13
SERPINB11,Approved symbol,SERPINB11,serpin family B member 11,HGNC:14221,18q21.33
SERPINB11,Previous symbol,SERPINB8P1,serpin family B member 8 pseudogene 1,HGNC:8953,6p25.2
SERPINB5,Approved symbol,SERPINB5,serpin family B member 5,HGNC:8949,18q21.33
SERPINB7,Approved symbol,SERPINB7,serpin family B member 7,HGNC:13902,18q21.33
SERPINB8,Approved symbol,SERPINB8,serpin family B member 8,HGNC:8952,18q22.1
SERPINE2,Approved symbol,SERPINE2,serpin family E member 2,HGNC:8951,2q36.1
SESN2,Approved symbol,SESN2,sestrin 2,HGNC:20746,1p35.3
SETD4,Approved symbol,SETD4,SET domain containing 4,HGNC:1258,21q22.12
SETD8,Previous symbol,KMT5A,lysine methyltransferase 5A,HGNC:29489,12q24.31
SETD9,Approved symbol,SETD9,SET domain containing 9,HGNC:28508,5q11.2
SETMAR,Approved symbol,SETMAR,SET domain and mariner transposase fusion gene,HGNC:10762,3p26.1
SETX,Approved symbol,SETX,senataxin,HGNC:445,9q34.13
SEZ6L2,Approved symbol,SEZ6L2,seizure related 6 homolog like 2,HGNC:30844,16p11.2
SF3A1,Approved symbol,SF3A1,splicing factor 3a subunit 1,HGNC:10765,22q12.2
SF3A2,Approved symbol,SF3A2,splicing factor 3a subunit 2,HGNC:10766,19p13.3
SF3B1,Approved symbol,SF3B1,splicing factor 3b subunit 1,HGNC:10768,2q33.1
SF3B1,Alias symbol,SF3B2,splicing factor 3b subunit 2,HGNC:10769,11q13.1
SFMBT2,Approved symbol,SFMBT2,Scm like with four mbt domains 2,HGNC:20256,10p14
SFPQ,Approved symbol,SFPQ,splicing factor proline and glutamine rich,HGNC:10774,1p34.3
SFRP4,Approved symbol,SFRP4,secreted frizzled related protein 4,HGNC:10778,7p14.1
SFSWAP,Approved symbol,SFSWAP,splicing factor SWAP,HGNC:10790,12q24.33
SFTPA1,Approved symbol,SFTPA1,surfactant protein A1,HGNC:10798,10q22.3
SFXN2,Approved symbol,SFXN2,sideroflexin 2,HGNC:16086,10q24.32
SFXN4,Approved symbol,SFXN4,sideroflexin 4,HGNC:16088,10q26.11
SFXN5,Approved symbol,SFXN5,sideroflexin 5,HGNC:16073,2p13.2
SGCA,Approved symbol,SGCA,sarcoglycan alpha,HGNC:10805,17q21.33
SGCD,Approved symbol,SGCD,sarcoglycan delta,HGNC:10807,5q33.2-q33.3
SGIP1,Approved symbol,SGIP1,SH3GL interacting endocytic adaptor 1,HGNC:25412,1p31.3
SGK1,Approved symbol,SGK1,serum/glucocorticoid regulated kinase 1,HGNC:10810,6q23.2
PRAG1,Approved symbol,PRAG1,"PEAK1 related, kinase-activating pseudokinase 1",HGNC:25438,8p23.1
SGOL2,Previous symbol,SGO2,shugoshin 2,HGNC:30812,2q33.1
SGSM2,Approved symbol,SGSM2,small G protein signaling modulator 2,HGNC:29026,17p13.3
SH2D2A,Approved symbol,SH2D2A,SH2 domain containing 2A,HGNC:10821,1q23.1
SH2D3C,Approved symbol,SH2D3C,SH2 domain containing 3C,HGNC:16884,9q34.11
SH2D4A,Approved symbol,SH2D4A,SH2 domain containing 4A,HGNC:26102,8p21.3
SH3BP5,Approved symbol,SH3BP5,SH3 domain binding protein 5,HGNC:10827,3p25.1
SH3D19,Approved symbol,SH3D19,SH3 domain containing 19,HGNC:30418,4q31.3
SH3GL1,Approved symbol,SH3GL1,"SH3 domain containing GRB2 like 1, endophilin A2",HGNC:10830,19p13.3
SH3GL2,Approved symbol,SH3GL2,"SH3 domain containing GRB2 like 2, endophilin A1",HGNC:10831,9p22.2
SH3KBP1,Approved symbol,SH3KBP1,SH3 domain containing kinase binding protein 1,HGNC:13867,Xp22.12
SH3PXD2B,Approved symbol,SH3PXD2B,SH3 and PX domains 2B,HGNC:29242,5q35.1
SH3TC2,Approved symbol,SH3TC2,SH3 domain and tetratricopeptide repeats 2,HGNC:29427,5q32
SHANK1,Approved symbol,SHANK1,SH3 and multiple ankyrin repeat domains 1,HGNC:15474,19q13.33
SHANK2,Approved symbol,SHANK2,SH3 and multiple ankyrin repeat domains 2,HGNC:14295,11q13.3-q13.4
SHANK3,Approved symbol,SHANK3,SH3 and multiple ankyrin repeat domains 3,HGNC:14294,22q13.33
SHF,Approved symbol,SHF,Src homology 2 domain containing F,HGNC:25116,15q21.1
SHH,Approved symbol,SHH,sonic hedgehog signaling molecule,HGNC:10848,7q36.3
SHISA5,Approved symbol,SHISA5,shisa family member 5,HGNC:30376,3p21.31
SHISA6,Approved symbol,SHISA6,shisa family member 6,HGNC:34491,17p12
SHISA9,Approved symbol,SHISA9,shisa family member 9,HGNC:37231,16p13.12
SHROOM1,Approved symbol,SHROOM1,shroom family member 1,HGNC:24084,5q31.1
SHROOM4,Approved symbol,SHROOM4,shroom family member 4,HGNC:29215,Xp11.22
SI,Approved symbol,SI,sucrase-isomaltase,HGNC:10856,3q26.1
SI,Alias symbol,PMEL,premelanosome protein,HGNC:10880,12q13.2
SIAH3,Approved symbol,SIAH3,siah E3 ubiquitin protein ligase family member 3,HGNC:30553,13q14.13
SIDT1,Approved symbol,SIDT1,SID1 transmembrane family member 1,HGNC:25967,3q13.2
SIDT2,Approved symbol,SIDT2,SID1 transmembrane family member 2,HGNC:24272,11q23.3
SIGLEC1,Approved symbol,SIGLEC1,sialic acid binding Ig like lectin 1,HGNC:11127,20p13
SIGLEC5,Approved symbol,SIGLEC5,sialic acid binding Ig like lectin 5,HGNC:10874,19q13.41
SIK3,Approved symbol,SIK3,SIK family kinase 3,HGNC:29165,11q23.3
SIM2,Approved symbol,SIM2,SIM bHLH transcription factor 2,HGNC:10883,21q22.13
SIPA1,Approved symbol,SIPA1,signal-induced proliferation-associated 1,HGNC:10885,11q13.1
SIPA1L1,Approved symbol,SIPA1L1,signal induced proliferation associated 1 like 1,HGNC:20284,14q24.2
SIPA1L2,Approved symbol,SIPA1L2,signal induced proliferation associated 1 like 2,HGNC:23800,1q42.2
SIRT2,Approved symbol,SIRT2,sirtuin 2,HGNC:10886,19q13.2
SIX4,Approved symbol,SIX4,SIX homeobox 4,HGNC:10890,14q23.1
SIX5,Approved symbol,SIX5,SIX homeobox 5,HGNC:10891,19q13.32
SKA3,Approved symbol,SKA3,spindle and kinetochore associated complex subunit 3,HGNC:20262,13q12.11
SKAP2,Approved symbol,SKAP2,src kinase associated phosphoprotein 2,HGNC:15687,7p15.2
SKI,Approved symbol,SKI,SKI proto-oncogene,HGNC:10896,1p36.33-p36.32
SKI,Alias symbol,HHAT,hedgehog acyltransferase,HGNC:18270,1q32.2
SKIV2L2,Previous symbol,MTREX,Mtr4 exosome RNA helicase,HGNC:18734,5q11.2
SKP2,Approved symbol,SKP2,S-phase kinase associated protein 2,HGNC:10901,5p13.2
SLC10A3,Approved symbol,SLC10A3,solute carrier family 10 member 3,HGNC:22979,Xq28
SLC10A4,Approved symbol,SLC10A4,solute carrier family 10 member 4,HGNC:22980,4p11
SLC11A1,Approved symbol,SLC11A1,solute carrier family 11 member 1,HGNC:10907,2q35
SLC12A1,Approved symbol,SLC12A1,solute carrier family 12 member 1,HGNC:10910,15q21.1
SLC12A5,Approved symbol,SLC12A5,solute carrier family 12 member 5,HGNC:13818,20q13.12
SLC12A8,Approved symbol,SLC12A8,solute carrier family 12 member 8,HGNC:15595,3q21.2
SLC13A3,Approved symbol,SLC13A3,solute carrier family 13 member 3,HGNC:14430,20q13.12
SLC13A4,Approved symbol,SLC13A4,solute carrier family 13 member 4,HGNC:15827,7q33
SLC16A11,Approved symbol,SLC16A11,solute carrier family 16 member 11,HGNC:23093,17p13.1
SLC16A7,Approved symbol,SLC16A7,solute carrier family 16 member 7,HGNC:10928,12q14.1
SLC16A9,Approved symbol,SLC16A9,solute carrier family 16 member 9,HGNC:23520,10q21.2
SLC17A2,Approved symbol,SLC17A2,solute carrier family 17 member 2,HGNC:10930,6p22.2
SLC17A2,Previous symbol,SLC34A1,solute carrier family 34 member 1,HGNC:11019,5q35.3
SLC17A4,Approved symbol,SLC17A4,solute carrier family 17 member 4,HGNC:10932,6p22.2
SLC18A3,Approved symbol,SLC18A3,solute carrier family 18 member A3,HGNC:10936,10q11.23
SLC1A6,Approved symbol,SLC1A6,solute carrier family 1 member 6,HGNC:10944,19p13.12
SLC1A7,Approved symbol,SLC1A7,solute carrier family 1 member 7,HGNC:10945,1p32.3
SLC20A2,Approved symbol,SLC20A2,solute carrier family 20 member 2,HGNC:10947,8p11.21
SLC22A12,Approved symbol,SLC22A12,solute carrier family 22 member 12,HGNC:17989,11q13.1
SLC22A15,Approved symbol,SLC22A15,solute carrier family 22 member 15,HGNC:20301,1p13.1
SLC22A16,Approved symbol,SLC22A16,solute carrier family 22 member 16,HGNC:20302,6q21
SLC22A17,Approved symbol,SLC22A17,solute carrier family 22 member 17,HGNC:23095,14q11.2
SLC22A23,Approved symbol,SLC22A23,solute carrier family 22 member 23,HGNC:21106,6p25.2
SLC22A25,Approved symbol,SLC22A25,solute carrier family 22 member 25,HGNC:32935,11q12.3
SLC22A31,Approved symbol,SLC22A31,solute carrier family 22 member 31,HGNC:27091,16q24.3
SLC22A4,Approved symbol,SLC22A4,solute carrier family 22 member 4,HGNC:10968,5q31.1
SLC22A6,Approved symbol,SLC22A6,solute carrier family 22 member 6,HGNC:10970,11q12.3
SLC24A2,Approved symbol,SLC24A2,solute carrier family 24 member 2,HGNC:10976,9p22.1
SLC24A3,Approved symbol,SLC24A3,solute carrier family 24 member 3,HGNC:10977,20p11.23
SLC25A12,Approved symbol,SLC25A12,solute carrier family 25 member 12,HGNC:10982,2q31.1
SLC25A14,Approved symbol,SLC25A14,solute carrier family 25 member 14,HGNC:10984,Xq26.1
SLC25A16,Approved symbol,SLC25A16,solute carrier family 25 member 16,HGNC:10986,10q21.3
SLC25A20,Approved symbol,SLC25A20,solute carrier family 25 member 20,HGNC:1421,3p21.31
SLC25A26,Approved symbol,SLC25A26,solute carrier family 25 member 26,HGNC:20661,3p14.1
SLC25A39,Approved symbol,SLC25A39,solute carrier family 25 member 39,HGNC:24279,17q21.31
SLC25A41,Approved symbol,SLC25A41,solute carrier family 25 member 41,HGNC:28533,19p13.3
SLC26A11,Approved symbol,SLC26A11,solute carrier family 26 member 11,HGNC:14471,17q25.3
SLC26A8,Approved symbol,SLC26A8,solute carrier family 26 member 8,HGNC:14468,6p21.31
SLC27A1,Approved symbol,SLC27A1,solute carrier family 27 member 1,HGNC:10995,19p13.11
SLC27A3,Approved symbol,SLC27A3,solute carrier family 27 member 3,HGNC:10997,1q21.3
SLC27A4,Approved symbol,SLC27A4,solute carrier family 27 member 4,HGNC:10998,9q34.11
SLC29A1,Approved symbol,SLC29A1,solute carrier family 29 member 1 (Augustine blood group),HGNC:11003,6p21.1
SLC29A4,Approved symbol,SLC29A4,solute carrier family 29 member 4,HGNC:23097,7p22.1
SLC2A1,Approved symbol,SLC2A1,solute carrier family 2 member 1,HGNC:11005,1p34.2
SLC2A13,Approved symbol,SLC2A13,solute carrier family 2 member 13,HGNC:15956,12q12
SLC2A3,Approved symbol,SLC2A3,solute carrier family 2 member 3,HGNC:11007,12p13.31
SLC30A5,Approved symbol,SLC30A5,solute carrier family 30 member 5,HGNC:19089,5q13.1-q13.2
SLC34A1,Approved symbol,SLC34A1,solute carrier family 34 member 1,HGNC:11019,5q35.3
SLC34A3,Approved symbol,SLC34A3,solute carrier family 34 member 3,HGNC:20305,9q34.3
SLC35A1,Approved symbol,SLC35A1,solute carrier family 35 member A1,HGNC:11021,6q15
SLC35A5,Approved symbol,SLC35A5,solute carrier family 35 member A5,HGNC:20792,3q13.2
SLC35B1,Approved symbol,SLC35B1,solute carrier family 35 member B1,HGNC:20798,17q21.33
SLC35D3,Approved symbol,SLC35D3,solute carrier family 35 member D3,HGNC:15621,6q23.3
SLC35F3,Approved symbol,SLC35F3,solute carrier family 35 member F3,HGNC:23616,1q42.2
SLC36A2,Approved symbol,SLC36A2,solute carrier family 36 member 2,HGNC:18762,5q33.1
SLC36A3,Approved symbol,SLC36A3,solute carrier family 36 member 3,HGNC:19659,5q33.1
SLC37A4,Approved symbol,SLC37A4,solute carrier family 37 member 4,HGNC:4061,11q23.3
SLC38A11,Approved symbol,SLC38A11,solute carrier family 38 member 11,HGNC:26836,2q24.3
SLC38A3,Approved symbol,SLC38A3,solute carrier family 38 member 3,HGNC:18044,3p21.31
SLC38A5,Approved symbol,SLC38A5,solute carrier family 38 member 5,HGNC:18070,Xp11.23
SLC38A8,Approved symbol,SLC38A8,solute carrier family 38 member 8,HGNC:32434,16q23.3
SLC39A1,Approved symbol,SLC39A1,solute carrier family 39 member 1,HGNC:12876,1q21.3
SLC39A13,Approved symbol,SLC39A13,solute carrier family 39 member 13,HGNC:20859,11p11.2
SLC39A3,Approved symbol,SLC39A3,solute carrier family 39 member 3,HGNC:17128,19p13.3
SLC39A5,Approved symbol,SLC39A5,solute carrier family 39 member 5,HGNC:20502,12q13.3
SLC39A8,Approved symbol,SLC39A8,solute carrier family 39 member 8,HGNC:20862,4q24
SLC41A3,Approved symbol,SLC41A3,solute carrier family 41 member 3,HGNC:31046,3q21.2-q21.3
SLC43A2,Approved symbol,SLC43A2,solute carrier family 43 member 2,HGNC:23087,17p13.3
SLC44A1,Approved symbol,SLC44A1,solute carrier family 44 member 1,HGNC:18798,9q31.1-q31.2
SLC44A2,Approved symbol,SLC44A2,solute carrier family 44 member 2,HGNC:17292,19p13.2
SLC44A3,Approved symbol,SLC44A3,solute carrier family 44 member 3,HGNC:28689,1p21.3
SLC44A5,Approved symbol,SLC44A5,solute carrier family 44 member 5,HGNC:28524,1p31.1
SLC45A4,Approved symbol,SLC45A4,solute carrier family 45 member 4,HGNC:29196,8q24.3
SLC4A1,Approved symbol,SLC4A1,solute carrier family 4 member 1 (Diego blood group),HGNC:11027,17q21.31
SLC4A11,Approved symbol,SLC4A11,solute carrier family 4 member 11,HGNC:16438,20p13
SLC4A2,Approved symbol,SLC4A2,solute carrier family 4 member 2,HGNC:11028,7q36.1
SLC4A4,Approved symbol,SLC4A4,solute carrier family 4 member 4,HGNC:11030,4q13.3
SLC4A5,Approved symbol,SLC4A5,solute carrier family 4 member 5,HGNC:18168,2p13.1
SLC4A5,Previous symbol,SLC4A4,solute carrier family 4 member 4,HGNC:11030,4q13.3
SLC5A11,Approved symbol,SLC5A11,solute carrier family 5 member 11,HGNC:23091,16p12.1
SLC5A3,Approved symbol,SLC5A3,solute carrier family 5 member 3,HGNC:11038,21q22.11
SLC5A4,Approved symbol,SLC5A4,solute carrier family 5 member 4,HGNC:11039,22q12.3
SLC5A5,Approved symbol,SLC5A5,solute carrier family 5 member 5,HGNC:11040,19p13.11
SLC6A12,Approved symbol,SLC6A12,solute carrier family 6 member 12,HGNC:11045,12p13.33
SLC6A13,Approved symbol,SLC6A13,solute carrier family 6 member 13,HGNC:11046,12p13.33
SLC6A15,Approved symbol,SLC6A15,solute carrier family 6 member 15,HGNC:13621,12q21.31
SLC6A16,Approved symbol,SLC6A16,solute carrier family 6 member 16,HGNC:13622,19q13.33
SLC7A11,Approved symbol,SLC7A11,solute carrier family 7 member 11,HGNC:11059,4q28.3
SLC7A2,Approved symbol,SLC7A2,solute carrier family 7 member 2,HGNC:11060,8p22
SLC7A3,Approved symbol,SLC7A3,solute carrier family 7 member 3,HGNC:11061,Xq13.1
SLC7A4,Approved symbol,SLC7A4,solute carrier family 7 member 4,HGNC:11062,22q11.21
SLC7A9,Approved symbol,SLC7A9,solute carrier family 7 member 9,HGNC:11067,19q13.11
SLC8A1,Approved symbol,SLC8A1,solute carrier family 8 member A1,HGNC:11068,2p22.1
SLC8A2,Approved symbol,SLC8A2,solute carrier family 8 member A2,HGNC:11069,19q13.32
SLC8A3,Approved symbol,SLC8A3,solute carrier family 8 member A3,HGNC:11070,14q24.2
SLC9A1,Approved symbol,SLC9A1,solute carrier family 9 member A1,HGNC:11071,1p36.11
SLC9A2,Approved symbol,SLC9A2,solute carrier family 9 member A2,HGNC:11072,2q12.1
SLC9A5,Approved symbol,SLC9A5,solute carrier family 9 member A5,HGNC:11078,16q22.1
SLC9A6,Approved symbol,SLC9A6,solute carrier family 9 member A6,HGNC:11079,Xq26.3
SLC9A7,Approved symbol,SLC9A7,solute carrier family 9 member A7,HGNC:17123,Xp11.3
SLC9B2,Approved symbol,SLC9B2,solute carrier family 9 member B2,HGNC:25143,4q24
SLCO1A2,Approved symbol,SLCO1A2,solute carrier organic anion transporter family member 1A2,HGNC:10956,12p12.1
SLCO1B1,Approved symbol,SLCO1B1,solute carrier organic anion transporter family member 1B1,HGNC:10959,12p12.1
SLCO1B3,Approved symbol,SLCO1B3,solute carrier organic anion transporter family member 1B3,HGNC:10961,12p12.2
SLCO1B7,Approved symbol,SLCO1B7,solute carrier organic anion transporter family member 1B7 (putative),HGNC:32934,12p12.2
SLCO1C1,Approved symbol,SLCO1C1,solute carrier organic anion transporter family member 1C1,HGNC:13819,12p12.2
SLCO2A1,Approved symbol,SLCO2A1,solute carrier organic anion transporter family member 2A1,HGNC:10955,3q22.1-q22.2
SLCO3A1,Approved symbol,SLCO3A1,solute carrier organic anion transporter family member 3A1,HGNC:10952,15q26.1
SLCO5A1,Approved symbol,SLCO5A1,solute carrier organic anion transporter family member 5A1,HGNC:19046,8q13.3
SLCO6A1,Approved symbol,SLCO6A1,solute carrier organic anion transporter family member 6A1,HGNC:23613,5q21.1
SLFN12,Approved symbol,SLFN12,schlafen family member 12,HGNC:25500,17q12
SLFN14,Approved symbol,SLFN14,schlafen family member 14,HGNC:32689,17q12
SLIT1,Approved symbol,SLIT1,slit guidance ligand 1,HGNC:11085,10q24.1
SLIT1,Alias symbol,SLIT3,slit guidance ligand 3,HGNC:11087,5q34-q35.1
SLIT2,Approved symbol,SLIT2,slit guidance ligand 2,HGNC:11086,4p15.31
SLIT2,Alias symbol,SLIT3,slit guidance ligand 3,HGNC:11087,5q34-q35.1
SLIT3,Approved symbol,SLIT3,slit guidance ligand 3,HGNC:11087,5q34-q35.1
SLIT3,Alias symbol,SLIT1,slit guidance ligand 1,HGNC:11085,10q24.1
SLITRK1,Approved symbol,SLITRK1,SLIT and NTRK like family member 1,HGNC:20297,13q31.1
SLITRK2,Approved symbol,SLITRK2,SLIT and NTRK like family member 2,HGNC:13449,Xq27.3
SLITRK4,Approved symbol,SLITRK4,SLIT and NTRK like family member 4,HGNC:23502,Xq27.3
SLITRK5,Approved symbol,SLITRK5,SLIT and NTRK like family member 5,HGNC:20295,13q31.2
SLMAP,Approved symbol,SLMAP,sarcolemma associated protein,HGNC:16643,3p14.3
SMAD4,Approved symbol,SMAD4,SMAD family member 4,HGNC:6770,18q21.2
SMAD6,Approved symbol,SMAD6,SMAD family member 6,HGNC:6772,15q22.31
SMAD9,Approved symbol,SMAD9,SMAD family member 9,HGNC:6774,13q13.3
SMAP1,Approved symbol,SMAP1,small ArfGAP 1,HGNC:19651,6q13
SMARCA2,Approved symbol,SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",HGNC:11098,9p24.3
SMARCA4,Approved symbol,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",HGNC:11100,19p13.2
SMARCB1,Approved symbol,SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",HGNC:11103,22q11.23
SMARCC1,Approved symbol,SMARCC1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1",HGNC:11104,3p21.31
SMARCE1,Approved symbol,SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",HGNC:11109,17q21.2
SMC1A,Approved symbol,SMC1A,structural maintenance of chromosomes 1A,HGNC:11111,Xp11.22
SMC1B,Approved symbol,SMC1B,structural maintenance of chromosomes 1B,HGNC:11112,22q13.31
SMC2,Approved symbol,SMC2,structural maintenance of chromosomes 2,HGNC:14011,9q31.1
SMC6,Approved symbol,SMC6,structural maintenance of chromosomes 6,HGNC:20466,2p24.2
SMCHD1,Approved symbol,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,HGNC:29090,18p11.32
SMCO4,Approved symbol,SMCO4,single-pass membrane protein with coiled-coil domains 4,HGNC:24810,11q21
SMDT1,Approved symbol,SMDT1,single-pass membrane protein with aspartate rich tail 1,HGNC:25055,22q13.2
SMEK1,Previous symbol,PPP4R3A,protein phosphatase 4 regulatory subunit 3A,HGNC:20219,14q32.12
SMG1,Approved symbol,SMG1,SMG1 nonsense mediated mRNA decay associated PI3K related kinase,HGNC:30045,16p12.3
SMG7,Approved symbol,SMG7,SMG7 nonsense mediated mRNA decay factor,HGNC:16792,1q25.3
SMNDC1,Approved symbol,SMNDC1,survival motor neuron domain containing 1,HGNC:16900,10q25.2
SMOC1,Approved symbol,SMOC1,SPARC related modular calcium binding 1,HGNC:20318,14q24.1
SMPD1,Approved symbol,SMPD1,sphingomyelin phosphodiesterase 1,HGNC:11120,11p15.4
SMPD4,Approved symbol,SMPD4,sphingomyelin phosphodiesterase 4,HGNC:32949,2q21.1
SMPDL3B,Approved symbol,SMPDL3B,sphingomyelin phosphodiesterase acid like 3B,HGNC:21416,1p35.3
SMTN,Approved symbol,SMTN,smoothelin,HGNC:11126,22q12.2
SMTNL1,Approved symbol,SMTNL1,smoothelin like 1,HGNC:32394,11q12.1
SMU1,Approved symbol,SMU1,SMU1 DNA replication regulator and spliceosomal factor,HGNC:18247,9p21.1
SMURF1,Approved symbol,SMURF1,SMAD specific E3 ubiquitin protein ligase 1,HGNC:16807,7q22.1
SMURF2,Approved symbol,SMURF2,SMAD specific E3 ubiquitin protein ligase 2,HGNC:16809,17q23.3-q24.1
SMYD1,Approved symbol,SMYD1,SET and MYND domain containing 1,HGNC:20986,2p11.2
SNAP47,Approved symbol,SNAP47,synaptosome associated protein 47,HGNC:30669,1q42.13
SNAPC4,Approved symbol,SNAPC4,small nuclear RNA activating complex polypeptide 4,HGNC:11137,9q34.3
SNCAIP,Approved symbol,SNCAIP,synuclein alpha interacting protein,HGNC:11139,5q23.2
SND1,Approved symbol,SND1,staphylococcal nuclease and tudor domain containing 1,HGNC:30646,7q32.1
SNPH,Approved symbol,SNPH,syntaphilin,HGNC:15931,20p13
SNRK,Approved symbol,SNRK,SNF related kinase,HGNC:30598,3p22.1
SNTA1,Approved symbol,SNTA1,syntrophin alpha 1,HGNC:11167,20q11.21
SNTG2,Approved symbol,SNTG2,syntrophin gamma 2,HGNC:13741,2p25.3
SNUPN,Approved symbol,SNUPN,snurportin 1,HGNC:14245,15q24.2
SNX21,Approved symbol,SNX21,sorting nexin family member 21,HGNC:16154,20q13.12
SNX29,Approved symbol,SNX29,sorting nexin 29,HGNC:30542,16p13.13-p13.12
SOCS6,Approved symbol,SOCS6,suppressor of cytokine signaling 6,HGNC:16833,18q22.2
SOD1,Approved symbol,SOD1,superoxide dismutase 1,HGNC:11179,21q22.11
SOD3,Approved symbol,SOD3,superoxide dismutase 3,HGNC:11181,4p15.2
SOGA1,Approved symbol,SOGA1,"suppressor of glucose, autophagy associated 1",HGNC:16111,20q11.23
SOGA2,Previous symbol,MTCL1,microtubule crosslinking factor 1,HGNC:29121,18p11.22
SOGA3,Approved symbol,SOGA3,SOGA family member 3,HGNC:21494,6q22.33
SORBS1,Approved symbol,SORBS1,sorbin and SH3 domain containing 1,HGNC:14565,10q24.1
SORBS3,Approved symbol,SORBS3,sorbin and SH3 domain containing 3,HGNC:30907,8p21.3
SORCS1,Approved symbol,SORCS1,sortilin related VPS10 domain containing receptor 1,HGNC:16697,10q25.1
SORD,Approved symbol,SORD,sorbitol dehydrogenase,HGNC:11184,15q21.1
SORL1,Approved symbol,SORL1,sortilin related receptor 1,HGNC:11185,11q24.1
SOS1,Approved symbol,SOS1,SOS Ras/Rac guanine nucleotide exchange factor 1,HGNC:11187,2p22.1
SOS2,Approved symbol,SOS2,SOS Ras/Rho guanine nucleotide exchange factor 2,HGNC:11188,14q21.3
SOX12,Approved symbol,SOX12,SRY-box transcription factor 12,HGNC:11198,20p13
SOX15,Approved symbol,SOX15,SRY-box transcription factor 15,HGNC:11196,17p13.1
SOX3,Approved symbol,SOX3,SRY-box transcription factor 3,HGNC:11199,Xq27.1
SOX6,Approved symbol,SOX6,SRY-box transcription factor 6,HGNC:16421,11p15.2
SOX9,Approved symbol,SOX9,SRY-box transcription factor 9,HGNC:11204,17q24.3
SP140L,Approved symbol,SP140L,SP140 nuclear body protein like,HGNC:25105,2q37.1
SP2,Approved symbol,SP2,Sp2 transcription factor,HGNC:11207,17q21.32
SP6,Approved symbol,SP6,Sp6 transcription factor,HGNC:14530,17q21.32
SPACA1,Approved symbol,SPACA1,sperm acrosome associated 1,HGNC:14967,6q15
SPAG1,Approved symbol,SPAG1,sperm associated antigen 1,HGNC:11212,8q22.2
SPAG17,Approved symbol,SPAG17,sperm associated antigen 17,HGNC:26620,1p12
SPAG4,Approved symbol,SPAG4,sperm associated antigen 4,HGNC:11214,20q11.22
SPAG8,Approved symbol,SPAG8,sperm associated antigen 8,HGNC:14105,9p13.3
SPAG9,Approved symbol,SPAG9,sperm associated antigen 9,HGNC:14524,17q21.33
SPANXN3,Approved symbol,SPANXN3,SPANX family member N3,HGNC:33176,Xq27.3
SPARCL1,Approved symbol,SPARCL1,SPARC like 1,HGNC:11220,4q22.1
SPATA17,Approved symbol,SPATA17,spermatogenesis associated 17,HGNC:25184,1q41
SPATA19,Approved symbol,SPATA19,spermatogenesis associated 19,HGNC:30614,11q25
SPATA20,Approved symbol,SPATA20,spermatogenesis associated 20,HGNC:26125,17q21.33
SPATA31C2,Approved symbol,SPATA31C2,SPATA31 subfamily C member 2,HGNC:24508,9q22.1
SPATA31D1,Approved symbol,SPATA31D1,SPATA31 subfamily D member 1,HGNC:37283,9q21.32
SPATC1,Approved symbol,SPATC1,spermatogenesis and centriole associated 1,HGNC:30510,8q24.3
SPECC1L,Approved symbol,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1 like,HGNC:29022,22q11.23
SPEF2,Approved symbol,SPEF2,sperm flagellar 2,HGNC:26293,5p13.2
SPEG,Approved symbol,SPEG,striated muscle enriched protein kinase,HGNC:16901,2q35
SPEN,Approved symbol,SPEN,spen family transcriptional repressor,HGNC:17575,1p36.21-p36.13
SPERT,Previous symbol,CBY2,chibby family member 2,HGNC:30720,13q14.13
SPG11,Approved symbol,SPG11,"SPG11 vesicle trafficking associated, spatacsin",HGNC:11226,15q21.1
SPG7,Approved symbol,SPG7,"SPG7 matrix AAA peptidase subunit, paraplegin",HGNC:11237,16q24.3
SPHKAP,Approved symbol,SPHKAP,"SPHK1 interactor, AKAP domain containing",HGNC:30619,2q36.3
SPICE1,Approved symbol,SPICE1,spindle and centriole associated protein 1,HGNC:25083,3q13.2
SPINK5,Approved symbol,SPINK5,serine peptidase inhibitor Kazal type 5,HGNC:15464,5q32
SPINT4,Approved symbol,SPINT4,"serine peptidase inhibitor, Kunitz type 4",HGNC:16130,20q13.12
SPIRE2,Approved symbol,SPIRE2,spire type actin nucleation factor 2,HGNC:30623,16q24.3
SPOCD1,Approved symbol,SPOCD1,SPOC domain containing 1,HGNC:26338,1p35.2
SPOCK1,Approved symbol,SPOCK1,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1",HGNC:11251,5q31.2
SPOCK2,Approved symbol,SPOCK2,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2",HGNC:13564,10q22.1
SPON2,Approved symbol,SPON2,spondin 2,HGNC:11253,4p16.3
SPPL2A,Approved symbol,SPPL2A,signal peptide peptidase like 2A,HGNC:30227,15q21.2
SPSB3,Approved symbol,SPSB3,splA/ryanodine receptor domain and SOCS box containing 3,HGNC:30629,16p13.3
SPTA1,Approved symbol,SPTA1,"spectrin alpha, erythrocytic 1",HGNC:11272,1q23.1
SPTAN1,Approved symbol,SPTAN1,"spectrin alpha, non-erythrocytic 1",HGNC:11273,9q34.11
SPTB,Approved symbol,SPTB,"spectrin beta, erythrocytic",HGNC:11274,14q23.3
SPTBN4,Approved symbol,SPTBN4,"spectrin beta, non-erythrocytic 4",HGNC:14896,19q13.2
SPTBN5,Approved symbol,SPTBN5,"spectrin beta, non-erythrocytic 5",HGNC:15680,15q21
SPTLC1,Approved symbol,SPTLC1,serine palmitoyltransferase long chain base subunit 1,HGNC:11277,9q22.31
SRBD1,Approved symbol,SRBD1,S1 RNA binding domain 1,HGNC:25521,2p21
SREK1,Approved symbol,SREK1,splicing regulatory glutamic acid and lysine rich protein 1,HGNC:17882,5q12.3
SRFBP1,Approved symbol,SRFBP1,serum response factor binding protein 1,HGNC:26333,5q23.1
SRGAP3,Approved symbol,SRGAP3,SLIT-ROBO Rho GTPase activating protein 3,HGNC:19744,3p25.3
SRPK2,Approved symbol,SRPK2,SRSF protein kinase 2,HGNC:11306,7q22.3
SRRM2,Approved symbol,SRRM2,serine/arginine repetitive matrix 2,HGNC:16639,16p13.3
SRRM4,Approved symbol,SRRM4,serine/arginine repetitive matrix 4,HGNC:29389,12q24.23
SRRM5,Approved symbol,SRRM5,serine/arginine repetitive matrix 5,HGNC:37248,19q13.31
SRRT,Approved symbol,SRRT,"serrate, RNA effector molecule",HGNC:24101,7q22.1
SRSF2,Approved symbol,SRSF2,serine and arginine rich splicing factor 2,HGNC:10783,17q25.2
SSBP2,Approved symbol,SSBP2,single stranded DNA binding protein 2,HGNC:15831,5q14.1
SSH2,Approved symbol,SSH2,slingshot protein phosphatase 2,HGNC:30580,17q11.2
SSPO,Previous symbol,SSPOP,"SCO-spondin, pseudogene",HGNC:21998,7q36.1
SSTR1,Approved symbol,SSTR1,somatostatin receptor 1,HGNC:11330,14q13
SSTR2,Approved symbol,SSTR2,somatostatin receptor 2,HGNC:11331,17q25.1
SSTR4,Approved symbol,SSTR4,somatostatin receptor 4,HGNC:11333,20p11.21
SSX7,Approved symbol,SSX7,SSX family member 7,HGNC:19653,Xp11.22
ST14,Approved symbol,ST14,ST14 transmembrane serine protease matriptase,HGNC:11344,11q24.3
ST18,Approved symbol,ST18,ST18 C2H2C-type zinc finger transcription factor,HGNC:18695,8q11.23
ST3GAL5,Approved symbol,ST3GAL5,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5",HGNC:10872,2p11.2
ST5,Previous symbol,DENND2B,DENN domain containing 2B,HGNC:11350,11p15.4
ST6GAL2,Approved symbol,ST6GAL2,"ST6 beta-galactoside alpha-2,6-sialyltransferase 2",HGNC:10861,2q12.3
ST6GALNAC3,Approved symbol,ST6GALNAC3,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3",HGNC:19343,1p31.1
ST6GALNAC5,Approved symbol,ST6GALNAC5,"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5",HGNC:19342,1p31.1
ST8SIA2,Approved symbol,ST8SIA2,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",HGNC:10870,15q26.1
ST8SIA3,Approved symbol,ST8SIA3,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3",HGNC:14269,18q21.31
ST8SIA4,Approved symbol,ST8SIA4,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4",HGNC:10871,5q21.1
ST8SIA5,Approved symbol,ST8SIA5,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5",HGNC:17827,18q21.1
ST8SIA6,Approved symbol,ST8SIA6,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6",HGNC:23317,10p12.33
STAG2,Approved symbol,STAG2,stromal antigen 2,HGNC:11355,Xq25
STAP2,Approved symbol,STAP2,signal transducing adaptor family member 2,HGNC:30430,19p13.3
STARD10,Approved symbol,STARD10,StAR related lipid transfer domain containing 10,HGNC:10666,11q13.4
STARD8,Approved symbol,STARD8,StAR related lipid transfer domain containing 8,HGNC:19161,Xq13.1
STAT5B,Approved symbol,STAT5B,signal transducer and activator of transcription 5B,HGNC:11367,17q21.2
STAU1,Approved symbol,STAU1,staufen double-stranded RNA binding protein 1,HGNC:11370,20q13.13
STAU2,Approved symbol,STAU2,staufen double-stranded RNA binding protein 2,HGNC:11371,8q21.11
STIL,Approved symbol,STIL,STIL centriolar assembly protein,HGNC:10879,1p33
STK10,Approved symbol,STK10,serine/threonine kinase 10,HGNC:11388,5q35.1
STK11,Approved symbol,STK11,serine/threonine kinase 11,HGNC:11389,19p13.3
STK24-AS1,Approved symbol,STK24-AS1,STK24 antisense RNA 1,HGNC:39935,13q32.2
STK32B,Approved symbol,STK32B,serine/threonine kinase 32B,HGNC:14217,4p16.2
STMN2,Approved symbol,STMN2,stathmin 2,HGNC:10577,8q21.13
STOML2,Approved symbol,STOML2,stomatin like 2,HGNC:14559,9p13.3
STOML3,Approved symbol,STOML3,stomatin like 3,HGNC:19420,13q13.2
STOX2,Approved symbol,STOX2,storkhead box 2,HGNC:25450,4q35.1
STRA6,Approved symbol,STRA6,signaling receptor and transporter of retinol STRA6,HGNC:30650,15q24.1
STRA8,Approved symbol,STRA8,stimulated by retinoic acid 8,HGNC:30653,7q33
STRADB,Approved symbol,STRADB,STE20 related adaptor beta,HGNC:13205,2q33.1
STRBP,Approved symbol,STRBP,spermatid perinuclear RNA binding protein,HGNC:16462,9q33.1-q33.3
STRN4,Approved symbol,STRN4,striatin 4,HGNC:15721,19q13.32
STT3B,Approved symbol,STT3B,STT3 oligosaccharyltransferase complex catalytic subunit B,HGNC:30611,3p23
STUB1,Approved symbol,STUB1,STIP1 homology and U-box containing protein 1,HGNC:11427,16p13.3
STX5,Approved symbol,STX5,syntaxin 5,HGNC:11440,11q12.3
STXBP2,Approved symbol,STXBP2,syntaxin binding protein 2,HGNC:11445,19p13.2
SUGP1,Approved symbol,SUGP1,SURP and G-patch domain containing 1,HGNC:18643,19p13.11
SULF1,Approved symbol,SULF1,sulfatase 1,HGNC:20391,8q13.2-q13.3
SULF2,Approved symbol,SULF2,sulfatase 2,HGNC:20392,20q13.12
SULT1A1,Approved symbol,SULT1A1,sulfotransferase family 1A member 1,HGNC:11453,16p11.2
SUN2,Approved symbol,SUN2,Sad1 and UNC84 domain containing 2,HGNC:14210,22q13.1
SUN5,Approved symbol,SUN5,Sad1 and UNC84 domain containing 5,HGNC:16252,20q11.21
SUPT16H,Approved symbol,SUPT16H,"SPT16 homolog, facilitates chromatin remodeling subunit",HGNC:11465,14q11.2
SUPT3H,Approved symbol,SUPT3H,"SPT3 homolog, SAGA and STAGA complex component",HGNC:11466,6p21.1
SUPT6H,Approved symbol,SUPT6H,"SPT6 homolog, histone chaperone and transcription elongation factor",HGNC:11470,17q11.2
SUSD3,Approved symbol,SUSD3,sushi domain containing 3,HGNC:28391,9q22.31
SUSD5,Approved symbol,SUSD5,sushi domain containing 5,HGNC:29061,3p22.3
SV2A,Approved symbol,SV2A,synaptic vesicle glycoprotein 2A,HGNC:20566,1q21.2
SV2B,Approved symbol,SV2B,synaptic vesicle glycoprotein 2B,HGNC:16874,15q26.1
SVEP1,Approved symbol,SVEP1,"sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1",HGNC:15985,9q31.3
SVIL,Approved symbol,SVIL,supervillin,HGNC:11480,10p11.23
SYBU,Approved symbol,SYBU,syntabulin,HGNC:26011,8q23.2
SYCP1,Approved symbol,SYCP1,synaptonemal complex protein 1,HGNC:11487,1p13.2
SYCP2L,Approved symbol,SYCP2L,synaptonemal complex protein 2 like,HGNC:21537,6p24.2
SYN1,Approved symbol,SYN1,synapsin I,HGNC:11494,Xp11.3-p11.23
SYNC,Approved symbol,SYNC,"syncoilin, intermediate filament protein",HGNC:28897,1p35.1
SYNE1,Approved symbol,SYNE1,spectrin repeat containing nuclear envelope protein 1,HGNC:17089,6q25.2
SYNGR2,Approved symbol,SYNGR2,synaptogyrin 2,HGNC:11499,17q25.3
SYNPO2L,Approved symbol,SYNPO2L,synaptopodin 2 like,HGNC:23532,10q22.2
SYNPR,Approved symbol,SYNPR,synaptoporin,HGNC:16507,3p14.2
SYPL2,Approved symbol,SYPL2,synaptophysin like 2,HGNC:27638,1p13.3
SYS1-DBNDD2,Approved symbol,SYS1-DBNDD2,SYS1-DBNDD2 readthrough (NMD candidate),HGNC:33535,20q13.12
SYT16,Approved symbol,SYT16,synaptotagmin 16,HGNC:23142,14q23.2
SYT3,Approved symbol,SYT3,synaptotagmin 3,HGNC:11511,19q13.33
SYT7,Approved symbol,SYT7,synaptotagmin 7,HGNC:11514,11q12.2
SYTL1,Approved symbol,SYTL1,synaptotagmin like 1,HGNC:15584,1p36.11
SYTL2,Approved symbol,SYTL2,synaptotagmin like 2,HGNC:15585,11q14.1
SYTL5,Approved symbol,SYTL5,synaptotagmin like 5,HGNC:15589,Xp11.4
T,Previous symbol,TBXT,T-box transcription factor T,HGNC:11515,6q27
TACC2,Approved symbol,TACC2,transforming acidic coiled-coil containing protein 2,HGNC:11523,10q26.13
TACR1,Approved symbol,TACR1,tachykinin receptor 1,HGNC:11526,2p12
TAF10,Approved symbol,TAF10,TATA-box binding protein associated factor 10,HGNC:11543,11p15.4
TAF1D,Approved symbol,TAF1D,"TATA-box binding protein associated factor, RNA polymerase I subunit D",HGNC:28759,11q21
TAF3,Approved symbol,TAF3,TATA-box binding protein associated factor 3,HGNC:17303,10p14
TAF5L,Approved symbol,TAF5L,TATA-box binding protein associated factor 5 like,HGNC:17304,1q42.13
TAF9,Approved symbol,TAF9,TATA-box binding protein associated factor 9,HGNC:11542,5q13.2
TAF9B,Approved symbol,TAF9B,TATA-box binding protein associated factor 9b,HGNC:17306,Xq21.1
TAGAP,Approved symbol,TAGAP,T cell activation RhoGTPase activating protein,HGNC:15669,6q25.3
TAGLN,Approved symbol,TAGLN,transgelin,HGNC:11553,11q23.3
TAL1,Approved symbol,TAL1,"TAL bHLH transcription factor 1, erythroid differentiation factor",HGNC:11556,1p33
TALDO1,Approved symbol,TALDO1,transaldolase 1,HGNC:11559,11p15.5
TANC2,Approved symbol,TANC2,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2",HGNC:30212,17q23.2-q23.3
TANGO6,Approved symbol,TANGO6,transport and golgi organization 6 homolog,HGNC:25749,16q22.1
TAOK2,Approved symbol,TAOK2,TAO kinase 2,HGNC:16835,16p11.2
TARM1,Approved symbol,TARM1,"T cell-interacting, activating receptor on myeloid cells 1",HGNC:37250,19q13.42
TARS,Previous symbol,TARS1,threonyl-tRNA synthetase 1,HGNC:11572,5p13.3
TAS2R9,Approved symbol,TAS2R9,taste 2 receptor member 9,HGNC:14917,12p13.2
TATDN1,Approved symbol,TATDN1,TatD DNase domain containing 1,HGNC:24220,8q24.13
TAX1BP1,Approved symbol,TAX1BP1,Tax1 binding protein 1,HGNC:11575,7p15.2
TBC1D1,Approved symbol,TBC1D1,TBC1 domain family member 1,HGNC:11578,4p14
TBC1D10B,Approved symbol,TBC1D10B,TBC1 domain family member 10B,HGNC:24510,16p11.2
TBC1D24,Approved symbol,TBC1D24,TBC1 domain family member 24,HGNC:29203,16p13.3
TBC1D2B,Approved symbol,TBC1D2B,TBC1 domain family member 2B,HGNC:29183,15q24.3-q25.1
TBC1D5,Approved symbol,TBC1D5,TBC1 domain family member 5,HGNC:19166,3p24.3
TBC1D8B,Approved symbol,TBC1D8B,TBC1 domain family member 8B,HGNC:24715,Xq22.3
TBC1D9,Approved symbol,TBC1D9,TBC1 domain family member 9,HGNC:21710,4q31.21
TBCD,Approved symbol,TBCD,tubulin folding cofactor D,HGNC:11581,17q25.3
TBCK,Approved symbol,TBCK,TBC1 domain containing kinase,HGNC:28261,4q24
TBK1,Approved symbol,TBK1,TANK binding kinase 1,HGNC:11584,12q14.2
TBL1X,Approved symbol,TBL1X,transducin beta like 1 X-linked,HGNC:11585,Xp22.31-p22.2
TBX2,Approved symbol,TBX2,T-box transcription factor 2,HGNC:11597,17q23.2
TBX22,Approved symbol,TBX22,T-box transcription factor 22,HGNC:11600,Xq21.1
TBX5,Approved symbol,TBX5,T-box transcription factor 5,HGNC:11604,12q24.21
TCEB3,Previous symbol,ELOA,elongin A,HGNC:11620,1p36.11
TCERG1,Approved symbol,TCERG1,transcription elongation regulator 1,HGNC:15630,5q32
TCF19,Approved symbol,TCF19,transcription factor 19,HGNC:11629,6p21.33
TCF7L2,Approved symbol,TCF7L2,transcription factor 7 like 2,HGNC:11641,10q25.2-q25.3
TCIRG1,Approved symbol,TCIRG1,"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3",HGNC:11647,11q13.2
TCP10,Previous symbol,TCP10L3,"t-complex 10 like 3, pseudogene",HGNC:11656,6q27
TCTE1,Approved symbol,TCTE1,t-complex-associated-testis-expressed 1,HGNC:11693,6p21.1
TCTN2,Approved symbol,TCTN2,tectonic family member 2,HGNC:25774,12q24.31
TDP2,Approved symbol,TDP2,tyrosyl-DNA phosphodiesterase 2,HGNC:17768,6p22.3
TDRD5,Approved symbol,TDRD5,tudor domain containing 5,HGNC:20614,1q25.2
TEAD4,Approved symbol,TEAD4,TEA domain transcription factor 4,HGNC:11717,12p13.33
TECPR1,Approved symbol,TECPR1,tectonin beta-propeller repeat containing 1,HGNC:22214,7q21.3
TECRL,Approved symbol,TECRL,"trans-2,3-enoyl-CoA reductase like",HGNC:27365,4q13.1
TECTA,Approved symbol,TECTA,tectorin alpha,HGNC:11720,11q23.3
TEK,Approved symbol,TEK,TEK receptor tyrosine kinase,HGNC:11724,9p21.2
TEKT2,Approved symbol,TEKT2,tektin 2,HGNC:11725,1p34.3
TENM1,Approved symbol,TENM1,teneurin transmembrane protein 1,HGNC:8117,Xq25
TENM2,Approved symbol,TENM2,teneurin transmembrane protein 2,HGNC:29943,5q34
TENM3,Approved symbol,TENM3,teneurin transmembrane protein 3,HGNC:29944,4q34.3-q35.1
TENM4,Approved symbol,TENM4,teneurin transmembrane protein 4,HGNC:29945,11q14.1
TEP1,Approved symbol,TEP1,telomerase associated protein 1,HGNC:11726,14q11.2
TEP1,Alias symbol,PTEN,phosphatase and tensin homolog,HGNC:9588,10q23.31
TESK1,Approved symbol,TESK1,testis associated actin remodelling kinase 1,HGNC:11731,9p13.3
TESK2,Approved symbol,TESK2,testis associated actin remodelling kinase 2,HGNC:11732,1p34.1
TET2,Approved symbol,TET2,tet methylcytosine dioxygenase 2,HGNC:25941,4q24
TET3,Approved symbol,TET3,tet methylcytosine dioxygenase 3,HGNC:28313,2p13.1
TEX14,Approved symbol,TEX14,"testis expressed 14, intercellular bridge forming factor",HGNC:11737,17q22
TEX15,Approved symbol,TEX15,"testis expressed 15, meiosis and synapsis associated",HGNC:11738,8p12
TFAP2A,Approved symbol,TFAP2A,transcription factor AP-2 alpha,HGNC:11742,6p24.3
TFAP2B,Approved symbol,TFAP2B,transcription factor AP-2 beta,HGNC:11743,6p12.3
TFAP2E,Approved symbol,TFAP2E,transcription factor AP-2 epsilon,HGNC:30774,1p34.3
TFEB,Approved symbol,TFEB,transcription factor EB,HGNC:11753,6p21.1
TFPT,Approved symbol,TFPT,TCF3 fusion partner,HGNC:13630,19q13.42
TFR2,Approved symbol,TFR2,transferrin receptor 2,HGNC:11762,7q22.1
TG,Approved symbol,TG,thyroglobulin,HGNC:11764,8q24.22
TGFBR1,Approved symbol,TGFBR1,transforming growth factor beta receptor 1,HGNC:11772,9q22.33
TGFBRAP1,Approved symbol,TGFBRAP1,transforming growth factor beta receptor associated protein 1,HGNC:16836,2q12.1-q12.2
TGIF1,Approved symbol,TGIF1,TGFB induced factor homeobox 1,HGNC:11776,18p11.31
TGIF2LY,Approved symbol,TGIF2LY,TGFB induced factor homeobox 2 like Y-linked,HGNC:18569,Yp11.2
TGM3,Approved symbol,TGM3,transglutaminase 3,HGNC:11779,20p13
TGM4,Approved symbol,TGM4,transglutaminase 4,HGNC:11780,3p21.31
TGM5,Approved symbol,TGM5,transglutaminase 5,HGNC:11781,15q15.2
TGS1,Approved symbol,TGS1,trimethylguanosine synthase 1,HGNC:17843,8q12.1
THADA,Approved symbol,THADA,THADA armadillo repeat containing,HGNC:19217,2p21
THAP4,Approved symbol,THAP4,THAP domain containing 4,HGNC:23187,2q37.3
THAP5,Approved symbol,THAP5,THAP domain containing 5,HGNC:23188,7q31.1
THAP6,Approved symbol,THAP6,THAP domain containing 6,HGNC:23189,4q21.1
THAP8,Approved symbol,THAP8,THAP domain containing 8,HGNC:23191,19q13.12
THEG,Approved symbol,THEG,theg spermatid protein,HGNC:13706,19p13.3
THEMIS2,Approved symbol,THEMIS2,thymocyte selection associated family member 2,HGNC:16839,1p35.3
THNSL2,Approved symbol,THNSL2,threonine synthase like 2,HGNC:25602,2p11.2
THOC5,Approved symbol,THOC5,THO complex 5,HGNC:19074,22q12.2
THOC6,Approved symbol,THOC6,THO complex 6,HGNC:28369,16p13.3
THOP1,Approved symbol,THOP1,thimet oligopeptidase 1,HGNC:11793,19p13.3
THSD7A,Approved symbol,THSD7A,thrombospondin type 1 domain containing 7A,HGNC:22207,7p21.3
THSD7B,Approved symbol,THSD7B,thrombospondin type 1 domain containing 7B,HGNC:29348,2q22.1
TIAM1,Approved symbol,TIAM1,TIAM Rac1 associated GEF 1,HGNC:11805,21q22.11
TIAM2,Approved symbol,TIAM2,TIAM Rac1 associated GEF 2,HGNC:11806,6q25.2-q25.3
TICRR,Approved symbol,TICRR,TOPBP1 interacting checkpoint and replication regulator,HGNC:28704,15q26.1
TIE1,Approved symbol,TIE1,tyrosine kinase with immunoglobulin like and EGF like domains 1,HGNC:11809,1p34.2
TIGD2,Approved symbol,TIGD2,tigger transposable element derived 2,HGNC:18333,4q22.1
TIGD3,Approved symbol,TIGD3,tigger transposable element derived 3,HGNC:18334,11q13.1
TIGD7,Approved symbol,TIGD7,tigger transposable element derived 7,HGNC:18331,16p13.3
TIMM21,Approved symbol,TIMM21,translocase of inner mitochondrial membrane 21,HGNC:25010,18q22.3
TIMMDC1,Approved symbol,TIMMDC1,translocase of inner mitochondrial membrane domain containing 1,HGNC:1321,3q13.33
TIRAP,Approved symbol,TIRAP,TIR domain containing adaptor protein,HGNC:17192,11q24.2
TJP1,Approved symbol,TJP1,tight junction protein 1,HGNC:11827,15q13.1
TLCD2,Approved symbol,TLCD2,TLC domain containing 2,HGNC:33522,17p13.3
TLE1,Approved symbol,TLE1,"TLE family member 1, transcriptional corepressor",HGNC:11837,9q21.32
TLE2,Approved symbol,TLE2,"TLE family member 2, transcriptional corepressor",HGNC:11838,19p13.3
TLE4,Approved symbol,TLE4,"TLE family member 4, transcriptional corepressor",HGNC:11840,9q21.31
TLN1,Approved symbol,TLN1,talin 1,HGNC:11845,9p13.3
TLN2,Approved symbol,TLN2,talin 2,HGNC:15447,15q22.2
TLR7,Approved symbol,TLR7,toll like receptor 7,HGNC:15631,Xp22.2
TLX3,Approved symbol,TLX3,T cell leukemia homeobox 3,HGNC:13532,5q35.1
TM4SF1,Approved symbol,TM4SF1,transmembrane 4 L six family member 1,HGNC:11853,3q25.1
RPGR,Approved symbol,RPGR,retinitis pigmentosa GTPase regulator,HGNC:10295,Xp11.4
TM4SF4,Approved symbol,TM4SF4,transmembrane 4 L six family member 4,HGNC:11856,3q25.1
TM9SF3,Approved symbol,TM9SF3,transmembrane 9 superfamily member 3,HGNC:21529,10q24.1
TM9SF4,Approved symbol,TM9SF4,transmembrane 9 superfamily member 4,HGNC:30797,20q11.21
TMC3,Approved symbol,TMC3,transmembrane channel like 3,HGNC:22995,15q25.1
TMCC1,Approved symbol,TMCC1,transmembrane and coiled-coil domain family 1,HGNC:29116,3q22.1
TMCO4,Approved symbol,TMCO4,transmembrane and coiled-coil domains 4,HGNC:27393,1p36.13
TMEFF1,Approved symbol,TMEFF1,transmembrane protein with EGF like and two follistatin like domains 1,HGNC:11866,9q31.1
TMEM104,Approved symbol,TMEM104,transmembrane protein 104,HGNC:25984,17q25.1
TMEM105,Approved symbol,TMEM105,TMEM105 long non-coding RNA,HGNC:26794,17q25.3
TMEM107,Approved symbol,TMEM107,transmembrane protein 107,HGNC:28128,17p13.1
TMEM108,Approved symbol,TMEM108,transmembrane protein 108,HGNC:28451,3q22.1
TMEM11,Approved symbol,TMEM11,transmembrane protein 11,HGNC:16823,17p11.2
TMEM117,Approved symbol,TMEM117,transmembrane protein 117,HGNC:25308,12q12
TMEM131,Approved symbol,TMEM131,transmembrane protein 131,HGNC:30366,2q11.2
TMEM132A,Approved symbol,TMEM132A,transmembrane protein 132A,HGNC:31092,11q12.2
TMEM132C,Approved symbol,TMEM132C,transmembrane protein 132C,HGNC:25436,12q24.32
TMEM132D,Approved symbol,TMEM132D,transmembrane protein 132D,HGNC:29411,12q24.33
TMEM132E,Approved symbol,TMEM132E,transmembrane protein 132E,HGNC:26991,17q12
TMEM151A,Approved symbol,TMEM151A,transmembrane protein 151A,HGNC:28497,11q13.2
TMEM161A,Approved symbol,TMEM161A,transmembrane protein 161A,HGNC:26020,19p13.11
TMEM161B,Approved symbol,TMEM161B,transmembrane protein 161B,HGNC:28483,5q14.3
TMEM164,Approved symbol,TMEM164,transmembrane protein 164,HGNC:26217,Xq23
TMEM168,Approved symbol,TMEM168,transmembrane protein 168,HGNC:25826,7q31.1
TMEM170A,Approved symbol,TMEM170A,transmembrane protein 170A,HGNC:29577,16q23.1
TMEM175,Approved symbol,TMEM175,transmembrane protein 175,HGNC:28709,4p16.3
TMEM184B,Approved symbol,TMEM184B,transmembrane protein 184B,HGNC:1310,22q13.1
TMEM187,Approved symbol,TMEM187,transmembrane protein 187,HGNC:13705,Xq28
TMEM198,Approved symbol,TMEM198,transmembrane protein 198,HGNC:33704,2q35
TMEM201,Approved symbol,TMEM201,transmembrane protein 201,HGNC:33719,1p36.22
TMEM214,Approved symbol,TMEM214,transmembrane protein 214,HGNC:25983,2p23.3
TMEM221,Approved symbol,TMEM221,transmembrane protein 221,HGNC:21943,19p13.11
TMEM225,Approved symbol,TMEM225,transmembrane protein 225,HGNC:32390,11q24.1
TMEM229A,Approved symbol,TMEM229A,transmembrane protein 229A,HGNC:37279,7q31.32
TMEM232,Approved symbol,TMEM232,transmembrane protein 232,HGNC:37270,5q22.1
TMEM35,Previous symbol,TMEM35A,transmembrane protein 35A,HGNC:25864,Xq22.1
TMEM43,Approved symbol,TMEM43,transmembrane protein 43,HGNC:28472,3p25.1
TMEM44,Approved symbol,TMEM44,transmembrane protein 44,HGNC:25120,3q29
TMEM5,Previous symbol,RXYLT1,ribitol xylosyltransferase 1,HGNC:13530,12q14.2
TMEM51,Approved symbol,TMEM51,transmembrane protein 51,HGNC:25488,1p36.21
TMEM63C,Approved symbol,TMEM63C,transmembrane protein 63C,HGNC:23787,14q24.3
TMEM8A,Previous symbol,PGAP6,post-glycosylphosphatidylinositol attachment to proteins 6,HGNC:17205,16p13.3
TMEM9,Approved symbol,TMEM9,transmembrane protein 9,HGNC:18823,1q32.1
TMIGD1,Approved symbol,TMIGD1,transmembrane and immunoglobulin domain containing 1,HGNC:32431,17q11.2
TMPRSS11A,Approved symbol,TMPRSS11A,transmembrane serine protease 11A,HGNC:27954,4q13.2
TMPRSS11F,Approved symbol,TMPRSS11F,transmembrane serine protease 11F,HGNC:29994,4q13.2
TMPRSS15,Approved symbol,TMPRSS15,transmembrane serine protease 15,HGNC:9490,21q21.1
TMPRSS7,Approved symbol,TMPRSS7,transmembrane serine protease 7,HGNC:30846,3q13.2
TMPRSS9,Approved symbol,TMPRSS9,transmembrane serine protease 9,HGNC:30079,19p13.3
TNC,Approved symbol,TNC,tenascin C,HGNC:5318,9q33.1
TNFAIP1,Approved symbol,TNFAIP1,TNF alpha induced protein 1,HGNC:11894,17q11.2
TNFRSF10B,Approved symbol,TNFRSF10B,TNF receptor superfamily member 10b,HGNC:11905,8p21.3
TNFRSF14,Approved symbol,TNFRSF14,TNF receptor superfamily member 14,HGNC:11912,1p36.32
TNFRSF19,Approved symbol,TNFRSF19,TNF receptor superfamily member 19,HGNC:11915,13q12.12
TNFRSF21,Approved symbol,TNFRSF21,TNF receptor superfamily member 21,HGNC:13469,6p12.3
TNIK,Approved symbol,TNIK,TRAF2 and NCK interacting kinase,HGNC:30765,3q26.2-q26.31
TNIP2,Approved symbol,TNIP2,TNFAIP3 interacting protein 2,HGNC:19118,4p16.3
TNIP3,Approved symbol,TNIP3,TNFAIP3 interacting protein 3,HGNC:19315,4q27
TNKS,Approved symbol,TNKS,tankyrase,HGNC:11941,8p23.1
TNKS1BP1,Approved symbol,TNKS1BP1,tankyrase 1 binding protein 1,HGNC:19081,11q12.1
TNKS2,Approved symbol,TNKS2,tankyrase 2,HGNC:15677,10q23.32
TNN,Approved symbol,TNN,tenascin N,HGNC:22942,1q25.1
TNNC2,Approved symbol,TNNC2,"troponin C2, fast skeletal type",HGNC:11944,20q13.12
TNNI3K,Approved symbol,TNNI3K,TNNI3 interacting kinase,HGNC:19661,1p31.1
TNNT2,Approved symbol,TNNT2,"troponin T2, cardiac type",HGNC:11949,1q32.1
TNNT3,Approved symbol,TNNT3,"troponin T3, fast skeletal type",HGNC:11950,11p15.5
TNRC18,Approved symbol,TNRC18,trinucleotide repeat containing 18,HGNC:11962,7p22.1
TNRC6A,Approved symbol,TNRC6A,trinucleotide repeat containing adaptor 6A,HGNC:11969,16p12.1
TNS1,Approved symbol,TNS1,tensin 1,HGNC:11973,2q35
TNXB,Approved symbol,TNXB,tenascin XB,HGNC:11976,6p21.33-p21.32
TOMM40L,Approved symbol,TOMM40L,translocase of outer mitochondrial membrane 40 like,HGNC:25756,1q23.3
TOP1,Approved symbol,TOP1,DNA topoisomerase I,HGNC:11986,20q12
TOP2A,Approved symbol,TOP2A,DNA topoisomerase II alpha,HGNC:11989,17q21.2
TOPBP1,Approved symbol,TOPBP1,DNA topoisomerase II binding protein 1,HGNC:17008,3q22.1
TOR1AIP2,Approved symbol,TOR1AIP2,torsin 1A interacting protein 2,HGNC:24055,1q25.2
TOX2,Approved symbol,TOX2,TOX high mobility group box family member 2,HGNC:16095,20q13.12
TP53,Approved symbol,TP53,tumor protein p53,HGNC:11998,17p13.1
TP53AIP1,Approved symbol,TP53AIP1,tumor protein p53 regulated apoptosis inducing protein 1,HGNC:29984,11q24.3
TP53I11,Approved symbol,TP53I11,tumor protein p53 inducible protein 11,HGNC:16842,11p11.2
TP53INP2,Approved symbol,TP53INP2,tumor protein p53 inducible nuclear protein 2,HGNC:16104,20q11.22
TP53TG3D,Approved symbol,TP53TG3D,TP53 target 3D,HGNC:44657,16p11.2
TPBGL,Approved symbol,TPBGL,trophoblast glycoprotein like,HGNC:44159,11q13.4
TPH1,Approved symbol,TPH1,tryptophan hydroxylase 1,HGNC:12008,11p15.1
TPH2,Approved symbol,TPH2,tryptophan hydroxylase 2,HGNC:20692,12q21.1
TPH2,Alias symbol,TDO2,"tryptophan 2,3-dioxygenase",HGNC:11708,4q32.1
TPO,Approved symbol,TPO,thyroid peroxidase,HGNC:12015,2p25.3
TPO,Alias symbol,THPO,thrombopoietin,HGNC:11795,3q27.1
TPPP2,Approved symbol,TPPP2,tubulin polymerization promoting protein family member 2,HGNC:19293,14q11.2
TPRG1,Approved symbol,TPRG1,tumor protein p63 regulated 1,HGNC:24759,3q28
TPST2,Approved symbol,TPST2,tyrosylprotein sulfotransferase 2,HGNC:12021,22q12.1
TPTE2,Approved symbol,TPTE2,transmembrane phosphoinositide 3-phosphatase and tensin homolog 2,HGNC:17299,13q12.11
TRA2B,Approved symbol,TRA2B,transformer 2 beta homolog,HGNC:10781,3q27.2
TRAF3,Approved symbol,TRAF3,TNF receptor associated factor 3,HGNC:12033,14q32.32
TRAF3IP2,Approved symbol,TRAF3IP2,TRAF3 interacting protein 2,HGNC:1343,6q21
TRAF6,Approved symbol,TRAF6,TNF receptor associated factor 6,HGNC:12036,11p12
TRAFD1,Approved symbol,TRAFD1,TRAF-type zinc finger domain containing 1,HGNC:24808,12q24.13
TRAK1,Approved symbol,TRAK1,trafficking kinesin protein 1,HGNC:29947,3p22.1
TRANK1,Approved symbol,TRANK1,tetratricopeptide repeat and ankyrin repeat containing 1,HGNC:29011,3p22.2
TRAPPC10,Approved symbol,TRAPPC10,trafficking protein particle complex subunit 10,HGNC:11868,21q22.3
TRAPPC11,Approved symbol,TRAPPC11,trafficking protein particle complex subunit 11,HGNC:25751,4q35.1
TRAPPC3L,Approved symbol,TRAPPC3L,trafficking protein particle complex subunit 3L,HGNC:21090,6q22.1
TRAPPC4,Approved symbol,TRAPPC4,trafficking protein particle complex subunit 4,HGNC:19943,11q23.3
TRAPPC9,Approved symbol,TRAPPC9,trafficking protein particle complex subunit 9,HGNC:30832,8q24.3
TRAT1,Approved symbol,TRAT1,T cell receptor associated transmembrane adaptor 1,HGNC:30698,3q13.13
TRDMT1,Approved symbol,TRDMT1,tRNA aspartic acid methyltransferase 1,HGNC:2977,10p13
TRDN,Approved symbol,TRDN,triadin,HGNC:12261,6q22.31
TREH,Approved symbol,TREH,trehalase,HGNC:12266,11q23.3
TREM1,Approved symbol,TREM1,triggering receptor expressed on myeloid cells 1,HGNC:17760,6p21.1
TRGJP,Approved symbol,TRGJP,T cell receptor gamma joining P,HGNC:12279,7p14.1
TRHDE,Approved symbol,TRHDE,thyrotropin releasing hormone degrading enzyme,HGNC:30748,12q21.1
TRIM15,Approved symbol,TRIM15,tripartite motif containing 15,HGNC:16284,6p22.1
TRIM17,Approved symbol,TRIM17,tripartite motif containing 17,HGNC:13430,1q42.13
TRIM28,Approved symbol,TRIM28,tripartite motif containing 28,HGNC:16384,19q13.43
TRIM3,Approved symbol,TRIM3,tripartite motif containing 3,HGNC:10064,11p15.4
TRIM41,Approved symbol,TRIM41,tripartite motif containing 41,HGNC:19013,5q35.3
TRIM42,Approved symbol,TRIM42,tripartite motif containing 42,HGNC:19014,3q23
TRIM48,Approved symbol,TRIM48,tripartite motif containing 48,HGNC:19021,11q11
TRIM51,Approved symbol,TRIM51,tripartite motif-containing 51,HGNC:19023,11q12.1
TRIM58,Approved symbol,TRIM58,tripartite motif containing 58,HGNC:24150,1q44
TRIM60,Approved symbol,TRIM60,tripartite motif containing 60,HGNC:21162,4q32.3
TRIM64C,Approved symbol,TRIM64C,tripartite motif containing 64C,HGNC:37148,11p11.12
TRIM66,Approved symbol,TRIM66,tripartite motif containing 66,HGNC:29005,11p15.4
TRIM67,Approved symbol,TRIM67,tripartite motif containing 67,HGNC:31859,1q42.2
TRIM77,Approved symbol,TRIM77,tripartite motif containing 77,HGNC:34228,11q14.3
TRIML1,Approved symbol,TRIML1,tripartite motif family like 1,HGNC:26698,4q35.2
TRIML2,Approved symbol,TRIML2,tripartite motif family like 2,HGNC:26378,4q35.2
TRIP12,Approved symbol,TRIP12,thyroid hormone receptor interactor 12,HGNC:12306,2q36.3
TRMT112,Approved symbol,TRMT112,tRNA methyltransferase activator subunit 11-2,HGNC:26940,11q13.1
TRMT2B,Approved symbol,TRMT2B,tRNA methyltransferase 2 homolog B,HGNC:25748,Xq22.1
TRMT5,Approved symbol,TRMT5,tRNA methyltransferase 5,HGNC:23141,14q23.1
TRMT61A,Approved symbol,TRMT61A,tRNA methyltransferase 61A,HGNC:23790,14q32.33
TRMT61B,Approved symbol,TRMT61B,tRNA methyltransferase 61B,HGNC:26070,2p23.2
TRO,Approved symbol,TRO,trophinin,HGNC:12326,Xp11.21
TRPC3,Approved symbol,TRPC3,transient receptor potential cation channel subfamily C member 3,HGNC:12335,4q27
TRPC4,Approved symbol,TRPC4,transient receptor potential cation channel subfamily C member 4,HGNC:12336,13q13.3
TRPC5,Approved symbol,TRPC5,transient receptor potential cation channel subfamily C member 5,HGNC:12337,Xq23
TRPC6,Approved symbol,TRPC6,transient receptor potential cation channel subfamily C member 6,HGNC:12338,11q22.1
TRPC7,Approved symbol,TRPC7,transient receptor potential cation channel subfamily C member 7,HGNC:20754,5q31.1
TRPC7,Previous symbol,TRPM2,transient receptor potential cation channel subfamily M member 2,HGNC:12339,21q22.3
TRPM1,Approved symbol,TRPM1,transient receptor potential cation channel subfamily M member 1,HGNC:7146,15q13.3
TRPM2,Approved symbol,TRPM2,transient receptor potential cation channel subfamily M member 2,HGNC:12339,21q22.3
TRPM3,Approved symbol,TRPM3,transient receptor potential cation channel subfamily M member 3,HGNC:17992,9q21.12-q21.13
TRPM6,Approved symbol,TRPM6,transient receptor potential cation channel subfamily M member 6,HGNC:17995,9q21.13
TRPM7,Approved symbol,TRPM7,transient receptor potential cation channel subfamily M member 7,HGNC:17994,15q21.2
TRPM8,Approved symbol,TRPM8,transient receptor potential cation channel subfamily M member 8,HGNC:17961,2q37.1
TRPS1,Approved symbol,TRPS1,transcriptional repressor GATA binding 1,HGNC:12340,8q23.3
TRPV3,Approved symbol,TRPV3,transient receptor potential cation channel subfamily V member 3,HGNC:18084,17p13.2
TRPV5,Approved symbol,TRPV5,transient receptor potential cation channel subfamily V member 5,HGNC:3145,7q34
TRPV6,Approved symbol,TRPV6,transient receptor potential cation channel subfamily V member 6,HGNC:14006,7q34
TSC1,Approved symbol,TSC1,TSC complex subunit 1,HGNC:12362,9q34
TSC2,Approved symbol,TSC2,TSC complex subunit 2,HGNC:12363,16p13.3
TSC22D1,Approved symbol,TSC22D1,TSC22 domain family member 1,HGNC:16826,13q14.11
TSC22D3,Approved symbol,TSC22D3,TSC22 domain family member 3,HGNC:3051,Xq22.3
TSC22D4,Approved symbol,TSC22D4,TSC22 domain family member 4,HGNC:21696,7q22.1
TSGA10,Approved symbol,TSGA10,testis specific 10,HGNC:14927,2q11.2
TSHB,Approved symbol,TSHB,thyroid stimulating hormone subunit beta,HGNC:12372,1p13.2
TSHR,Approved symbol,TSHR,thyroid stimulating hormone receptor,HGNC:12373,14q24-q31
TSHZ2,Approved symbol,TSHZ2,teashirt zinc finger homeobox 2,HGNC:13010,20q13.2
TSLP,Approved symbol,TSLP,thymic stromal lymphopoietin,HGNC:30743,5q22.1
TSNARE1,Approved symbol,TSNARE1,t-SNARE domain containing 1,HGNC:26437,8q24.3
TSNAX,Approved symbol,TSNAX,translin associated factor X,HGNC:12380,1q42.2
TSPAN12,Approved symbol,TSPAN12,tetraspanin 12,HGNC:21641,7q31.31
TSPAN15,Approved symbol,TSPAN15,tetraspanin 15,HGNC:23298,10q22.1
TSPAN33,Approved symbol,TSPAN33,tetraspanin 33,HGNC:28743,7q32.1
TSPAN6,Approved symbol,TSPAN6,tetraspanin 6,HGNC:11858,Xq22.1
TSPYL4,Approved symbol,TSPYL4,TSPY like 4,HGNC:21559,6q22.1
TSPYL6,Approved symbol,TSPYL6,TSPY like 6,HGNC:14521,2p16.2
TSSK4,Approved symbol,TSSK4,testis specific serine kinase 4,HGNC:19825,14q12
TSTD3,Approved symbol,TSTD3,thiosulfate sulfurtransferase like domain containing 3,HGNC:40910,6q16.2
TTBK1,Approved symbol,TTBK1,tau tubulin kinase 1,HGNC:19140,6p21.1
TTC17,Approved symbol,TTC17,tetratricopeptide repeat domain 17,HGNC:25596,11p12-p11.2
TTC3,Approved symbol,TTC3,tetratricopeptide repeat domain 3,HGNC:12393,21q22.13
TTC30A,Approved symbol,TTC30A,tetratricopeptide repeat domain 30A,HGNC:25853,2q31.2
TTC32,Approved symbol,TTC32,tetratricopeptide repeat domain 32,HGNC:32954,2p24.1
TTC36,Approved symbol,TTC36,tetratricopeptide repeat domain 36,HGNC:33708,11q23.3
TTC38,Approved symbol,TTC38,tetratricopeptide repeat domain 38,HGNC:26082,22q13.31
TTC40,Previous symbol,CFAP46,cilia and flagella associated protein 46,HGNC:25247,10q26.3
TTC5,Approved symbol,TTC5,tetratricopeptide repeat domain 5,HGNC:19274,14q11.2
TTC6,Approved symbol,TTC6,tetratricopeptide repeat domain 6,HGNC:19739,14q21.1
TTC7B,Approved symbol,TTC7B,tetratricopeptide repeat domain 7B,HGNC:19858,14q32.11
TTF2,Approved symbol,TTF2,transcription termination factor 2,HGNC:12398,1p13.1
TTLL5,Approved symbol,TTLL5,tubulin tyrosine ligase like 5,HGNC:19963,14q24.3
TTLL5,Previous symbol,TTLL10,tubulin tyrosine ligase like 10,HGNC:26693,1p36.33
TTLL6,Approved symbol,TTLL6,tubulin tyrosine ligase like 6,HGNC:26664,17q21.32
TTLL8,Approved symbol,TTLL8,tubulin tyrosine ligase like 8,HGNC:34000,22q13.33
TTLL9,Approved symbol,TTLL9,tubulin tyrosine ligase like 9,HGNC:16118,20q11
TTN,Approved symbol,TTN,titin,HGNC:12403,2q31.2
TTYH3,Approved symbol,TTYH3,tweety family member 3,HGNC:22222,7p22.3
TUB,Approved symbol,TUB,TUB bipartite transcription factor,HGNC:12406,11p15.4
TUBA1A,Approved symbol,TUBA1A,tubulin alpha 1a,HGNC:20766,12q13.12
TUBA3C,Approved symbol,TUBA3C,tubulin alpha 3c,HGNC:12408,13q12.11
TUBB3,Approved symbol,TUBB3,tubulin beta 3 class III,HGNC:20772,16q24.3
TUBB6,Approved symbol,TUBB6,tubulin beta 6 class V,HGNC:20776,18p11.21
TUBGCP3,Approved symbol,TUBGCP3,tubulin gamma complex associated protein 3,HGNC:18598,13q34
TUBGCP5,Approved symbol,TUBGCP5,tubulin gamma complex associated protein 5,HGNC:18600,15q11.2
TULP2,Approved symbol,TULP2,TUB like protein 2,HGNC:12424,19q13.33
TULP4,Approved symbol,TULP4,TUB like protein 4,HGNC:15530,6q25.3
TWIST2,Approved symbol,TWIST2,twist family bHLH transcription factor 2,HGNC:20670,2q37.3
TXLNA,Approved symbol,TXLNA,taxilin alpha,HGNC:30685,1p35.2
TXLNB,Approved symbol,TXLNB,taxilin beta,HGNC:21617,6q24.1
TXNDC11,Approved symbol,TXNDC11,thioredoxin domain containing 11,HGNC:28030,16p13.13
TXNDC8,Approved symbol,TXNDC8,thioredoxin domain containing 8,HGNC:31454,9q31.3
TXNIP,Approved symbol,TXNIP,thioredoxin interacting protein,HGNC:16952,1q21.1
TXNRD3,Approved symbol,TXNRD3,thioredoxin reductase 3,HGNC:20667,3q21.3
TYK2,Approved symbol,TYK2,tyrosine kinase 2,HGNC:12440,19p13.2
TYMP,Approved symbol,TYMP,thymidine phosphorylase,HGNC:3148,22q13.33
TYMS,Approved symbol,TYMS,thymidylate synthetase,HGNC:12441,18p11.32
TYR,Approved symbol,TYR,tyrosinase,HGNC:12442,11q14.3
TYRO3,Approved symbol,TYRO3,TYRO3 protein tyrosine kinase,HGNC:12446,15q15.1
U2AF1,Approved symbol,U2AF1,U2 small nuclear RNA auxiliary factor 1,HGNC:12453,21q22.3
U2SURP,Approved symbol,U2SURP,U2 snRNP associated SURP domain containing,HGNC:30855,3q23
UACA,Approved symbol,UACA,uveal autoantigen with coiled-coil domains and ankyrin repeats,HGNC:15947,15q23
UBAP2L,Approved symbol,UBAP2L,ubiquitin associated protein 2 like,HGNC:29877,1q21.3
UBC,Approved symbol,UBC,ubiquitin C,HGNC:12468,12q24.3
UBE2QL1,Approved symbol,UBE2QL1,ubiquitin conjugating enzyme E2 Q family like 1,HGNC:37269,5p15.31
UBE3B,Approved symbol,UBE3B,ubiquitin protein ligase E3B,HGNC:13478,12q24.11
UBE3D,Approved symbol,UBE3D,ubiquitin protein ligase E3D,HGNC:21381,6q14.1
UBE4B,Approved symbol,UBE4B,ubiquitination factor E4B,HGNC:12500,1p36.22
UBL7,Approved symbol,UBL7,ubiquitin like 7,HGNC:28221,15q24.1
UBQLN2,Approved symbol,UBQLN2,ubiquilin 2,HGNC:12509,Xp11.21
UBR1,Approved symbol,UBR1,ubiquitin protein ligase E3 component n-recognin 1,HGNC:16808,15q15.2
UBR3,Approved symbol,UBR3,ubiquitin protein ligase E3 component n-recognin 3,HGNC:30467,2q31.1
UBR4,Approved symbol,UBR4,ubiquitin protein ligase E3 component n-recognin 4,HGNC:30313,1p36.13
UBR5,Approved symbol,UBR5,ubiquitin protein ligase E3 component n-recognin 5,HGNC:16806,8q22.3
UBR7,Approved symbol,UBR7,ubiquitin protein ligase E3 component n-recognin 7,HGNC:20344,14q32.12
UBXN2B,Approved symbol,UBXN2B,UBX domain protein 2B,HGNC:27035,8q12.1
UBXN8,Approved symbol,UBXN8,UBX domain protein 8,HGNC:30307,8p12
UCMA,Approved symbol,UCMA,upper zone of growth plate and cartilage matrix associated,HGNC:25205,10p13
UCP1,Approved symbol,UCP1,uncoupling protein 1,HGNC:12517,4q31.1
UCP2,Approved symbol,UCP2,uncoupling protein 2,HGNC:12518,11q13.4
UFM1,Approved symbol,UFM1,ubiquitin fold modifier 1,HGNC:20597,13q13.3
UGP2,Approved symbol,UGP2,UDP-glucose pyrophosphorylase 2,HGNC:12527,2p15
UGT1A10,Approved symbol,UGT1A10,UDP glucuronosyltransferase family 1 member A10,HGNC:12531,2q37.1
UGT2A1,Approved symbol,UGT2A1,UDP glucuronosyltransferase family 2 member A1 complex locus,HGNC:12542,4q13.3
UGT2B15,Approved symbol,UGT2B15,UDP glucuronosyltransferase family 2 member B15,HGNC:12546,4q13.2
UGT2B4,Approved symbol,UGT2B4,UDP glucuronosyltransferase family 2 member B4,HGNC:12553,4q13.3
UGT3A1,Approved symbol,UGT3A1,UDP glycosyltransferase family 3 member A1,HGNC:26625,5p13.2
UHRF1BP1,Approved symbol,UHRF1BP1,UHRF1 binding protein 1,HGNC:21216,6p21.31
UHRF2,Approved symbol,UHRF2,ubiquitin like with PHD and ring finger domains 2,HGNC:12557,9p24.1
ULK2,Approved symbol,ULK2,unc-51 like autophagy activating kinase 2,HGNC:13480,17p11.2
ULK4,Approved symbol,ULK4,unc-51 like kinase 4,HGNC:15784,3p22.1
UMOD,Approved symbol,UMOD,uromodulin,HGNC:12559,16p12.3
UNC13A,Approved symbol,UNC13A,unc-13 homolog A,HGNC:23150,19p13.11
UNC13B,Approved symbol,UNC13B,unc-13 homolog B,HGNC:12566,9p13.3
UNC13C,Approved symbol,UNC13C,unc-13 homolog C,HGNC:23149,15q21.3
UNC45B,Approved symbol,UNC45B,unc-45 myosin chaperone B,HGNC:14304,17q12
UNC5B,Approved symbol,UNC5B,unc-5 netrin receptor B,HGNC:12568,10q22.1
UNC5C,Approved symbol,UNC5C,unc-5 netrin receptor C,HGNC:12569,4q22.3
UNC5D,Approved symbol,UNC5D,unc-5 netrin receptor D,HGNC:18634,8p12
UNC79,Approved symbol,UNC79,"unc-79 homolog, NALCN channel complex subunit",HGNC:19966,14q32.12
UNC80,Approved symbol,UNC80,"unc-80 homolog, NALCN channel complex subunit",HGNC:26582,2q34
Unknown,Unmatched,,,,
UPF1,Approved symbol,UPF1,UPF1 RNA helicase and ATPase,HGNC:9962,19p13.11
UPF3B,Approved symbol,UPF3B,UPF3B regulator of nonsense mediated mRNA decay,HGNC:20439,Xq24
UPK2,Approved symbol,UPK2,uroplakin 2,HGNC:12579,11q23.3
UPK3B,Approved symbol,UPK3B,uroplakin 3B,HGNC:21444,7q11.23
UPRT,Approved symbol,UPRT,uracil phosphoribosyltransferase homolog,HGNC:28334,Xq13.3
URM1,Approved symbol,URM1,ubiquitin related modifier 1,HGNC:28378,9q34.11
UROC1,Approved symbol,UROC1,urocanate hydratase 1,HGNC:26444,3q21.3
USH1G,Approved symbol,USH1G,USH1 protein network component sans,HGNC:16356,17q25.1
USH2A,Approved symbol,USH2A,usherin,HGNC:12601,1q41
USP1,Approved symbol,USP1,ubiquitin specific peptidase 1,HGNC:12607,1p31.3
USP10,Approved symbol,USP10,ubiquitin specific peptidase 10,HGNC:12608,16q24.1
USP10,Alias symbol,USP32,ubiquitin specific peptidase 32,HGNC:19143,17q23.3
USP11,Approved symbol,USP11,ubiquitin specific peptidase 11,HGNC:12609,Xp11.3
USP13,Approved symbol,USP13,ubiquitin specific peptidase 13,HGNC:12611,3q26.33
USP14,Approved symbol,USP14,ubiquitin specific peptidase 14,HGNC:12612,18p11.32
USP15,Approved symbol,USP15,ubiquitin specific peptidase 15,HGNC:12613,12q14.1
USP21,Approved symbol,USP21,ubiquitin specific peptidase 21,HGNC:12620,1q23.3
USP21,Alias symbol,USP25,ubiquitin specific peptidase 25,HGNC:12624,21q21.1
USP25,Approved symbol,USP25,ubiquitin specific peptidase 25,HGNC:12624,21q21.1
USP32,Approved symbol,USP32,ubiquitin specific peptidase 32,HGNC:19143,17q23.3
USP37,Approved symbol,USP37,ubiquitin specific peptidase 37,HGNC:20063,2q35
USP4,Approved symbol,USP4,ubiquitin specific peptidase 4,HGNC:12627,3p21.31
USP40,Approved symbol,USP40,ubiquitin specific peptidase 40,HGNC:20069,2q37.1
USP42,Approved symbol,USP42,ubiquitin specific peptidase 42,HGNC:20068,7p22.1
USP6,Approved symbol,USP6,ubiquitin specific peptidase 6,HGNC:12629,17p13.2
USP9X,Approved symbol,USP9X,ubiquitin specific peptidase 9 X-linked,HGNC:12632,Xp11.4
USPL1,Approved symbol,USPL1,ubiquitin specific peptidase like 1,HGNC:20294,13q12.3
UTP20,Approved symbol,UTP20,UTP20 small subunit processome component,HGNC:17897,12q23.2
UTP23,Approved symbol,UTP23,UTP23 small subunit processome component,HGNC:28224,8q24.11
UTRN,Approved symbol,UTRN,utrophin,HGNC:12635,6q24.2
VAC14,Approved symbol,VAC14,VAC14 component of PIKFYVE complex,HGNC:25507,16q22.1-q22.2
VANGL1,Approved symbol,VANGL1,VANGL planar cell polarity protein 1,HGNC:15512,1p13.1
VARS2,Approved symbol,VARS2,"valyl-tRNA synthetase 2, mitochondrial",HGNC:21642,6p21.33
VARS2,Previous symbol,VARS1,valyl-tRNA synthetase 1,HGNC:12651,6p21.33
VAV2,Approved symbol,VAV2,vav guanine nucleotide exchange factor 2,HGNC:12658,9q34.2
VAV3,Approved symbol,VAV3,vav guanine nucleotide exchange factor 3,HGNC:12659,1p13.3
VAX1,Approved symbol,VAX1,ventral anterior homeobox 1,HGNC:12660,10q25.3
VCPKMT,Approved symbol,VCPKMT,valosin containing protein lysine methyltransferase,HGNC:20352,14q21.3
VDAC1,Approved symbol,VDAC1,voltage dependent anion channel 1,HGNC:12669,5q31.1
VEZF1,Approved symbol,VEZF1,vascular endothelial zinc finger 1,HGNC:12949,17q22
VHL,Approved symbol,VHL,von Hippel-Lindau tumor suppressor,HGNC:12687,3p25.3
VILL,Approved symbol,VILL,villin like,HGNC:30906,3p22.2
VIP,Approved symbol,VIP,vasoactive intestinal peptide,HGNC:12693,6q25.2
VIP,Alias symbol,CPAMD8,C3 and PZP like alpha-2-macroglobulin domain containing 8,HGNC:23228,19p13.11
VN1R4,Approved symbol,VN1R4,vomeronasal 1 receptor 4,HGNC:19871,19q13.42
VPS13A,Approved symbol,VPS13A,vacuolar protein sorting 13 homolog A,HGNC:1908,9q21.2
VPS13B,Approved symbol,VPS13B,vacuolar protein sorting 13 homolog B,HGNC:2183,8q22.2
VPS13C,Approved symbol,VPS13C,vacuolar protein sorting 13 homolog C,HGNC:23594,15q22.2
VPS13D,Approved symbol,VPS13D,vacuolar protein sorting 13 homolog D,HGNC:23595,1p36.22-p36.21
VPS16,Approved symbol,VPS16,VPS16 core subunit of CORVET and HOPS complexes,HGNC:14584,20p13
VPS28,Approved symbol,VPS28,VPS28 subunit of ESCRT-I,HGNC:18178,8q24.3
VPS33B,Approved symbol,VPS33B,VPS33B late endosome and lysosome associated,HGNC:12712,15q26.1
VPS35,Approved symbol,VPS35,VPS35 retromer complex component,HGNC:13487,16q11.2
VPS36,Approved symbol,VPS36,vacuolar protein sorting 36 homolog,HGNC:20312,13q14.3
VPS45,Approved symbol,VPS45,vacuolar protein sorting 45 homolog,HGNC:14579,1q21.2
VPS4A,Approved symbol,VPS4A,vacuolar protein sorting 4 homolog A,HGNC:13488,16q23.1
VPS9D1,Approved symbol,VPS9D1,VPS9 domain containing 1,HGNC:13526,16q24.3
VSIG2,Approved symbol,VSIG2,V-set and immunoglobulin domain containing 2,HGNC:17149,11q24.2
VSTM4,Approved symbol,VSTM4,V-set and transmembrane domain containing 4,HGNC:26470,10q11.23
VWA1,Approved symbol,VWA1,von Willebrand factor A domain containing 1,HGNC:30910,1p36.33
VWA3A,Approved symbol,VWA3A,von Willebrand factor A domain containing 3A,HGNC:27088,16p12.2
VWA5B1,Approved symbol,VWA5B1,von Willebrand factor A domain containing 5B1,HGNC:26538,1p36.12
VWA8,Approved symbol,VWA8,von Willebrand factor A domain containing 8,HGNC:29071,13q14.11
VWCE,Approved symbol,VWCE,von Willebrand factor C and EGF domains,HGNC:26487,11q12.2
VWDE,Approved symbol,VWDE,von Willebrand factor D and EGF domains,HGNC:21897,7p21.3
VWF,Approved symbol,VWF,von Willebrand factor,HGNC:12726,12p13.31
WAPAL,Previous symbol,WAPL,WAPL cohesin release factor,HGNC:23293,10q23.2
WASF2,Approved symbol,WASF2,WASP family member 2,HGNC:12733,1p36.11
WBP1,Approved symbol,WBP1,WW domain binding protein 1,HGNC:12737,2p13.1
WBP1,Alias symbol,DDOST,dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit,HGNC:2728,1p36.12
WBP1L,Approved symbol,WBP1L,WW domain binding protein 1 like,HGNC:23510,10q24.32
WBSCR17,Previous symbol,GALNT17,polypeptide N-acetylgalactosaminyltransferase 17,HGNC:16347,7q11.22
WDFY4,Approved symbol,WDFY4,WDFY family member 4,HGNC:29323,10q11.23
WDR11,Approved symbol,WDR11,WD repeat domain 11,HGNC:13831,10q26.12
WDR11,Previous symbol,PHIP,pleckstrin homology domain interacting protein,HGNC:15673,6q14.1
WDR16,Previous symbol,CFAP52,cilia and flagella associated protein 52,HGNC:16053,17p13.1
WDR17,Approved symbol,WDR17,WD repeat domain 17,HGNC:16661,4q34.2
WDR27,Approved symbol,WDR27,WD repeat domain 27,HGNC:21248,6q27
WDR33,Approved symbol,WDR33,WD repeat domain 33,HGNC:25651,2q14.3
WDR34,Previous symbol,DYNC2I2,dynein 2 intermediate chain 2,HGNC:28296,9q34.11
WDR37,Approved symbol,WDR37,WD repeat domain 37,HGNC:31406,10p15.3
WDR44,Approved symbol,WDR44,WD repeat domain 44,HGNC:30512,Xq24
WDR63,Previous symbol,DNAI3,dynein axonemal intermediate chain 3,HGNC:30711,1p22.3
WDR64,Approved symbol,WDR64,WD repeat domain 64,HGNC:26570,1q43
WDR65,Previous symbol,CFAP57,cilia and flagella associated protein 57,HGNC:26485,1p34.2
WDR66,Previous symbol,CFAP251,cilia and flagella associated protein 251,HGNC:28506,12q24.31
WDR7,Approved symbol,WDR7,WD repeat domain 7,HGNC:13490,18q21.31
WDR73,Approved symbol,WDR73,WD repeat domain 73,HGNC:25928,15q25.2
WDR75,Approved symbol,WDR75,WD repeat domain 75,HGNC:25725,2q32.2
WDR81,Approved symbol,WDR81,WD repeat domain 81,HGNC:26600,17p13.3
WDR87,Approved symbol,WDR87,WD repeat domain 87,HGNC:29934,19q13.13
WDR90,Approved symbol,WDR90,WD repeat domain 90,HGNC:26960,16p13.3
WDR96,Previous symbol,CFAP43,cilia and flagella associated protein 43,HGNC:26684,10q25.1
WHSC1,Previous symbol,NSD2,nuclear receptor binding SET domain protein 2,HGNC:12766,4p16.3
WI2-1959D15.1,Unmatched,,,,
WI2-2373I1.2,Unmatched,,,,
WIPI1,Approved symbol,WIPI1,"WD repeat domain, phosphoinositide interacting 1",HGNC:25471,17q24.2
WISP2,Previous symbol,CCN5,cellular communication network factor 5,HGNC:12770,20q13.12
WIZ,Approved symbol,WIZ,WIZ zinc finger,HGNC:30917,19p13.12
WNK1,Approved symbol,WNK1,WNK lysine deficient protein kinase 1,HGNC:14540,12p13.33
WNK2,Approved symbol,WNK2,WNK lysine deficient protein kinase 2,HGNC:14542,9q22.31
WNK3,Approved symbol,WNK3,WNK lysine deficient protein kinase 3,HGNC:14543,Xp11.22
WNT4,Approved symbol,WNT4,Wnt family member 4,HGNC:12783,1p36.12
WNT5A,Approved symbol,WNT5A,Wnt family member 5A,HGNC:12784,3p14.3
WNT6,Approved symbol,WNT6,Wnt family member 6,HGNC:12785,2q35
WRN,Approved symbol,WRN,WRN RecQ like helicase,HGNC:12791,8p12
WRNIP1,Approved symbol,WRNIP1,WRN helicase interacting protein 1,HGNC:20876,6p25.2
WSCD2,Approved symbol,WSCD2,WSC domain containing 2,HGNC:29117,12q23.3
WWC1,Approved symbol,WWC1,WW and C2 domain containing 1,HGNC:29435,5q34
WWC2,Approved symbol,WWC2,WW and C2 domain containing 2,HGNC:24148,4q35.1
WWC3,Approved symbol,WWC3,WWC family member 3,HGNC:29237,Xp22.2
XBP1,Approved symbol,XBP1,X-box binding protein 1,HGNC:12801,22q12.1
XBP1,Previous symbol,XBP1P1,X-box binding protein 1 pseudogene 1,HGNC:12802,5q22.2
XIRP2,Approved symbol,XIRP2,xin actin binding repeat containing 2,HGNC:14303,2q24.3
XKR5,Approved symbol,XKR5,XK related 5,HGNC:20782,8p23.1
XKR6,Approved symbol,XKR6,XK related 6,HGNC:27806,8p23.1
XKRX,Approved symbol,XKRX,XK related X-linked,HGNC:29845,Xq22.1
XPNPEP1,Approved symbol,XPNPEP1,X-prolyl aminopeptidase 1,HGNC:12822,10q25.1
XPO4,Approved symbol,XPO4,exportin 4,HGNC:17796,13q12.11
XRCC6,Approved symbol,XRCC6,X-ray repair cross complementing 6,HGNC:4055,22q13.2
MICA-AS1,Approved symbol,MICA-AS1,MICA antisense RNA 1,HGNC:53631,6p21.33
XYLB,Approved symbol,XYLB,xylulokinase,HGNC:12839,3p22.2
XYLT1,Approved symbol,XYLT1,xylosyltransferase 1,HGNC:15516,16p12.3
YAF2,Approved symbol,YAF2,YY1 associated factor 2,HGNC:17363,12q12
YAP1,Approved symbol,YAP1,Yes1 associated transcriptional regulator,HGNC:16262,11q22.1
YBX3,Approved symbol,YBX3,Y-box binding protein 3,HGNC:2428,12p13.2
YJEFN3,Approved symbol,YJEFN3,YjeF N-terminal domain containing 3,HGNC:24785,19p13.11
YPEL4,Approved symbol,YPEL4,yippee like 4,HGNC:18328,11q12.1
YTHDC2,Approved symbol,YTHDC2,YTH domain containing 2,HGNC:24721,5q22.2
YWHAB,Approved symbol,YWHAB,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta,HGNC:12849,20q13.12
YWHAZ,Approved symbol,YWHAZ,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,HGNC:12855,8q22.3
Z95704.2,Unmatched,,,,
ZBBX,Approved symbol,ZBBX,zinc finger B-box domain containing,HGNC:26245,3q26.1
ZBED4,Approved symbol,ZBED4,zinc finger BED-type containing 4,HGNC:20721,22q13.33
ZBED6,Approved symbol,ZBED6,zinc finger BED-type containing 6,HGNC:33273,1q32.1
ZBP1,Approved symbol,ZBP1,Z-DNA binding protein 1,HGNC:16176,20q13.31
ZBTB12,Approved symbol,ZBTB12,zinc finger and BTB domain containing 12,HGNC:19066,6p21.33
ZBTB16,Approved symbol,ZBTB16,zinc finger and BTB domain containing 16,HGNC:12930,11q23.2
ZBTB18,Approved symbol,ZBTB18,zinc finger and BTB domain containing 18,HGNC:13030,1q44
ZBTB40,Approved symbol,ZBTB40,zinc finger and BTB domain containing 40,HGNC:29045,1p36.12
ZBTB43,Approved symbol,ZBTB43,zinc finger and BTB domain containing 43,HGNC:17908,9q33.3
ZBTB45,Approved symbol,ZBTB45,zinc finger and BTB domain containing 45,HGNC:23715,19q13.43
ZBTB6,Approved symbol,ZBTB6,zinc finger and BTB domain containing 6,HGNC:16764,9q33.2
ZBTB7C,Approved symbol,ZBTB7C,zinc finger and BTB domain containing 7C,HGNC:31700,18q21.1
ZC3H12B,Approved symbol,ZC3H12B,zinc finger CCCH-type containing 12B,HGNC:17407,Xq11.2-q12
ZC3H13,Approved symbol,ZC3H13,zinc finger CCCH-type containing 13,HGNC:20368,13q14.13
ZC3H14,Approved symbol,ZC3H14,zinc finger CCCH-type containing 14,HGNC:20509,14q31.3
ZC3H18,Approved symbol,ZC3H18,zinc finger CCCH-type containing 18,HGNC:25091,16q24.2
ZC3H3,Approved symbol,ZC3H3,zinc finger CCCH-type containing 3,HGNC:28972,8q24.3
ZC3H4,Approved symbol,ZC3H4,zinc finger CCCH-type containing 4,HGNC:17808,19q13.32
ZC4H2,Approved symbol,ZC4H2,zinc finger C4H2-type containing,HGNC:24931,Xq11.2
ZCCHC11,Previous symbol,TUT4,terminal uridylyl transferase 4,HGNC:28981,1p32.3
ZCCHC24,Approved symbol,ZCCHC24,zinc finger CCHC-type containing 24,HGNC:26911,10q22.3
ZCWPW2,Approved symbol,ZCWPW2,zinc finger CW-type and PWWP domain containing 2,HGNC:23574,3p24.1
ZDBF2,Approved symbol,ZDBF2,zinc finger DBF-type containing 2,HGNC:29313,2q33.3
ZDHHC13,Approved symbol,ZDHHC13,zinc finger DHHC-type palmitoyltransferase 13,HGNC:18413,11p15.1
ZDHHC17,Approved symbol,ZDHHC17,zinc finger DHHC-type palmitoyltransferase 17,HGNC:18412,12q21.2
ZDHHC19,Approved symbol,ZDHHC19,zinc finger DHHC-type palmitoyltransferase 19,HGNC:20713,3q29
ZDHHC23,Approved symbol,ZDHHC23,zinc finger DHHC-type palmitoyltransferase 23,HGNC:28654,3q13.31
ZDHHC24,Approved symbol,ZDHHC24,zinc finger DHHC-type containing 24,HGNC:27387,11q13.2
ZEB2,Approved symbol,ZEB2,zinc finger E-box binding homeobox 2,HGNC:14881,2q22.3
ZFAND1,Approved symbol,ZFAND1,zinc finger AN1-type containing 1,HGNC:25858,8q21.13
ZFAND4,Approved symbol,ZFAND4,zinc finger AN1-type containing 4,HGNC:23504,10q11.22
ZFAT,Approved symbol,ZFAT,zinc finger and AT-hook domain containing,HGNC:19899,8q24.22
ZFHX2,Approved symbol,ZFHX2,zinc finger homeobox 2,HGNC:20152,14q11.2
ZFHX3,Approved symbol,ZFHX3,zinc finger homeobox 3,HGNC:777,16q22.2-q22.3
ZFHX4,Approved symbol,ZFHX4,zinc finger homeobox 4,HGNC:30939,8q21.13
ZFP36L1,Approved symbol,ZFP36L1,ZFP36 ring finger protein like 1,HGNC:1107,14q24.1
ZFP36L2,Approved symbol,ZFP36L2,ZFP36 ring finger protein like 2,HGNC:1108,2p21
ZFP37,Approved symbol,ZFP37,ZFP37 zinc finger protein,HGNC:12863,9q32
ZFP41,Approved symbol,ZFP41,ZFP41 zinc finger protein,HGNC:26786,8q24.3
ZFP62,Approved symbol,ZFP62,ZFP62 zinc finger protein,HGNC:23241,5q35.3
ZFPM2,Approved symbol,ZFPM2,"zinc finger protein, FOG family member 2",HGNC:16700,8q23
ZFYVE19,Approved symbol,ZFYVE19,zinc finger FYVE-type containing 19,HGNC:20758,15q15.1
ZFYVE20,Previous symbol,RBSN,"rabenosyn, RAB effector",HGNC:20759,3p25.1
ZG16,Approved symbol,ZG16,zymogen granule protein 16,HGNC:30961,16p11.2
ZHX2,Approved symbol,ZHX2,zinc fingers and homeoboxes 2,HGNC:18513,8q24.13
ZHX3,Approved symbol,ZHX3,zinc fingers and homeoboxes 3,HGNC:15935,20q12
ZIC1,Approved symbol,ZIC1,Zic family member 1,HGNC:12872,3q24
ZIC3,Approved symbol,ZIC3,Zic family member 3,HGNC:12874,Xq26.3
ZIC4,Approved symbol,ZIC4,Zic family member 4,HGNC:20393,3q24
ZIM2,Approved symbol,ZIM2,zinc finger imprinted 2,HGNC:12875,19q13.43
ZKSCAN1,Approved symbol,ZKSCAN1,zinc finger with KRAB and SCAN domains 1,HGNC:13101,7q22.1
ZMIZ1,Approved symbol,ZMIZ1,zinc finger MIZ-type containing 1,HGNC:16493,10q22.3
ZMYND8,Approved symbol,ZMYND8,zinc finger MYND-type containing 8,HGNC:9397,20q13.12
ZNF112,Approved symbol,ZNF112,zinc finger protein 112,HGNC:12892,19q13.31
ZNF135,Approved symbol,ZNF135,zinc finger protein 135,HGNC:12919,19q13.43
ZNF160,Approved symbol,ZNF160,zinc finger protein 160,HGNC:12948,19q13.42
ZNF169,Approved symbol,ZNF169,zinc finger protein 169,HGNC:12957,9q22.32
ZNF175,Approved symbol,ZNF175,zinc finger protein 175,HGNC:12964,19q13.41
ZNF177,Approved symbol,ZNF177,zinc finger protein 177,HGNC:12966,19p13.2
ZNF182,Approved symbol,ZNF182,zinc finger protein 182,HGNC:13001,Xp11.23
ZNF184,Approved symbol,ZNF184,zinc finger protein 184,HGNC:12975,6p22.1
ZNF185,Approved symbol,ZNF185,zinc finger protein 185 with LIM domain,HGNC:12976,Xq28
ZNF211,Approved symbol,ZNF211,zinc finger protein 211,HGNC:13003,19q13.4
ZNF219,Approved symbol,ZNF219,zinc finger protein 219,HGNC:13011,14q11
ZNF227,Approved symbol,ZNF227,zinc finger protein 227,HGNC:13020,19q13.31
ZNF234,Approved symbol,ZNF234,zinc finger protein 234,HGNC:13027,19q13.31
ZNF248,Approved symbol,ZNF248,zinc finger protein 248,HGNC:13041,10p11.21
ZNF25,Approved symbol,ZNF25,zinc finger protein 25,HGNC:13043,10p11.21
ZNF251,Approved symbol,ZNF251,zinc finger protein 251,HGNC:13045,8q24.3
ZNF254,Approved symbol,ZNF254,zinc finger protein 254,HGNC:13047,19p13
ZNF257,Approved symbol,ZNF257,zinc finger protein 257,HGNC:13498,19p12
ZNF264,Approved symbol,ZNF264,zinc finger protein 264,HGNC:13057,19q13.43
ZNF292,Approved symbol,ZNF292,zinc finger protein 292,HGNC:18410,6q14.3
ZNF324,Approved symbol,ZNF324,zinc finger protein 324,HGNC:14096,19q13.43
ZNF324B,Approved symbol,ZNF324B,zinc finger protein 324B,HGNC:33107,19q13.43
ZNF331,Approved symbol,ZNF331,zinc finger protein 331,HGNC:15489,19q13.42
ZNF333,Approved symbol,ZNF333,zinc finger protein 333,HGNC:15624,19p13.12
ZNF334,Approved symbol,ZNF334,zinc finger protein 334,HGNC:15806,20q13.12
ZNF33A,Approved symbol,ZNF33A,zinc finger protein 33A,HGNC:13096,10p11.1
ZNF354A,Approved symbol,ZNF354A,zinc finger protein 354A,HGNC:11628,5q35.3
ZNF354C,Approved symbol,ZNF354C,zinc finger protein 354C,HGNC:16736,5q35.3
ZNF365,Approved symbol,ZNF365,zinc finger protein 365,HGNC:18194,10q21.2
ZNF385D,Approved symbol,ZNF385D,zinc finger protein 385D,HGNC:26191,3p24.3
ZNF417,Approved symbol,ZNF417,zinc finger protein 417,HGNC:20646,19q13.43
ZNF425,Approved symbol,ZNF425,zinc finger protein 425,HGNC:20690,7q36.1
ZNF426,Approved symbol,ZNF426,zinc finger protein 426,HGNC:20725,19p13.2
ZNF43,Approved symbol,ZNF43,zinc finger protein 43,HGNC:13109,19p12
ZNF430,Approved symbol,ZNF430,zinc finger protein 430,HGNC:20808,19p12
ZNF454,Approved symbol,ZNF454,zinc finger protein 454,HGNC:21200,5q35.3
ZNF461,Approved symbol,ZNF461,zinc finger protein 461,HGNC:21629,19q13.13
ZNF462,Approved symbol,ZNF462,zinc finger protein 462,HGNC:21684,9q31.2
ZNF470,Approved symbol,ZNF470,zinc finger protein 470,HGNC:22220,19q13.43
ZNF471,Approved symbol,ZNF471,zinc finger protein 471,HGNC:23226,19q13.43
ZNF483,Approved symbol,ZNF483,zinc finger protein 483,HGNC:23384,9q31.3
ZNF486,Approved symbol,ZNF486,zinc finger protein 486,HGNC:20807,19p12
ZNF493,Approved symbol,ZNF493,zinc finger protein 493,HGNC:23708,19p12
ZNF507,Approved symbol,ZNF507,zinc finger protein 507,HGNC:23783,19q13.11
ZNF512B,Approved symbol,ZNF512B,zinc finger protein 512B,HGNC:29212,20q13.33
ZNF513,Approved symbol,ZNF513,zinc finger protein 513,HGNC:26498,2p23.3
ZNF518B,Approved symbol,ZNF518B,zinc finger protein 518B,HGNC:29365,4p16.1
ZNF519,Approved symbol,ZNF519,zinc finger protein 519,HGNC:30574,18p11.21
ZNF521,Approved symbol,ZNF521,zinc finger protein 521,HGNC:24605,18q11.2
ZNF540,Approved symbol,ZNF540,zinc finger protein 540,HGNC:25331,19q13.13
ZNF541,Approved symbol,ZNF541,zinc finger protein 541,HGNC:25294,19q13.33
ZNF550,Approved symbol,ZNF550,zinc finger protein 550,HGNC:28643,19q13.43
ZNF558,Approved symbol,ZNF558,zinc finger protein 558,HGNC:26422,19p13.2
ZNF559,Approved symbol,ZNF559,zinc finger protein 559,HGNC:28197,19p13.2
ZNF560,Approved symbol,ZNF560,zinc finger protein 560,HGNC:26484,19p13.2
ZNF562,Approved symbol,ZNF562,zinc finger protein 562,HGNC:25950,19p13.2
ZNF566,Approved symbol,ZNF566,zinc finger protein 566,HGNC:25919,19q13.12
ZNF568,Approved symbol,ZNF568,zinc finger protein 568,HGNC:25392,19q13.12
ZNF570,Approved symbol,ZNF570,zinc finger protein 570,HGNC:26416,19q13.12
ZNF578,Approved symbol,ZNF578,zinc finger protein 578,HGNC:26449,19q13.41
ZNF580,Approved symbol,ZNF580,zinc finger protein 580,HGNC:29473,19q13.42
ZNF581,Approved symbol,ZNF581,zinc finger protein 581,HGNC:25017,19q13.42
ZNF582,Approved symbol,ZNF582,zinc finger protein 582,HGNC:26421,19q13.43
ZNF583,Approved symbol,ZNF583,zinc finger protein 583,HGNC:26427,19q13.43
ZNF585A,Approved symbol,ZNF585A,zinc finger protein 585A,HGNC:26305,19q13.12
ZNF585B,Approved symbol,ZNF585B,zinc finger protein 585B,HGNC:30948,19q13.12
ZNF587,Approved symbol,ZNF587,zinc finger protein 587,HGNC:30955,19q13.43
ZNF594,Approved symbol,ZNF594,zinc finger protein 594,HGNC:29392,17p13.2
ZNF598,Approved symbol,ZNF598,"zinc finger protein 598, E3 ubiquitin ligase",HGNC:28079,16p13.3
ZNF599,Approved symbol,ZNF599,zinc finger protein 599,HGNC:26408,19q13.11
ZNF600,Approved symbol,ZNF600,zinc finger protein 600,HGNC:30951,19q13.42
ZNF608,Approved symbol,ZNF608,zinc finger protein 608,HGNC:29238,5q23.2
ZNF619,Approved symbol,ZNF619,zinc finger protein 619,HGNC:26910,3p22.1
ZNF623,Approved symbol,ZNF623,zinc finger protein 623,HGNC:29084,8q24.3
ZNF626,Approved symbol,ZNF626,zinc finger protein 626,HGNC:30461,19p12
ZNF629,Approved symbol,ZNF629,zinc finger protein 629,HGNC:29008,16p11.2
ZNF630,Approved symbol,ZNF630,zinc finger protein 630,HGNC:28855,Xp11.23
ZNF644,Approved symbol,ZNF644,zinc finger protein 644,HGNC:29222,1p22.2
ZNF645,Previous symbol,CBLL2,Cbl proto-oncogene like 2,HGNC:26371,Xp22.11
ZNF646,Approved symbol,ZNF646,zinc finger protein 646,HGNC:29004,16p11.2
ZNF664,Approved symbol,ZNF664,zinc finger protein 664,HGNC:25406,12q24.31
ZNF668,Approved symbol,ZNF668,zinc finger protein 668,HGNC:25821,16p11.2
ZNF669,Approved symbol,ZNF669,zinc finger protein 669,HGNC:25736,1q44
ZNF674,Approved symbol,ZNF674,zinc finger protein 674,HGNC:17625,Xp11.3
ZNF675,Approved symbol,ZNF675,zinc finger protein 675,HGNC:30768,19p12
ZNF677,Approved symbol,ZNF677,zinc finger protein 677,HGNC:28730,19q13.42
ZNF679,Approved symbol,ZNF679,zinc finger protein 679,HGNC:28650,7q11.21
ZNF680,Approved symbol,ZNF680,zinc finger protein 680,HGNC:26897,7q11.21
ZNF688,Approved symbol,ZNF688,zinc finger protein 688,HGNC:30489,16p11.2
ZNF7,Approved symbol,ZNF7,zinc finger protein 7,HGNC:13139,8q24.3
ZNF703,Approved symbol,ZNF703,zinc finger protein 703,HGNC:25883,8p11.23
ZNF707,Approved symbol,ZNF707,zinc finger protein 707,HGNC:27815,8q24.3
ZNF709,Approved symbol,ZNF709,zinc finger protein 709,HGNC:20629,19p13.2
ZNF710,Approved symbol,ZNF710,zinc finger protein 710,HGNC:25352,15q26.1
ZNF717,Approved symbol,ZNF717,zinc finger protein 717,HGNC:29448,3p12.3
ZNF721,Approved symbol,ZNF721,zinc finger protein 721,HGNC:29425,4p16.3
ZNF727,Approved symbol,ZNF727,zinc finger protein 727,HGNC:22785,7q11.21
ZNF729,Approved symbol,ZNF729,zinc finger protein 729,HGNC:32464,19p12
ZNF732,Approved symbol,ZNF732,zinc finger protein 732,HGNC:37138,4p16.3
ZNF737,Approved symbol,ZNF737,zinc finger protein 737,HGNC:32468,19p12
ZNF74,Approved symbol,ZNF74,zinc finger protein 74,HGNC:13144,22q11.21
ZNF761,Approved symbol,ZNF761,zinc finger protein 761,HGNC:23179,19q13.42
ZNF768,Approved symbol,ZNF768,zinc finger protein 768,HGNC:26273,16p11.2
ZNF778,Approved symbol,ZNF778,zinc finger protein 778,HGNC:26479,16q24.3
ZNF783,Approved symbol,ZNF783,zinc finger protein 783,HGNC:27222,7q36.1
ZNF786,Approved symbol,ZNF786,zinc finger protein 786,HGNC:21806,7q36.1
ZNF787,Approved symbol,ZNF787,zinc finger protein 787,HGNC:26998,19q13.43
ZNF800,Approved symbol,ZNF800,zinc finger protein 800,HGNC:27267,7q31.33
ZNF804A,Approved symbol,ZNF804A,zinc finger protein 804A,HGNC:21711,2q32.1
ZNF804B,Approved symbol,ZNF804B,zinc finger protein 804B,HGNC:21958,7q21.13
ZNF808,Approved symbol,ZNF808,zinc finger protein 808,HGNC:33230,19q13.41
ZNF81,Approved symbol,ZNF81,zinc finger protein 81,HGNC:13156,Xp11.23
ZNF829,Approved symbol,ZNF829,zinc finger protein 829,HGNC:34032,19q13.12
ZNF839,Approved symbol,ZNF839,zinc finger protein 839,HGNC:20345,14q32.31
ZNF844,Approved symbol,ZNF844,zinc finger protein 844,HGNC:25932,19p13.2
ZNF845,Approved symbol,ZNF845,zinc finger protein 845,HGNC:25112,19q13.42
ZNF862,Approved symbol,ZNF862,zinc finger protein 862,HGNC:34519,7q36.1
ZNF891,Approved symbol,ZNF891,zinc finger protein 891,HGNC:38709,12q24.33
ZNF98,Approved symbol,ZNF98,zinc finger protein 98,HGNC:13174,19p12
ZNF99,Approved symbol,ZNF99,zinc finger protein 99,HGNC:13175,19p12
ZNFX1,Approved symbol,ZNFX1,zinc finger NFX1-type containing 1,HGNC:29271,20q13.13
ZSCAN18,Approved symbol,ZSCAN18,zinc finger and SCAN domain containing 18,HGNC:21037,19q13.43
ZSCAN2,Approved symbol,ZSCAN2,zinc finger and SCAN domain containing 2,HGNC:20994,15q25.2
ZSCAN20,Approved symbol,ZSCAN20,zinc finger and SCAN domain containing 20,HGNC:13093,1p35.1
ZSCAN25,Approved symbol,ZSCAN25,zinc finger and SCAN domain containing 25,HGNC:21961,7q22.1
ZSCAN32,Approved symbol,ZSCAN32,zinc finger and SCAN domain containing 32,HGNC:20812,16p13.3
ZSWIM1,Approved symbol,ZSWIM1,zinc finger SWIM-type containing 1,HGNC:16155,20q13.12
ZSWIM5,Approved symbol,ZSWIM5,zinc finger SWIM-type containing 5,HGNC:29299,1p34.1
ZXDB,Approved symbol,ZXDB,zinc finger X-linked duplicated B,HGNC:13199,Xp11.21
ZXDC,Approved symbol,ZXDC,ZXD family zinc finger C,HGNC:28160,3q21.3